,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
3143,GO:0043228,0.00296497869784105,0.999034778197578,21,48,non-membrane-bounded organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;KITLG;MRO;PHLDA1;PLEKHH2;CAMSAP3;SDC4;PRKACB;HMGN5;PTPN7;ACSL4;FHOD3;ESPN;MARK4;PDE4B;CGN;UNC119;WT1
3147,GO:0043232,0.00296497869784105,0.999034778197578,21,48,intracellular non-membrane-bounded organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;KITLG;MRO;PHLDA1;PLEKHH2;CAMSAP3;SDC4;PRKACB;HMGN5;PTPN7;ACSL4;FHOD3;ESPN;MARK4;PDE4B;CGN;UNC119;WT1
4083,GO:0051017,0.00420384177028739,0.999796074726242,5,6,actin filament bundle assembly,BP,PIK3R1;ITGB5;SDC4;ESPN;CTGF
4754,GO:0061572,0.00420384177028739,0.999796074726242,5,6,actin filament bundle organization,BP,PIK3R1;ITGB5;SDC4;ESPN;CTGF
687,GO:0005813,0.00870005463517926,0.99922848016626,5,7,centrosome,CC,CAMSAP3;PRKACB;MARK4;PDE4B;UNC119
1002,GO:0007266,0.0105046458682262,1,3,3,Rho protein signal transduction,BP,RHOB;RHOJ;ITGA3
655,GO:0005730,0.0141461818844879,0.999182842459489,4,5,nucleolus,CC,CDKN1A;MRO;PHLDA1;WT1
1001,GO:0007265,0.0146690568310064,0.997989469550337,5,9,Ras protein signal transduction,BP,CDKN1A;RHOB;KITLG;RHOJ;ITGA3
1959,GO:0030038,0.0147450165139565,0.99913633838456,4,5,contractile actin filament bundle assembly,BP,PIK3R1;ITGB5;SDC4;CTGF
3117,GO:0043149,0.0147450165139565,0.99913633838456,4,5,stress fiber assembly,BP,PIK3R1;ITGB5;SDC4;CTGF
931,GO:0007015,0.0157001591571802,0.996855411935548,8,13,actin filament organization,BP,ACTN2;PLEKHH2;PIK3R1;ITGB5;SDC4;FHOD3;ESPN;CTGF
12,GO:0000086,0.0160548964313353,1,3,3,G2/M transition of mitotic cell cycle,BP,CDKN1A;PHLDA1;FOXO4
3409,GO:0044839,0.0160548964313353,1,3,3,cell cycle G2/M phase transition,BP,CDKN1A;PHLDA1;FOXO4
946,GO:0007050,0.0217806211376491,0.997204924713648,4,8,cell cycle arrest,BP,CDKN1A;GAS6;HMGN5;FOXO4
2158,GO:0031032,0.0222237704893392,0.996154791410774,6,10,actomyosin structure organization,BP,ACTN2;PIK3R1;ITGB5;SDC4;FHOD3;CTGF
4913,GO:0071156,0.0284965426327953,0.997641434464448,3,5,regulation of cell cycle arrest,BP,CDKN1A;HMGN5;FOXO4
1097,GO:0008092,0.0309811254986299,0.989290074968478,12,26,cytoskeletal protein binding,MF,ACTN2;MYO7A;REEP1;PLEKHH2;CAMSAP3;FHOD3;RAB39B;ESPN;MARK4;DAAM2;PDE4B;CGN
2574,GO:0033158,0.0350011381116786,1,2,2,regulation of protein import into nucleus, translocation,BP,CDKN1A;GAS6
590,GO:0005178,0.0369116728116207,0.994045629862305,5,8,integrin binding,MF,ACTN2;MFGE8;LAMA5;CTGF;ITGA3
2170,GO:0031091,0.0370467925994271,0.997607468767517,3,4,platelet alpha granule,CC,ACTN2;GAS6;SERPINA5
963,GO:0007160,0.0371474353143714,0.991005753455157,7,13,cell-matrix adhesion,BP,ACTN2;PIK3R1;LAMA5;ITGB5;SDC4;CTGF;ITGA3
207,GO:0001968,0.0375180467628534,0.997563730793064,3,4,fibronectin binding,MF,SDC4;CTGF;ITGA3
688,GO:0005815,0.0378962686103995,0.993176815019745,5,9,microtubule organizing center,CC,CAMSAP3;PRKACB;MARK4;PDE4B;UNC119
4371,GO:0060041,0.0399381348494218,1,2,2,retina development in camera-type eye,BP,RHOJ;DLL1
1953,GO:0030029,0.0399478477785221,0.984621422191899,13,31,actin filament-based process,BP,ACTN2;MYO7A;RHOJ;NUAK2;PLEKHH2;PIK3R1;ITGB5;SDC4;FHOD3;ESPN;DAAM2;PDE4B;CTGF
2000,GO:0030198,0.0400703563856714,0.988207368006828,9,17,extracellular matrix organization,BP,LAMA1;LAMA5;GAS6;ITGB5;ITGB8;CRISPLD2;CTGF;ITGA3;WT1
3099,GO:0043062,0.0400703563856714,0.988207368006828,9,17,extracellular structure organization,BP,LAMA1;LAMA5;GAS6;ITGB5;ITGB8;CRISPLD2;CTGF;ITGA3;WT1
2665,GO:0034605,0.0403637669669048,1,2,2,cellular response to heat,BP,CDKN1A;SLC52A3
1552,GO:0015631,0.0417321880367823,0.994880527494202,4,6,tubulin binding,MF,REEP1;CAMSAP3;MARK4;PDE4B
3419,GO:0045023,0.0452281925392619,1,2,2,G0 to G1 transition,BP,FOXO4;CTGF
4829,GO:0070316,0.0452281925392619,1,2,2,regulation of G0 to G1 transition,BP,FOXO4;CTGF
3451,GO:0045171,0.0458284227183568,1,2,2,intercellular bridge,CC,PRKACB;UNC119
2649,GO:0034349,0.0479511845492166,1,2,2,glial cell apoptotic process,BP,GAS6;DLL1
2650,GO:0034350,0.0479511845492166,1,2,2,regulation of glial cell apoptotic process,BP,GAS6;DLL1
2651,GO:0034351,0.0479511845492166,1,2,2,negative regulation of glial cell apoptotic process,BP,GAS6;DLL1
1591,GO:0016043,0.0487307589241924,0.975370885031007,35,121,cellular component organization,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;REEP1;PRND;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;ESPN;MARK4;DAAM2;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
5034,GO:0071840,0.0487307589241924,0.975370885031007,35,121,cellular component organization or biogenesis,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;REEP1;PRND;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;ESPN;MARK4;DAAM2;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
2343,GO:0032231,0.0502865287336429,0.996284721490258,3,4,regulation of actin filament bundle assembly,BP,PIK3R1;SDC4;CTGF
4224,GO:0051492,0.0502865287336429,0.996284721490258,3,4,regulation of stress fiber assembly,BP,PIK3R1;SDC4;CTGF
658,GO:0005740,0.050537439356805,0.992165296057812,4,7,mitochondrial envelope,CC,HMGCS2;REEP1;SLC25A53;ACSL4
2296,GO:0031966,0.050537439356805,0.992165296057812,4,7,mitochondrial membrane,CC,HMGCS2;REEP1;SLC25A53;ACSL4
1958,GO:0030036,0.0506046540367385,0.981140133152885,11,26,actin cytoskeleton organization,BP,ACTN2;RHOJ;NUAK2;PLEKHH2;PIK3R1;ITGB5;SDC4;FHOD3;ESPN;DAAM2;CTGF
3557,GO:0045786,0.0519366358652014,0.985794875832738,6,16,negative regulation of cell cycle,BP,CDKN1A;RHOB;GAS6;PRKACB;HMGN5;FOXO4
5290,GO:0090136,0.0547187486836824,1,2,2,epithelial cell-cell adhesion,BP,CAMSAP3;ITGB5
1218,GO:0009314,0.0556675398713058,0.990177245861322,4,8,response to radiation,BP,CDKN1A;RHOB;PIK3R1;UNC119
2175,GO:0031100,0.0573251994056978,0.995506353977548,3,4,animal organ regeneration,BP,CDKN1A;GAS6;CLDN1
3020,GO:0042493,0.0593460910184226,0.986266092912437,5,11,response to drug,BP,CDKN1A;GAS6;PDE4B;CLDN1;ITGA3
3415,GO:0044877,0.059468458935279,0.978016753127966,10,24,macromolecular complex binding,MF,ACTN2;MYO7A;CDKN1A;MFGE8;PIK3R1;LAMA5;HMGN5;ESPN;CTGF;ITGA3
5600,GO:1901136,0.059518012881891,1,2,2,carbohydrate derivative catabolic process,BP,SDC4;PDE4B
1949,GO:0030016,0.0600621430764777,0.990086150944219,4,7,myofibril,CC,ACTN2;SDC4;FHOD3;PDE4B
4114,GO:0051130,0.0618647125119568,0.976130561985134,10,28,positive regulation of cellular component organization,BP,ACTN2;MFGE8;PIK3R1;GAS6;SDC4;ESPN;DLL1;CLDN1;CTGF;ITGA3
215,GO:0002020,0.0621003126964357,1,2,2,protease binding,MF,SERPINA5;ITGA3
5493,GO:0098858,0.0624702746680921,0.986855532029394,5,9,actin-based cell projection,CC,ACTN2;MYO7A;KITLG;ESPN;ITGA3
930,GO:0007010,0.0626847075511251,0.972552758211928,14,37,cytoskeleton organization,BP,ACTN2;RHOJ;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;LAMA5;ITGB5;SDC4;FHOD3;ESPN;MARK4;DAAM2;CTGF
143,GO:0001764,0.0649471447946064,1,2,2,neuron migration,BP,GAS6;ITGA3
547,GO:0004866,0.0663001797961582,0.996235770195395,2,3,endopeptidase inhibitor activity,MF,GAS6;SERPINA5
2048,GO:0030414,0.0663001797961582,0.996235770195395,2,3,peptidase inhibitor activity,MF,GAS6;SERPINA5
4684,GO:0061134,0.0663001797961582,0.996235770195395,2,3,peptidase regulator activity,MF,GAS6;SERPINA5
4685,GO:0061135,0.0663001797961582,0.996235770195395,2,3,endopeptidase regulator activity,MF,GAS6;SERPINA5
4315,GO:0052548,0.0675650553719652,0.990572701643021,3,6,regulation of endopeptidase activity,BP,GAS6;SERPINA5;CTGF
1167,GO:0008630,0.0676875625218567,1,2,2,intrinsic apoptotic signaling pathway in response to DNA damage,BP,CDKN1A;PIK3R1
2674,GO:0034644,0.0676875625218567,1,2,2,cellular response to UV,BP,CDKN1A;PIK3R1
684,GO:0005801,0.0698311315682525,1,2,2,cis-Golgi network,CC,PIK3R1;CTGF
1052,GO:0007568,0.0698509076344553,0.985777237751784,4,9,aging,BP,CDKN1A;FOXO4;CLDN1;CTGF
3274,GO:0043954,0.0715871018294197,1,2,2,cellular component maintenance,BP,CAMSAP3;ITGA3
2453,GO:0032640,0.0723524483375567,1,2,2,tumor necrosis factor production,BP,PIK3R1;GAS6
2465,GO:0032680,0.0723524483375567,1,2,2,regulation of tumor necrosis factor production,BP,PIK3R1;GAS6
4396,GO:0060090,0.0723524483375567,1,2,2,binding, bridging,MF,PIK3R1;GAS6
5017,GO:0071706,0.0723524483375567,1,2,2,tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
5853,GO:1903555,0.0723524483375567,1,2,2,regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1;GAS6
1551,GO:0015630,0.0725310417393356,0.982121391086982,5,11,microtubule cytoskeleton,CC,CAMSAP3;PRKACB;MARK4;PDE4B;UNC119
4875,GO:0070663,0.075611958278143,0.988910946349386,3,6,regulation of leukocyte proliferation,BP,CDKN1A;KITLG;SDC4
150,GO:0001786,0.0761146291130669,0.995305140392562,2,3,phosphatidylserine binding,MF,MFGE8;GAS6
1146,GO:0008380,0.0794907895270578,1,2,2,RNA splicing,BP,PIK3R1;WT1
4225,GO:0051493,0.0797266179336885,0.972385984508563,8,18,regulation of cytoskeleton organization,BP,ACTN2;PLEKHH2;CAMSAP3;PIK3R1;SDC4;FHOD3;ESPN;CTGF
1014,GO:0007338,0.0810501693110851,0.994806377023004,2,3,single fertilization,BP,MFGE8;SERPINA5
5212,GO:0072583,0.0814761656885289,0.99476237538858,2,3,clathrin-dependent endocytosis,BP,DLL1;UNC119
5417,GO:0097458,0.0815007248476215,0.967162937565699,10,26,neuron part,CC,ACTN2;MYO7A;NRTN;ACSL4;RAB39B;ESPN;MARK4;TMEM163;PDE4B;ITGA3
1974,GO:0030100,0.0834087179051542,0.981874872207152,4,9,regulation of endocytosis,BP,MFGE8;GAS6;DLL1;UNC119
4207,GO:0051385,0.0840531257081832,0.994492991490378,2,3,response to mineralocorticoid,BP,CDKN1A;CTGF
9,GO:0000077,0.0847350734406627,0.994420785235609,2,3,DNA damage checkpoint,BP,CDKN1A;FOXO4
2246,GO:0031570,0.0847350734406627,0.994420785235609,2,3,DNA integrity checkpoint,BP,CDKN1A;FOXO4
3398,GO:0044773,0.0847350734406627,0.994420785235609,2,3,mitotic DNA damage checkpoint,BP,CDKN1A;FOXO4
3399,GO:0044774,0.0847350734406627,0.994420785235609,2,3,mitotic DNA integrity checkpoint,BP,CDKN1A;FOXO4
4915,GO:0071158,0.0847350734406627,0.994420785235609,2,3,positive regulation of cell cycle arrest,BP,CDKN1A;FOXO4
5685,GO:1901988,0.0847350734406627,0.994420785235609,2,3,negative regulation of cell cycle phase transition,BP,CDKN1A;FOXO4
5687,GO:1901991,0.0847350734406627,0.994420785235609,2,3,negative regulation of mitotic cell cycle phase transition,BP,CDKN1A;FOXO4
691,GO:0005856,0.0866655493853255,0.959747066636583,14,37,cytoskeleton,CC,ACTN2;MYO7A;FRMPD1;KITLG;PLEKHH2;CAMSAP3;PRKACB;PTPN7;FHOD3;ESPN;MARK4;PDE4B;CGN;UNC119
3090,GO:0043015,0.0871742453149511,1,2,2,gamma-tubulin binding,MF,MARK4;PDE4B
4390,GO:0060076,0.0876436871175171,1,2,2,excitatory synapse,CC,PDE4B;ITGA3
992,GO:0007229,0.0886718017617769,0.979046624045359,5,9,integrin-mediated signaling pathway,BP,LAMA5;ITGB5;ITGB8;CTGF;ITGA3
975,GO:0007179,0.0889208242921013,0.981356016254229,4,8,transforming growth factor beta receptor signaling pathway,BP,DKK3;ITGB5;CGN;ITGA3
4112,GO:0051128,0.0890398887376971,0.955103444174318,17,53,regulation of cellular component organization,BP,ACTN2;CDKN1A;RHOJ;PLEKHH2;CAMSAP3;MFGE8;PIK3R1;GAS6;SDC4;FHOD3;ESPN;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
3350,GO:0044429,0.0894473264232847,0.981203392564057,4,8,mitochondrial part,CC,HMGCS2;REEP1;SLC25A53;ACSL4
1221,GO:0009416,0.0902538369802863,0.987655153232187,3,5,response to light stimulus,BP,CDKN1A;PIK3R1;UNC119
2952,GO:0042113,0.0905435288814093,0.987596954877237,3,5,B cell activation,BP,CDKN1A;PIK3R1;DLL1
138,GO:0001755,0.0930368792950532,0.987092080859638,3,5,neural crest cell migration,BP,NRTN;KITLG;LAMA5
3993,GO:0050764,0.0946312187956854,0.993330074553323,2,3,regulation of phagocytosis,BP,MFGE8;GAS6
3994,GO:0050766,0.0946312187956854,0.993330074553323,2,3,positive regulation of phagocytosis,BP,MFGE8;GAS6
1855,GO:0021675,0.0976822260524988,1,1,1,nerve development,BP,NRTN
4314,GO:0052547,0.0985908343331574,0.982249515382377,3,7,regulation of peptidase activity,BP,GAS6;SERPINA5;CTGF
5050,GO:0071897,0.0987662507735974,0.99285076956928,2,3,DNA biosynthetic process,BP,CDKN1A;CTGF
5773,GO:1902903,0.100918480057395,0.969928672604547,6,12,regulation of supramolecular fiber organization,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;FHOD3;CTGF
6,GO:0000060,0.10179500084905,0.992490966080784,2,3,protein import into nucleus, translocation,BP,CDKN1A;GAS6
1302,GO:0010212,0.105420848671674,0.989055630221182,2,4,response to ionizing radiation,BP,CDKN1A;RHOB
4984,GO:0071479,0.105420848671674,0.989055630221182,2,4,cellular response to ionizing radiation,BP,CDKN1A;RHOB
847,GO:0006720,0.107641093427278,0.99177571653349,2,3,isoprenoid metabolic process,BP,HMGCS2;SDC4
1083,GO:0008017,0.108344195938891,0.983839411095308,3,5,microtubule binding,MF,REEP1;CAMSAP3;MARK4
808,GO:0006508,0.108868542761463,0.963309302875292,6,16,proteolysis,BP,GAS6;PRKACB;SERPINA5;DHH;FOXO4;CTGF
4983,GO:0071478,0.11052408917251,0.9807149306603,3,6,cellular response to radiation,BP,CDKN1A;RHOB;PIK3R1
1219,GO:0009408,0.110659717238498,0.991395743077066,2,3,response to heat,BP,CDKN1A;SLC52A3
4558,GO:0060627,0.111724500998969,0.962053320760423,6,16,regulation of vesicle-mediated transport,BP,ACTN2;MFGE8;GAS6;SDC4;DLL1;UNC119
2252,GO:0031589,0.113049618116037,0.956498123393654,8,19,cell-substrate adhesion,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;CTGF;ITGA3
3168,GO:0043277,0.113665914199375,0.991010152273861,2,3,apoptotic cell clearance,BP,MFGE8;GAS6
5775,GO:1902905,0.11475253553597,0.979619080720976,3,6,positive regulation of supramolecular fiber organization,BP,ACTN2;SDC4;CTGF
1678,GO:0016604,0.115066652632656,0.979536815606327,3,6,nuclear body,CC,CDKN1A;FOXO4;WT1
2398,GO:0032403,0.115559636853676,0.95195922165327,9,23,protein complex binding,MF,ACTN2;MYO7A;CDKN1A;MFGE8;PIK3R1;LAMA5;ESPN;CTGF;ITGA3
1773,GO:0019209,0.116234947134171,0.99067497049812,2,3,kinase activator activity,MF,CDKN1A;GAS6
2028,GO:0030295,0.116234947134171,0.99067497049812,2,3,protein kinase activator activity,MF,CDKN1A;GAS6
543,GO:0004857,0.116729471323747,0.979099367013186,3,6,enzyme inhibitor activity,MF,CDKN1A;GAS6;SERPINA5
660,GO:0005743,0.117316992401325,0.990532236770907,2,3,mitochondrial inner membrane,CC,HMGCS2;SLC25A53
1819,GO:0019866,0.117316992401325,0.990532236770907,2,3,organelle inner membrane,CC,HMGCS2;SLC25A53
1047,GO:0007530,0.122617107331062,0.989819773255906,2,3,sex determination,BP,DHH;WT1
953,GO:0007093,0.12339592453591,0.985876148112822,2,4,mitotic cell cycle checkpoint,BP,CDKN1A;FOXO4
2344,GO:0032233,0.124104805703309,0.989615821591158,2,3,positive regulation of actin filament bundle assembly,BP,SDC4;CTGF
4228,GO:0051496,0.124104805703309,0.989615821591158,2,3,positive regulation of stress fiber assembly,BP,SDC4;CTGF
3141,GO:0043226,0.126918042285239,0.93347297173011,45,174,organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;RHOB;KITLG;MRO;PHLDA1;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;ESPN;GPSM1;MARK4;DAAM2;TMEM163;DLL1;PDE4B;CGN;CTGF;UNC119;ITGA3;WT1
3079,GO:0042953,0.129957655995714,1,1,1,lipoprotein transport,BP,UNC119
3414,GO:0044872,0.129957655995714,1,1,1,lipoprotein localization,BP,UNC119
3561,GO:0045806,0.129957655995714,1,1,1,negative regulation of endocytosis,BP,UNC119
3785,GO:0048261,0.129957655995714,1,1,1,negative regulation of receptor-mediated endocytosis,BP,UNC119
4155,GO:0051233,0.129957655995714,1,1,1,spindle midzone,CC,UNC119
5213,GO:0072584,0.129957655995714,1,1,1,caveolin-mediated endocytosis,BP,UNC119
5559,GO:1900186,0.129957655995714,1,1,1,negative regulation of clathrin-dependent endocytosis,BP,UNC119
6102,GO:2000369,0.129957655995714,1,1,1,regulation of clathrin-dependent endocytosis,BP,UNC119
6208,GO:2001286,0.129957655995714,1,1,1,regulation of caveolin-mediated endocytosis,BP,UNC119
6209,GO:2001287,0.129957655995714,1,1,1,negative regulation of caveolin-mediated endocytosis,BP,UNC119
6062,GO:2000107,0.130618388289411,0.988702431778476,2,3,negative regulation of leukocyte apoptotic process,BP,KITLG;GAS6
1720,GO:0017015,0.133838803967426,0.988238573021576,2,3,regulation of transforming growth factor beta receptor signaling pathway,BP,DKK3;ITGA3
5887,GO:1903844,0.133838803967426,0.988238573021576,2,3,regulation of cellular response to transforming growth factor beta stimulus,BP,DKK3;ITGA3
37,GO:0000287,0.13469056707657,0.988114532680348,2,3,magnesium ion binding,MF,NUAK2;PRKACB
991,GO:0007224,0.134897219602748,0.983667293089486,2,4,smoothened signaling pathway,BP,PRKACB;DHH
3562,GO:0045807,0.136483847812446,0.973652816890099,3,6,positive regulation of endocytosis,BP,MFGE8;GAS6;DLL1
4098,GO:0051056,0.136901927420493,0.963970884158227,4,9,regulation of small GTPase mediated signal transduction,BP,RHOB;KITLG;RHOJ;ITGA3
1113,GO:0008201,0.137165877587085,0.971189041418935,3,7,heparin binding,MF,SERPINA5;CRISPLD2;CTGF
1471,GO:0014032,0.137562695026096,0.973342280443156,3,6,neural crest cell development,BP,NRTN;KITLG;LAMA5
1472,GO:0014033,0.137562695026096,0.973342280443156,3,6,neural crest cell differentiation,BP,NRTN;KITLG;LAMA5
4024,GO:0050821,0.138251747553042,0.987589792166492,2,3,protein stabilization,BP,CDKN1A;PIK3R1
1319,GO:0010466,0.140849109564649,0.982471347770251,2,4,negative regulation of peptidase activity,BP,GAS6;SERPINA5
1448,GO:0010951,0.140849109564649,0.982471347770251,2,4,negative regulation of endopeptidase activity,BP,GAS6;SERPINA5
3580,GO:0045861,0.140849109564649,0.982471347770251,2,4,negative regulation of proteolysis,BP,GAS6;SERPINA5
634,GO:0005543,0.1413151137936,0.962328752945991,4,9,phospholipid binding,MF,ACTN2;MFGE8;GAS6;SERPINA5
1138,GO:0008333,0.141460175768441,0.987108558556907,2,3,endosome to lysosome transport,BP,GPRASP1;RHOB
2171,GO:0031093,0.142677825838438,0.986923822043604,2,3,platelet alpha granule lumen,CC,ACTN2;GAS6
4227,GO:0051495,0.143917018908436,0.969063616754307,3,7,positive regulation of cytoskeleton organization,BP,ACTN2;SDC4;CTGF
2537,GO:0032970,0.144018691673835,0.945079227498445,7,16,regulation of actin filament-based process,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;FHOD3;PDE4B;CTGF
1133,GO:0008289,0.144611029687875,0.952411578327283,5,13,lipid binding,MF,ACTN2;MFGE8;GAS6;SERPINA5;UNC119
5673,GO:1901888,0.144834715270153,0.986593752526954,2,3,regulation of cell junction assembly,BP,SDC4;CLDN1
5674,GO:1901890,0.144834715270153,0.986593752526954,2,3,positive regulation of cell junction assembly,BP,SDC4;CLDN1
786,GO:0006396,0.145506881801684,0.986490149941915,2,3,RNA processing,BP,PIK3R1;WT1
944,GO:0007045,0.147561386148598,0.974352909243049,3,5,cell-substrate adherens junction assembly,BP,ACTN2;LAMA5;SDC4
2646,GO:0034333,0.147561386148598,0.974352909243049,3,5,adherens junction assembly,BP,ACTN2;LAMA5;SDC4
3757,GO:0048041,0.147561386148598,0.974352909243049,3,5,focal adhesion assembly,BP,ACTN2;LAMA5;SDC4
3362,GO:0044446,0.148420682296464,0.911329765338765,29,106,intracellular organelle part,CC,ACTN2;MYO7A;CDKN1A;HMGCS2;REEP1;RHOB;MRO;PHLDA1;PLEKHH2;CAMSAP3;PIK3R1;SLC25A53;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;ACSL4;CRISPLD2;FHOD3;FOXO4;ESPN;GPSM1;MARK4;TMEM163;PDE4B;CGN;UNC119;WT1
1085,GO:0008022,0.149996509221852,0.985789128805342,2,3,protein C-terminus binding,MF,LAMA1;CTGF
2297,GO:0031967,0.151224743977816,0.956880025706832,4,10,organelle envelope,CC,HMGCS2;REEP1;SLC25A53;ACSL4
2301,GO:0031975,0.151224743977816,0.956880025706832,4,10,envelope,CC,HMGCS2;REEP1;SLC25A53;ACSL4
1976,GO:0030104,0.15185574313563,0.985494227727901,2,3,water homeostasis,BP,PRKACB;CLDN1
4052,GO:0050891,0.15185574313563,0.985494227727901,2,3,multicellular organismal water homeostasis,BP,PRKACB;CLDN1
1220,GO:0009411,0.152571336996059,0.985380006990522,2,3,response to UV,BP,CDKN1A;PIK3R1
3351,GO:0044430,0.152840689270776,0.926198920276195,11,29,cytoskeletal part,CC,ACTN2;MYO7A;PLEKHH2;CAMSAP3;PRKACB;FHOD3;ESPN;MARK4;PDE4B;CGN;UNC119
3172,GO:0043292,0.152990995472147,0.957869430254046,4,9,contractile fiber,CC,ACTN2;SDC4;FHOD3;PDE4B
3364,GO:0044449,0.152990995472147,0.957869430254046,4,9,contractile fiber part,CC,ACTN2;SDC4;FHOD3;PDE4B
2304,GO:0031983,0.15328197791943,0.968666733020895,3,6,vesicle lumen,CC,ACTN2;GAS6;CRISPLD2
2701,GO:0034774,0.15328197791943,0.968666733020895,3,6,secretory granule lumen,CC,ACTN2;GAS6;CRISPLD2
4419,GO:0060205,0.15328197791943,0.968666733020895,3,6,cytoplasmic vesicle lumen,CC,ACTN2;GAS6;CRISPLD2
4877,GO:0070665,0.155244924683832,0.979430656004764,2,4,positive regulation of leukocyte proliferation,BP,CDKN1A;KITLG
666,GO:0005769,0.155413406805376,0.963454575036165,3,8,early endosome,CC,RHOB;RIN3;TMEM163
1771,GO:0019207,0.155565055249318,0.967964354303936,3,6,kinase regulator activity,MF,CDKN1A;PIK3R1;GAS6
639,GO:0005576,0.15740544476807,0.905509951079409,26,96,extracellular region,CC,LAMA1;ACTN2;FRMPD1;NRTN;DKK3;RHOB;KITLG;PRND;RHOJ;MFGE8;CLDN11;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DHH;DAAM2;DLL1;CTGF;UNC119;ITGA3
5415,GO:0097435,0.157423338410478,0.932884090670454,8,20,supramolecular fiber organization,BP,ACTN2;PLEKHH2;PIK3R1;ITGB5;SDC4;FHOD3;ESPN;CTGF
2026,GO:0030285,0.157555491038058,1,1,1,integral component of synaptic vesicle membrane,CC,TMEM163
2206,GO:0031300,0.157555491038058,1,1,1,intrinsic component of organelle membrane,CC,TMEM163
2207,GO:0031301,0.157555491038058,1,1,1,integral component of organelle membrane,CC,TMEM163
2280,GO:0031901,0.157555491038058,1,1,1,early endosome membrane,CC,TMEM163
5448,GO:0098563,0.157555491038058,1,1,1,intrinsic component of synaptic vesicle membrane,CC,TMEM163
5632,GO:1901565,0.15780302877811,0.984532827789064,2,3,organonitrogen compound catabolic process,BP,SDC4;PDE4B
4709,GO:0061298,0.158263483322295,1,1,1,retina vasculature development in camera-type eye,BP,RHOJ
4710,GO:0061299,0.158263483322295,1,1,1,retina vasculature morphogenesis in camera-type eye,BP,RHOJ
898,GO:0006910,0.158723044076973,1,1,1,phagocytosis, recognition,BP,MFGE8
899,GO:0006911,0.158723044076973,1,1,1,phagocytosis, engulfment,BP,MFGE8
1148,GO:0008429,0.158723044076973,1,1,1,phosphatidylethanolamine binding,MF,MFGE8
6111,GO:2000425,0.158723044076973,1,1,1,regulation of apoptotic cell clearance,BP,MFGE8
6112,GO:2000427,0.158723044076973,1,1,1,positive regulation of apoptotic cell clearance,BP,MFGE8
894,GO:0006898,0.159127525121467,0.978574832750225,2,4,receptor-mediated endocytosis,BP,DLL1;UNC119
574,GO:0005113,0.16002825263626,1,1,1,patched binding,MF,DHH
2014,GO:0030238,0.16002825263626,1,1,1,male sex determination,BP,DHH
2588,GO:0033327,0.16002825263626,1,1,1,Leydig cell differentiation,BP,DHH
1950,GO:0030017,0.16279287976883,0.965702137013961,3,6,sarcomere,CC,ACTN2;FHOD3;PDE4B
1951,GO:0030018,0.16279287976883,0.965702137013961,3,6,Z disc,CC,ACTN2;FHOD3;PDE4B
2271,GO:0031674,0.16279287976883,0.965702137013961,3,6,I band,CC,ACTN2;FHOD3;PDE4B
2528,GO:0032944,0.163334019515541,0.97449015105203,2,5,regulation of mononuclear cell proliferation,BP,CDKN1A;SDC4
3961,GO:0050670,0.163334019515541,0.97449015105203,2,5,regulation of lymphocyte proliferation,BP,CDKN1A;SDC4
5649,GO:1901654,0.165544147217572,0.961888562713274,3,7,response to ketone,BP,CDKN1A;GAS6;CLDN1
4039,GO:0050867,0.166216543951465,0.950733674720093,4,10,positive regulation of cell activation,BP,CDKN1A;PIK3R1;GAS6;CTGF
3171,GO:0043281,0.16686700629016,0.976823682876702,2,4,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GAS6;CTGF
6066,GO:2000116,0.16686700629016,0.976823682876702,2,4,regulation of cysteine-type endopeptidase activity,BP,GAS6;CTGF
4028,GO:0050839,0.167046649429295,0.937947756734931,6,14,cell adhesion molecule binding,MF,ACTN2;MFGE8;LAMA5;CGN;CTGF;ITGA3
1680,GO:0016607,0.167316004283941,0.976720246846761,2,4,nuclear speck,CC,FOXO4;WT1
5744,GO:1902589,0.167350340986633,0.911595648688218,13,39,single-organism organelle organization,BP,ACTN2;RHOJ;NUAK2;PLEKHH2;PIK3R1;LAMA5;ITGB5;SDC4;FHOD3;ESPN;MARK4;DAAM2;CTGF
1446,GO:0010948,0.170292928014288,0.958128624446215,3,8,negative regulation of cell cycle process,BP,CDKN1A;HMGN5;FOXO4
1937,GO:0022898,0.171265809826246,0.982254716889603,2,3,regulation of transmembrane transporter activity,BP,ACTN2;PDE4B
2399,GO:0032409,0.171265809826246,0.982254716889603,2,3,regulation of transporter activity,BP,ACTN2;PDE4B
2402,GO:0032412,0.171265809826246,0.982254716889603,2,3,regulation of ion transmembrane transporter activity,BP,ACTN2;PDE4B
6203,GO:2001257,0.171265809826246,0.982254716889603,2,3,regulation of cation channel activity,BP,ACTN2;PDE4B
1992,GO:0030175,0.173054179626707,0.962390294945802,3,6,filopodium,CC,ACTN2;KITLG;ITGA3
5699,GO:1902107,0.173286922256922,0.981900505075599,2,3,positive regulation of leukocyte differentiation,BP,KITLG;GAS6
5867,GO:1903708,0.173286922256922,0.981900505075599,2,3,positive regulation of hemopoiesis,BP,KITLG;GAS6
2239,GO:0031491,0.173719154367228,1,1,1,nucleosome binding,MF,HMGN5
2240,GO:0031492,0.173719154367228,1,1,1,nucleosomal DNA binding,MF,HMGN5
1008,GO:0007275,0.174038975055738,0.894066605400234,35,129,multicellular organism development,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;DHH;FOXO4;GPSM1;MARK4;DAAM2;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
1987,GO:0030162,0.174668195870412,0.945601668941736,4,11,regulation of proteolysis,BP,GAS6;PRKACB;SERPINA5;CTGF
3328,GO:0044325,0.174734327496763,0.981644877316782,2,3,ion channel binding,MF,ACTN2;PDE4B
496,GO:0003779,0.17529913088904,0.929024762652897,7,16,actin binding,MF,ACTN2;MYO7A;PLEKHH2;FHOD3;ESPN;DAAM2;CGN
4037,GO:0050865,0.175624226735395,0.936854982598469,5,14,regulation of cell activation,BP,CDKN1A;PIK3R1;GAS6;SDC4;CTGF
3684,GO:0046718,0.176860700407341,0.961132013105424,3,6,viral entry into host cell,BP,GAS6;ITGB5;CLDN1
227,GO:0002066,0.17771247310762,0.960848256701854,3,6,columnar/cuboidal epithelial cell development,BP,MYO7A;CDKN1A;DLL1
5655,GO:1901681,0.178017511641702,0.955258667856732,3,8,sulfur compound binding,MF,SERPINA5;CRISPLD2;CTGF
641,GO:0005604,0.178590936292756,1,2,2,basement membrane,CC,LAMA1;LAMA5
642,GO:0005605,0.178590936292756,1,2,2,basal lamina,CC,LAMA1;LAMA5
3158,GO:0043256,0.178590936292756,1,2,2,laminin complex,CC,LAMA1;LAMA5
3343,GO:0044420,0.178590936292756,1,2,2,extracellular matrix component,CC,LAMA1;LAMA5
41,GO:0000307,0.178725793413606,1,1,1,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A
230,GO:0002069,0.178725793413606,1,1,1,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
231,GO:0002070,0.178725793413606,1,1,1,epithelial cell maturation,BP,CDKN1A
545,GO:0004861,0.178725793413606,1,1,1,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A
923,GO:0006978,0.178725793413606,1,1,1,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A
1299,GO:0010165,0.178725793413606,1,1,1,response to X-ray,BP,CDKN1A
1303,GO:0010224,0.178725793413606,1,1,1,response to UV-B,BP,CDKN1A
1667,GO:0016538,0.178725793413606,1,1,1,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A
1835,GO:0019912,0.178725793413606,1,1,1,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
2042,GO:0030332,0.178725793413606,1,1,1,cyclin binding,MF,CDKN1A
2630,GO:0034198,0.178725793413606,1,1,1,cellular response to amino acid starvation,BP,CDKN1A
2868,GO:0036296,0.178725793413606,1,1,1,response to increased oxygen levels,BP,CDKN1A
3071,GO:0042771,0.178725793413606,1,1,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CDKN1A
3072,GO:0042772,0.178725793413606,1,1,1,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A
3540,GO:0045736,0.178725793413606,1,1,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
3679,GO:0046685,0.178725793413606,1,1,1,response to arsenic-containing substance,BP,CDKN1A
4210,GO:0051412,0.178725793413606,1,1,1,response to corticosterone,BP,CDKN1A
4353,GO:0055093,0.178725793413606,1,1,1,response to hyperoxia,BP,CDKN1A
4541,GO:0060574,0.178725793413606,1,1,1,intestinal epithelial cell maturation,BP,CDKN1A
4542,GO:0060575,0.178725793413606,1,1,1,intestinal epithelial cell differentiation,BP,CDKN1A
4543,GO:0060576,0.178725793413606,1,1,1,intestinal epithelial cell development,BP,CDKN1A
4863,GO:0070557,0.178725793413606,1,1,1,PCNA-p21 complex,CC,CDKN1A
4987,GO:0071493,0.178725793413606,1,1,1,cellular response to UV-B,BP,CDKN1A
5338,GO:0090399,0.178725793413606,1,1,1,replicative senescence,BP,CDKN1A
5339,GO:0090400,0.178725793413606,1,1,1,stress-induced premature senescence,BP,CDKN1A
5901,GO:1904030,0.178725793413606,1,1,1,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
3945,GO:0048864,0.179495712999818,0.956968583560051,3,7,stem cell development,BP,NRTN;KITLG;LAMA5
4268,GO:0051726,0.179821676664998,0.919892994246751,7,25,regulation of cell cycle,BP,CDKN1A;RHOB;GAS6;PRKACB;HMGN5;FOXO4;CTGF
632,GO:0005539,0.179974768446581,0.954520170915423,3,8,glycosaminoglycan binding,MF,SERPINA5;CRISPLD2;CTGF
2532,GO:0032956,0.183812925350135,0.929483572162527,6,14,regulation of actin cytoskeleton organization,BP,ACTN2;PLEKHH2;PIK3R1;SDC4;FHOD3;CTGF
1135,GO:0008305,0.183892643457558,0.964145072557149,3,5,integrin complex,CC,ITGB5;ITGB8;ITGA3
5459,GO:0098636,0.183892643457558,0.964145072557149,3,5,protein complex involved in cell adhesion,CC,ITGB5;ITGB8;ITGA3
208,GO:0001972,0.185989468089241,1,1,1,retinoic acid binding,MF,SERPINA5
233,GO:0002080,0.185989468089241,1,1,1,acrosomal membrane,CC,SERPINA5
548,GO:0004867,0.185989468089241,1,1,1,serine-type endopeptidase inhibitor activity,MF,SERPINA5
619,GO:0005501,0.185989468089241,1,1,1,retinoid binding,MF,SERPINA5
1015,GO:0007342,0.185989468089241,1,1,1,fusion of sperm to egg plasma membrane,BP,SERPINA5
1817,GO:0019840,0.185989468089241,1,1,1,isoprenoid binding,MF,SERPINA5
2172,GO:0031094,0.185989468089241,1,1,1,platelet dense tubular network,CC,SERPINA5
2190,GO:0031210,0.185989468089241,1,1,1,phosphatidylcholine binding,MF,SERPINA5
2337,GO:0032190,0.185989468089241,1,1,1,acrosin binding,MF,SERPINA5
2845,GO:0036024,0.185989468089241,1,1,1,protein C inhibitor-TMPRSS7 complex,CC,SERPINA5
2846,GO:0036025,0.185989468089241,1,1,1,protein C inhibitor-TMPRSS11E complex,CC,SERPINA5
2847,GO:0036026,0.185989468089241,1,1,1,protein C inhibitor-PLAT complex,CC,SERPINA5
2848,GO:0036027,0.185989468089241,1,1,1,protein C inhibitor-PLAU complex,CC,SERPINA5
2849,GO:0036028,0.185989468089241,1,1,1,protein C inhibitor-thrombin complex,CC,SERPINA5
2850,GO:0036029,0.185989468089241,1,1,1,protein C inhibitor-KLK3 complex,CC,SERPINA5
2851,GO:0036030,0.185989468089241,1,1,1,protein C inhibitor-plasma kallikrein complex,CC,SERPINA5
3420,GO:0045026,0.185989468089241,1,1,1,plasma membrane fusion,BP,SERPINA5
4078,GO:0050997,0.185989468089241,1,1,1,quaternary ammonium group binding,MF,SERPINA5
4681,GO:0061107,0.185989468089241,1,1,1,seminal vesicle development,BP,SERPINA5
4847,GO:0070405,0.185989468089241,1,1,1,ammonium ion binding,MF,SERPINA5
5386,GO:0097179,0.185989468089241,1,1,1,protease inhibitor complex,CC,SERPINA5
5387,GO:0097180,0.185989468089241,1,1,1,serine protease inhibitor complex,CC,SERPINA5
5388,GO:0097181,0.185989468089241,1,1,1,protein C inhibitor-coagulation factor V complex,CC,SERPINA5
5389,GO:0097182,0.185989468089241,1,1,1,protein C inhibitor-coagulation factor Xa complex,CC,SERPINA5
5390,GO:0097183,0.185989468089241,1,1,1,protein C inhibitor-coagulation factor XI complex,CC,SERPINA5
2618,GO:0034059,0.187797566196327,1,1,1,response to anoxia,BP,CTGF
2837,GO:0035988,0.187797566196327,1,1,1,chondrocyte proliferation,BP,CTGF
4818,GO:0070278,0.187797566196327,1,1,1,extracellular matrix constituent secretion,BP,CTGF
4831,GO:0070318,0.187797566196327,1,1,1,positive regulation of G0 to G1 transition,BP,CTGF
4986,GO:0071482,0.18870057873129,0.979093988719233,2,3,cellular response to light stimulus,BP,CDKN1A;PIK3R1
4165,GO:0051249,0.188999286157238,0.939170796570444,4,11,regulation of lymphocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4
2333,GO:0032153,0.189144695052241,1,1,1,cell division site,CC,RHOB
2334,GO:0032154,0.189144695052241,1,1,1,cleavage furrow,CC,RHOB
2335,GO:0032155,0.189144695052241,1,1,1,cell division site part,CC,RHOB
3031,GO:0042542,0.189144695052241,1,1,1,response to hydrogen peroxide,BP,RHOB
4823,GO:0070301,0.189144695052241,1,1,1,cellular response to hydrogen peroxide,BP,RHOB
5429,GO:0097610,0.189144695052241,1,1,1,cell surface furrow,CC,RHOB
4861,GO:0070542,0.19044292094463,0.971119094352629,2,4,response to fatty acid,BP,CLDN1;CTGF
3662,GO:0046578,0.191544772434209,0.970838844609541,2,4,regulation of Ras protein signal transduction,BP,KITLG;ITGA3
519,GO:0004421,0.191973451164778,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS2
842,GO:0006695,0.191973451164778,1,1,1,cholesterol biosynthetic process,BP,HMGCS2
1115,GO:0008203,0.191973451164778,1,1,1,cholesterol metabolic process,BP,HMGCS2
1134,GO:0008299,0.191973451164778,1,1,1,isoprenoid biosynthetic process,BP,HMGCS2
1606,GO:0016125,0.191973451164778,1,1,1,sterol metabolic process,BP,HMGCS2
1607,GO:0016126,0.191973451164778,1,1,1,sterol biosynthetic process,BP,HMGCS2
3723,GO:0046912,0.191973451164778,1,1,1,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS2
3732,GO:0046950,0.191973451164778,1,1,1,cellular ketone body metabolic process,BP,HMGCS2
3733,GO:0046951,0.191973451164778,1,1,1,ketone body biosynthetic process,BP,HMGCS2
5708,GO:1902224,0.191973451164778,1,1,1,ketone body metabolic process,BP,HMGCS2
5750,GO:1902652,0.191973451164778,1,1,1,secondary alcohol metabolic process,BP,HMGCS2
5751,GO:1902653,0.191973451164778,1,1,1,secondary alcohol biosynthetic process,BP,HMGCS2
5684,GO:1901987,0.192676297213938,0.966485962039411,2,5,regulation of cell cycle phase transition,BP,CDKN1A;FOXO4
5686,GO:1901990,0.192676297213938,0.966485962039411,2,5,regulation of mitotic cell cycle phase transition,BP,CDKN1A;FOXO4
1824,GO:0019887,0.19490592315172,0.969976421736403,2,4,protein kinase regulator activity,MF,CDKN1A;GAS6
1215,GO:0009266,0.195839728597134,0.969734805861443,2,4,response to temperature stimulus,BP,CDKN1A;SLC52A3
1242,GO:0009725,0.197000709997724,0.90331510412206,9,27,response to hormone,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;FOXO4;CLDN1;CTGF;ITGA3;WT1
714,GO:0005924,0.197929900379475,0.918269880023408,6,17,cell-substrate adherens junction,CC,ACTN2;RHOB;ITGB5;MPZL1;SDC4;ITGA3
715,GO:0005925,0.197929900379475,0.918269880023408,6,17,focal adhesion,CC,ACTN2;RHOB;ITGB5;MPZL1;SDC4;ITGA3
204,GO:0001960,0.19822793233265,1,1,1,negative regulation of cytokine-mediated signaling pathway,BP,GAS6
601,GO:0005245,0.19822793233265,1,1,1,voltage-gated calcium channel activity,MF,GAS6
609,GO:0005262,0.19822793233265,1,1,1,calcium channel activity,MF,GAS6
794,GO:0006465,0.19822793233265,1,1,1,signal peptide processing,BP,GAS6
819,GO:0006611,0.19822793233265,1,1,1,protein export from nucleus,BP,GAS6
1402,GO:0010803,0.19822793233265,1,1,1,regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
1403,GO:0010804,0.19822793233265,1,1,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
1532,GO:0015085,0.19822793233265,1,1,1,calcium ion transmembrane transporter activity,MF,GAS6
1763,GO:0019062,0.19822793233265,1,1,1,virion attachment to host cell,BP,GAS6
1764,GO:0019064,0.19822793233265,1,1,1,fusion of virus membrane with host plasma membrane,BP,GAS6
2029,GO:0030296,0.19822793233265,1,1,1,protein tyrosine kinase activator activity,MF,GAS6
2437,GO:0032571,0.19822793233265,1,1,1,response to vitamin K,BP,GAS6
2467,GO:0032689,0.19822793233265,1,1,1,negative regulation of interferon-gamma production,BP,GAS6
2468,GO:0032692,0.19822793233265,1,1,1,negative regulation of interleukin-1 production,BP,GAS6
2471,GO:0032715,0.19822793233265,1,1,1,negative regulation of interleukin-6 production,BP,GAS6
2472,GO:0032720,0.19822793233265,1,1,1,negative regulation of tumor necrosis factor production,BP,GAS6
2496,GO:0032814,0.19822793233265,1,1,1,regulation of natural killer cell activation,BP,GAS6
2497,GO:0032816,0.19822793233265,1,1,1,positive regulation of natural killer cell activation,BP,GAS6
2498,GO:0032823,0.19822793233265,1,1,1,regulation of natural killer cell differentiation,BP,GAS6
2499,GO:0032825,0.19822793233265,1,1,1,positive regulation of natural killer cell differentiation,BP,GAS6
2575,GO:0033159,0.19822793233265,1,1,1,negative regulation of protein import into nucleus, translocation,BP,GAS6
2762,GO:0035455,0.19822793233265,1,1,1,response to interferon-alpha,BP,GAS6
2763,GO:0035457,0.19822793233265,1,1,1,cellular response to interferon-alpha,BP,GAS6
2790,GO:0035701,0.19822793233265,1,1,1,hematopoietic stem cell migration,BP,GAS6
2795,GO:0035754,0.19822793233265,1,1,1,B cell chemotaxis,BP,GAS6
2914,GO:0039663,0.19822793233265,1,1,1,membrane fusion involved in viral entry into host cell,BP,GAS6
3092,GO:0043027,0.19822793233265,1,1,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,GAS6
3093,GO:0043028,0.19822793233265,1,1,1,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,GAS6
3340,GO:0044406,0.19822793233265,1,1,1,adhesion of symbiont to host,BP,GAS6
3374,GO:0044650,0.19822793233265,1,1,1,adhesion of symbiont to host cell,BP,GAS6
3403,GO:0044800,0.19822793233265,1,1,1,multi-organism membrane fusion,BP,GAS6
3406,GO:0044803,0.19822793233265,1,1,1,multi-organism membrane organization,BP,GAS6
3510,GO:0045621,0.19822793233265,1,1,1,positive regulation of lymphocyte differentiation,BP,GAS6
3690,GO:0046813,0.19822793233265,1,1,1,receptor-mediated virion attachment to host cell,BP,GAS6
3694,GO:0046825,0.19822793233265,1,1,1,regulation of protein export from nucleus,BP,GAS6
3695,GO:0046827,0.19822793233265,1,1,1,positive regulation of protein export from nucleus,BP,GAS6
3978,GO:0050710,0.19822793233265,1,1,1,negative regulation of cytokine secretion,BP,GAS6
3979,GO:0050711,0.19822793233265,1,1,1,negative regulation of interleukin-1 secretion,BP,GAS6
4125,GO:0051168,0.19822793233265,1,1,1,nuclear export,BP,GAS6
4597,GO:0060761,0.19822793233265,1,1,1,negative regulation of response to cytokine stimulus,BP,GAS6
4795,GO:0070168,0.19822793233265,1,1,1,negative regulation of biomineral tissue development,BP,GAS6
4935,GO:0071307,0.19822793233265,1,1,1,cellular response to vitamin K,BP,GAS6
5211,GO:0072577,0.19822793233265,1,1,1,endothelial cell apoptotic process,BP,GAS6
5218,GO:0072604,0.19822793233265,1,1,1,interleukin-6 secretion,BP,GAS6
5224,GO:0072661,0.19822793233265,1,1,1,protein targeting to plasma membrane,BP,GAS6
5359,GO:0097017,0.19822793233265,1,1,1,renal protein absorption,BP,GAS6
5360,GO:0097018,0.19822793233265,1,1,1,renal albumin absorption,BP,GAS6
5362,GO:0097028,0.19822793233265,1,1,1,dendritic cell differentiation,BP,GAS6
5364,GO:0097048,0.19822793233265,1,1,1,dendritic cell apoptotic process,BP,GAS6
5400,GO:0097241,0.19822793233265,1,1,1,hematopoietic stem cell migration to bone marrow,BP,GAS6
5401,GO:0097252,0.19822793233265,1,1,1,oligodendrocyte apoptotic process,BP,GAS6
5553,GO:1900141,0.19822793233265,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
5554,GO:1900142,0.19822793233265,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
5555,GO:1900165,0.19822793233265,1,1,1,negative regulation of interleukin-6 secretion,BP,GAS6
5854,GO:1903556,0.19822793233265,1,1,1,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6
5903,GO:1904035,0.19822793233265,1,1,1,regulation of epithelial cell apoptotic process,BP,GAS6
5904,GO:1904036,0.19822793233265,1,1,1,negative regulation of epithelial cell apoptotic process,BP,GAS6
6100,GO:2000351,0.19822793233265,1,1,1,regulation of endothelial cell apoptotic process,BP,GAS6
6101,GO:2000352,0.19822793233265,1,1,1,negative regulation of endothelial cell apoptotic process,BP,GAS6
6119,GO:2000508,0.19822793233265,1,1,1,regulation of dendritic cell chemotaxis,BP,GAS6
6120,GO:2000510,0.19822793233265,1,1,1,positive regulation of dendritic cell chemotaxis,BP,GAS6
6121,GO:2000532,0.19822793233265,1,1,1,regulation of renal albumin absorption,BP,GAS6
6122,GO:2000533,0.19822793233265,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
6136,GO:2000668,0.19822793233265,1,1,1,regulation of dendritic cell apoptotic process,BP,GAS6
6137,GO:2000669,0.19822793233265,1,1,1,negative regulation of dendritic cell apoptotic process,BP,GAS6
4399,GO:0060119,0.198931086293918,0.977128100146572,2,3,inner ear receptor cell development,BP,MYO7A;SDC4
4401,GO:0060122,0.198931086293918,0.977128100146572,2,3,inner ear receptor stereocilium organization,BP,MYO7A;SDC4
3366,GO:0044451,0.20055800157941,0.949115146243438,3,7,nucleoplasm part,CC,CDKN1A;FOXO4;WT1
841,GO:0006694,0.200604407798725,0.949097281315103,3,7,steroid biosynthetic process,BP,HMGCS2;DKK3;DHH
1114,GO:0008202,0.200604407798725,0.949097281315103,3,7,steroid metabolic process,BP,HMGCS2;DKK3;DHH
5262,GO:0090004,0.202875815963837,0.976347984266265,2,3,positive regulation of establishment of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5800,GO:1903078,0.202875815963837,0.976347984266265,2,3,positive regulation of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5912,GO:1904377,0.202875815963837,0.976347984266265,2,3,positive regulation of protein localization to cell periphery,BP,PIK3R1;ITGA3
2011,GO:0030234,0.20409514551404,0.914845727749535,6,17,enzyme regulator activity,MF,CDKN1A;PIK3R1;GAS6;SERPINA5;RIN3;GPSM1
671,GO:0005775,0.204437739554864,1,1,1,vacuolar lumen,CC,SDC4
737,GO:0006026,0.204437739554864,1,1,1,aminoglycan catabolic process,BP,SDC4
738,GO:0006027,0.204437739554864,1,1,1,glycosaminoglycan catabolic process,BP,SDC4
3097,GO:0043034,0.204437739554864,1,1,1,costamere,CC,SDC4
3133,GO:0043202,0.204437739554864,1,1,1,lysosomal lumen,CC,SDC4
4779,GO:0070053,0.204437739554864,1,1,1,thrombospondin receptor activity,MF,SDC4
5056,GO:0071971,0.204437739554864,1,1,1,extracellular exosome assembly,BP,SDC4
5847,GO:1903541,0.204437739554864,1,1,1,regulation of exosomal secretion,BP,SDC4
5848,GO:1903543,0.204437739554864,1,1,1,positive regulation of exosomal secretion,BP,SDC4
5851,GO:1903551,0.204437739554864,1,1,1,regulation of extracellular exosome assembly,BP,SDC4
5852,GO:1903553,0.204437739554864,1,1,1,positive regulation of extracellular exosome assembly,BP,SDC4
1589,GO:0016032,0.205077642653537,0.923335020271591,5,13,viral process,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
2960,GO:0042157,0.205515786431402,0.975819004715869,2,3,lipoprotein metabolic process,BP,PRND;PRKACB
152,GO:0001817,0.205737610858333,0.933250611115936,4,10,regulation of cytokine production,BP,PIK3R1;GAS6;DLL1;PDE4B
1222,GO:0009566,0.206905465148989,0.966804823247711,2,4,fertilization,BP,MFGE8;SERPINA5
4996,GO:0071559,0.207215261480554,0.920796528119203,5,14,response to transforming growth factor beta,BP,DKK3;ITGB5;CLDN1;CGN;ITGA3
4997,GO:0071560,0.207215261480554,0.920796528119203,5,14,cellular response to transforming growth factor beta stimulus,BP,DKK3;ITGB5;CLDN1;CGN;ITGA3
8,GO:0000075,0.207809172138674,0.961986229793647,2,5,cell cycle checkpoint,BP,CDKN1A;FOXO4
3345,GO:0044422,0.209817506906358,0.867008036941566,29,110,organelle part,CC,ACTN2;MYO7A;CDKN1A;HMGCS2;REEP1;RHOB;MRO;PHLDA1;PLEKHH2;CAMSAP3;PIK3R1;SLC25A53;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;ACSL4;CRISPLD2;FHOD3;FOXO4;ESPN;GPSM1;MARK4;TMEM163;PDE4B;CGN;UNC119;WT1
1267,GO:0009897,0.210060031158547,0.945405898640769,3,7,external side of plasma membrane,CC,MFGE8;SERPINA5;ITGA3
1235,GO:0009628,0.211302737386693,0.901712973582033,7,24,response to abiotic stimulus,BP,CDKN1A;RHOB;SLC52A3;PIK3R1;CLDN1;CTGF;UNC119
5746,GO:1902612,0.212395247609072,1,1,1,regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
5747,GO:1902613,0.212395247609072,1,1,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,DKK3
6009,GO:1990262,0.212395247609072,1,1,1,anti-Mullerian hormone signaling pathway,BP,DKK3
1086,GO:0008037,0.212829209862217,0.974324622520823,2,3,cell recognition,BP,MFGE8;LAMA5
3558,GO:0045787,0.215243989384329,0.923881443069744,4,13,positive regulation of cell cycle,BP,CDKN1A;HMGN5;FOXO4;CTGF
2789,GO:0035690,0.217369907833348,0.96392042612594,2,4,cellular response to drug,BP,GAS6;PDE4B
2406,GO:0032420,0.217439323065605,0.973360664006245,2,3,stereocilium,CC,MYO7A;ESPN
2407,GO:0032421,0.217439323065605,0.973360664006245,2,3,stereocilium bundle,CC,MYO7A;ESPN
5494,GO:0098862,0.217439323065605,0.973360664006245,2,3,cluster of actin-based cell projections,CC,MYO7A;ESPN
703,GO:0005902,0.217525489357057,0.973342484798548,2,3,microvillus,CC,MYO7A;ESPN
1286,GO:0009991,0.222155255458468,0.912805458373281,5,14,response to extracellular stimulus,BP,CDKN1A;NUAK2;GAS6;ACSL4;FOXO4
2267,GO:0031667,0.222155255458468,0.912805458373281,5,14,response to nutrient levels,BP,CDKN1A;NUAK2;GAS6;ACSL4;FOXO4
4914,GO:0071157,0.222472023416901,0.986308100495783,1,2,negative regulation of cell cycle arrest,BP,HMGN5
3144,GO:0043229,0.224702652738234,0.859952590775773,39,153,intracellular organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;RHOB;KITLG;MRO;PHLDA1;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;SDC4;PRKACB;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;ESPN;GPSM1;MARK4;TMEM163;DLL1;PDE4B;CGN;CTGF;UNC119;WT1
709,GO:0005915,0.225426258625157,1,1,1,zonula adherens,CC,CAMSAP3
858,GO:0006771,0.225426258625157,1,1,1,riboflavin metabolic process,BP,SLC52A3
1440,GO:0010923,0.225426258625157,1,1,1,negative regulation of phosphatase activity,BP,CAMSAP3
2338,GO:0032217,0.225426258625157,1,1,1,riboflavin transporter activity,MF,SLC52A3
2339,GO:0032218,0.225426258625157,1,1,1,riboflavin transport,BP,SLC52A3
2644,GO:0034331,0.225426258625157,1,1,1,cell junction maintenance,BP,CAMSAP3
2661,GO:0034453,0.225426258625157,1,1,1,microtubule anchoring,BP,CAMSAP3
2746,GO:0035305,0.225426258625157,1,1,1,negative regulation of dephosphorylation,BP,CAMSAP3
3060,GO:0042726,0.225426258625157,1,1,1,flavin-containing compound metabolic process,BP,SLC52A3
3467,GO:0045217,0.225426258625157,1,1,1,cell-cell junction maintenance,BP,CAMSAP3
3468,GO:0045218,0.225426258625157,1,1,1,zonula adherens maintenance,BP,CAMSAP3
4081,GO:0051011,0.225426258625157,1,1,1,microtubule minus-end binding,MF,CAMSAP3
153,GO:0001818,0.22605513493308,0.96144221677641,2,4,negative regulation of cytokine production,BP,GAS6;DLL1
71,GO:0001077,0.226460535057426,1,1,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,WT1
84,GO:0001228,0.226460535057426,1,1,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,WT1
1019,GO:0007354,0.226460535057426,1,1,1,zygotic determination of anterior/posterior axis, embryo,BP,WT1
1020,GO:0007356,0.226460535057426,1,1,1,thorax and anterior abdomen determination,BP,WT1
1311,GO:0010385,0.226460535057426,1,1,1,double-stranded methylated DNA binding,MF,WT1
2501,GO:0032836,0.226460535057426,1,1,1,glomerular basement membrane development,BP,WT1
2765,GO:0035502,0.226460535057426,1,1,1,metanephric part of ureteric bud development,BP,WT1
2803,GO:0035801,0.226460535057426,1,1,1,adrenal cortex development,BP,WT1
2804,GO:0035802,0.226460535057426,1,1,1,adrenal cortex formation,BP,WT1
3388,GO:0044729,0.226460535057426,1,1,1,hemi-methylated DNA-binding,MF,WT1
4659,GO:0061032,0.226460535057426,1,1,1,visceral serous pericardium development,BP,WT1
4888,GO:0070742,0.226460535057426,1,1,1,C2H2 zinc finger domain binding,MF,WT1
5131,GO:0072166,0.226460535057426,1,1,1,posterior mesonephric tubule development,BP,WT1
5170,GO:0072262,0.226460535057426,1,1,1,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,WT1
5175,GO:0072298,0.226460535057426,1,1,1,regulation of metanephric glomerulus development,BP,WT1
5176,GO:0072299,0.226460535057426,1,1,1,negative regulation of metanephric glomerulus development,BP,WT1
5177,GO:0072301,0.226460535057426,1,1,1,regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
5178,GO:0072302,0.226460535057426,1,1,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,WT1
5995,GO:1905941,0.226460535057426,1,1,1,positive regulation of gonad development,BP,WT1
6044,GO:2000020,0.226460535057426,1,1,1,positive regulation of male gonad development,BP,WT1
6083,GO:2000194,0.226460535057426,1,1,1,regulation of female gonad development,BP,WT1
6084,GO:2000195,0.226460535057426,1,1,1,negative regulation of female gonad development,BP,WT1
6183,GO:2001074,0.226460535057426,1,1,1,regulation of metanephric ureteric bud development,BP,WT1
6184,GO:2001076,0.226460535057426,1,1,1,positive regulation of metanephric ureteric bud development,BP,WT1
3087,GO:0043005,0.227489869731098,0.90147204505537,6,17,neuron projection,CC,ACTN2;NRTN;RAB39B;MARK4;PDE4B;ITGA3
1159,GO:0008584,0.231397846598248,0.936702024767906,3,7,male gonad development,BP,KITLG;DHH;WT1
3661,GO:0046546,0.231397846598248,0.936702024767906,3,7,development of primary male sexual characteristics,BP,KITLG;DHH;WT1
4906,GO:0070925,0.231556710032364,0.900357724189754,6,16,organelle assembly,BP,ACTN2;MYO7A;LAMA5;SDC4;FHOD3;MARK4
318,GO:0002576,0.232461552522192,0.959565057866254,2,4,platelet degranulation,BP,ACTN2;GAS6
4916,GO:0071214,0.233956381341107,0.932376040206915,3,8,cellular response to abiotic stimulus,BP,CDKN1A;RHOB;PIK3R1
1963,GO:0030048,0.235244003924597,0.939840513407881,3,6,actin filament-based movement,BP,ACTN2;MYO7A;PDE4B
4167,GO:0051251,0.235263850447315,0.931797535571702,3,8,positive regulation of lymphocyte activation,BP,CDKN1A;PIK3R1;GAS6
4200,GO:0051346,0.238881025510145,0.930186738957013,3,8,negative regulation of hydrolase activity,BP,CAMSAP3;GAS6;SERPINA5
954,GO:0007095,0.239790145329651,1,1,1,mitotic G2 DNA damage checkpoint,BP,FOXO4
1312,GO:0010389,0.239790145329651,1,1,1,regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
1452,GO:0010972,0.239790145329651,1,1,1,negative regulation of G2/M transition of mitotic cell cycle,BP,FOXO4
2248,GO:0031572,0.239790145329651,1,1,1,G2 DNA damage checkpoint,BP,FOXO4
2821,GO:0035902,0.239790145329651,1,1,1,response to immobilization stress,BP,FOXO4
3407,GO:0044818,0.239790145329651,1,1,1,mitotic G2/M transition checkpoint,BP,FOXO4
4830,GO:0070317,0.239790145329651,1,1,1,negative regulation of G0 to G1 transition,BP,FOXO4
5762,GO:1902749,0.239790145329651,1,1,1,regulation of cell cycle G2/M phase transition,BP,FOXO4
5763,GO:1902750,0.239790145329651,1,1,1,negative regulation of cell cycle G2/M phase transition,BP,FOXO4
6025,GO:1990785,0.239790145329651,1,1,1,response to water-immersion restraint stress,BP,FOXO4
6027,GO:1990841,0.239790145329651,1,1,1,promoter-specific chromatin binding,MF,FOXO4
5398,GO:0097205,0.240327848930657,0.957202775384482,2,4,renal filtration,BP,GAS6;ITGA3
2666,GO:0034612,0.241269497986985,0.951136320151028,2,5,response to tumor necrosis factor,BP,GAS6;CLDN1
4952,GO:0071356,0.241269497986985,0.951136320151028,2,5,cellular response to tumor necrosis factor,BP,GAS6;CLDN1
3941,GO:0048856,0.242046615955112,0.843857565603719,35,133,anatomical structure development,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;DHH;FOXO4;GPSM1;MARK4;DAAM2;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
140,GO:0001757,0.242253440799622,1,1,1,somite specification,BP,DLL1
274,GO:0002313,0.242253440799622,1,1,1,mature B cell differentiation involved in immune response,BP,DLL1
275,GO:0002315,0.242253440799622,1,1,1,marginal zone B cell differentiation,BP,DLL1
280,GO:0002335,0.242253440799622,1,1,1,mature B cell differentiation,BP,DLL1
1023,GO:0007379,0.242253440799622,1,1,1,segment specification,BP,DLL1
1856,GO:0021679,0.242253440799622,1,1,1,cerebellar molecular layer development,BP,DLL1
1857,GO:0021680,0.242253440799622,1,1,1,cerebellar Purkinje cell layer development,BP,DLL1
1861,GO:0021687,0.242253440799622,1,1,1,cerebellar molecular layer morphogenesis,BP,DLL1
1862,GO:0021688,0.242253440799622,1,1,1,cerebellar molecular layer formation,BP,DLL1
1863,GO:0021692,0.242253440799622,1,1,1,cerebellar Purkinje cell layer morphogenesis,BP,DLL1
1864,GO:0021693,0.242253440799622,1,1,1,cerebellar Purkinje cell layer structural organization,BP,DLL1
1868,GO:0021698,0.242253440799622,1,1,1,cerebellar cortex structural organization,BP,DLL1
2150,GO:0030957,0.242253440799622,1,1,1,Tat protein binding,MF,DLL1
2448,GO:0032613,0.242253440799622,1,1,1,interleukin-10 production,BP,DLL1
2460,GO:0032653,0.242253440799622,1,1,1,regulation of interleukin-10 production,BP,DLL1
2469,GO:0032693,0.242253440799622,1,1,1,negative regulation of interleukin-10 production,BP,DLL1
2898,GO:0038084,0.242253440799622,1,1,1,vascular endothelial growth factor signaling pathway,BP,DLL1
3450,GO:0045168,0.242253440799622,1,1,1,cell-cell signaling involved in cell fate commitment,BP,DLL1
3633,GO:0046331,0.242253440799622,1,1,1,lateral inhibition,BP,DLL1
3834,GO:0048532,0.242253440799622,1,1,1,anatomical structure arrangement,BP,DLL1
3881,GO:0048665,0.242253440799622,1,1,1,neuron fate specification,BP,DLL1
4372,GO:0060042,0.242253440799622,1,1,1,retina morphogenesis in camera-type eye,BP,DLL1
4615,GO:0060844,0.242253440799622,1,1,1,arterial endothelial cell fate commitment,BP,DLL1
4616,GO:0060846,0.242253440799622,1,1,1,blood vessel endothelial cell fate commitment,BP,DLL1
4617,GO:0060847,0.242253440799622,1,1,1,endothelial cell fate specification,BP,DLL1
4618,GO:0060853,0.242253440799622,1,1,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,DLL1
5065,GO:0072014,0.242253440799622,1,1,1,proximal tubule development,BP,DLL1
5374,GO:0097101,0.242253440799622,1,1,1,blood vessel endothelial cell fate specification,BP,DLL1
5375,GO:0097102,0.242253440799622,1,1,1,endothelial tip cell fate specification,BP,DLL1
5584,GO:1900746,0.242253440799622,1,1,1,regulation of vascular endothelial growth factor signaling pathway,BP,DLL1
5736,GO:1902547,0.242253440799622,1,1,1,regulation of cellular response to vascular endothelial growth factor stimulus,BP,DLL1
6118,GO:2000505,0.242253440799622,1,1,1,regulation of energy homeostasis,BP,DLL1
920,GO:0006974,0.243006084650093,0.925835818863708,3,9,cellular response to DNA damage stimulus,BP,CDKN1A;PIK3R1;FOXO4
5292,GO:0090150,0.243272122707179,0.893456898584497,6,16,establishment of protein localization to membrane,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
3344,GO:0044421,0.243701960815663,0.843274825122765,23,87,extracellular region part,CC,LAMA1;ACTN2;FRMPD1;DKK3;RHOB;KITLG;RHOJ;MFGE8;CLDN11;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DHH;DAAM2;CTGF;UNC119;ITGA3
945,GO:0007049,0.245238592446761,0.869053837774638,9,33,cell cycle,BP,CDKN1A;RHOB;PHLDA1;GAS6;PRKACB;HMGN5;FOXO4;MARK4;CTGF
306,GO:0002474,0.245511007504088,1,1,1,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5
307,GO:0002478,0.245511007504088,1,1,1,antigen processing and presentation of exogenous peptide antigen,BP,ITGB5
308,GO:0002479,0.245511007504088,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5
1823,GO:0019884,0.245511007504088,1,1,1,antigen processing and presentation of exogenous antigen,BP,ITGB5
2682,GO:0034684,0.245511007504088,1,1,1,integrin alphav-beta5 complex,CC,ITGB5
3043,GO:0042590,0.245511007504088,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5
3742,GO:0048002,0.245511007504088,1,1,1,antigen processing and presentation of peptide antigen,BP,ITGB5
1905,GO:0022402,0.246107132761703,0.873376279905668,8,29,cell cycle process,BP,CDKN1A;RHOB;PHLDA1;GAS6;HMGN5;FOXO4;MARK4;CTGF
918,GO:0006970,0.247289657399062,1,1,1,response to osmotic stress,BP,CLDN1
919,GO:0006972,0.247289657399062,1,1,1,hyperosmotic response,BP,CLDN1
1090,GO:0008065,0.247289657399062,1,1,1,establishment of blood-nerve barrier,BP,CLDN1
1237,GO:0009651,0.247289657399062,1,1,1,response to salt stress,BP,CLDN1
1308,GO:0010288,0.247289657399062,1,1,1,response to lead ion,BP,CLDN1
1580,GO:0015893,0.247289657399062,1,1,1,drug transport,BP,CLDN1
2597,GO:0033561,0.247289657399062,1,1,1,regulation of water loss via skin,BP,CLDN1
3030,GO:0042538,0.247289657399062,1,1,1,hyperosmotic salinity response,BP,CLDN1
4741,GO:0061436,0.247289657399062,1,1,1,establishment of skin barrier,BP,CLDN1
4770,GO:0061772,0.247289657399062,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
4930,GO:0071284,0.247289657399062,1,1,1,cellular response to lead ion,BP,CLDN1
5346,GO:0090557,0.247289657399062,1,1,1,establishment of endothelial intestinal barrier,BP,CLDN1
5413,GO:0097421,0.247289657399062,1,1,1,liver regeneration,BP,CLDN1
5819,GO:1903348,0.247289657399062,1,1,1,positive regulation of bicellular tight junction assembly,BP,CLDN1
5849,GO:1903544,0.247289657399062,1,1,1,response to butyrate,BP,CLDN1
5850,GO:1903545,0.247289657399062,1,1,1,cellular response to butyrate,BP,CLDN1
6156,GO:2000810,0.247289657399062,1,1,1,regulation of bicellular tight junction assembly,BP,CLDN1
707,GO:0005912,0.248530187550699,0.874772023239795,8,24,adherens junction,CC,ACTN2;RHOB;CAMSAP3;ITGB5;MPZL1;SDC4;DLL1;ITGA3
5509,GO:0099080,0.252270528044165,0.885463930112242,6,18,supramolecular complex,CC,ACTN2;CAMSAP3;SDC4;FHOD3;ESPN;PDE4B
5510,GO:0099081,0.252270528044165,0.885463930112242,6,18,supramolecular polymer,CC,ACTN2;CAMSAP3;SDC4;FHOD3;ESPN;PDE4B
5517,GO:0099512,0.252270528044165,0.885463930112242,6,18,supramolecular fiber,CC,ACTN2;CAMSAP3;SDC4;FHOD3;ESPN;PDE4B
704,GO:0005903,0.252962117636343,1,1,1,brush border,CC,ESPN
1962,GO:0030046,0.252962117636343,1,1,1,parallel actin filament bundle assembly,BP,ESPN
2285,GO:0031941,0.252962117636343,1,1,1,filamentous actin,CC,ESPN
2408,GO:0032426,0.252962117636343,1,1,1,stereocilium tip,CC,ESPN
3392,GO:0044764,0.255774611429981,0.893913190738372,5,14,multi-organism cellular process,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
5865,GO:1903706,0.256030206790128,0.908402510332604,4,10,regulation of hemopoiesis,BP,KITLG;PIK3R1;GAS6;DLL1
1955,GO:0030031,0.256488890543674,0.908162702977992,4,10,cell projection assembly,BP,ACTN2;LAMA5;ESPN;MARK4
3102,GO:0043067,0.256622630512791,0.850359872706092,12,44,regulation of programmed cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
54,GO:0000922,0.25790474649293,0.981186976672113,1,2,spindle pole,CC,UNC119
1954,GO:0030030,0.258163586796384,0.851193300318666,12,38,cell projection organization,BP,ACTN2;MYO7A;NRTN;CAMSAP3;PIK3R1;LAMA5;SDC4;SEMA6C;ACSL4;ESPN;MARK4;ITGA3
3465,GO:0045214,0.258917844258831,0.951366986872041,2,4,sarcomere organization,BP,ACTN2;FHOD3
294,GO:0002429,0.259126738942493,0.92461898586308,3,7,immune response-activating cell surface receptor signaling pathway,BP,PIK3R1;PRKACB;PDE4B
356,GO:0002768,0.259126738942493,0.92461898586308,3,7,immune response-regulating cell surface receptor signaling pathway,BP,PIK3R1;PRKACB;PDE4B
1662,GO:0016485,0.25922288161615,0.951268243143607,2,4,protein processing,BP,GAS6;PRKACB
1470,GO:0014031,0.260272858446611,0.924100762778048,3,7,mesenchymal cell development,BP,NRTN;KITLG;LAMA5
327,GO:0002684,0.260694477628575,0.87916206721225,6,19,positive regulation of immune system process,BP,CDKN1A;KITLG;PIK3R1;GAS6;PRKACB;PDE4B
2174,GO:0031099,0.261414321237179,0.919810434062673,3,8,regeneration,BP,CDKN1A;GAS6;CLDN1
1966,GO:0030055,0.261687767355916,0.879615309362351,6,18,cell-substrate junction,CC,ACTN2;RHOB;ITGB5;MPZL1;SDC4;ITGA3
1053,GO:0007569,0.26261782924734,0.980434358598886,1,2,cell aging,BP,CDKN1A
1310,GO:0010332,0.26261782924734,0.980434358598886,1,2,response to gamma radiation,BP,CDKN1A
4985,GO:0071480,0.26261782924734,0.980434358598886,1,2,cellular response to gamma radiation,BP,CDKN1A
5337,GO:0090398,0.26261782924734,0.980434358598886,1,2,cellular senescence,BP,CDKN1A
935,GO:0007029,0.262989453458,1,1,1,endoplasmic reticulum organization,BP,REEP1
2279,GO:0031849,0.262989453458,1,1,1,olfactory receptor binding,MF,REEP1
5026,GO:0071782,0.262989453458,1,1,1,endoplasmic reticulum tubular network,CC,REEP1
5027,GO:0071786,0.262989453458,1,1,1,endoplasmic reticulum tubular network organization,BP,REEP1
5490,GO:0098827,0.262989453458,1,1,1,endoplasmic reticulum subcompartment,CC,REEP1
3466,GO:0045216,0.264464769561132,0.887250244358043,5,15,cell-cell junction organization,BP,ACTN2;CAMSAP3;LAMA5;SDC4;CLDN1
4082,GO:0051015,0.264793858719136,0.927644251501018,3,6,actin filament binding,MF,ACTN2;MYO7A;ESPN
1066,GO:0007605,0.266474383194187,0.921270785474799,3,7,sensory perception of sound,BP,MYO7A;SLC52A3;ESPN
4071,GO:0050954,0.266474383194187,0.921270785474799,3,7,sensory perception of mechanical stimulus,BP,MYO7A;SLC52A3;ESPN
1731,GO:0017112,0.267043916069965,1,1,1,Rab guanyl-nucleotide exchange factor activity,MF,RIN3
549,GO:0004869,0.267470138552335,0.9796414428592,1,2,cysteine-type endopeptidase inhibitor activity,MF,GAS6
1996,GO:0030183,0.267595833515565,0.948519910307998,2,4,B cell differentiation,BP,PIK3R1;DLL1
5395,GO:0097193,0.268667257879027,0.941319910327557,2,5,intrinsic apoptotic signaling pathway,BP,CDKN1A;PIK3R1
4173,GO:0051260,0.268785346196422,0.920205006670941,3,7,protein homooligomerization,BP,ACTN2;PRND;CLDN1
897,GO:0006909,0.269769358044141,0.898467016337053,4,11,phagocytosis,BP,MYO7A;MFGE8;PIK3R1;GAS6
2019,GO:0030260,0.27005191139426,0.919618304255159,3,7,entry into host cell,BP,GAS6;ITGB5;CLDN1
3341,GO:0044409,0.27005191139426,0.919618304255159,3,7,entry into host,BP,GAS6;ITGB5;CLDN1
4263,GO:0051701,0.27005191139426,0.919618304255159,3,7,interaction with host,BP,GAS6;ITGB5;CLDN1
4279,GO:0051806,0.27005191139426,0.919618304255159,3,7,entry into cell of other organism involved in symbiotic interaction,BP,GAS6;ITGB5;CLDN1
4280,GO:0051828,0.27005191139426,0.919618304255159,3,7,entry into other organism involved in symbiotic interaction,BP,GAS6;ITGB5;CLDN1
1000,GO:0007264,0.2706785766882,0.880987018317233,5,17,small GTPase mediated signal transduction,BP,CDKN1A;RHOB;KITLG;RHOJ;ITGA3
3339,GO:0044403,0.271069710044276,0.88490618738525,5,14,symbiosis, encompassing mutualism through parasitism,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
3342,GO:0044419,0.271069710044276,0.88490618738525,5,14,interspecies interaction between organisms,BP,MFGE8;PIK3R1;GAS6;ITGB5;CLDN1
6061,GO:2000106,0.27205276645723,0.947027011705287,2,4,regulation of leukocyte apoptotic process,BP,KITLG;GAS6
333,GO:0002694,0.272262626054074,0.894971711467496,4,12,regulation of leukocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4
621,GO:0005507,0.272467736294783,1,1,1,copper ion binding,MF,PRND
807,GO:0006501,0.272467736294783,1,1,1,C-terminal protein lipidation,BP,PRND
884,GO:0006878,0.272467736294783,1,1,1,cellular copper ion homeostasis,BP,PRND
1758,GO:0018410,0.272467736294783,1,1,1,C-terminal protein amino acid modification,BP,PRND
2194,GO:0031225,0.272467736294783,1,1,1,anchored component of membrane,CC,PRND
3265,GO:0043687,0.272467736294783,1,1,1,post-translational protein modification,BP,PRND
4341,GO:0055070,0.272467736294783,1,1,1,copper ion homeostasis,BP,PRND
5275,GO:0090068,0.272919662691033,0.911372116340152,3,9,positive regulation of cell cycle process,BP,CDKN1A;FOXO4;CTGF
2386,GO:0032355,0.273794527300626,0.93508415865847,2,6,response to estradiol,BP,DHH;CTGF
922,GO:0006977,0.275659188385426,0.978261189006547,1,2,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,CDKN1A
2247,GO:0031571,0.275659188385426,0.978261189006547,1,2,mitotic G1 DNA damage checkpoint,BP,CDKN1A
3401,GO:0044783,0.275659188385426,0.978261189006547,1,2,G1 DNA damage checkpoint,BP,CDKN1A
3408,GO:0044819,0.275659188385426,0.978261189006547,1,2,mitotic G1/S transition checkpoint,BP,CDKN1A
5036,GO:0071850,0.275659188385426,0.978261189006547,1,2,mitotic cell cycle arrest,BP,CDKN1A
5190,GO:0072395,0.275659188385426,0.978261189006547,1,2,signal transduction involved in cell cycle checkpoint,BP,CDKN1A
5191,GO:0072401,0.275659188385426,0.978261189006547,1,2,signal transduction involved in DNA integrity checkpoint,BP,CDKN1A
5192,GO:0072413,0.275659188385426,0.978261189006547,1,2,signal transduction involved in mitotic cell cycle checkpoint,BP,CDKN1A
5193,GO:0072422,0.275659188385426,0.978261189006547,1,2,signal transduction involved in DNA damage checkpoint,BP,CDKN1A
5194,GO:0072431,0.275659188385426,0.978261189006547,1,2,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,CDKN1A
5724,GO:1902400,0.275659188385426,0.978261189006547,1,2,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,CDKN1A
5725,GO:1902402,0.275659188385426,0.978261189006547,1,2,signal transduction involved in mitotic DNA damage checkpoint,BP,CDKN1A
5726,GO:1902403,0.275659188385426,0.978261189006547,1,2,signal transduction involved in mitotic DNA integrity checkpoint,BP,CDKN1A
5765,GO:1902807,0.275659188385426,0.978261189006547,1,2,negative regulation of cell cycle G1/S phase transition,BP,CDKN1A
6069,GO:2000134,0.275659188385426,0.978261189006547,1,2,negative regulation of G1/S transition of mitotic cell cycle,BP,CDKN1A
3515,GO:0045637,0.27633776909775,0.916679458524235,3,7,regulation of myeloid cell differentiation,BP,KITLG;PIK3R1;DLL1
4532,GO:0060548,0.276689228264557,0.847083267534285,9,33,negative regulation of cell death,BP,CDKN1A;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;CTGF;WT1
5980,GO:1905477,0.277707388950045,0.945102811937776,2,4,positive regulation of protein localization to membrane,BP,PIK3R1;ITGA3
3391,GO:0044763,0.277891068684442,0.837470160571989,47,191,single-organism cellular process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;DKK3;RHOB;KITLG;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;DAAM2;DLL1;PDE4B;CLDN1;CTGF;UNC119;ITGA3;WT1
3405,GO:0044802,0.278617908433732,0.859172523066267,7,23,single-organism membrane organization,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;SERPINA5;ITGA3
3370,GO:0044463,0.278944151132915,0.861864209157707,7,20,cell projection part,CC,ACTN2;MYO7A;PRKACB;ESPN;MARK4;PDE4B;ITGA3
3262,GO:0043627,0.281784226469689,0.977193809110154,1,2,response to estrogen,BP,DHH
1088,GO:0008047,0.283226377569736,0.909204473271889,3,8,enzyme activator activity,MF,CDKN1A;GAS6;RIN3
495,GO:0003774,0.284016292460341,0.957499166200822,2,3,motor activity,MF,MYO7A;CGN
1655,GO:0016459,0.284016292460341,0.957499166200822,2,3,myosin complex,CC,MYO7A;CGN
501,GO:0004112,0.284661831527311,1,1,1,cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
502,GO:0004114,0.284661831527311,1,1,1,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE4B
503,GO:0004115,0.284661831527311,1,1,1,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE4B
763,GO:0006195,0.284661831527311,1,1,1,purine nucleotide catabolic process,BP,PDE4B
764,GO:0006198,0.284661831527311,1,1,1,cAMP catabolic process,BP,PDE4B
1199,GO:0009154,0.284661831527311,1,1,1,purine ribonucleotide catabolic process,BP,PDE4B
1202,GO:0009166,0.284661831527311,1,1,1,nucleotide catabolic process,BP,PDE4B
1210,GO:0009214,0.284661831527311,1,1,1,cyclic nucleotide catabolic process,BP,PDE4B
1214,GO:0009261,0.284661831527311,1,1,1,ribonucleotide catabolic process,BP,PDE4B
2449,GO:0032623,0.284661831527311,1,1,1,interleukin-2 production,BP,PDE4B
2461,GO:0032663,0.284661831527311,1,1,1,regulation of interleukin-2 production,BP,PDE4B
2478,GO:0032743,0.284661831527311,1,1,1,positive regulation of interleukin-2 production,BP,PDE4B
3642,GO:0046434,0.284661831527311,1,1,1,organophosphate catabolic process,BP,PDE4B
5038,GO:0071867,0.284661831527311,1,1,1,response to monoamine,BP,PDE4B
5039,GO:0071868,0.284661831527311,1,1,1,cellular response to monoamine stimulus,BP,PDE4B
5040,GO:0071869,0.284661831527311,1,1,1,response to catecholamine,BP,PDE4B
5041,GO:0071870,0.284661831527311,1,1,1,cellular response to catecholamine stimulus,BP,PDE4B
5042,GO:0071871,0.284661831527311,1,1,1,response to epinephrine,BP,PDE4B
5043,GO:0071872,0.284661831527311,1,1,1,cellular response to epinephrine stimulus,BP,PDE4B
5205,GO:0072523,0.284661831527311,1,1,1,purine-containing compound catabolic process,BP,PDE4B
5596,GO:1901078,0.284661831527311,1,1,1,negative regulation of relaxation of muscle,BP,PDE4B
5612,GO:1901292,0.284661831527311,1,1,1,nucleoside phosphate catabolic process,BP,PDE4B
5624,GO:1901385,0.284661831527311,1,1,1,regulation of voltage-gated calcium channel activity,BP,PDE4B
5666,GO:1901841,0.284661831527311,1,1,1,regulation of high voltage-gated calcium channel activity,BP,PDE4B
5676,GO:1901898,0.284661831527311,1,1,1,negative regulation of relaxation of cardiac muscle,BP,PDE4B
2963,GO:0042175,0.28598568943298,0.889398552728137,4,11,nuclear outer membrane-endoplasmic reticulum membrane network,CC,REEP1;PIK3R1;ACSL4;GPSM1
1160,GO:0008585,0.286759161558709,0.941952046086175,2,4,female gonad development,BP,KITLG;WT1
3660,GO:0046545,0.286759161558709,0.941952046086175,2,4,development of primary female sexual characteristics,BP,KITLG;WT1
1278,GO:0009954,0.2870498932941,0.976251902235843,1,2,proximal/distal pattern formation,BP,DLL1
3551,GO:0045766,0.287110803549886,0.941827884284615,2,4,positive regulation of angiogenesis,BP,RHOB;DLL1
3948,GO:0048871,0.291900329480162,0.883710889992336,4,12,multicellular organismal homeostasis,BP,PRKACB;DLL1;CLDN1;CTGF
1405,GO:0010811,0.292146057001253,0.940035460146791,2,4,positive regulation of cell-substrate adhesion,BP,SDC4;ITGA3
529,GO:0004690,0.292967647916063,1,1,1,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB
530,GO:0004691,0.292967647916063,1,1,1,cAMP-dependent protein kinase activity,MF,PRKACB
3582,GO:0045879,0.292967647916063,1,1,1,negative regulation of smoothened signaling pathway,BP,PRKACB
4608,GO:0060831,0.292967647916063,1,1,1,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
4867,GO:0070613,0.292967647916063,1,1,1,regulation of protein processing,BP,PRKACB
5408,GO:0097338,0.292967647916063,1,1,1,response to clozapine,BP,PRKACB
5643,GO:1901620,0.292967647916063,1,1,1,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
5644,GO:1901621,0.292967647916063,1,1,1,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
5816,GO:1903317,0.292967647916063,1,1,1,regulation of protein maturation,BP,PRKACB
3594,GO:0045930,0.293838600933503,0.926749060636541,2,6,negative regulation of mitotic cell cycle,BP,CDKN1A;FOXO4
5260,GO:0090002,0.293994101169315,0.873068725572438,5,13,establishment of protein localization to plasma membrane,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
1422,GO:0010861,0.295157834876284,1,1,1,thyroid hormone receptor activator activity,MF,ACTN2
1957,GO:0030035,0.295157834876284,1,1,1,microspike assembly,BP,ACTN2
2020,GO:0030274,0.295157834876284,1,1,1,LIM domain binding,MF,ACTN2
2047,GO:0030375,0.295157834876284,1,1,1,thyroid hormone receptor coactivator activity,MF,ACTN2
2120,GO:0030836,0.295157834876284,1,1,1,positive regulation of actin filament depolymerization,BP,ACTN2
2234,GO:0031432,0.295157834876284,1,1,1,titin binding,MF,ACTN2
2401,GO:0032411,0.295157834876284,1,1,1,positive regulation of transporter activity,BP,ACTN2
2404,GO:0032414,0.295157834876284,1,1,1,positive regulation of ion transmembrane transporter activity,BP,ACTN2
2906,GO:0038166,0.295157834876284,1,1,1,angiotensin-activated signaling pathway,BP,ACTN2
3154,GO:0043243,0.295157834876284,1,1,1,positive regulation of protein complex disassembly,BP,ACTN2
4175,GO:0051262,0.295157834876284,1,1,1,protein tetramerization,BP,ACTN2
4185,GO:0051289,0.295157834876284,1,1,1,protein homotetramerization,BP,ACTN2
4204,GO:0051373,0.295157834876284,1,1,1,FATZ binding,MF,ACTN2
4262,GO:0051695,0.295157834876284,1,1,1,actin filament uncapping,BP,ACTN2
4783,GO:0070080,0.295157834876284,1,1,1,titin Z domain binding,MF,ACTN2
5258,GO:0086097,0.295157834876284,1,1,1,phospholipase C-activating angiotensin-activated signaling pathway,BP,ACTN2
5588,GO:1901018,0.295157834876284,1,1,1,positive regulation of potassium ion transmembrane transporter activity,BP,ACTN2
5672,GO:1901881,0.295157834876284,1,1,1,positive regulation of protein depolymerization,BP,ACTN2
5913,GO:1904385,0.295157834876284,1,1,1,cellular response to angiotensin,BP,ACTN2
6022,GO:1990776,0.295157834876284,1,1,1,response to angiotensin,BP,ACTN2
6038,GO:2000008,0.295157834876284,1,1,1,regulation of protein localization to cell surface,BP,ACTN2
6039,GO:2000009,0.295157834876284,1,1,1,negative regulation of protein localization to cell surface,BP,ACTN2
6185,GO:2001135,0.295157834876284,1,1,1,regulation of endocytic recycling,BP,ACTN2
6186,GO:2001137,0.295157834876284,1,1,1,positive regulation of endocytic recycling,BP,ACTN2
6205,GO:2001259,0.295157834876284,1,1,1,positive regulation of cation channel activity,BP,ACTN2
893,GO:0006897,0.295923175313386,0.847342754787777,7,23,endocytosis,BP,MYO7A;MFGE8;PIK3R1;GAS6;RIN3;DLL1;UNC119
1084,GO:0008021,0.29631588315284,0.925685409313379,2,6,synaptic vesicle,CC,TMEM163;PDE4B
3396,GO:0044770,0.296536694888932,0.89920808252207,3,9,cell cycle phase transition,BP,CDKN1A;PHLDA1;FOXO4
3397,GO:0044772,0.296536694888932,0.89920808252207,3,9,mitotic cell cycle phase transition,BP,CDKN1A;PHLDA1;FOXO4
5532,GO:0101002,0.29720914961383,1,1,1,ficolin-1-rich granule,CC,CRISPLD2
5931,GO:1904813,0.29720914961383,1,1,1,ficolin-1-rich granule lumen,CC,CRISPLD2
5187,GO:0072341,0.297647431208055,0.930006439647387,2,5,modified amino acid binding,MF,MFGE8;GAS6
493,GO:0003723,0.298167414049086,0.937856228707806,2,4,RNA binding,MF,HMGN5;WT1
1305,GO:0010243,0.299923113173281,0.838774026224316,8,25,response to organonitrogen compound,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;FOXO4;PDE4B;CTGF;WT1
5199,GO:0072509,0.301411510166981,0.973566689909062,1,2,divalent inorganic cation transmembrane transporter activity,MF,GAS6
2138,GO:0030888,0.302855963200152,0.973287058949095,1,2,regulation of B cell proliferation,BP,CDKN1A
2139,GO:0030890,0.302855963200152,0.973287058949095,1,2,positive regulation of B cell proliferation,BP,CDKN1A
2948,GO:0042100,0.302855963200152,0.973287058949095,1,2,B cell proliferation,BP,CDKN1A
4036,GO:0050864,0.302855963200152,0.973287058949095,1,2,regulation of B cell activation,BP,CDKN1A
4042,GO:0050871,0.302855963200152,0.973287058949095,1,2,positive regulation of B cell activation,BP,CDKN1A
1054,GO:0007584,0.302954157480703,0.936095862282384,2,4,response to nutrient,BP,GAS6;ACSL4
3145,GO:0043230,0.304449664863126,0.802996203213554,17,60,extracellular organelle,CC,ACTN2;FRMPD1;RHOB;RHOJ;MFGE8;CLDN11;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DAAM2;ITGA3
4781,GO:0070062,0.304449664863126,0.802996203213554,17,60,extracellular exosome,CC,ACTN2;FRMPD1;RHOB;RHOJ;MFGE8;CLDN11;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DAAM2;ITGA3
5856,GO:1903561,0.304449664863126,0.802996203213554,17,60,extracellular vesicle,CC,ACTN2;FRMPD1;RHOB;RHOJ;MFGE8;CLDN11;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;DAAM2;ITGA3
3905,GO:0048731,0.304668650361151,0.793159327851591,32,123,system development,BP,ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;DHH;FOXO4;GPSM1;MARK4;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
887,GO:0006886,0.304835955707265,0.862268018911679,5,15,intracellular protein transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6
1444,GO:0010941,0.305286745691719,0.813318112675252,12,46,regulation of cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
86,GO:0001502,0.305591535797204,0.972752628273855,1,2,cartilage condensation,BP,CTGF
5472,GO:0098743,0.305591535797204,0.972752628273855,1,2,cell aggregation,BP,CTGF
3875,GO:0048646,0.305888005688804,0.810848873882093,13,46,anatomical structure formation involved in morphogenesis,BP,ACTN2;RHOB;MFGE8;LAMA5;ITGB5;SDC4;PRKACB;FHOD3;FOXO4;DLL1;CTGF;ITGA3;WT1
2152,GO:0030971,0.307712527368254,0.934321239700121,2,4,receptor tyrosine kinase binding,MF,PIK3R1;GAS6
6024,GO:1990782,0.307712527368254,0.934321239700121,2,4,protein tyrosine kinase binding,MF,PIK3R1;GAS6
2336,GO:0032182,0.309043598921249,1,1,1,ubiquitin-like protein binding,MF,MARK4
3116,GO:0043130,0.309043598921249,1,1,1,ubiquitin binding,MF,MARK4
3954,GO:0050321,0.309043598921249,1,1,1,tau-protein kinase activity,MF,MARK4
5435,GO:0097711,0.309043598921249,1,1,1,ciliary basal body docking,BP,MARK4
693,GO:0005865,0.310142712345993,1,1,1,striated muscle thin filament,CC,FHOD3
2874,GO:0036379,0.310142712345993,1,1,1,myofilament,CC,FHOD3
4250,GO:0051639,0.310142712345993,1,1,1,actin filament network formation,BP,FHOD3
4321,GO:0055003,0.310142712345993,1,1,1,cardiac myofibril assembly,BP,FHOD3
2051,GO:0030426,0.310604091348603,1,1,1,growth cone,CC,ITGA3
2052,GO:0030427,0.310604091348603,1,1,1,site of polarized growth,CC,ITGA3
2681,GO:0034667,0.310604091348603,1,1,1,integrin alpha3-beta1 complex,CC,ITGA3
2707,GO:0035023,0.310604091348603,1,1,1,regulation of Rho protein signal transduction,BP,ITGA3
2708,GO:0035024,0.310604091348603,1,1,1,negative regulation of Rho protein signal transduction,BP,ITGA3
2783,GO:0035640,0.310604091348603,1,1,1,exploration behavior,BP,ITGA3
3151,GO:0043236,0.310604091348603,1,1,1,laminin binding,MF,ITGA3
3664,GO:0046580,0.310604091348603,1,1,1,negative regulation of Ras protein signal transduction,BP,ITGA3
4029,GO:0050840,0.310604091348603,1,1,1,extracellular matrix binding,MF,ITGA3
4100,GO:0051058,0.310604091348603,1,1,1,negative regulation of small GTPase mediated signal transduction,BP,ITGA3
4977,GO:0071437,0.310604091348603,1,1,1,invadopodium,CC,ITGA3
4978,GO:0071438,0.310604091348603,1,1,1,invadopodium membrane,CC,ITGA3
5369,GO:0097062,0.310604091348603,1,1,1,dendritic spine maintenance,BP,ITGA3
5186,GO:0072332,0.310799666311315,0.971717472485223,1,2,intrinsic apoptotic signaling pathway by p53 class mediator,BP,CDKN1A
407,GO:0003159,0.310875202191932,0.971702287609132,1,2,morphogenesis of an endothelium,BP,RHOB
4694,GO:0061154,0.310875202191932,0.971702287609132,1,2,endothelial tube morphogenesis,BP,RHOB
1063,GO:0007601,0.311084109640615,0.93304884167269,2,4,visual perception,BP,MYO7A;UNC119
4070,GO:0050953,0.311084109640615,0.93304884167269,2,4,sensory perception of light stimulus,BP,MYO7A;UNC119
4873,GO:0070661,0.311912346755216,0.890933683112526,3,9,leukocyte proliferation,BP,CDKN1A;KITLG;SDC4
625,GO:0005516,0.312767970382869,0.932408702932152,2,4,calmodulin binding,MF,MYO7A;CAMSAP3
5697,GO:1902105,0.313510353550707,0.893557119793206,3,8,regulation of leukocyte differentiation,BP,KITLG;PIK3R1;GAS6
2039,GO:0030325,0.314812093068457,0.922845838515233,2,5,adrenal gland development,BP,DKK3;WT1
326,GO:0002683,0.315694312259925,0.872011399017411,4,11,negative regulation of immune system process,BP,KITLG;PIK3R1;SDC4;DLL1
3129,GO:0043197,0.31602911890779,0.931160067725387,2,4,dendritic spine,CC,ACTN2;PDE4B
3324,GO:0044309,0.31602911890779,0.931160067725387,2,4,neuron spine,CC,ACTN2;PDE4B
1216,GO:0009267,0.316519800097094,0.888399349539232,3,9,cellular response to starvation,BP,CDKN1A;NUAK2;GAS6
3046,GO:0042594,0.316519800097094,0.888399349539232,3,9,response to starvation,BP,CDKN1A;NUAK2;GAS6
521,GO:0004467,0.317771047217055,1,1,1,long-chain fatty acid-CoA ligase activity,MF,ACSL4
673,GO:0005777,0.317771047217055,1,1,1,peroxisome,CC,ACSL4
674,GO:0005778,0.317771047217055,1,1,1,peroxisomal membrane,CC,ACSL4
686,GO:0005811,0.317771047217055,1,1,1,lipid particle,CC,ACSL4
1553,GO:0015645,0.317771047217055,1,1,1,fatty acid ligase activity,MF,ACSL4
1713,GO:0016874,0.317771047217055,1,1,1,ligase activity,MF,ACSL4
1714,GO:0016877,0.317771047217055,1,1,1,ligase activity, forming carbon-sulfur bonds,MF,ACSL4
1715,GO:0016878,0.317771047217055,1,1,1,acid-thiol ligase activity,MF,ACSL4
2282,GO:0031903,0.317771047217055,1,1,1,microbody membrane,CC,ACSL4
2294,GO:0031957,0.317771047217055,1,1,1,very long-chain fatty acid-CoA ligase activity,MF,ACSL4
3037,GO:0042579,0.317771047217055,1,1,1,microbody,CC,ACSL4
3356,GO:0044438,0.317771047217055,1,1,1,microbody part,CC,ACSL4
3357,GO:0044439,0.317771047217055,1,1,1,peroxisomal part,CC,ACSL4
3741,GO:0047676,0.317771047217055,1,1,1,arachidonate-CoA ligase activity,MF,ACSL4
4406,GO:0060136,0.317771047217055,1,1,1,embryonic process involved in female pregnancy,BP,ACSL4
4881,GO:0070672,0.317771047217055,1,1,1,response to interleukin-15,BP,ACSL4
5535,GO:0102391,0.317771047217055,1,1,1,decanoate--CoA ligase activity,MF,ACSL4
3783,GO:0048259,0.31791782716708,0.970264774304635,1,2,regulation of receptor-mediated endocytosis,BP,UNC119
880,GO:0006869,0.318307065014316,0.921345283368892,2,5,lipid transport,BP,SERPINA5;ACSL4
1427,GO:0010876,0.318307065014316,0.921345283368892,2,5,lipid localization,BP,SERPINA5;ACSL4
1447,GO:0010950,0.318434970705953,0.970157511615183,1,2,positive regulation of endopeptidase activity,BP,CTGF
3170,GO:0043280,0.318434970705953,0.970157511615183,1,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CTGF
6181,GO:2001056,0.318434970705953,0.970157511615183,1,2,positive regulation of cysteine-type endopeptidase activity,BP,CTGF
3508,GO:0045619,0.318616222659075,0.970119861928505,1,2,regulation of lymphocyte differentiation,BP,GAS6
1914,GO:0022412,0.318621462533726,0.884518380024391,3,10,cellular process involved in reproduction in multicellular organism,BP,SERPINA5;DHH;WT1
3017,GO:0042490,0.319160544208222,0.895449828061724,3,7,mechanoreceptor differentiation,BP,MYO7A;SDC4;DLL1
4397,GO:0060113,0.319160544208222,0.895449828061724,3,7,inner ear receptor cell differentiation,BP,MYO7A;SDC4;DLL1
330,GO:0002687,0.319850017336862,0.920678206443155,2,5,positive regulation of leukocyte migration,BP,KITLG;GAS6
1100,GO:0008134,0.322030466956166,0.888960055592299,3,8,transcription factor binding,MF,PIK3R1;FOXO4;DLL1
4246,GO:0051604,0.322742038731555,0.91942023951336,2,5,protein maturation,BP,GAS6;PRKACB
2423,GO:0032504,0.323583150092776,0.826923128560364,7,24,multicellular organism reproduction,BP,KITLG;CLDN11;SERPINA5;ACSL4;DHH;ITGA3;WT1
3861,GO:0048609,0.323583150092776,0.826923128560364,7,24,multicellular organismal reproductive process,BP,KITLG;CLDN11;SERPINA5;ACSL4;DHH;ITGA3;WT1
2529,GO:0032945,0.3239082765377,0.969007830819082,1,2,negative regulation of mononuclear cell proliferation,BP,SDC4
2956,GO:0042129,0.3239082765377,0.969007830819082,1,2,regulation of T cell proliferation,BP,SDC4
2957,GO:0042130,0.3239082765377,0.969007830819082,1,2,negative regulation of T cell proliferation,BP,SDC4
3963,GO:0050672,0.3239082765377,0.969007830819082,1,2,negative regulation of lymphocyte proliferation,BP,SDC4
4040,GO:0050868,0.3239082765377,0.969007830819082,1,2,negative regulation of T cell activation,BP,SDC4
4876,GO:0070664,0.3239082765377,0.969007830819082,1,2,negative regulation of leukocyte proliferation,BP,SDC4
5791,GO:1903038,0.3239082765377,0.969007830819082,1,2,negative regulation of leukocyte cell-cell adhesion,BP,SDC4
589,GO:0005173,0.324267163445513,1,1,1,stem cell factor receptor binding,MF,KITLG
1355,GO:0010623,0.324267163445513,1,1,1,programmed cell death involved in cell development,BP,KITLG
2547,GO:0033023,0.324267163445513,1,1,1,mast cell homeostasis,BP,KITLG
2548,GO:0033024,0.324267163445513,1,1,1,mast cell apoptotic process,BP,KITLG
2549,GO:0033025,0.324267163445513,1,1,1,regulation of mast cell apoptotic process,BP,KITLG
2550,GO:0033026,0.324267163445513,1,1,1,negative regulation of mast cell apoptotic process,BP,KITLG
2551,GO:0033028,0.324267163445513,1,1,1,myeloid cell apoptotic process,BP,KITLG
2552,GO:0033032,0.324267163445513,1,1,1,regulation of myeloid cell apoptotic process,BP,KITLG
2553,GO:0033033,0.324267163445513,1,1,1,negative regulation of myeloid cell apoptotic process,BP,KITLG
2732,GO:0035234,0.324267163445513,1,1,1,ectopic germ cell programmed cell death,BP,KITLG
3513,GO:0045634,0.324267163445513,1,1,1,regulation of melanocyte differentiation,BP,KITLG
3514,GO:0045636,0.324267163445513,1,1,1,positive regulation of melanocyte differentiation,BP,KITLG
3760,GO:0048070,0.324267163445513,1,1,1,regulation of developmental pigmentation,BP,KITLG
3761,GO:0048087,0.324267163445513,1,1,1,positive regulation of developmental pigmentation,BP,KITLG
4067,GO:0050932,0.324267163445513,1,1,1,regulation of pigment cell differentiation,BP,KITLG
4068,GO:0050942,0.324267163445513,1,1,1,positive regulation of pigment cell differentiation,BP,KITLG
4874,GO:0070662,0.324267163445513,1,1,1,mast cell proliferation,BP,KITLG
4878,GO:0070666,0.324267163445513,1,1,1,regulation of mast cell proliferation,BP,KITLG
4879,GO:0070668,0.324267163445513,1,1,1,positive regulation of mast cell proliferation,BP,KITLG
5691,GO:1902033,0.324267163445513,1,1,1,regulation of hematopoietic stem cell proliferation,BP,KITLG
5692,GO:1902035,0.324267163445513,1,1,1,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
3611,GO:0045989,0.324735279048651,0.968831810248065,1,2,positive regulation of striated muscle contraction,BP,CTGF
4505,GO:0060452,0.324735279048651,0.968831810248065,1,2,positive regulation of cardiac muscle contraction,BP,CTGF
3944,GO:0048863,0.325425148159942,0.86347293236477,4,12,stem cell differentiation,BP,NRTN;KITLG;LAMA5;FOXO4
2260,GO:0031647,0.326362785609014,0.917831213419853,2,5,regulation of protein stability,BP,CDKN1A;PIK3R1
5515,GO:0099503,0.326683790518682,0.831343055286727,6,23,secretory vesicle,CC,ACTN2;GAS6;SERPINA5;CRISPLD2;TMEM163;PDE4B
2687,GO:0034698,0.326999425208013,0.926873280033638,2,4,response to gonadotropin,BP,ITGA3;WT1
3355,GO:0044437,0.327373031715627,0.917385048986036,2,5,vacuolar part,CC,MYO7A;SDC4
2422,GO:0032502,0.328058763947028,0.775398947683616,35,137,developmental process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;DHH;FOXO4;GPSM1;MARK4;DAAM2;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
3395,GO:0044767,0.328058763947028,0.775398947683616,35,137,single-organism developmental process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;DHH;FOXO4;GPSM1;MARK4;DAAM2;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
1560,GO:0015711,0.328534562328129,0.916870558014259,2,5,organic anion transport,BP,SLC52A3;ACSL4
5222,GO:0072657,0.329700870827943,0.833236372708697,6,19,protein localization to membrane,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
485,GO:0003682,0.329986797924804,0.925682670471959,2,4,chromatin binding,MF,HMGN5;FOXO4
3175,GO:0043297,0.331293982615541,0.967414190657624,1,2,apical junction assembly,BP,CLDN1
4892,GO:0070830,0.331293982615541,0.967414190657624,1,2,bicellular tight junction assembly,BP,CLDN1
4678,GO:0061097,0.332990579876272,0.909062700049511,2,6,regulation of protein tyrosine kinase activity,BP,GAS6;UNC119
4679,GO:0061098,0.332990579876272,0.909062700049511,2,6,positive regulation of protein tyrosine kinase activity,BP,GAS6;UNC119
5261,GO:0090003,0.333053255769697,0.924450113073739,2,4,regulation of establishment of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5798,GO:1903076,0.333053255769697,0.924450113073739,2,4,regulation of protein localization to plasma membrane,BP,PIK3R1;ITGA3
5874,GO:1903729,0.333053255769697,0.924450113073739,2,4,regulation of plasma membrane organization,BP,PIK3R1;ITGA3
5910,GO:1904375,0.333053255769697,0.924450113073739,2,4,regulation of protein localization to cell periphery,BP,PIK3R1;ITGA3
2645,GO:0034332,0.333763949086959,0.887722556900891,3,7,adherens junction organization,BP,ACTN2;LAMA5;SDC4
1161,GO:0008589,0.334831152601552,0.96663355876229,1,2,regulation of smoothened signaling pathway,BP,PRKACB
4894,GO:0070848,0.335455248100145,0.809227796496841,8,30,response to growth factor,BP,DKK3;GAS6;ITGB5;DLL1;CLDN1;CGN;CTGF;ITGA3
4956,GO:0071363,0.335455248100145,0.809227796496841,8,30,cellular response to growth factor stimulus,BP,DKK3;GAS6;ITGB5;DLL1;CLDN1;CGN;CTGF;ITGA3
200,GO:0001953,0.336641371954337,1,1,1,negative regulation of cell-matrix adhesion,BP,PIK3R1
561,GO:0005068,0.336641371954337,1,1,1,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1
581,GO:0005158,0.336641371954337,1,1,1,insulin receptor binding,MF,PIK3R1
582,GO:0005159,0.336641371954337,1,1,1,insulin-like growth factor receptor binding,MF,PIK3R1
585,GO:0005165,0.336641371954337,1,1,1,neurotrophin receptor binding,MF,PIK3R1
586,GO:0005167,0.336641371954337,1,1,1,neurotrophin TRK receptor binding,MF,PIK3R1
587,GO:0005168,0.336641371954337,1,1,1,neurotrophin TRKA receptor binding,MF,PIK3R1
925,GO:0006986,0.336641371954337,1,1,1,response to unfolded protein,BP,PIK3R1
2094,GO:0030674,0.336641371954337,1,1,1,protein binding, bridging,MF,PIK3R1
2151,GO:0030968,0.336641371954337,1,1,1,endoplasmic reticulum unfolded protein response,BP,PIK3R1
2481,GO:0032760,0.336641371954337,1,1,1,positive regulation of tumor necrosis factor production,BP,PIK3R1
2568,GO:0033120,0.336641371954337,1,1,1,positive regulation of RNA splicing,BP,PIK3R1
2669,GO:0034620,0.336641371954337,1,1,1,cellular response to unfolded protein,BP,PIK3R1
2775,GO:0035591,0.336641371954337,1,1,1,signaling adaptor activity,MF,PIK3R1
2833,GO:0035966,0.336641371954337,1,1,1,response to topologically incorrect protein,BP,PIK3R1
2834,GO:0035967,0.336641371954337,1,1,1,cellular response to topologically incorrect protein,BP,PIK3R1
2870,GO:0036312,0.336641371954337,1,1,1,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1
3115,GO:0043125,0.336641371954337,1,1,1,ErbB-3 class receptor binding,MF,PIK3R1
3213,GO:0043484,0.336641371954337,1,1,1,regulation of RNA splicing,BP,PIK3R1
3243,GO:0043559,0.336641371954337,1,1,1,insulin binding,MF,PIK3R1
3668,GO:0046626,0.336641371954337,1,1,1,regulation of insulin receptor signaling pathway,BP,PIK3R1
4229,GO:0051531,0.336641371954337,1,1,1,NFAT protein import into nucleus,BP,PIK3R1
4471,GO:0060396,0.336641371954337,1,1,1,growth hormone receptor signaling pathway,BP,PIK3R1
4962,GO:0071378,0.336641371954337,1,1,1,cellular response to growth hormone stimulus,BP,PIK3R1
5363,GO:0097038,0.336641371954337,1,1,1,perinuclear endoplasmic reticulum,CC,PIK3R1
5547,GO:1900101,0.336641371954337,1,1,1,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
5548,GO:1900103,0.336641371954337,1,1,1,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1
5855,GO:1903557,0.336641371954337,1,1,1,positive regulation of tumor necrosis factor superfamily cytokine production,BP,PIK3R1
6018,GO:1990578,0.336641371954337,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
2655,GO:0034394,0.336894568292563,0.966172918146172,1,2,protein localization to cell surface,BP,ACTN2
939,GO:0007034,0.3373506897641,0.92270490878071,2,4,vacuolar transport,BP,GPRASP1;RHOB
941,GO:0007041,0.3373506897641,0.92270490878071,2,4,lysosomal transport,BP,GPRASP1;RHOB
2444,GO:0032609,0.337884939980429,0.912669663204079,2,5,interferon-gamma production,BP,GAS6;PDE4B
2456,GO:0032649,0.337884939980429,0.912669663204079,2,5,regulation of interferon-gamma production,BP,GAS6;PDE4B
3724,GO:0046914,0.338462150957183,0.855256073332961,4,12,transition metal ion binding,MF,PRND;DHH;TMEM163;WT1
2493,GO:0032801,0.338506877450678,1,1,1,receptor catabolic process,BP,GPRASP1
3546,GO:0045744,0.338506877450678,1,1,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1
6005,GO:1990172,0.338506877450678,1,1,1,G-protein coupled receptor catabolic process,BP,GPRASP1
1147,GO:0008406,0.338821198667046,0.875772538221448,3,9,gonad development,BP,KITLG;DHH;WT1
3446,GO:0045137,0.338821198667046,0.875772538221448,3,9,development of primary sexual characteristics,BP,KITLG;DHH;WT1
3463,GO:0045210,0.339429767196147,1,1,1,FasL biosynthetic process,BP,PHLDA1
4866,GO:0070588,0.340194798492892,0.911615595417872,2,5,calcium ion transmembrane transport,BP,GAS6;PDE4B
335,GO:0002696,0.34204034659863,0.873900335675567,3,9,positive regulation of leukocyte activation,BP,CDKN1A;PIK3R1;GAS6
544,GO:0004860,0.342177415423191,0.964975762575999,1,2,protein kinase inhibitor activity,MF,CDKN1A
1774,GO:0019210,0.342177415423191,0.964975762575999,1,2,kinase inhibitor activity,MF,CDKN1A
2027,GO:0030291,0.342177415423191,0.964975762575999,1,2,protein serine/threonine kinase inhibitor activity,MF,CDKN1A
4654,GO:0061024,0.342243887364567,0.798318043807522,9,33,membrane organization,BP,ACTN2;REEP1;MFGE8;PIK3R1;LAMA5;GAS6;SERPINA5;RIN3;ITGA3
1128,GO:0008277,0.342299796803692,0.910649356663838,2,5,regulation of G-protein coupled receptor protein signaling pathway,BP,GPRASP1;GPSM1
943,GO:0007044,0.342369895905787,0.883050939441588,3,7,cell-substrate junction assembly,BP,ACTN2;LAMA5;SDC4
4716,GO:0061318,0.342675376673819,0.964861590147969,1,2,renal filtration cell differentiation,BP,WT1
5063,GO:0072010,0.342675376673819,0.964861590147969,1,2,glomerular epithelium development,BP,WT1
5077,GO:0072050,0.342675376673819,0.964861590147969,1,2,S-shaped body morphogenesis,BP,WT1
5111,GO:0072112,0.342675376673819,0.964861590147969,1,2,glomerular visceral epithelial cell differentiation,BP,WT1
5160,GO:0072217,0.342675376673819,0.964861590147969,1,2,negative regulation of metanephros development,BP,WT1
5174,GO:0072284,0.342675376673819,0.964861590147969,1,2,metanephric S-shaped body morphogenesis,BP,WT1
5181,GO:0072311,0.342675376673819,0.964861590147969,1,2,glomerular epithelial cell differentiation,BP,WT1
2530,GO:0032946,0.344172144717499,0.953794575306166,1,3,positive regulation of mononuclear cell proliferation,BP,CDKN1A
3962,GO:0050671,0.344172144717499,0.953794575306166,1,3,positive regulation of lymphocyte proliferation,BP,CDKN1A
60,GO:0000981,0.344319536976671,0.90971717040779,2,5,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,FOXO4;WT1
258,GO:0002253,0.345838668402549,0.875655288585706,3,8,activation of immune response,BP,PIK3R1;PRKACB;PDE4B
350,GO:0002757,0.345838668402549,0.875655288585706,3,8,immune response-activating signal transduction,BP,PIK3R1;PRKACB;PDE4B
355,GO:0002764,0.345838668402549,0.875655288585706,3,8,immune response-regulating signaling pathway,BP,PIK3R1;PRKACB;PDE4B
2742,GO:0035295,0.34621676532654,0.790308624841041,10,36,tube development,BP,CDKN1A;RHOB;LAMA5;SDC4;PRKACB;CRISPLD2;DLL1;CTGF;ITGA3;WT1
716,GO:0005929,0.347030337446808,0.880484334968491,3,7,cilium,CC,MYO7A;PRKACB;MARK4
3359,GO:0044441,0.347030337446808,0.880484334968491,3,7,ciliary part,CC,MYO7A;PRKACB;MARK4
3081,GO:0042981,0.347577984490651,0.783466508442393,11,43,regulation of apoptotic process,BP,ACTN2;CDKN1A;RHOB;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;CTGF;WT1
4055,GO:0050900,0.348082246071194,0.81889624390259,6,20,leukocyte migration,BP,KITLG;PIK3R1;GAS6;SDC4;PDE4B;ITGA3
1726,GO:0017048,0.348179529614974,1,1,1,Rho GTPase binding,MF,DAAM2
877,GO:0006839,0.350102655825925,0.963131220209313,1,2,mitochondrial transport,BP,SLC25A53
2295,GO:0031960,0.3517287910901,0.868189698406537,3,9,response to corticosteroid,BP,CDKN1A;CLDN1;CTGF
1852,GO:0021549,0.352271477047463,0.962616158816101,1,2,cerebellum development,BP,DLL1
1853,GO:0021575,0.352271477047463,0.962616158816101,1,2,hindbrain morphogenesis,BP,DLL1
1854,GO:0021587,0.352271477047463,0.962616158816101,1,2,cerebellum morphogenesis,BP,DLL1
1865,GO:0021695,0.352271477047463,0.962616158816101,1,2,cerebellar cortex development,BP,DLL1
1866,GO:0021696,0.352271477047463,0.962616158816101,1,2,cerebellar cortex morphogenesis,BP,DLL1
1867,GO:0021697,0.352271477047463,0.962616158816101,1,2,cerebellar cortex formation,BP,DLL1
1903,GO:0022037,0.352271477047463,0.962616158816101,1,2,metencephalon development,BP,DLL1
4226,GO:0051494,0.355166735332169,0.884304979529614,3,6,negative regulation of cytoskeleton organization,BP,PLEKHH2;FHOD3;ESPN
3036,GO:0042578,0.356002139617656,0.904226923662507,2,5,phosphoric ester hydrolase activity,MF,PTPN7;PDE4B
127,GO:0001709,0.356132664347323,0.96168812952911,1,2,cell fate determination,BP,DLL1
1060,GO:0007596,0.356807287078758,0.824062593649839,5,17,blood coagulation,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5
1061,GO:0007599,0.356807287078758,0.824062593649839,5,17,hemostasis,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5
4021,GO:0050817,0.356807287078758,0.824062593649839,5,17,coagulation,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5
273,GO:0002312,0.356927169350679,0.961495405597133,1,2,B cell activation involved in immune response,BP,DLL1
3210,GO:0043473,0.357185783600724,0.903661262240372,2,5,pigmentation,BP,MYO7A;KITLG
2391,GO:0032386,0.358020407613687,0.842561997914671,4,12,regulation of intracellular transport,BP,CDKN1A;REEP1;PIK3R1;GAS6
4472,GO:0060401,0.358900838943166,0.961014028179865,1,2,cytosolic calcium ion transport,BP,CTGF
6097,GO:2000278,0.359780742428801,0.960798211374346,1,2,regulation of DNA biosynthetic process,BP,CDKN1A
3764,GO:0048145,0.359948630558375,0.895775720563449,2,6,regulation of fibroblast proliferation,BP,CDKN1A;GAS6
3765,GO:0048146,0.359948630558375,0.895775720563449,2,6,positive regulation of fibroblast proliferation,BP,CDKN1A;GAS6
3675,GO:0046661,0.360217697901604,0.859908642505249,3,10,male sex differentiation,BP,KITLG;DHH;WT1
1610,GO:0016197,0.361311126798999,0.862428781070614,3,9,endosomal transport,BP,ACTN2;GPRASP1;RHOB
929,GO:0007009,0.362558270832829,0.823461452483464,5,15,plasma membrane organization,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
5223,GO:0072659,0.362558270832829,0.823461452483464,5,15,protein localization to plasma membrane,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
6023,GO:1990778,0.362558270832829,0.823461452483464,5,15,protein localization to cell periphery,BP,ACTN2;PIK3R1;LAMA5;GAS6;ITGA3
1833,GO:0019904,0.36496430012199,0.821764562762707,5,15,protein domain specific binding,MF,ACTN2;MYO7A;ESPN;ITGA3;WT1
1241,GO:0009719,0.365047819491402,0.762502873885078,13,49,response to endogenous stimulus,BP,ACTN2;CDKN1A;DKK3;PIK3R1;ITGB5;PRKACB;FOXO4;PDE4B;CLDN1;CGN;CTGF;ITGA3;WT1
248,GO:0002220,0.365384796115867,0.959406078199242,1,2,innate immune response activating cell surface receptor signaling pathway,BP,PRKACB
250,GO:0002223,0.365384796115867,0.959406078199242,1,2,stimulatory C-type lectin receptor signaling pathway,BP,PRKACB
5047,GO:0071887,0.365562097228531,0.899608330557265,2,5,leukocyte apoptotic process,BP,KITLG;GAS6
168,GO:0001843,0.366666548736509,0.89906737911569,2,5,neural tube closure,BP,SDC4;PRKACB
1062,GO:0007600,0.366823238049488,0.834260612800154,4,13,sensory perception,BP,MYO7A;SLC52A3;ESPN;UNC119
2959,GO:0042149,0.367814297215366,0.958793027054178,1,2,cellular response to glucose starvation,BP,NUAK2
1089,GO:0008064,0.368112544794,0.877327213073653,3,6,regulation of actin polymerization or depolymerization,BP,ACTN2;PLEKHH2;FHOD3
1105,GO:0008154,0.368112544794,0.877327213073653,3,6,actin polymerization or depolymerization,BP,ACTN2;PLEKHH2;FHOD3
2116,GO:0030832,0.368112544794,0.877327213073653,3,6,regulation of actin filament length,BP,ACTN2;PLEKHH2;FHOD3
1978,GO:0030133,0.369606931608983,0.849400589840485,3,12,transport vesicle,CC,CRISPLD2;TMEM163;PDE4B
146,GO:0001776,0.370351827646458,0.897251244541342,2,5,leukocyte homeostasis,BP,KITLG;PDE4B
1243,GO:0009743,0.37090072072364,0.890112322547669,2,6,response to carbohydrate,BP,GAS6;CTGF
1245,GO:0009746,0.37090072072364,0.890112322547669,2,6,response to hexose,BP,GAS6;CTGF
1246,GO:0009749,0.37090072072364,0.890112322547669,2,6,response to glucose,BP,GAS6;CTGF
2640,GO:0034284,0.37090072072364,0.890112322547669,2,6,response to monosaccharide,BP,GAS6;CTGF
1236,GO:0009636,0.372571715123852,0.896148986528277,2,5,response to toxic substance,BP,CDKN1A;CLDN1
820,GO:0006612,0.373339113184635,0.957377233007135,1,2,protein targeting to membrane,BP,GAS6
3118,GO:0043154,0.374447650845985,0.957089503486284,1,2,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,GAS6
6067,GO:2000117,0.374447650845985,0.957089503486284,1,2,negative regulation of cysteine-type endopeptidase activity,BP,GAS6
3516,GO:0045638,0.374669537550906,0.895101596764014,2,5,negative regulation of myeloid cell differentiation,BP,PIK3R1;DLL1
18,GO:0000146,0.37474907864624,1,1,1,microfilament motor activity,MF,MYO7A
137,GO:0001754,0.37474907864624,1,1,1,eye photoreceptor cell differentiation,BP,MYO7A
183,GO:0001917,0.37474907864624,1,1,1,photoreceptor inner segment,CC,MYO7A
239,GO:0002093,0.37474907864624,1,1,1,auditory receptor cell morphogenesis,BP,MYO7A
240,GO:0002139,0.37474907864624,1,1,1,stereocilia coupling link,CC,MYO7A
241,GO:0002140,0.37474907864624,1,1,1,stereocilia tip link,CC,MYO7A
1256,GO:0009886,0.37474907864624,1,1,1,post-embryonic animal morphogenesis,BP,MYO7A
1657,GO:0016461,0.37474907864624,1,1,1,unconventional myosin complex,CC,MYO7A
1716,GO:0016887,0.37474907864624,1,1,1,ATPase activity,MF,MYO7A
2140,GO:0030898,0.37474907864624,1,1,1,actin-dependent ATPase activity,MF,MYO7A
2236,GO:0031477,0.37474907864624,1,1,1,myosin VII complex,CC,MYO7A
3006,GO:0042461,0.37474907864624,1,1,1,photoreceptor cell development,BP,MYO7A
3007,GO:0042462,0.37474907864624,1,1,1,eye photoreceptor cell development,BP,MYO7A
3047,GO:0042623,0.37474907864624,1,1,1,ATPase activity, coupled,MF,MYO7A
3228,GO:0043531,0.37474907864624,1,1,1,ADP binding,MF,MYO7A
3844,GO:0048563,0.37474907864624,1,1,1,post-embryonic animal organ morphogenesis,BP,MYO7A
3848,GO:0048569,0.37474907864624,1,1,1,post-embryonic animal organ development,BP,MYO7A
4394,GO:0060088,0.37474907864624,1,1,1,auditory receptor cell stereocilium organization,BP,MYO7A
4398,GO:0060117,0.37474907864624,1,1,1,auditory receptor cell development,BP,MYO7A
6014,GO:1990427,0.37474907864624,1,1,1,stereocilia tip-link density,CC,MYO7A
6016,GO:1990435,0.37474907864624,1,1,1,upper tip-link density,CC,MYO7A
871,GO:0006816,0.374975098567949,0.854018264752599,3,9,calcium ion transport,BP,GAS6;PDE4B;CTGF
393,GO:0003104,0.375042981151726,0.95693447379038,1,2,positive regulation of glomerular filtration,BP,GAS6
3101,GO:0043066,0.37510367504912,0.777903224997436,8,31,negative regulation of apoptotic process,BP,CDKN1A;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;WT1
3104,GO:0043069,0.37510367504912,0.777903224997436,8,31,negative regulation of programmed cell death,BP,CDKN1A;KITLG;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;WT1
325,GO:0002682,0.375362121930819,0.77898277754634,8,29,regulation of immune system process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;DLL1;PDE4B
1292,GO:0010033,0.375678834833127,0.742712531248381,17,69,response to organic substance,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;ITGB5;PRKACB;ACSL4;DHH;FOXO4;DLL1;PDE4B;CLDN1;CGN;CTGF;ITGA3;WT1
5440,GO:0097734,0.376546646479232,0.956541322987153,1,2,extracellular exosome biogenesis,BP,SDC4
6006,GO:1990182,0.376546646479232,0.956541322987153,1,2,exosomal secretion,BP,SDC4
1012,GO:0007286,0.378188415701413,0.956109466992827,1,2,spermatid development,BP,DHH
3825,GO:0048515,0.378188415701413,0.956109466992827,1,2,spermatid differentiation,BP,DHH
92,GO:0001523,0.378564501451195,0.956010157608503,1,2,retinoid metabolic process,BP,SDC4
848,GO:0006721,0.378564501451195,0.956010157608503,1,2,terpenoid metabolic process,BP,SDC4
1605,GO:0016101,0.378564501451195,0.956010157608503,1,2,diterpenoid metabolic process,BP,SDC4
3290,GO:0044089,0.378698504152168,0.822276551274502,4,15,positive regulation of cellular component biogenesis,BP,SDC4;ESPN;CLDN1;CTGF
562,GO:0005080,0.379311666968292,0.955812436603449,1,2,protein kinase C binding,MF,SDC4
4146,GO:0051205,0.381710722992243,0.955173753527912,1,2,protein insertion into membrane,BP,REEP1
199,GO:0001952,0.38193241553466,0.89143210243433,2,5,regulation of cell-matrix adhesion,BP,PIK3R1;SDC4
700,GO:0005887,0.382579626421542,0.766346140327489,9,33,integral component of plasma membrane,CC,SLC52A3;ITGB5;MPZL1;SDC4;ITGB8;DLL1;CLDN1;SLC18B1;ITGA3
539,GO:0004721,0.382782833291872,0.954886440849729,1,2,phosphoprotein phosphatase activity,MF,PTPN7
540,GO:0004725,0.382782833291872,0.954886440849729,1,2,protein tyrosine phosphatase activity,MF,PTPN7
2752,GO:0035335,0.382782833291872,0.954886440849729,1,2,peptidyl-tyrosine dephosphorylation,BP,PTPN7
4843,GO:0070382,0.38382067544771,0.878384574173313,2,7,exocytic vesicle,CC,TMEM163;PDE4B
4655,GO:0061025,0.384394224805278,0.878063084577786,2,7,membrane fusion,BP,GAS6;SERPINA5
5446,GO:0098552,0.385892299663703,0.823702989881563,4,12,side of membrane,CC,MFGE8;SERPINA5;PTPN7;ITGA3
1011,GO:0007283,0.390892066245666,0.843927658177579,3,9,spermatogenesis,BP,CLDN11;SERPINA5;DHH
3775,GO:0048232,0.390892066245666,0.843927658177579,3,9,male gamete generation,BP,CLDN11;SERPINA5;DHH
1255,GO:0009880,0.391758551289362,0.878892610707459,2,6,embryonic pattern specification,BP,DLL1;WT1
1306,GO:0010256,0.392451933691939,0.787159982996744,6,19,endomembrane system organization,BP,ACTN2;REEP1;PIK3R1;LAMA5;GAS6;ITGA3
1721,GO:0017016,0.393158101778336,0.898091264839181,2,4,Ras GTPase binding,MF,RIN3;DAAM2
2203,GO:0031267,0.393158101778336,0.898091264839181,2,4,small GTPase binding,MF,RIN3;DAAM2
4085,GO:0051020,0.393158101778336,0.898091264839181,2,4,GTPase binding,MF,RIN3;DAAM2
564,GO:0005088,0.39344788358683,0.81360355693598,4,14,Ras guanyl-nucleotide exchange factor activity,MF,ACTN2;NRTN;KITLG;RIN3
5884,GO:1903828,0.393542658817512,0.885425146556401,2,5,negative regulation of cellular protein localization,BP,ACTN2;GAS6
2976,GO:0042306,0.393929501217966,0.841965847502401,3,9,regulation of protein import into nucleus,BP,CDKN1A;PIK3R1;GAS6
3691,GO:0046822,0.393929501217966,0.841965847502401,3,9,regulation of nucleocytoplasmic transport,BP,CDKN1A;PIK3R1;GAS6
5846,GO:1903533,0.393929501217966,0.841965847502401,3,9,regulation of protein targeting,BP,CDKN1A;PIK3R1;GAS6
5917,GO:1904589,0.393929501217966,0.841965847502401,3,9,regulation of protein import,BP,CDKN1A;PIK3R1;GAS6
5638,GO:1901576,0.394211801502552,0.72495892623589,18,73,organic substance biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;SDC4;HMGN5;ACSL4;DHH;FOXO4;DLL1;CTGF;ITGA3;WT1
55,GO:0000930,0.394331543344147,0.951716472883317,1,2,gamma-tubulin complex,CC,PDE4B
3365,GO:0044450,0.394331543344147,0.951716472883317,1,2,microtubule organizing center part,CC,PDE4B
2421,GO:0032501,0.394628154555934,0.722067595568527,38,152,multicellular organismal process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;SLC52A3;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;DHH;FOXO4;ESPN;GPSM1;MARK4;DAAM2;DLL1;PDE4B;CLDN1;CTGF;UNC119;ITGA3;WT1
2578,GO:0033209,0.394731372926305,0.951604238221842,1,2,tumor necrosis factor-mediated signaling pathway,BP,GAS6
4327,GO:0055013,0.394816896734858,0.884755210033832,2,5,cardiac muscle cell development,BP,ACTN2;FHOD3
4133,GO:0051180,0.395022806271731,0.9515223251233,1,2,vitamin transport,BP,SLC52A3
4135,GO:0051183,0.395022806271731,0.9515223251233,1,2,vitamin transporter activity,MF,SLC52A3
4530,GO:0060539,0.395833797543844,0.951293909265842,1,2,diaphragm development,BP,WT1
4555,GO:0060606,0.396180735470269,0.876439605698393,2,6,tube closure,BP,SDC4;PRKACB
1283,GO:0009986,0.396291479122563,0.761493691498186,8,30,cell surface,CC,RHOB;MFGE8;ITGB5;MPZL1;SDC4;ITGB8;SERPINA5;ITGA3
5161,GO:0072223,0.397135040539506,0.950925963821404,1,2,metanephric glomerular mesangium development,BP,WT1
5162,GO:0072224,0.397135040539506,0.950925963821404,1,2,metanephric glomerulus development,BP,WT1
5165,GO:0072239,0.397135040539506,0.950925963821404,1,2,metanephric glomerulus vasculature development,BP,WT1
2287,GO:0031944,0.397365740736388,0.950860543146906,1,2,negative regulation of glucocorticoid metabolic process,BP,DKK3
2290,GO:0031947,0.397365740736388,0.950860543146906,1,2,negative regulation of glucocorticoid biosynthetic process,BP,DKK3
2376,GO:0032345,0.397365740736388,0.950860543146906,1,2,negative regulation of aldosterone metabolic process,BP,DKK3
2379,GO:0032348,0.397365740736388,0.950860543146906,1,2,negative regulation of aldosterone biosynthetic process,BP,DKK3
2382,GO:0032351,0.397365740736388,0.950860543146906,1,2,negative regulation of hormone metabolic process,BP,DKK3
2384,GO:0032353,0.397365740736388,0.950860543146906,1,2,negative regulation of hormone biosynthetic process,BP,DKK3
5269,GO:0090032,0.397365740736388,0.950860543146906,1,2,negative regulation of steroid hormone biosynthetic process,BP,DKK3
6057,GO:2000065,0.397365740736388,0.950860543146906,1,2,negative regulation of cortisol biosynthetic process,BP,DKK3
1178,GO:0009059,0.398144689491802,0.727966684372166,15,60,macromolecule biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;SDC4;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1888,GO:0021904,0.399341409377285,0.950297982916065,1,2,dorsal/ventral neural tube patterning,BP,PRKACB
4186,GO:0051291,0.399894040107277,0.935391039161841,1,3,protein heterooligomerization,BP,CLDN1
102,GO:0001573,0.399952719198427,1,1,1,ganglioside metabolic process,BP,ITGB8
830,GO:0006643,0.399952719198427,1,1,1,membrane lipid metabolic process,BP,ITGB8
834,GO:0006664,0.399952719198427,1,1,1,glycolipid metabolic process,BP,ITGB8
835,GO:0006665,0.399952719198427,1,1,1,sphingolipid metabolic process,BP,ITGB8
836,GO:0006672,0.399952719198427,1,1,1,ceramide metabolic process,BP,ITGB8
837,GO:0006687,0.399952719198427,1,1,1,glycosphingolipid metabolic process,BP,ITGB8
2683,GO:0034686,0.399952719198427,1,1,1,integrin alphav-beta8 complex,CC,ITGB8
5835,GO:1903509,0.399952719198427,1,1,1,liposaccharide metabolic process,BP,ITGB8
6015,GO:1990430,0.399952719198427,1,1,1,extracellular matrix protein binding,MF,ITGB8
1631,GO:0016324,0.400056395084762,0.813768201120193,4,12,apical plasma membrane,CC,MYO7A;SLC52A3;DLL1;CLDN1
4627,GO:0060911,0.400578598149413,0.9499435869496,1,2,cardiac cell fate commitment,BP,WT1
4630,GO:0060923,0.400578598149413,0.9499435869496,1,2,cardiac muscle cell fate commitment,BP,WT1
3296,GO:0044232,0.401280587656919,0.949741773968633,1,2,organelle membrane contact site,CC,ACSL4
3297,GO:0044233,0.401280587656919,0.949741773968633,1,2,ER-mitochondrion membrane contact site,CC,ACSL4
1064,GO:0007602,0.401850632236815,0.949577505788113,1,2,phototransduction,BP,UNC119
1225,GO:0009583,0.401850632236815,0.949577505788113,1,2,detection of light stimulus,BP,UNC119
4172,GO:0051259,0.402552731220055,0.832666155985284,3,10,protein oligomerization,BP,ACTN2;PRND;CLDN1
3462,GO:0045202,0.40399837918471,0.776760075936309,6,20,synapse,CC,ACTN2;MYO7A;LAMA5;TMEM163;PDE4B;ITGA3
3086,GO:0042995,0.404115823457495,0.73904530919253,11,38,cell projection,CC,ACTN2;MYO7A;NRTN;KITLG;PLEKHH2;PRKACB;RAB39B;ESPN;MARK4;PDE4B;ITGA3
5536,GO:0120025,0.404115823457495,0.73904530919253,11,38,plasma membrane bounded cell projection,CC,ACTN2;MYO7A;NRTN;KITLG;PLEKHH2;PRKACB;RAB39B;ESPN;MARK4;PDE4B;ITGA3
105,GO:0001618,0.404165231149045,0.87977506248527,2,5,virus receptor activity,MF,ITGB5;CLDN1
821,GO:0006629,0.404206731307435,0.75573712521481,8,29,lipid metabolic process,BP,HMGCS2;DKK3;KITLG;PIK3R1;SDC4;ITGB8;ACSL4;DHH
4357,GO:0055119,0.40550144404242,0.948517188300825,1,2,relaxation of cardiac muscle,BP,PDE4B
5595,GO:1901077,0.40550144404242,0.948517188300825,1,2,regulation of relaxation of muscle,BP,PDE4B
5675,GO:1901897,0.40550144404242,0.948517188300825,1,2,regulation of relaxation of cardiac muscle,BP,PDE4B
3441,GO:0045121,0.405800766202306,0.878891891708018,2,5,membrane raft,CC,SDC4;DLL1
5492,GO:0098857,0.405800766202306,0.878891891708018,2,5,membrane microdomain,CC,SDC4;DLL1
5484,GO:0098802,0.406850913273668,0.838398808126269,3,8,plasma membrane receptor complex,CC,ITGB5;ITGB8;ITGA3
1438,GO:0010921,0.407378033808672,0.947966566161765,1,2,regulation of phosphatase activity,BP,CAMSAP3
1527,GO:0014911,0.407564394659981,0.947911676343681,1,2,positive regulation of smooth muscle cell migration,BP,FOXO4
4121,GO:0051151,0.407564394659981,0.947911676343681,1,2,negative regulation of smooth muscle cell differentiation,BP,FOXO4
661,GO:0005759,0.407652699339952,0.94788565433531,1,2,mitochondrial matrix,CC,HMGCS2
4703,GO:0061213,0.407790117094102,0.932466876007792,1,3,positive regulation of mesonephros development,BP,WT1
2643,GO:0034330,0.407873045877878,0.786478132202754,5,17,cell junction organization,BP,ACTN2;CAMSAP3;LAMA5;SDC4;CLDN1
1762,GO:0019058,0.407968848316218,0.837672600842329,3,8,viral life cycle,BP,GAS6;ITGB5;CLDN1
2415,GO:0032456,0.40830171724638,0.947694138704721,1,2,endocytic recycling,BP,ACTN2
3202,GO:0043434,0.408359043023451,0.786106492424629,5,17,response to peptide hormone,BP,ACTN2;PIK3R1;PRKACB;FOXO4;CTGF
2311,GO:0032008,0.408553060079123,0.947619847980655,1,2,positive regulation of TOR signaling,BP,GAS6
1822,GO:0019882,0.408856138011252,0.947530174101655,1,2,antigen processing and presentation,BP,ITGB5
3862,GO:0048630,0.409262560964634,0.947409765558837,1,2,skeletal muscle tissue growth,BP,DLL1
3863,GO:0048631,0.409262560964634,0.947409765558837,1,2,regulation of skeletal muscle tissue growth,BP,DLL1
3864,GO:0048633,0.409262560964634,0.947409765558837,1,2,positive regulation of skeletal muscle tissue growth,BP,DLL1
3871,GO:0048641,0.409262560964634,0.947409765558837,1,2,regulation of skeletal muscle tissue development,BP,DLL1
3872,GO:0048643,0.409262560964634,0.947409765558837,1,2,positive regulation of skeletal muscle tissue development,BP,DLL1
5658,GO:1901700,0.410062419737397,0.727174400934224,12,48,response to oxygen-containing compound,BP,ACTN2;CDKN1A;RHOB;PIK3R1;GAS6;PRKACB;DHH;FOXO4;PDE4B;CLDN1;CTGF;WT1
5368,GO:0097061,0.410849286835306,0.946937947886115,1,2,dendritic spine organization,BP,ITGA3
103,GO:0001578,0.411027263816856,0.946884853999146,1,2,microtubule bundle formation,BP,MARK4
643,GO:0005606,0.411689340770632,1,1,1,laminin-1 complex,CC,LAMA1
644,GO:0005608,0.411689340770632,1,1,1,laminin-3 complex,CC,LAMA1
2268,GO:0031668,0.411750029904576,0.826447408611956,3,10,cellular response to extracellular stimulus,BP,CDKN1A;NUAK2;GAS6
2269,GO:0031669,0.411750029904576,0.826447408611956,3,10,cellular response to nutrient levels,BP,CDKN1A;NUAK2;GAS6
406,GO:0003158,0.411885204282849,0.802501946400492,4,13,endothelium development,BP,RHOB;LAMA5;DLL1;CLDN1
61,GO:0000982,0.411961886784812,0.94660546789545,1,2,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,WT1
4610,GO:0060839,0.412865565424821,0.946334419023252,1,2,endothelial cell fate commitment,BP,DLL1
3400,GO:0044782,0.413134745348717,0.888363900967561,2,4,cilium organization,BP,LAMA5;MARK4
4429,GO:0060271,0.413134745348717,0.888363900967561,2,4,cilium assembly,BP,LAMA5;MARK4
4988,GO:0071495,0.413646548438571,0.724747480863264,12,46,cellular response to endogenous stimulus,BP,ACTN2;DKK3;PIK3R1;ITGB5;PRKACB;FOXO4;PDE4B;CLDN1;CGN;CTGF;ITGA3;WT1
4812,GO:0070252,0.413678752866525,0.874587865604056,2,5,actin-mediated cell contraction,BP,ACTN2;PDE4B
2750,GO:0035315,0.414949558432253,0.887455223728634,2,4,hair cell differentiation,BP,MYO7A;DLL1
3018,GO:0042491,0.414949558432253,0.887455223728634,2,4,auditory receptor cell differentiation,BP,MYO7A;DLL1
147,GO:0001779,0.416982722426291,0.94508810241393,1,2,natural killer cell differentiation,BP,GAS6
4647,GO:0060996,0.416990627122708,0.945085691469422,1,2,dendritic spine development,BP,ACSL4
1441,GO:0010927,0.417744355145467,0.872334057262963,2,5,cellular component assembly involved in morphogenesis,BP,ACTN2;FHOD3
2015,GO:0030239,0.417744355145467,0.872334057262963,2,5,myofibril assembly,BP,ACTN2;FHOD3
4531,GO:0060541,0.417889172943707,0.778765051361484,5,17,respiratory system development,BP,LAMA5;CRISPLD2;CTGF;ITGA3;WT1
4960,GO:0071375,0.419280006692051,0.797059010352525,4,13,cellular response to peptide hormone stimulus,BP,ACTN2;PIK3R1;PRKACB;FOXO4
5648,GO:1901653,0.419280006692051,0.797059010352525,4,13,cellular response to peptide,BP,ACTN2;PIK3R1;PRKACB;FOXO4
2392,GO:0032387,0.419360091763961,0.944359858138566,1,2,negative regulation of intracellular transport,BP,GAS6
2978,GO:0042308,0.419360091763961,0.944359858138566,1,2,negative regulation of protein import into nucleus,BP,GAS6
3201,GO:0043433,0.419360091763961,0.944359858138566,1,2,negative regulation of sequence-specific DNA binding transcription factor activity,BP,GAS6
3692,GO:0046823,0.419360091763961,0.944359858138566,1,2,negative regulation of nucleocytoplasmic transport,BP,GAS6
5330,GO:0090317,0.419360091763961,0.944359858138566,1,2,negative regulation of intracellular protein transport,BP,GAS6
5918,GO:1904590,0.419360091763961,0.944359858138566,1,2,negative regulation of protein import,BP,GAS6
201,GO:0001954,0.419469548636956,0.944326176714645,1,2,positive regulation of cell-matrix adhesion,BP,SDC4
4285,GO:0051893,0.419469548636956,0.944326176714645,1,2,regulation of focal adhesion assembly,BP,SDC4
4286,GO:0051894,0.419469548636956,0.944326176714645,1,2,positive regulation of focal adhesion assembly,BP,SDC4
5284,GO:0090109,0.419469548636956,0.944326176714645,1,2,regulation of cell-substrate junction assembly,BP,SDC4
5822,GO:1903391,0.419469548636956,0.944326176714645,1,2,regulation of adherens junction organization,BP,SDC4
5823,GO:1903393,0.419469548636956,0.944326176714645,1,2,positive regulation of adherens junction organization,BP,SDC4
3368,GO:0044456,0.419835018773792,0.777253468185264,5,17,synapse part,CC,ACTN2;LAMA5;TMEM163;PDE4B;ITGA3
1449,GO:0010952,0.420004648587016,0.927779869273763,1,3,positive regulation of peptidase activity,BP,CTGF
118,GO:0001676,0.420520382338522,0.944002136482475,1,2,long-chain fatty acid metabolic process,BP,ACSL4
4974,GO:0071417,0.421298089143142,0.763054404886578,6,20,cellular response to organonitrogen compound,BP,ACTN2;PIK3R1;PRKACB;FOXO4;PDE4B;WT1
2046,GO:0030374,0.421505331286831,0.94369728601565,1,2,ligand-dependent nuclear receptor transcription coactivator activity,MF,ACTN2
5378,GO:0097110,0.422039268806408,0.943531570840442,1,2,scaffold protein binding,MF,DLL1
1177,GO:0009058,0.422268006677995,0.700111982073609,18,74,biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;SDC4;HMGN5;ACSL4;DHH;FOXO4;DLL1;CTGF;ITGA3;WT1
1462,GO:0014002,0.422803480987507,0.943293826754866,1,2,astrocyte development,BP,DLL1
3122,GO:0043169,0.423045004714716,0.713819964285015,13,47,cation binding,MF,ACTN2;CDKN1A;PRND;NUAK2;GAS6;PRKACB;SERPINA5;DHH;TMEM163;DLL1;PDE4B;ITGA3;WT1
4820,GO:0070293,0.424464954866454,0.942774666931507,1,2,renal absorption,BP,GAS6
1828,GO:0019899,0.425049810240495,0.7254446226369,10,36,enzyme binding,MF,CDKN1A;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;RIN3;FOXO4;DAAM2;ITGA3
2242,GO:0031527,0.425617967283457,0.942412543835675,1,2,filopodium membrane,CC,ITGA3
1629,GO:0016311,0.425791096783626,0.859328446771518,2,6,dephosphorylation,BP,CAMSAP3;PTPN7
378,GO:0003014,0.426513105870057,0.81623639224284,3,10,renal system process,BP,GAS6;PRKACB;ITGA3
2076,GO:0030551,0.427314197453301,0.94187705984637,1,2,cyclic nucleotide binding,MF,PDE4B
2077,GO:0030552,0.427314197453301,0.94187705984637,1,2,cAMP binding,MF,PDE4B
1309,GO:0010324,0.427430026290469,0.941840373843813,1,2,membrane invagination,BP,MFGE8
5506,GO:0099024,0.427430026290469,0.941840373843813,1,2,plasma membrane invagination,BP,MFGE8
111,GO:0001657,0.427580574916921,0.812391883885625,3,11,ureteric bud development,BP,LAMA5;SDC4;WT1
5129,GO:0072163,0.427580574916921,0.812391883885625,3,11,mesonephric epithelium development,BP,LAMA5;SDC4;WT1
5130,GO:0072164,0.427580574916921,0.812391883885625,3,11,mesonephric tubule development,BP,LAMA5;SDC4;WT1
2741,GO:0035282,0.427646385042466,0.86675075929331,2,5,segmentation,BP,DLL1;WT1
1673,GO:0016579,0.427898866222607,0.941691723117741,1,2,protein deubiquitination,BP,FOXO4
4871,GO:0070646,0.427898866222607,0.941691723117741,1,2,protein modification by small protein removal,BP,FOXO4
3107,GO:0043086,0.428087043543942,0.786083970373669,4,15,negative regulation of catalytic activity,BP,CDKN1A;CAMSAP3;GAS6;SERPINA5
3663,GO:0046579,0.429589753119909,0.923959457320442,1,3,positive regulation of Ras protein signal transduction,BP,KITLG
4099,GO:0051057,0.429589753119909,0.923959457320442,1,3,positive regulation of small GTPase mediated signal transduction,BP,KITLG
2060,GO:0030507,0.431818453172813,0.878805304771021,2,4,spectrin binding,MF,MYO7A;CAMSAP3
2587,GO:0033293,0.432210070895858,0.940312959636532,1,2,monocarboxylic acid binding,MF,SERPINA5
1732,GO:0017124,0.432974625106831,0.940066205547196,1,2,SH3 domain binding,MF,ESPN
4176,GO:0051270,0.43339620816366,0.717696274671053,10,37,regulation of cellular component movement,BP,LAMA1;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;PDE4B;ITGA3
1780,GO:0019218,0.433730799104274,0.854533129257949,2,6,regulation of steroid metabolic process,BP,DKK3;DHH
4020,GO:0050810,0.433730799104274,0.854533129257949,2,6,regulation of steroid biosynthetic process,BP,DKK3;DHH
154,GO:0001819,0.43380928113356,0.854485283218558,2,6,positive regulation of cytokine production,BP,PIK3R1;PDE4B
388,GO:0003091,0.433987455577609,0.939738276235122,1,2,renal water homeostasis,BP,PRKACB
721,GO:0005952,0.433987455577609,0.939738276235122,1,2,cAMP-dependent protein kinase complex,CC,PRKACB
2631,GO:0034199,0.433987455577609,0.939738276235122,1,2,activation of protein kinase A activity,BP,PRKACB
5426,GO:0097546,0.433987455577609,0.939738276235122,1,2,ciliary base,CC,PRKACB
5656,GO:1901698,0.435537878812694,0.729577916082554,8,29,response to nitrogen compound,BP,ACTN2;CDKN1A;PIK3R1;PRKACB;FOXO4;PDE4B;CTGF;WT1
5993,GO:1905939,0.435616745231975,0.939208243979922,1,2,regulation of gonad development,BP,WT1
5994,GO:1905940,0.435616745231975,0.939208243979922,1,2,negative regulation of gonad development,BP,WT1
6042,GO:2000018,0.435616745231975,0.939208243979922,1,2,regulation of male gonad development,BP,WT1
701,GO:0005891,0.435631001723949,0.939203592442052,1,2,voltage-gated calcium channel complex,CC,PDE4B
2690,GO:0034704,0.435631001723949,0.939203592442052,1,2,calcium channel complex,CC,PDE4B
5589,GO:1901019,0.435631001723949,0.939203592442052,1,2,regulation of calcium ion transmembrane transporter activity,BP,PDE4B
645,GO:0005610,0.436113884365142,1,1,1,laminin-5 complex,CC,LAMA5
3105,GO:0043083,0.436113884365142,1,1,1,synaptic cleft,CC,LAMA5
3159,GO:0043259,0.436113884365142,1,1,1,laminin-10 complex,CC,LAMA5
3160,GO:0043260,0.436113884365142,1,1,1,laminin-11 complex,CC,LAMA5
3057,GO:0042693,0.436224153812982,0.921240157421187,1,3,muscle cell fate commitment,BP,WT1
3812,GO:0048471,0.436272145269426,0.761180497060853,5,19,perinuclear region of cytoplasm,CC,CDKN1A;PIK3R1;PRKACB;CTGF;ITGA3
740,GO:0006066,0.436406759049928,0.938950123366848,1,2,alcohol metabolic process,BP,HMGCS2
3621,GO:0046165,0.436406759049928,0.938950123366848,1,2,alcohol biosynthetic process,BP,HMGCS2
4113,GO:0051129,0.436520640375201,0.76833627031323,5,15,negative regulation of cellular component organization,BP,PLEKHH2;FHOD3;ESPN;UNC119;ITGA3
4264,GO:0051704,0.437683398653652,0.702449187928966,12,50,multi-organism process,BP,MFGE8;CLDN11;PIK3R1;GAS6;ITGB5;SERPINA5;ACSL4;DHH;PDE4B;CLDN1;ITGA3;WT1
902,GO:0006915,0.43814039081914,0.702345819063306,12,49,apoptotic process,BP,ACTN2;CDKN1A;RHOB;KITLG;PHLDA1;NUAK2;PIK3R1;GAS6;HMGN5;DLL1;CTGF;WT1
2092,GO:0030672,0.43855218354906,0.920271194742714,1,3,synaptic vesicle membrane,CC,TMEM163
5514,GO:0099501,0.43855218354906,0.920271194742714,1,3,exocytic vesicle membrane,CC,TMEM163
3550,GO:0045765,0.439268911554828,0.816681963848337,3,8,regulation of angiogenesis,BP,RHOB;FOXO4;DLL1
926,GO:0006996,0.439719583670564,0.687197118815421,17,65,organelle organization,BP,ACTN2;MYO7A;REEP1;RHOJ;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;LAMA5;ITGB5;SDC4;HMGN5;FHOD3;ESPN;MARK4;DAAM2;CTGF
5153,GO:0072203,0.43990557751124,0.937798137867334,1,2,cell proliferation involved in metanephros development,BP,WT1
2270,GO:0031670,0.440792974058252,0.937503664368704,1,2,cellular response to nutrient,BP,GAS6
4932,GO:0071295,0.440792974058252,0.937503664368704,1,2,cellular response to vitamin,BP,GAS6
2642,GO:0034329,0.44096959885112,0.778235746477387,4,14,cell junction assembly,BP,ACTN2;LAMA5;SDC4;CLDN1
1094,GO:0008081,0.441145718710073,0.937386350236795,1,2,phosphoric diester hydrolase activity,MF,PDE4B
5356,GO:0097009,0.441178180222354,0.937375546918242,1,2,energy homeostasis,BP,DLL1
3565,GO:0045823,0.441458866521031,0.919050526230238,1,3,positive regulation of heart contraction,BP,CTGF
3597,GO:0045933,0.441458866521031,0.919050526230238,1,3,positive regulation of muscle contraction,BP,CTGF
563,GO:0005085,0.443582608602614,0.774123722623193,4,15,guanyl-nucleotide exchange factor activity,MF,ACTN2;NRTN;KITLG;RIN3
1166,GO:0008625,0.443672194799315,0.936541778353669,1,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,PIK3R1
5991,GO:1905897,0.443672194799315,0.936541778353669,1,2,regulation of response to endoplasmic reticulum stress,BP,PIK3R1
5992,GO:1905898,0.443672194799315,0.936541778353669,1,2,positive regulation of response to endoplasmic reticulum stress,BP,PIK3R1
2400,GO:0032410,0.443943068907475,0.936450776077886,1,2,negative regulation of transporter activity,BP,ACTN2
2403,GO:0032413,0.443943068907475,0.936450776077886,1,2,negative regulation of ion transmembrane transporter activity,BP,ACTN2
5586,GO:1901016,0.443943068907475,0.936450776077886,1,2,regulation of potassium ion transmembrane transporter activity,BP,ACTN2
5587,GO:1901017,0.443943068907475,0.936450776077886,1,2,negative regulation of potassium ion transmembrane transporter activity,BP,ACTN2
698,GO:0005884,0.443999858128573,0.857233060548141,2,5,actin filament,CC,ACTN2;ESPN
151,GO:0001816,0.446164444337848,0.776708975506993,4,13,cytokine production,BP,PIK3R1;GAS6;DLL1;PDE4B
2154,GO:0031012,0.446942188109547,0.75253992822151,5,19,extracellular matrix,CC,LAMA1;MFGE8;LAMA5;CRISPLD2;CTGF
5082,GO:0072070,0.447456826211955,0.935262320147412,1,2,loop of Henle development,BP,DLL1
157,GO:0001823,0.448269423366043,0.794751468531527,3,12,mesonephros development,BP,LAMA5;SDC4;WT1
2044,GO:0030335,0.448597040706688,0.735941719522201,6,24,positive regulation of cell migration,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
4178,GO:0051272,0.448597040706688,0.735941719522201,6,24,positive regulation of cellular component movement,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
6075,GO:2000147,0.448597040706688,0.735941719522201,6,24,positive regulation of cell motility,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
3740,GO:0047485,0.44889069845398,0.934773064019071,1,2,protein N-terminus binding,MF,MYO7A
1343,GO:0010564,0.450069538943399,0.765675392555348,4,17,regulation of cell cycle process,BP,CDKN1A;HMGN5;FOXO4;CTGF
677,GO:0005789,0.450496104947947,0.799036134180822,3,10,endoplasmic reticulum membrane,CC,REEP1;ACSL4;GPSM1
1964,GO:0030049,0.45066414137416,0.934164490329126,1,2,muscle filament sliding,BP,ACTN2
2584,GO:0033275,0.45066414137416,0.934164490329126,1,2,actin-myosin filament sliding,BP,ACTN2
3109,GO:0043112,0.452822719797223,0.933418577783845,1,2,receptor metabolic process,BP,GPRASP1
2195,GO:0031226,0.453624011326503,0.705730478548861,9,34,intrinsic component of plasma membrane,CC,SLC52A3;ITGB5;MPZL1;SDC4;ITGB8;DLL1;CLDN1;SLC18B1;ITGA3
4206,GO:0051384,0.454685118903901,0.835206394535158,2,7,response to glucocorticoid,BP,CDKN1A;CLDN1
1846,GO:0021532,0.455949270811574,0.912782388561534,1,3,neural tube patterning,BP,PRKACB
4035,GO:0050863,0.456041421728688,0.840574811659195,2,6,regulation of T cell activation,BP,PIK3R1;SDC4
5790,GO:1903037,0.456041421728688,0.840574811659195,2,6,regulation of leukocyte cell-cell adhesion,BP,PIK3R1;SDC4
2281,GO:0031902,0.456579700534727,0.912502665172873,1,3,late endosome membrane,CC,RHOB
2303,GO:0031982,0.457410761678217,0.661385157473841,24,96,vesicle,CC,ACTN2;MYO7A;FRMPD1;RHOB;PHLDA1;RHOJ;MFGE8;CLDN11;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;DAAM2;TMEM163;DLL1;PDE4B;ITGA3
1990,GO:0030168,0.457732989619284,0.793694382892942,3,10,platelet activation,BP,RHOB;PIK3R1;GAS6
959,GO:0007155,0.457822541871708,0.670956219386188,17,64,cell adhesion,BP,LAMA1;ACTN2;RHOB;KITLG;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;ITGB8;DLL1;CLDN1;CTGF;ITGA3
1921,GO:0022610,0.457822541871708,0.670956219386188,17,64,biological adhesion,BP,LAMA1;ACTN2;RHOB;KITLG;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;ITGB8;DLL1;CLDN1;CTGF;ITGA3
291,GO:0002407,0.45863560616319,0.931381377866229,1,2,dendritic cell chemotaxis,BP,GAS6
2871,GO:0036336,0.45863560616319,0.931381377866229,1,2,dendritic cell migration,BP,GAS6
5864,GO:1903672,0.458849730081778,0.931305535188064,1,2,positive regulation of sprouting angiogenesis,BP,DLL1
3452,GO:0045177,0.459470676531085,0.766305775721014,4,13,apical part of cell,CC,MYO7A;SLC52A3;DLL1;CLDN1
627,GO:0005520,0.460452927776091,0.93073586311779,1,2,insulin-like growth factor binding,MF,CTGF
2836,GO:0035987,0.461188092264696,0.93047355735275,1,2,endodermal cell differentiation,BP,ITGB5
2853,GO:0036064,0.461224096672772,0.930460693604694,1,2,ciliary basal body,CC,MARK4
818,GO:0006606,0.46147427569174,0.7909048762649,3,10,protein import into nucleus,BP,CDKN1A;PIK3R1;GAS6
900,GO:0006913,0.46147427569174,0.7909048762649,3,10,nucleocytoplasmic transport,BP,CDKN1A;PIK3R1;GAS6
1724,GO:0017038,0.46147427569174,0.7909048762649,3,10,protein import,BP,CDKN1A;PIK3R1;GAS6
3389,GO:0044744,0.46147427569174,0.7909048762649,3,10,protein targeting to nucleus,BP,CDKN1A;PIK3R1;GAS6
4126,GO:0051169,0.46147427569174,0.7909048762649,3,10,nuclear transport,BP,CDKN1A;PIK3R1;GAS6
4127,GO:0051170,0.46147427569174,0.7909048762649,3,10,nuclear import,BP,CDKN1A;PIK3R1;GAS6
5745,GO:1902593,0.46147427569174,0.7909048762649,3,10,single-organism nuclear import,BP,CDKN1A;PIK3R1;GAS6
2697,GO:0034764,0.462556933362726,0.929983347307482,1,2,positive regulation of transmembrane transport,BP,ACTN2
2700,GO:0034767,0.462556933362726,0.929983347307482,1,2,positive regulation of ion transmembrane transport,BP,ACTN2
5623,GO:1901381,0.462556933362726,0.929983347307482,1,2,positive regulation of potassium ion transmembrane transport,BP,ACTN2
5907,GO:1904064,0.462556933362726,0.929983347307482,1,2,positive regulation of cation transmembrane transport,BP,ACTN2
5189,GO:0072359,0.464091412644229,0.680524956319585,12,45,circulatory system development,BP,ACTN2;RHOB;RHOJ;MFGE8;LAMA5;ITGB8;FHOD3;FOXO4;DLL1;CTGF;ITGA3;WT1
5518,GO:0099513,0.464754394541952,0.788443442346965,3,10,polymeric cytoskeletal fiber,CC,ACTN2;CAMSAP3;ESPN
260,GO:0002262,0.464872677532709,0.834848450984171,2,6,myeloid cell homeostasis,BP,KITLG;PDE4B
4192,GO:0051302,0.465160503953178,0.908636001997401,1,3,regulation of cell division,BP,DLL1
3306,GO:0044255,0.465241807819458,0.724007720236835,6,22,cellular lipid metabolic process,BP,HMGCS2;KITLG;PIK3R1;SDC4;ITGB8;ACSL4
3703,GO:0046872,0.465322816627789,0.679825683886264,12,44,metal ion binding,MF,ACTN2;CDKN1A;PRND;NUAK2;GAS6;PRKACB;DHH;TMEM163;DLL1;PDE4B;ITGA3;WT1
1840,GO:0019953,0.46635771198405,0.735114997057186,5,20,sexual reproduction,BP,MFGE8;CLDN11;SERPINA5;DHH;WT1
119,GO:0001678,0.46662052837396,0.833701330813358,2,6,cellular glucose homeostasis,BP,PIK3R1;GAS6
1127,GO:0008270,0.466628872884048,0.787030171277495,3,10,zinc ion binding,MF,DHH;TMEM163;WT1
30,GO:0000226,0.466636488915364,0.822585369108726,2,8,microtubule cytoskeleton organization,BP,CAMSAP3;MARK4
933,GO:0007017,0.466636488915364,0.822585369108726,2,8,microtubule-based process,BP,CAMSAP3;MARK4
3990,GO:0050730,0.467014913232094,0.780527205660671,3,12,regulation of peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6;UNC119
3991,GO:0050731,0.467014913232094,0.780527205660671,3,12,positive regulation of peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6;UNC119
3763,GO:0048144,0.467236688373251,0.826803005161717,2,7,fibroblast proliferation,BP,CDKN1A;GAS6
5764,GO:1902806,0.468826016154274,0.897124064128637,1,4,regulation of cell cycle G1/S phase transition,BP,CDKN1A
6049,GO:2000045,0.468826016154274,0.897124064128637,1,4,regulation of G1/S transition of mitotic cell cycle,BP,CDKN1A
1442,GO:0010934,0.469606203006362,0.927421256119684,1,2,macrophage cytokine production,BP,GAS6
2451,GO:0032635,0.469606203006362,0.927421256119684,1,2,interleukin-6 production,BP,GAS6
2463,GO:0032675,0.469606203006362,0.927421256119684,1,2,regulation of interleukin-6 production,BP,GAS6
3971,GO:0050701,0.469606203006362,0.927421256119684,1,2,interleukin-1 secretion,BP,GAS6
3973,GO:0050704,0.469606203006362,0.927421256119684,1,2,regulation of interleukin-1 secretion,BP,GAS6
3975,GO:0050707,0.469606203006362,0.927421256119684,1,2,regulation of cytokine secretion,BP,GAS6
2370,GO:0032330,0.470726101382681,0.90606819852233,1,3,regulation of chondrocyte differentiation,BP,CTGF
2036,GO:0030318,0.470788915496115,0.926985167483366,1,2,melanocyte differentiation,BP,KITLG
148,GO:0001780,0.470848297899265,0.926963224517978,1,2,neutrophil homeostasis,BP,PDE4B
3693,GO:0046824,0.470880419127688,0.830886315387497,2,6,positive regulation of nucleocytoplasmic transport,BP,PIK3R1;GAS6
3811,GO:0048469,0.471267551438305,0.905815844548146,1,3,cell maturation,BP,CDKN1A
1973,GO:0030099,0.471632814147599,0.783233652526968,3,10,myeloid cell differentiation,BP,KITLG;PIK3R1;DLL1
4842,GO:0070374,0.472160028907254,0.812471440029332,2,10,positive regulation of ERK1 and ERK2 cascade,BP,GAS6;CTGF
1487,GO:0014070,0.472859962153486,0.703205028876764,7,29,response to organic cyclic compound,BP,CDKN1A;PRKACB;DHH;PDE4B;CLDN1;CTGF;WT1
1007,GO:0007272,0.473197979175576,0.822728517618042,2,7,ensheathment of neurons,BP,CLDN11;DHH
1142,GO:0008366,0.473197979175576,0.822728517618042,2,7,axon ensheathment,BP,CLDN11;DHH
4032,GO:0050851,0.473411227171535,0.829200928293467,2,6,antigen receptor-mediated signaling pathway,BP,PIK3R1;PDE4B
4033,GO:0050852,0.473411227171535,0.829200928293467,2,6,T cell receptor signaling pathway,BP,PIK3R1;PDE4B
2043,GO:0030334,0.473774832684014,0.687832851203902,9,34,regulation of cell migration,BP,LAMA1;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;ITGA3
6073,GO:2000145,0.473774832684014,0.687832851203902,9,34,regulation of cell motility,BP,LAMA1;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;ITGA3
2555,GO:0033043,0.473877578199772,0.696256027799883,8,29,regulation of organelle organization,BP,ACTN2;PLEKHH2;CAMSAP3;PIK3R1;SDC4;FHOD3;ESPN;CTGF
4223,GO:0051491,0.474272131727596,0.925690329134272,1,2,positive regulation of filopodium assembly,BP,ESPN
3590,GO:0045921,0.474851084368331,0.904134194496588,1,3,positive regulation of exocytosis,BP,SDC4
2573,GO:0033157,0.474994122818559,0.780663894338463,3,10,regulation of intracellular protein transport,BP,CDKN1A;PIK3R1;GAS6
5905,GO:1904062,0.475386101415631,0.827879007984044,2,6,regulation of cation transmembrane transport,BP,ACTN2;PDE4B
4529,GO:0060538,0.475722589655118,0.82765318082262,2,6,skeletal muscle organ development,BP,DLL1;WT1
166,GO:0001841,0.47697041978832,0.826814216654694,2,6,neural tube formation,BP,SDC4;PRKACB
1469,GO:0014020,0.47697041978832,0.826814216654694,2,6,primary neural tube formation,BP,SDC4;PRKACB
3678,GO:0046683,0.477809160080232,0.924359301838607,1,2,response to organophosphorus,BP,WT1
4241,GO:0051591,0.477809160080232,0.924359301838607,1,2,response to cAMP,BP,WT1
4939,GO:0071320,0.477809160080232,0.924359301838607,1,2,cellular response to cAMP,BP,WT1
4320,GO:0055002,0.477897566357108,0.826189319224687,2,6,striated muscle cell development,BP,ACTN2;FHOD3
2923,GO:0040017,0.480042261014743,0.707998585478043,6,25,positive regulation of locomotion,BP,RHOB;KITLG;PIK3R1;GAS6;FOXO4;ITGA3
988,GO:0007220,0.480192081883311,0.923453300030842,1,2,Notch receptor processing,BP,DLL1
4790,GO:0070161,0.481251501909404,0.690574542505898,8,28,anchoring junction,CC,ACTN2;RHOB;CAMSAP3;ITGB5;MPZL1;SDC4;DLL1;ITGA3
4006,GO:0050790,0.481337334450991,0.655328741579086,14,60,regulation of catalytic activity,BP,ACTN2;CDKN1A;NRTN;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;RIN3;GPSM1;CTGF;UNC119
4893,GO:0070838,0.481563298589696,0.772023748594203,3,11,divalent metal ion transport,BP,GAS6;PDE4B;CTGF
5201,GO:0072511,0.481563298589696,0.772023748594203,3,11,divalent inorganic cation transport,BP,GAS6;PDE4B;CTGF
3380,GO:0044707,0.481839463922509,0.641014779605849,36,146,single-multicellular organism process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;DKK3;RHOB;KITLG;RHOJ;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;ACSL4;CRISPLD2;FHOD3;DHH;FOXO4;GPSM1;MARK4;DAAM2;DLL1;PDE4B;CLDN1;CTGF;UNC119;ITGA3;WT1
4478,GO:0060416,0.482826960405212,0.922442733432377,1,2,response to growth hormone,BP,PIK3R1
765,GO:0006259,0.482950290609832,0.763721535011792,3,14,DNA metabolic process,BP,CDKN1A;KITLG;CTGF
2095,GO:0030695,0.48422864056172,0.821886869999714,2,6,GTPase regulator activity,MF,RIN3;GPSM1
4547,GO:0060589,0.48422864056172,0.821886869999714,2,6,nucleoside-triphosphatase regulator activity,MF,RIN3;GPSM1
95,GO:0001541,0.48508453804561,0.921569496510927,1,2,ovarian follicle development,BP,KITLG
1917,GO:0022602,0.48508453804561,0.921569496510927,1,2,ovulation cycle process,BP,KITLG
4044,GO:0050877,0.485381681283954,0.720316142164202,5,19,neurological system process,BP,MYO7A;SLC52A3;ESPN;UNC119;ITGA3
2728,GO:0035162,0.486612366876174,0.920974640508677,1,2,embryonic hemopoiesis,BP,KITLG
1017,GO:0007350,0.48839631258014,0.920276072655692,1,2,blastoderm segmentation,BP,WT1
1018,GO:0007351,0.48839631258014,0.920276072655692,1,2,tripartite regional subdivision,BP,WT1
1163,GO:0008595,0.48839631258014,0.920276072655692,1,2,anterior/posterior axis specification, embryo,BP,WT1
1250,GO:0009791,0.489345195754863,0.897125895470809,1,3,post-embryonic development,BP,MYO7A
3453,GO:0045178,0.490026703843207,0.896788077640504,1,3,basal part of cell,CC,CLDN11
5477,GO:0098773,0.490954828410742,0.82776074316351,2,5,skin epidermis development,BP,LAMA5;DLL1
2515,GO:0032886,0.492549806425292,0.895530814355105,1,3,regulation of microtubule-based process,BP,CAMSAP3
4857,GO:0070507,0.492549806425292,0.895530814355105,1,3,regulation of microtubule cytoskeleton organization,BP,CAMSAP3
5393,GO:0097191,0.492921870681371,0.80385312706193,2,8,extrinsic apoptotic signaling pathway,BP,KITLG;PIK3R1
4323,GO:0055007,0.492998293450131,0.766629201801223,3,10,cardiac muscle cell differentiation,BP,ACTN2;FHOD3;WT1
4196,GO:0051336,0.494045645901366,0.674565154861867,8,34,regulation of hydrolase activity,BP,ACTN2;NRTN;KITLG;CAMSAP3;GAS6;SERPINA5;RIN3;CTGF
4994,GO:0071548,0.494470446269694,0.894566778546774,1,3,response to dexamethasone,BP,CLDN1
2072,GO:0030539,0.494513668058769,0.883562236117024,1,4,male genitalia development,BP,WT1
1382,GO:0010712,0.496743049011618,0.893418240010925,1,3,regulation of collagen metabolic process,BP,CTGF
1383,GO:0010714,0.496743049011618,0.893418240010925,1,3,positive regulation of collagen metabolic process,BP,CTGF
2533,GO:0032963,0.496743049011618,0.893418240010925,1,3,collagen metabolic process,BP,CTGF
2534,GO:0032964,0.496743049011618,0.893418240010925,1,3,collagen biosynthetic process,BP,CTGF
2535,GO:0032965,0.496743049011618,0.893418240010925,1,3,regulation of collagen biosynthetic process,BP,CTGF
2536,GO:0032967,0.496743049011618,0.893418240010925,1,3,positive regulation of collagen biosynthetic process,BP,CTGF
3298,GO:0044236,0.496743049011618,0.893418240010925,1,3,multicellular organism metabolic process,BP,CTGF
3302,GO:0044246,0.496743049011618,0.893418240010925,1,3,regulation of multicellular organismal metabolic process,BP,CTGF
3305,GO:0044253,0.496743049011618,0.893418240010925,1,3,positive regulation of multicellular organismal metabolic process,BP,CTGF
3308,GO:0044259,0.496743049011618,0.893418240010925,1,3,multicellular organismal macromolecule metabolic process,BP,CTGF
648,GO:0005623,0.496938871296013,0.74122567009339,53,225,cell,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;MRO;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;UNC119;ITGA3;WT1
3371,GO:0044464,0.496938871296013,0.74122567009339,53,225,cell part,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;MRO;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;UNC119;ITGA3;WT1
4120,GO:0051150,0.496995841877072,0.893289955048891,1,3,regulation of smooth muscle cell differentiation,BP,FOXO4
4705,GO:0061217,0.497238590229627,0.882057216221613,1,4,regulation of mesonephros development,BP,WT1
5476,GO:0098772,0.498677495100857,0.663398199860469,9,37,molecular function regulator,MF,ACTN2;CDKN1A;NRTN;KITLG;PIK3R1;GAS6;SERPINA5;RIN3;GPSM1
5617,GO:1901360,0.499226657378815,0.632961762410253,16,69,organic cyclic compound metabolic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;HMGN5;DHH;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
5479,GO:0098793,0.499525445103973,0.795159010435452,2,9,presynapse,CC,TMEM163;PDE4B
1404,GO:0010810,0.500298614347545,0.765592090455734,3,9,regulation of cell-substrate adhesion,BP,PIK3R1;SDC4;ITGA3
804,GO:0006497,0.500332537052488,0.915489624002617,1,2,protein lipidation,BP,PRND
2961,GO:0042158,0.500332537052488,0.915489624002617,1,2,lipoprotein biosynthetic process,BP,PRND
5392,GO:0097190,0.500639466532505,0.751333420998792,3,13,apoptotic signaling pathway,BP,CDKN1A;KITLG;PIK3R1
567,GO:0005102,0.500665068229954,0.637676245795989,14,58,receptor binding,MF,LAMA1;ACTN2;NRTN;REEP1;KITLG;MFGE8;PIK3R1;LAMA5;GAS6;ITGB8;DHH;DLL1;CTGF;ITGA3
4002,GO:0050776,0.50070348093558,0.760481630087836,3,10,regulation of immune response,BP,PIK3R1;PRKACB;PDE4B
4004,GO:0050778,0.50070348093558,0.760481630087836,3,10,positive regulation of immune response,BP,PIK3R1;PRKACB;PDE4B
1830,GO:0019901,0.502651430724752,0.72577561419904,4,15,protein kinase binding,MF,CDKN1A;PIK3R1;GAS6;SDC4
3810,GO:0048468,0.504491476446386,0.626578637089945,17,68,cell development,BP,ACTN2;MYO7A;CDKN1A;NRTN;KITLG;CAMSAP3;PIK3R1;LAMA5;SDC4;SEMA6C;ACSL4;FHOD3;DHH;DLL1;CLDN1;ITGA3;WT1
4217,GO:0051447,0.504549811051901,0.889407381328993,1,3,negative regulation of meiotic cell cycle,BP,PRKACB
594,GO:0005201,0.505072731562131,0.913533529523149,1,2,extracellular matrix structural constituent,MF,LAMA1
2237,GO:0031489,0.505252619389128,0.889041278928604,1,3,myosin V binding,MF,RAB39B
872,GO:0006820,0.506161575262339,0.799200272024336,2,7,anion transport,BP,SLC52A3;ACSL4
5647,GO:1901652,0.506857131649596,0.703224888535671,5,18,response to peptide,BP,ACTN2;PIK3R1;PRKACB;FOXO4;CTGF
640,GO:0005578,0.507400920105622,0.721692689281297,4,15,proteinaceous extracellular matrix,CC,LAMA1;LAMA5;CRISPLD2;CTGF
354,GO:0002763,0.507710447329745,0.91243117167586,1,2,positive regulation of myeloid leukocyte differentiation,BP,KITLG
3517,GO:0045639,0.507710447329745,0.91243117167586,1,2,positive regulation of myeloid cell differentiation,BP,KITLG
1072,GO:0007613,0.507902478377917,0.912350527355615,1,2,memory,BP,ITGA3
2074,GO:0030545,0.508141528454262,0.797731918806412,2,7,receptor regulator activity,MF,ACTN2;GAS6
2075,GO:0030546,0.508141528454262,0.797731918806412,2,7,receptor activator activity,MF,ACTN2;GAS6
334,GO:0002695,0.508877842147908,0.887139528545433,1,3,negative regulation of leukocyte activation,BP,SDC4
4166,GO:0051250,0.508877842147908,0.887139528545433,1,3,negative regulation of lymphocyte activation,BP,SDC4
4940,GO:0071322,0.508993326719514,0.887078578353535,1,3,cellular response to carbohydrate stimulus,BP,GAS6
4941,GO:0071326,0.508993326719514,0.887078578353535,1,3,cellular response to monosaccharide stimulus,BP,GAS6
4942,GO:0071331,0.508993326719514,0.887078578353535,1,3,cellular response to hexose stimulus,BP,GAS6
4943,GO:0071333,0.508993326719514,0.887078578353535,1,3,cellular response to glucose stimulus,BP,GAS6
1027,GO:0007399,0.510112247159653,0.62085623314232,17,70,nervous system development,BP,MYO7A;NRTN;CAMSAP3;CLDN11;PIK3R1;GAS6;SDC4;SEMA6C;PRKACB;ACSL4;DHH;GPSM1;MARK4;DLL1;CLDN1;UNC119;ITGA3
689,GO:0005819,0.510392621344393,0.874606591291551,1,4,spindle,CC,UNC119
3827,GO:0048519,0.510412533699552,0.610645291079009,25,103,negative regulation of biological process,BP,ACTN2;CDKN1A;GPRASP1;DKK3;RHOB;KITLG;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;FHOD3;FOXO4;ESPN;DLL1;PDE4B;CTGF;UNC119;ITGA3;WT1
2447,GO:0032612,0.510797792835808,0.886123252410081,1,3,interleukin-1 production,BP,GAS6
2459,GO:0032652,0.510797792835808,0.886123252410081,1,3,regulation of interleukin-1 production,BP,GAS6
719,GO:0005943,0.511094004323166,0.911002424110554,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1
3244,GO:0043560,0.511094004323166,0.911002424110554,1,2,insulin receptor substrate binding,MF,PIK3R1
4045,GO:0050878,0.511631763761445,0.680762667872716,6,24,regulation of body fluid levels,BP,RHOB;PIK3R1;GAS6;PRKACB;SERPINA5;CLDN1
2238,GO:0031490,0.511845871995485,0.910682681808322,1,2,chromatin DNA binding,MF,HMGN5
211,GO:0001977,0.512087504825605,0.885437019384917,1,3,renal system process involved in regulation of blood volume,BP,GAS6
385,GO:0003071,0.512087504825605,0.885437019384917,1,3,renal system process involved in regulation of systemic arterial blood pressure,BP,GAS6
389,GO:0003093,0.512087504825605,0.885437019384917,1,3,regulation of glomerular filtration,BP,GAS6
390,GO:0003094,0.512087504825605,0.885437019384917,1,3,glomerular filtration,BP,GAS6
3378,GO:0044703,0.512229039825469,0.667670831027677,7,29,multi-organism reproductive process,BP,MFGE8;CLDN11;SERPINA5;ACSL4;DHH;ITGA3;WT1
3293,GO:0044092,0.512489588718092,0.69373285781842,5,21,negative regulation of molecular function,BP,ACTN2;CDKN1A;CAMSAP3;GAS6;SERPINA5
735,GO:0006023,0.512535703859873,0.885197868920733,1,3,aminoglycan biosynthetic process,BP,SDC4
736,GO:0006024,0.512535703859873,0.885197868920733,1,3,glycosaminoglycan biosynthetic process,BP,SDC4
1130,GO:0008284,0.512815181427957,0.676893537560016,6,27,positive regulation of cell proliferation,BP,CDKN1A;KITLG;GAS6;HMGN5;DLL1;CTGF
2527,GO:0032943,0.513334361899353,0.788550587836294,2,8,mononuclear cell proliferation,BP,CDKN1A;SDC4
3673,GO:0046651,0.513334361899353,0.788550587836294,2,8,lymphocyte proliferation,BP,CDKN1A;SDC4
1445,GO:0010942,0.513792264717286,0.716151045575179,4,15,positive regulation of cell death,BP,CDKN1A;RHOB;MARK4;CTGF
3103,GO:0043068,0.513792264717286,0.716151045575179,4,15,positive regulation of programmed cell death,BP,CDKN1A;RHOB;MARK4;CTGF
5239,GO:0086004,0.513984351311993,0.909768747136948,1,2,regulation of cardiac muscle cell contraction,BP,PDE4B
5801,GO:1903115,0.513984351311993,0.909768747136948,1,2,regulation of actin filament-based movement,BP,PDE4B
4971,GO:0071398,0.514575685465645,0.884104981473969,1,3,cellular response to fatty acid,BP,CLDN1
3487,GO:0045471,0.51503614697109,0.871901765227756,1,4,response to ethanol,BP,CLDN1
5619,GO:1901362,0.515310791430665,0.626385834942721,13,57,organic cyclic compound biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;PIK3R1;GAS6;HMGN5;DHH;FOXO4;DLL1;CTGF;ITGA3;WT1
352,GO:0002761,0.515539245362573,0.799681353098278,2,6,regulation of myeloid leukocyte differentiation,BP,KITLG;PIK3R1
983,GO:0007200,0.515719042435278,0.883489286236734,1,3,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,ACTN2
4349,GO:0055085,0.515911396242819,0.690650967274512,5,21,transmembrane transport,BP,ACTN2;SLC25A53;GAS6;PDE4B;SLC18B1
5978,GO:1905475,0.516471753032079,0.79899575964139,2,6,regulation of protein localization to membrane,BP,PIK3R1;ITGA3
93,GO:0001525,0.516525700603055,0.677430218578501,6,23,angiogenesis,BP,RHOB;MFGE8;LAMA5;FOXO4;DLL1;CTGF
116,GO:0001667,0.516786560684559,0.676052554578893,6,24,ameboidal-type cell migration,BP,NRTN;RHOB;KITLG;LAMA5;SDC4;ITGA3
149,GO:0001784,0.517682367946919,0.90817242440699,1,2,phosphotyrosine binding,MF,PIK3R1
2705,GO:0035014,0.517682367946919,0.90817242440699,1,2,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R1
3336,GO:0044381,0.517682367946919,0.90817242440699,1,2,glucose import in response to insulin stimulus,BP,PIK3R1
3472,GO:0045309,0.517682367946919,0.90817242440699,1,2,protein phosphorylated amino acid binding,MF,PIK3R1
3728,GO:0046935,0.517682367946919,0.90817242440699,1,2,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R1
4150,GO:0051219,0.517682367946919,0.90817242440699,1,2,phosphoprotein binding,MF,PIK3R1
5545,GO:1900076,0.517682367946919,0.90817242440699,1,2,regulation of cellular response to insulin stimulus,BP,PIK3R1
5546,GO:1900078,0.517682367946919,0.90817242440699,1,2,positive regulation of cellular response to insulin stimulus,BP,PIK3R1
6206,GO:2001273,0.517682367946919,0.90817242440699,1,2,regulation of glucose import in response to insulin stimulus,BP,PIK3R1
6207,GO:2001275,0.517682367946919,0.90817242440699,1,2,positive regulation of glucose import in response to insulin stimulus,BP,PIK3R1
3237,GO:0043548,0.518080001945628,0.907999571749082,1,2,phosphatidylinositol 3-kinase binding,MF,PIK3R1
797,GO:0006470,0.518153765362623,0.882170589923116,1,3,protein dephosphorylation,BP,PTPN7
969,GO:0007167,0.518468104521765,0.632337815032205,11,47,enzyme linked receptor protein signaling pathway,BP,NRTN;DKK3;PIK3R1;GAS6;ITGB5;MPZL1;FOXO4;DLL1;CGN;CTGF;ITGA3
5410,GO:0097367,0.518795811929381,0.622809704899292,13,58,carbohydrate derivative binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;SERPINA5;ACSL4;CRISPLD2;RAB39B;MARK4;PDE4B;CTGF;ITGA3
117,GO:0001669,0.519150558185654,0.907533027556675,1,2,acrosomal vesicle,CC,SERPINA5
5399,GO:0097223,0.519150558185654,0.907533027556675,1,2,sperm part,CC,SERPINA5
1699,GO:0016788,0.519832934349847,0.796512647903965,2,6,hydrolase activity, acting on ester bonds,MF,PTPN7;PDE4B
5461,GO:0098655,0.52100359559059,0.736817323734891,3,12,cation transmembrane transport,BP,ACTN2;GAS6;PDE4B
5465,GO:0098660,0.52100359559059,0.736817323734891,3,12,inorganic ion transmembrane transport,BP,ACTN2;GAS6;PDE4B
5467,GO:0098662,0.52100359559059,0.736817323734891,3,12,inorganic cation transmembrane transport,BP,ACTN2;GAS6;PDE4B
3121,GO:0043168,0.52116430963848,0.614513510861013,15,65,anion binding,MF,ACTN2;MYO7A;RHOB;RHOJ;NUAK2;MFGE8;GAS6;PRKACB;SERPINA5;ACSL4;CRISPLD2;RAB39B;MARK4;PDE4B;CTGF
486,GO:0003690,0.521732825894623,0.880213184999225,1,3,double-stranded DNA binding,MF,WT1
198,GO:0001948,0.52224708689089,0.906173918792978,1,2,glycoprotein binding,MF,ITGA3
1594,GO:0016050,0.523028659354329,0.781043910994487,2,8,vesicle organization,BP,MYO7A;SDC4
5737,GO:1902554,0.524134033185327,0.878887236075847,1,3,serine/threonine protein kinase complex,CC,CDKN1A
5776,GO:1902911,0.524134033185327,0.878887236075847,1,3,protein kinase complex,CC,CDKN1A
5113,GO:0072125,0.524529778905832,0.878667718718847,1,3,negative regulation of glomerular mesangial cell proliferation,BP,WT1
5301,GO:0090185,0.524529778905832,0.878667718718847,1,3,negative regulation of kidney development,BP,WT1
5309,GO:0090194,0.524529778905832,0.878667718718847,1,3,negative regulation of glomerulus development,BP,WT1
5661,GO:1901723,0.524529778905832,0.878667718718847,1,3,negative regulation of cell proliferation involved in kidney development,BP,WT1
1765,GO:0019079,0.526435450235116,0.904312558351592,1,2,viral genome replication,BP,GAS6
1526,GO:0014910,0.526603303918714,0.877512966062648,1,3,regulation of smooth muscle cell migration,BP,FOXO4
3253,GO:0043603,0.526964581423828,0.791181758603107,2,6,cellular amide metabolic process,BP,GAS6;ITGB8
3617,GO:0046058,0.527347679552777,0.864536769611623,1,4,cAMP metabolic process,BP,PDE4B
694,GO:0005874,0.529326899827024,0.863326086787865,1,4,microtubule,CC,CAMSAP3
2143,GO:0030902,0.531505303309039,0.874752204043217,1,3,hindbrain development,BP,DLL1
1910,GO:0022408,0.531620543853325,0.874686776866993,1,3,negative regulation of cell-cell adhesion,BP,SDC4
108,GO:0001654,0.531791542534218,0.696289074782759,4,17,eye development,BP,MYO7A;RHOJ;DLL1;WT1
5325,GO:0090287,0.53239775177956,0.730266366148743,3,11,regulation of cellular response to growth factor stimulus,BP,DKK3;DLL1;ITGA3
857,GO:0006767,0.532636483602329,0.901507408173778,1,2,water-soluble vitamin metabolic process,BP,SLC52A3
1829,GO:0019900,0.532933431311468,0.697091380286804,4,16,kinase binding,MF,CDKN1A;PIK3R1;GAS6;SDC4
1223,GO:0009581,0.533097256255671,0.873846234759254,1,3,detection of external stimulus,BP,UNC119
1224,GO:0009582,0.533097256255671,0.873846234759254,1,3,detection of abiotic stimulus,BP,UNC119
1733,GO:0017137,0.535264842968395,0.900300400378432,1,2,Rab GTPase binding,MF,RIN3
3375,GO:0044699,0.535577995817605,0.651592230769139,50,211,single-organism process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;GPRASP1;DKK3;RHOB;KITLG;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;DAAM2;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
3759,GO:0048066,0.535883374623877,0.872249488826871,1,3,developmental pigmentation,BP,KITLG
4066,GO:0050931,0.535883374623877,0.872249488826871,1,3,pigment cell differentiation,BP,KITLG
5276,GO:0090075,0.535958198858288,0.872206409331482,1,3,relaxation of muscle,BP,PDE4B
2889,GO:0038034,0.536400811604706,0.858937434476027,1,4,signal transduction in absence of ligand,BP,KITLG
5394,GO:0097192,0.536400811604706,0.858937434476027,1,4,extrinsic apoptotic signaling pathway in absence of ligand,BP,KITLG
2744,GO:0035303,0.537428753606741,0.871357646612746,1,3,regulation of dephosphorylation,BP,CAMSAP3
247,GO:0002218,0.539150439832389,0.870358838660438,1,3,activation of innate immune response,BP,PRKACB
351,GO:0002758,0.539150439832389,0.870358838660438,1,3,innate immune response-activating signal transduction,BP,PRKACB
1009,GO:0007276,0.539309819222002,0.689463659451335,4,17,gamete generation,BP,CLDN11;SERPINA5;DHH;WT1
827,GO:0006638,0.539791983653566,0.898195901404948,1,2,neutral lipid metabolic process,BP,ACSL4
828,GO:0006639,0.539791983653566,0.898195901404948,1,2,acylglycerol metabolic process,BP,ACSL4
829,GO:0006641,0.539791983653566,0.898195901404948,1,2,triglyceride metabolic process,BP,ACSL4
225,GO:0002064,0.539821677601491,0.690852006520413,4,16,epithelial cell development,BP,MYO7A;CDKN1A;DLL1;CLDN1
2037,GO:0030323,0.540757723337293,0.692162277435657,4,15,respiratory tube development,BP,LAMA5;CRISPLD2;CTGF;ITGA3
2038,GO:0030324,0.540757723337293,0.692162277435657,4,15,lung development,BP,LAMA5;CRISPLD2;CTGF;ITGA3
2616,GO:0033762,0.540777504030004,0.869409845007055,1,3,response to glucagon,BP,PRKACB
4961,GO:0071377,0.540777504030004,0.869409845007055,1,3,cellular response to glucagon stimulus,BP,PRKACB
5657,GO:1901699,0.541554244017217,0.654169689429357,6,23,cellular response to nitrogen compound,BP,ACTN2;PIK3R1;PRKACB;FOXO4;PDE4B;WT1
4449,GO:0060325,0.542903051944542,0.868162632677311,1,3,face morphogenesis,BP,CRISPLD2
4882,GO:0070673,0.542986383015386,0.868113563164091,1,3,response to interleukin-18,BP,CLDN1
1550,GO:0015629,0.542997450350598,0.659171262787674,6,19,actin cytoskeleton,CC,ACTN2;MYO7A;PLEKHH2;FHOD3;ESPN;CGN
4958,GO:0071371,0.543237536104222,0.896572295057096,1,2,cellular response to gonadotropin stimulus,BP,WT1
1975,GO:0030101,0.543730639053416,0.867674726758556,1,3,natural killer cell activation,BP,GAS6
1392,GO:0010761,0.543912046860571,0.867567604507185,1,3,fibroblast migration,BP,SDC4
1393,GO:0010762,0.543912046860571,0.867567604507185,1,3,regulation of fibroblast migration,BP,SDC4
2041,GO:0030330,0.545989626122752,0.852832311036289,1,4,DNA damage response, signal transduction by p53 class mediator,BP,CDKN1A
3070,GO:0042770,0.545989626122752,0.852832311036289,1,4,signal transduction in response to DNA damage,BP,CDKN1A
2592,GO:0033500,0.546065999998941,0.768343766097138,2,7,carbohydrate homeostasis,BP,PIK3R1;GAS6
3045,GO:0042593,0.546065999998941,0.768343766097138,2,7,glucose homeostasis,BP,PIK3R1;GAS6
4049,GO:0050885,0.546137246811514,0.895191055316135,1,2,neuromuscular process controlling balance,BP,MYO7A
4072,GO:0050957,0.546137246811514,0.895191055316135,1,2,equilibrioception,BP,MYO7A
2738,GO:0035265,0.547681966617907,0.75690157024647,2,9,organ growth,BP,DLL1;WT1
4355,GO:0055117,0.54949685939083,0.765563234242932,2,7,regulation of cardiac muscle contraction,BP,PDE4B;CTGF
195,GO:0001944,0.549618180047235,0.615605819332113,9,36,vasculature development,BP,RHOB;RHOJ;MFGE8;LAMA5;ITGB8;FOXO4;DLL1;CTGF;WT1
5188,GO:0072358,0.549618180047235,0.615605819332113,9,36,cardiovascular system development,BP,RHOB;RHOJ;MFGE8;LAMA5;ITGB8;FOXO4;DLL1;CTGF;WT1
53,GO:0000910,0.549892327858939,0.864001177107277,1,3,cytokinesis,BP,RHOB
659,GO:0005741,0.549965397779258,0.863957177567246,1,3,mitochondrial outer membrane,CC,ACSL4
1820,GO:0019867,0.549965397779258,0.863957177567246,1,3,outer membrane,CC,ACSL4
2298,GO:0031968,0.549965397779258,0.863957177567246,1,3,organelle outer membrane,CC,ACSL4
646,GO:0005615,0.55106077323528,0.610813611593509,9,43,extracellular space,CC,LAMA1;DKK3;KITLG;MFGE8;LAMA5;GAS6;SERPINA5;DHH;CTGF
491,GO:0003713,0.551173390466449,0.863228285195246,1,3,transcription coactivator activity,MF,ACTN2
2221,GO:0031346,0.551439072426894,0.76397993226252,2,7,positive regulation of cell projection organization,BP,ESPN;ITGA3
1258,GO:0009888,0.551934385073738,0.577921122712226,18,75,tissue development,BP,ACTN2;MYO7A;CDKN1A;NRTN;RHOB;KITLG;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;FHOD3;DLL1;CLDN1;CTGF;ITGA3;WT1
2305,GO:0031984,0.551944805823649,0.862761345091338,1,3,organelle subcompartment,CC,REEP1
235,GO:0002085,0.552634353779433,0.89204627719488,1,2,inhibition of neuroepithelial cell differentiation,BP,DLL1
1024,GO:0007386,0.552634353779433,0.89204627719488,1,2,compartment pattern specification,BP,DLL1
1499,GO:0014807,0.552634353779433,0.89204627719488,1,2,regulation of somitogenesis,BP,DLL1
2127,GO:0030857,0.552634353779433,0.89204627719488,1,2,negative regulation of epithelial cell differentiation,BP,DLL1
2928,GO:0040034,0.552634353779433,0.89204627719488,1,2,regulation of development, heterochronic,BP,DLL1
3502,GO:0045605,0.552634353779433,0.89204627719488,1,2,negative regulation of epidermal cell differentiation,BP,DLL1
3504,GO:0045607,0.552634353779433,0.89204627719488,1,2,regulation of auditory receptor cell differentiation,BP,DLL1
3505,GO:0045608,0.552634353779433,0.89204627719488,1,2,negative regulation of auditory receptor cell differentiation,BP,DLL1
3511,GO:0045631,0.552634353779433,0.89204627719488,1,2,regulation of mechanoreceptor differentiation,BP,DLL1
3512,GO:0045632,0.552634353779433,0.89204627719488,1,2,negative regulation of mechanoreceptor differentiation,BP,DLL1
3532,GO:0045683,0.552634353779433,0.89204627719488,1,2,negative regulation of epidermis development,BP,DLL1
3820,GO:0048505,0.552634353779433,0.89204627719488,1,2,regulation of timing of cell differentiation,BP,DLL1
4638,GO:0060972,0.552634353779433,0.89204627719488,1,2,left/right pattern formation,BP,DLL1
4908,GO:0070986,0.552634353779433,0.89204627719488,1,2,left/right axis specification,BP,DLL1
6170,GO:2000980,0.552634353779433,0.89204627719488,1,2,regulation of inner ear receptor cell differentiation,BP,DLL1
6171,GO:2000981,0.552634353779433,0.89204627719488,1,2,negative regulation of inner ear receptor cell differentiation,BP,DLL1
2352,GO:0032269,0.553108705610244,0.703756720840952,3,14,negative regulation of cellular protein metabolic process,BP,CDKN1A;GAS6;SERPINA5
2083,GO:0030658,0.555907025942893,0.838220329622392,1,5,transport vesicle membrane,CC,TMEM163
2619,GO:0034097,0.555982087770063,0.706207241873404,3,12,response to cytokine,BP,GAS6;ACSL4;CLDN1
3149,GO:0043234,0.556099155142563,0.593446343803482,12,45,protein complex,CC,LAMA1;MYO7A;CDKN1A;PIK3R1;LAMA5;ITGB5;ITGB8;SERPINA5;ESPN;PDE4B;CGN;ITGA3
2507,GO:0032870,0.558984672451189,0.653610579110831,5,19,cellular response to hormone stimulus,BP,ACTN2;PIK3R1;PRKACB;FOXO4;WT1
4222,GO:0051489,0.559093946037994,0.858378752658427,1,3,regulation of filopodium assembly,BP,ESPN
4322,GO:0055006,0.559187134921085,0.766006954873888,2,6,cardiac cell development,BP,ACTN2;FHOD3
284,GO:0002367,0.55966167673772,0.858026412828619,1,3,cytokine production involved in immune response,BP,GAS6
4677,GO:0061082,0.55966167673772,0.858026412828619,1,3,myeloid leukocyte cytokine production,BP,GAS6
3353,GO:0044432,0.559698841185835,0.649919986008052,5,21,endoplasmic reticulum part,CC,REEP1;PIK3R1;GAS6;ACSL4;GPSM1
1561,GO:0015718,0.560337536840493,0.857606133262051,1,3,monocarboxylic acid transport,BP,ACSL4
1581,GO:0015908,0.560337536840493,0.857606133262051,1,3,fatty acid transport,BP,ACSL4
1659,GO:0016477,0.56080490350848,0.586839362609135,12,50,cell migration,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;PDE4B;CTGF;ITGA3
845,GO:0006704,0.560928147061119,0.857238122701426,1,3,glucocorticoid biosynthetic process,BP,DKK3
1118,GO:0008211,0.560928147061119,0.857238122701426,1,3,glucocorticoid metabolic process,BP,DKK3
1432,GO:0010894,0.560928147061119,0.857238122701426,1,3,negative regulation of steroid biosynthetic process,BP,DKK3
2286,GO:0031943,0.560928147061119,0.857238122701426,1,3,regulation of glucocorticoid metabolic process,BP,DKK3
2289,GO:0031946,0.560928147061119,0.857238122701426,1,3,regulation of glucocorticoid biosynthetic process,BP,DKK3
2676,GO:0034650,0.560928147061119,0.857238122701426,1,3,cortisol metabolic process,BP,DKK3
2677,GO:0034651,0.560928147061119,0.857238122701426,1,3,cortisol biosynthetic process,BP,DKK3
3602,GO:0045939,0.560928147061119,0.857238122701426,1,3,negative regulation of steroid metabolic process,BP,DKK3
6056,GO:2000064,0.560928147061119,0.857238122701426,1,3,regulation of cortisol biosynthetic process,BP,DKK3
717,GO:0005938,0.561057501169156,0.679227600224806,4,13,cell cortex,CC,ACTN2;MYO7A;PLEKHH2;CTGF
5523,GO:0099568,0.561057501169156,0.679227600224806,4,13,cytoplasmic region,CC,ACTN2;MYO7A;PLEKHH2;CTGF
203,GO:0001959,0.561622777819432,0.856804407962011,1,3,regulation of cytokine-mediated signaling pathway,BP,GAS6
205,GO:0001961,0.561622777819432,0.856804407962011,1,3,positive regulation of cytokine-mediated signaling pathway,BP,GAS6
332,GO:0002690,0.561622777819432,0.856804407962011,1,3,positive regulation of leukocyte chemotaxis,BP,GAS6
4595,GO:0060759,0.561622777819432,0.856804407962011,1,3,regulation of response to cytokine stimulus,BP,GAS6
4596,GO:0060760,0.561622777819432,0.856804407962011,1,3,positive regulation of response to cytokine stimulus,BP,GAS6
4287,GO:0051896,0.561929049524761,0.856612871844354,1,3,regulation of protein kinase B signaling,BP,GAS6
4288,GO:0051897,0.561929049524761,0.856612871844354,1,3,positive regulation of protein kinase B signaling,BP,GAS6
2611,GO:0033674,0.562116241168226,0.629483128641896,6,28,positive regulation of kinase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
3579,GO:0045860,0.562116241168226,0.629483128641896,6,28,positive regulation of protein kinase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
5557,GO:1900181,0.562363740727912,0.856340703136058,1,3,negative regulation of protein localization to nucleus,BP,GAS6
2675,GO:0034645,0.562364462404347,0.580683054529343,13,56,cellular macromolecule biosynthetic process,BP,CDKN1A;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1701,GO:0016791,0.562713275282614,0.856121578641523,1,3,phosphatase activity,MF,PTPN7
43,GO:0000578,0.563185135509293,0.855825379756255,1,3,embryonic axis specification,BP,WT1
3726,GO:0046916,0.56332538954323,0.855737252642386,1,3,cellular transition metal ion homeostasis,BP,PRND
3831,GO:0048523,0.563733647600031,0.559383663508292,23,98,negative regulation of cellular process,BP,ACTN2;CDKN1A;GPRASP1;DKK3;RHOB;KITLG;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;FHOD3;FOXO4;ESPN;DLL1;CTGF;UNC119;ITGA3;WT1
4191,GO:0051301,0.564804601676256,0.698186491459369,3,12,cell division,BP,RHOB;MARK4;DLL1
656,GO:0005737,0.565590021148465,0.565544910310198,39,165,cytoplasm,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;GPRASP1;RHOB;KITLG;PHLDA1;RHOJ;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;SLC25A53;GAS6;ITGB5;SDC4;PRKACB;SERPINA5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;ESPN;GPSM1;MARK4;TMEM163;DLL1;PDE4B;CLDN1;CTGF;UNC119;ITGA3;WT1
5215,GO:0072594,0.565707354080727,0.697358776450413,3,12,establishment of protein localization to organelle,BP,CDKN1A;PIK3R1;GAS6
5329,GO:0090316,0.565765190522158,0.752091855923855,2,7,positive regulation of intracellular protein transport,BP,PIK3R1;GAS6
5947,GO:1904951,0.566226280775567,0.700319464562989,3,11,positive regulation of establishment of protein localization,BP,PIK3R1;GAS6;ITGA3
3377,GO:0044702,0.566762497693724,0.590654928416725,10,43,single organism reproductive process,BP,KITLG;MFGE8;CLDN11;PRKACB;ITGB8;SERPINA5;ACSL4;DHH;ITGA3;WT1
690,GO:0005829,0.566895325805702,0.561650913336577,19,76,cytosol,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;GPRASP1;RHOB;PHLDA1;RHOJ;PIK3R1;PRKACB;PTPN7;RIN3;FOXO4;GPSM1;MARK4;PDE4B;CTGF;UNC119;WT1
3824,GO:0048514,0.567219086623016,0.61608457534042,7,28,blood vessel morphogenesis,BP,RHOB;MFGE8;LAMA5;FOXO4;DLL1;CTGF;WT1
4839,GO:0070371,0.567788561571022,0.7334025631201,2,11,ERK1 and ERK2 cascade,BP,GAS6;CTGF
4840,GO:0070372,0.567788561571022,0.7334025631201,2,11,regulation of ERK1 and ERK2 cascade,BP,GAS6;CTGF
3089,GO:0043010,0.567953253691537,0.690116531072193,3,14,camera-type eye development,BP,RHOJ;DLL1;WT1
1284,GO:0009987,0.568400058668709,0.63575404467651,51,216,cellular process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;GPRASP1;DKK3;RHOB;KITLG;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;DAAM2;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
592,GO:0005198,0.568534821089764,0.628253676595424,6,23,structural molecule activity,MF,LAMA1;ACTN2;CLDN11;LAMA5;MPZL1;CLDN1
2594,GO:0033554,0.569057138707591,0.602486481796575,8,35,cellular response to stress,BP,CDKN1A;RHOB;NUAK2;SLC52A3;PIK3R1;GAS6;FOXO4;CTGF
1010,GO:0007281,0.569264181846652,0.738450738243489,2,9,germ cell development,BP,DHH;WT1
3650,GO:0046486,0.569368736441384,0.693988290392072,3,12,glycerolipid metabolic process,BP,KITLG;PIK3R1;ACSL4
2300,GO:0031974,0.569424571482916,0.582555756581994,11,47,membrane-enclosed lumen,CC,ACTN2;CDKN1A;HMGCS2;MRO;PHLDA1;GAS6;SDC4;PRKACB;CRISPLD2;FOXO4;WT1
3148,GO:0043233,0.569424571482916,0.582555756581994,11,47,organelle lumen,CC,ACTN2;CDKN1A;HMGCS2;MRO;PHLDA1;GAS6;SDC4;PRKACB;CRISPLD2;FOXO4;WT1
4776,GO:0070013,0.569424571482916,0.582555756581994,11,47,intracellular organelle lumen,CC,ACTN2;CDKN1A;HMGCS2;MRO;PHLDA1;GAS6;SDC4;PRKACB;CRISPLD2;FOXO4;WT1
3840,GO:0048545,0.56953928398024,0.693830765628508,3,12,response to steroid hormone,BP,CDKN1A;CLDN1;CTGF
124,GO:0001706,0.569666549222991,0.85171137252147,1,3,endoderm formation,BP,ITGB5
3174,GO:0043296,0.569923881022589,0.660857291325221,4,17,apical junction complex,CC,CAMSAP3;CLDN11;CLDN1;CGN
4118,GO:0051148,0.57094049216123,0.74770517910544,2,7,negative regulation of muscle cell differentiation,BP,FOXO4;DLL1
2920,GO:0040012,0.57099058602763,0.593938956794313,9,37,regulation of locomotion,BP,LAMA1;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;ITGA3
1459,GO:0012501,0.571452416683729,0.571852901411948,13,55,programmed cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;PHLDA1;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
3288,GO:0044087,0.572571893866955,0.624298796347045,6,23,regulation of cellular component biogenesis,BP,PIK3R1;SDC4;FHOD3;ESPN;CLDN1;CTGF
5659,GO:1901701,0.573000804704863,0.591931232620762,9,37,cellular response to oxygen-containing compound,BP,ACTN2;RHOB;PIK3R1;GAS6;PRKACB;FOXO4;PDE4B;CLDN1;WT1
4537,GO:0060562,0.573051928921713,0.621494187380269,6,25,epithelial tube morphogenesis,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;WT1
1698,GO:0016787,0.573803008196939,0.59718502746974,8,36,hydrolase activity,MF,MYO7A;RHOB;RHOJ;PTPN7;RAB39B;DHH;PDE4B;CGN
2254,GO:0031625,0.574006692096676,0.738897529365993,2,8,ubiquitin protein ligase binding,MF,CDKN1A;PRKACB
3337,GO:0044389,0.574006692096676,0.738897529365993,2,8,ubiquitin-like protein ligase binding,MF,CDKN1A;PRKACB
667,GO:0005770,0.57488426773967,0.83330051227825,1,4,late endosome,CC,RHOB
5794,GO:1903047,0.576279771173485,0.65154881448222,4,19,mitotic cell cycle process,BP,CDKN1A;PHLDA1;FOXO4;MARK4
3162,GO:0043267,0.576503708412722,0.847278378323586,1,3,negative regulation of potassium ion transport,BP,ACTN2
5621,GO:1901379,0.576503708412722,0.847278378323586,1,3,regulation of potassium ion transmembrane transport,BP,ACTN2
5622,GO:1901380,0.576503708412722,0.847278378323586,1,3,negative regulation of potassium ion transmembrane transport,BP,ACTN2
5906,GO:1904063,0.576503708412722,0.847278378323586,1,3,negative regulation of cation transmembrane transport,BP,ACTN2
4989,GO:0071496,0.576524425703599,0.68447124932596,3,13,cellular response to external stimulus,BP,CDKN1A;NUAK2;GAS6
44,GO:0000785,0.578229682253927,0.846143947201894,1,3,chromatin,CC,HMGN5
654,GO:0005694,0.578229682253927,0.846143947201894,1,3,chromosome,CC,HMGN5
3348,GO:0044427,0.578229682253927,0.846143947201894,1,3,chromosomal part,CC,HMGN5
3454,GO:0045184,0.578867719191369,0.573439852539479,11,46,establishment of protein localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;LAMA5;GAS6;RAB39B;UNC119;ITGA3
1185,GO:0009101,0.579696425406365,0.845174980150755,1,3,glycoprotein biosynthetic process,BP,PHLDA1
2078,GO:0030554,0.579716080813623,0.61724991401078,6,23,adenyl nucleotide binding,MF,MYO7A;NUAK2;PRKACB;ACSL4;MARK4;PDE4B
2434,GO:0032559,0.579716080813623,0.61724991401078,6,23,adenyl ribonucleotide binding,MF,MYO7A;NUAK2;PRKACB;ACSL4;MARK4;PDE4B
170,GO:0001845,0.579892639774508,0.845045011954003,1,3,phagolysosome assembly,BP,MYO7A
940,GO:0007040,0.579892639774508,0.845045011954003,1,3,lysosome organization,BP,MYO7A
5234,GO:0080171,0.579892639774508,0.845045011954003,1,3,lytic vacuole organization,BP,MYO7A
3163,GO:0043268,0.580660321386312,0.844535733714481,1,3,positive regulation of potassium ion transport,BP,ACTN2
624,GO:0005515,0.583632855722557,0.558894821497317,43,183,protein binding,MF,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;NRTN;REEP1;GPRASP1;RHOB;KITLG;PHLDA1;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;SERPINA5;PTPN7;RIN3;FHOD3;RAB39B;DHH;FOXO4;ESPN;MARK4;DAAM2;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
565,GO:0005092,0.584020786230825,0.842291672904556,1,3,GDP-dissociation inhibitor activity,MF,GPSM1
817,GO:0006605,0.584033158482829,0.680270110844592,3,12,protein targeting,BP,CDKN1A;PIK3R1;GAS6
1121,GO:0008217,0.584150349070822,0.725225901155183,2,9,regulation of blood pressure,BP,GAS6;DLL1
3238,GO:0043549,0.585857605134011,0.594380669323661,7,32,regulation of kinase activity,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;UNC119
657,GO:0005739,0.588135343923169,0.643200991616529,4,17,mitochondrion,CC,HMGCS2;REEP1;SLC25A53;ACSL4
1488,GO:0014074,0.588567383838695,0.839216984311176,1,3,response to purine-containing compound,BP,WT1
826,GO:0006637,0.588744483297823,0.873240737208472,1,2,acyl-CoA metabolic process,BP,ACSL4
1186,GO:0009108,0.588744483297823,0.873240737208472,1,2,coenzyme biosynthetic process,BP,ACSL4
2753,GO:0035336,0.588744483297823,0.873240737208472,1,2,long-chain fatty-acyl-CoA metabolic process,BP,ACSL4
2754,GO:0035337,0.588744483297823,0.873240737208472,1,2,fatty-acyl-CoA metabolic process,BP,ACSL4
2755,GO:0035338,0.588744483297823,0.873240737208472,1,2,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL4
2756,GO:0035383,0.588744483297823,0.873240737208472,1,2,thioester metabolic process,BP,ACSL4
2757,GO:0035384,0.588744483297823,0.873240737208472,1,2,thioester biosynthetic process,BP,ACSL4
3731,GO:0046949,0.588744483297823,0.873240737208472,1,2,fatty-acyl-CoA biosynthetic process,BP,ACSL4
4138,GO:0051188,0.588744483297823,0.873240737208472,1,2,cofactor biosynthetic process,BP,ACSL4
5000,GO:0071616,0.588744483297823,0.873240737208472,1,2,acyl-CoA biosynthetic process,BP,ACSL4
145,GO:0001775,0.588773468394506,0.582686986216059,8,35,cell activation,BP,CDKN1A;RHOB;PIK3R1;GAS6;SDC4;CRISPLD2;DLL1;CTGF
112,GO:0001658,0.588829845912706,0.720982007447533,2,9,branching involved in ureteric bud morphogenesis,BP,LAMA5;WT1
4568,GO:0060675,0.588829845912706,0.720982007447533,2,9,ureteric bud morphogenesis,BP,LAMA5;WT1
5133,GO:0072171,0.588829845912706,0.720982007447533,2,9,mesonephric tubule morphogenesis,BP,LAMA5;WT1
1259,GO:0009889,0.589068465368548,0.552955111782221,13,59,regulation of biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;DHH;FOXO4;DLL1;CTGF;ITGA3;WT1
4104,GO:0051093,0.589275472755963,0.604322269254636,6,26,negative regulation of developmental process,BP,PIK3R1;GAS6;PRKACB;FOXO4;DLL1;WT1
1669,GO:0016569,0.589388225869398,0.838657111187246,1,3,covalent chromatin modification,BP,HMGN5
5159,GO:0072216,0.589402375586677,0.822809687996296,1,4,positive regulation of metanephros development,BP,WT1
4281,GO:0051875,0.589540907459134,0.838552809518905,1,3,pigment granule localization,BP,MYO7A
4290,GO:0051904,0.589540907459134,0.838552809518905,1,3,pigment granule transport,BP,MYO7A
4291,GO:0051905,0.589540907459134,0.838552809518905,1,3,establishment of pigment granule localization,BP,MYO7A
3718,GO:0046890,0.589867823747872,0.7248179272847,2,8,regulation of lipid biosynthetic process,BP,DKK3;DHH
2955,GO:0042127,0.590828696326691,0.565172763013248,10,46,regulation of cell proliferation,BP,CDKN1A;KITLG;LAMA5;GAS6;SDC4;HMGN5;FOXO4;DLL1;CTGF;WT1
916,GO:0006955,0.591398253364197,0.591047338860422,7,29,immune response,BP,PIK3R1;GAS6;PRKACB;CRISPLD2;DLL1;PDE4B;CLDN1
1238,GO:0009653,0.591489076593372,0.534745755952013,20,83,anatomical structure morphogenesis,BP,ACTN2;MYO7A;NRTN;DKK3;RHOB;RHOJ;MFGE8;PIK3R1;LAMA5;ITGB5;SDC4;SEMA6C;PRKACB;CRISPLD2;FHOD3;FOXO4;DLL1;CTGF;ITGA3;WT1
5085,GO:0072075,0.592067830103359,0.836819185393034,1,3,metanephric mesenchyme development,BP,WT1
5866,GO:1903707,0.593105439848462,0.728346622089101,2,7,negative regulation of hemopoiesis,BP,PIK3R1;DLL1
4201,GO:0051347,0.593203999158693,0.59779331588,6,29,positive regulation of transferase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
3672,GO:0046649,0.595365861557943,0.614896573991986,5,21,lymphocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4;DLL1
6046,GO:2000026,0.595453493174482,0.551474121614673,12,51,regulation of multicellular organismal development,BP,LAMA1;RHOB;KITLG;PIK3R1;LAMA5;GAS6;PRKACB;FOXO4;DLL1;CTGF;ITGA3;WT1
2583,GO:0033273,0.595827731824845,0.834213635117431,1,3,response to vitamin,BP,GAS6
867,GO:0006811,0.596031776994556,0.59655598161159,6,27,ion transport,BP,ACTN2;SLC52A3;GAS6;ACSL4;PDE4B;CTGF
4766,GO:0061695,0.596242238051722,0.725530342792333,2,7,transferase complex, transferring phosphorus-containing groups,CC,CDKN1A;PIK3R1
4936,GO:0071310,0.597604197637835,0.541255171847984,14,61,cellular response to organic substance,BP,ACTN2;DKK3;PIK3R1;GAS6;ITGB5;PRKACB;FOXO4;DLL1;PDE4B;CLDN1;CGN;CTGF;ITGA3;WT1
1658,GO:0016462,0.597882163206983,0.607833816746461,5,25,pyrophosphatase activity,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
1705,GO:0016817,0.597882163206983,0.607833816746461,5,25,hydrolase activity, acting on acid anhydrides,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
1706,GO:0016818,0.597882163206983,0.607833816746461,5,25,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
1730,GO:0017111,0.597882163206983,0.607833816746461,5,25,nucleoside-triphosphatase activity,MF,MYO7A;RHOB;RHOJ;RAB39B;CGN
1362,GO:0010638,0.598178931870068,0.661244168045406,3,14,positive regulation of organelle organization,BP,ACTN2;SDC4;CTGF
5740,GO:1902580,0.599080125099583,0.583224586140104,7,29,single-organism cellular localization,BP,ACTN2;MYO7A;CDKN1A;PIK3R1;LAMA5;GAS6;ITGA3
566,GO:0005096,0.599451876701528,0.831672370340947,1,3,GTPase activator activity,MF,RIN3
4307,GO:0051961,0.599789913379203,0.722321723617027,2,7,negative regulation of nervous system development,BP,PRKACB;DLL1
1982,GO:0030141,0.59980686597923,0.628318647042613,4,19,secretory granule,CC,ACTN2;GAS6;SERPINA5;CRISPLD2
1132,GO:0008286,0.599985427692587,0.722144167114932,2,7,insulin receptor signaling pathway,BP,PIK3R1;FOXO4
2035,GO:0030316,0.600052385496615,0.831248441608567,1,3,osteoclast differentiation,BP,PIK3R1
3529,GO:0045670,0.600052385496615,0.831248441608567,1,3,regulation of osteoclast differentiation,BP,PIK3R1
3530,GO:0045671,0.600052385496615,0.831248441608567,1,3,negative regulation of osteoclast differentiation,BP,PIK3R1
527,GO:0004674,0.60053648026499,0.664402946845638,3,12,protein serine/threonine kinase activity,MF,NUAK2;PRKACB;MARK4
5902,GO:1904031,0.600620548132217,0.804902821014152,1,5,positive regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
328,GO:0002685,0.601170814484852,0.714487857371048,2,8,regulation of leukocyte migration,BP,KITLG;GAS6
5094,GO:0072091,0.601408008128948,0.866076821480833,1,2,regulation of stem cell proliferation,BP,KITLG
6134,GO:2000648,0.601408008128948,0.866076821480833,1,2,positive regulation of stem cell proliferation,BP,KITLG
3334,GO:0044346,0.601461922204486,0.830250177625856,1,3,fibroblast apoptotic process,BP,GAS6
6093,GO:2000269,0.601461922204486,0.830250177625856,1,3,regulation of fibroblast apoptotic process,BP,GAS6
6094,GO:2000270,0.601461922204486,0.830250177625856,1,3,negative regulation of fibroblast apoptotic process,BP,GAS6
2186,GO:0031143,0.601691585298533,0.830087098699887,1,3,pseudopodium,CC,ACTN2
1252,GO:0009798,0.60205600848682,0.708757244316783,2,9,axis specification,BP,DLL1;WT1
1300,GO:0010171,0.60245190773068,0.812971142313904,1,4,body morphogenesis,BP,CRISPLD2
4447,GO:0060323,0.60245190773068,0.812971142313904,1,4,head morphogenesis,BP,CRISPLD2
2031,GO:0030308,0.602974514869472,0.712816039878212,2,8,negative regulation of cell growth,BP,CDKN1A;WT1
810,GO:0006518,0.603293782115497,0.812322730598472,1,4,peptide metabolic process,BP,GAS6
6089,GO:2000242,0.603538767057814,0.712291708821003,2,8,negative regulation of reproductive process,BP,PRKACB;WT1
5615,GO:1901342,0.603669876637117,0.632170313539524,4,15,regulation of vasculature development,BP,RHOB;FOXO4;DLL1;WT1
2220,GO:0031345,0.603698525726149,0.828656904761297,1,3,negative regulation of cell projection organization,BP,ITGA3
4513,GO:0060491,0.604691200337393,0.81124271630825,1,4,regulation of cell projection assembly,BP,ESPN
3744,GO:0048009,0.605052330425501,0.82768695257625,1,3,insulin-like growth factor receptor signaling pathway,BP,PIK3R1
5742,GO:1902582,0.605665615250215,0.625736754749171,4,17,single-organism intracellular transport,BP,MYO7A;CDKN1A;PIK3R1;GAS6
5642,GO:1901617,0.605846870812188,0.710140250562297,2,8,organic hydroxy compound biosynthetic process,BP,HMGCS2;DKK3
1961,GO:0030042,0.60645861469196,0.739939563467382,2,5,actin filament depolymerization,BP,ACTN2;PLEKHH2
2118,GO:0030834,0.60645861469196,0.739939563467382,2,5,regulation of actin filament depolymerization,BP,ACTN2;PLEKHH2
3155,GO:0043244,0.60645861469196,0.739939563467382,2,5,regulation of protein complex disassembly,BP,ACTN2;PLEKHH2
3261,GO:0043624,0.60645861469196,0.739939563467382,2,5,cellular protein complex disassembly,BP,ACTN2;PLEKHH2
4174,GO:0051261,0.60645861469196,0.739939563467382,2,5,protein depolymerization,BP,ACTN2;PLEKHH2
5670,GO:1901879,0.60645861469196,0.739939563467382,2,5,regulation of protein depolymerization,BP,ACTN2;PLEKHH2
1972,GO:0030098,0.606823549652084,0.658235659041116,3,12,lymphocyte differentiation,BP,PIK3R1;GAS6;DLL1
4859,GO:0070527,0.607175606346836,0.826157213811904,1,3,platelet aggregation,BP,GAS6
626,GO:0005518,0.607364783027252,0.826020414202486,1,3,collagen binding,MF,ITGA3
595,GO:0005215,0.607891340392078,0.620144619386085,4,19,transporter activity,MF,SLC52A3;SLC25A53;GAS6;SLC18B1
4511,GO:0060485,0.608626866054366,0.620957204919049,4,18,mesenchyme development,BP,NRTN;KITLG;LAMA5;WT1
3304,GO:0044249,0.608703590972474,0.523833162816395,16,71,cellular biosynthetic process,BP,ACTN2;CDKN1A;HMGCS2;DKK3;KITLG;PRND;PHLDA1;PIK3R1;GAS6;HMGN5;ACSL4;FOXO4;DLL1;CTGF;ITGA3;WT1
3613,GO:0045995,0.609310780897267,0.629328650106473,4,14,regulation of embryonic development,BP,LAMA1;LAMA5;PRKACB;DLL1
5601,GO:1901137,0.609749535224777,0.701486858943119,2,9,carbohydrate derivative biosynthetic process,BP,PHLDA1;SDC4
3947,GO:0048870,0.609962842761591,0.536454897537094,12,51,cell motility,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;PDE4B;CTGF;ITGA3
4260,GO:0051674,0.609962842761591,0.536454897537094,12,51,localization of cell,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;PDE4B;CTGF;ITGA3
5702,GO:1902115,0.610405911777162,0.80677725519162,1,4,regulation of organelle assembly,BP,SDC4
5703,GO:1902117,0.610405911777162,0.80677725519162,1,4,positive regulation of organelle assembly,BP,SDC4
1048,GO:0007548,0.610516442977287,0.649019258441653,3,14,sex differentiation,BP,KITLG;DHH;WT1
5774,GO:1902904,0.611583210984736,0.73546827475431,2,5,negative regulation of supramolecular fiber organization,BP,PLEKHH2;FHOD3
3800,GO:0048333,0.611838648660034,0.822760946259389,1,3,mesodermal cell differentiation,BP,ITGA3
2710,GO:0035051,0.61248542307822,0.656344454248159,3,11,cardiocyte differentiation,BP,ACTN2;FHOD3;WT1
359,GO:0002792,0.612916847439673,0.821968404577824,1,3,negative regulation of peptide secretion,BP,GAS6
3977,GO:0050709,0.612916847439673,0.821968404577824,1,3,negative regulation of protein secretion,BP,GAS6
2733,GO:0035239,0.613954582419286,0.579080548653,6,26,tube morphogenesis,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;WT1
4197,GO:0051338,0.614443607700999,0.564384531614345,7,33,regulation of transferase activity,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;UNC119
1249,GO:0009790,0.6173533546553,0.534221551280304,11,45,embryo development,BP,LAMA1;MYO7A;KITLG;LAMA5;ITGB5;SDC4;PRKACB;ACSL4;DLL1;ITGA3;WT1
3556,GO:0045785,0.617705665269775,0.651149439646952,3,11,positive regulation of cell adhesion,BP,PIK3R1;SDC4;ITGA3
2502,GO:0032844,0.618008225580685,0.69862539263874,2,8,regulation of homeostatic process,BP,KITLG;DLL1
4038,GO:0050866,0.618045998213729,0.800682914627942,1,4,negative regulation of cell activation,BP,SDC4
266,GO:0002285,0.618108328704366,0.800632600911248,1,4,lymphocyte activation involved in immune response,BP,DLL1
2878,GO:0036477,0.618303686970666,0.65055117954485,3,11,somatodendritic compartment,CC,ACTN2;ACSL4;PDE4B
4094,GO:0051052,0.619608440419033,0.684918406228372,2,11,regulation of DNA metabolic process,BP,CDKN1A;KITLG
2739,GO:0035270,0.61988462179401,0.639560040682091,3,14,endocrine system development,BP,DKK3;DLL1;WT1
3882,GO:0048666,0.620024898822495,0.552470141077596,8,32,neuron development,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;SDC4;SEMA6C;ACSL4;ITGA3
912,GO:0006942,0.620081724167329,0.696631693187397,2,8,regulation of striated muscle contraction,BP,PDE4B;CTGF
1122,GO:0008219,0.620284191521867,0.521056263478829,13,57,cell death,BP,ACTN2;CDKN1A;RHOB;KITLG;PHLDA1;NUAK2;PIK3R1;GAS6;HMGN5;MARK4;DLL1;CTGF;WT1
3521,GO:0045661,0.620466014996317,0.816341843394338,1,3,regulation of myoblast differentiation,BP,DLL1
3522,GO:0045662,0.620466014996317,0.816341843394338,1,3,negative regulation of myoblast differentiation,BP,DLL1
734,GO:0006022,0.620538088728082,0.79866370194695,1,4,aminoglycan metabolic process,BP,SDC4
2001,GO:0030203,0.620538088728082,0.79866370194695,1,4,glycosaminoglycan metabolic process,BP,SDC4
2648,GO:0034341,0.62081684791553,0.798436868486469,1,4,response to interferon-gamma,BP,CLDN1
4948,GO:0071346,0.62081684791553,0.798436868486469,1,4,cellular response to interferon-gamma,BP,CLDN1
1274,GO:0009948,0.622417873662138,0.7971302780137,1,4,anterior/posterior axis specification,BP,WT1
964,GO:0007162,0.622539309746869,0.701139920407907,2,7,negative regulation of cell adhesion,BP,PIK3R1;SDC4
4454,GO:0060341,0.622826564392339,0.57086233944095,6,25,regulation of cellular localization,BP,ACTN2;CDKN1A;REEP1;PIK3R1;GAS6;ITGA3
3346,GO:0044424,0.624165789882533,0.517381363413311,43,183,intracellular part,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;GPRASP1;RHOB;KITLG;MRO;PHLDA1;RHOJ;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;SDC4;PRKACB;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;ESPN;GPSM1;MARK4;TMEM163;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
1920,GO:0022607,0.624660777692708,0.517285023838728,13,54,cellular component assembly,BP,ACTN2;MYO7A;PRND;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;FHOD3;ESPN;MARK4;CLDN1;CTGF
4774,GO:0065009,0.624731413644096,0.50921998084879,15,69,regulation of molecular function,BP,ACTN2;CDKN1A;NRTN;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;RIN3;GPSM1;PDE4B;CTGF;UNC119
3239,GO:0043550,0.624863165500148,0.813001104863948,1,3,regulation of lipid kinase activity,BP,PIK3R1
3240,GO:0043551,0.624863165500148,0.813001104863948,1,3,regulation of phosphatidylinositol 3-kinase activity,BP,PIK3R1
5871,GO:1903725,0.624863165500148,0.813001104863948,1,3,regulation of phospholipid metabolic process,BP,PIK3R1
3485,GO:0045446,0.626089310264556,0.638902695513108,3,12,endothelial cell differentiation,BP,LAMA5;DLL1;CLDN1
3059,GO:0042698,0.626459763067485,0.811776343105334,1,3,ovulation cycle,BP,KITLG
34,GO:0000278,0.62689079344515,0.599128264448278,4,20,mitotic cell cycle,BP,CDKN1A;PHLDA1;FOXO4;MARK4
298,GO:0002440,0.626947277759904,0.793398583764372,1,4,production of molecular mediator of immune response,BP,GAS6
3674,GO:0046660,0.628946980469292,0.688005618333682,2,8,female sex differentiation,BP,KITLG;WT1
5897,GO:1904019,0.62942431779123,0.809485435325634,1,3,epithelial cell apoptotic process,BP,GAS6
5083,GO:0072073,0.62979836596662,0.600913579816449,4,17,kidney epithelium development,BP,LAMA5;SDC4;DLL1;WT1
3142,GO:0043227,0.629841888010041,0.494901711944982,36,156,membrane-bounded organelle,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;RHOB;MRO;PHLDA1;RHOJ;NUAK2;MFGE8;CLDN11;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;ACSL4;CRISPLD2;RAB39B;FOXO4;GPSM1;DAAM2;TMEM163;DLL1;PDE4B;CTGF;ITGA3;WT1
5238,GO:0086003,0.630060701778905,0.808990798252393,1,3,cardiac muscle cell contraction,BP,PDE4B
5109,GO:0072110,0.630266578936984,0.790630428374072,1,4,glomerular mesangial cell proliferation,BP,WT1
5112,GO:0072124,0.630266578936984,0.790630428374072,1,4,regulation of glomerular mesangial cell proliferation,BP,WT1
5307,GO:0090192,0.630266578936984,0.790630428374072,1,4,regulation of glomerulus development,BP,WT1
5660,GO:1901722,0.630266578936984,0.790630428374072,1,4,regulation of cell proliferation involved in kidney development,BP,WT1
1336,GO:0010556,0.630368072310288,0.513774021881731,12,55,regulation of macromolecule biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
5214,GO:0072593,0.631115119769526,0.676631715953317,2,10,reactive oxygen species metabolic process,BP,CDKN1A;CTGF
3655,GO:0046530,0.6314075417801,0.847805120145316,1,2,photoreceptor cell differentiation,BP,MYO7A
5334,GO:0090382,0.631798616022731,0.78934313172814,1,4,phagosome maturation,BP,MYO7A
5650,GO:1901655,0.632093982133484,0.789094245443385,1,4,cellular response to ketone,BP,GAS6
4247,GO:0051606,0.632339313555915,0.788887346682604,1,4,detection of stimulus,BP,UNC119
1725,GO:0017046,0.632437188790068,0.807134640790107,1,3,peptide hormone binding,MF,PIK3R1
3035,GO:0042562,0.632437188790068,0.807134640790107,1,3,hormone binding,MF,PIK3R1
3698,GO:0046847,0.633237083286895,0.788128873287012,1,4,filopodium assembly,BP,ESPN
484,GO:0003677,0.634146735030133,0.630617907955599,3,12,DNA binding,MF,HMGN5;FOXO4;WT1
1140,GO:0008360,0.634157232958376,0.787349295223341,1,4,regulation of cell shape,BP,RHOJ
376,GO:0003012,0.634822019141657,0.593790298822471,4,18,muscle system process,BP,ACTN2;ITGB5;PDE4B;CTGF
907,GO:0006936,0.634822019141657,0.593790298822471,4,18,muscle contraction,BP,ACTN2;ITGB5;PDE4B;CTGF
2967,GO:0042221,0.635485732492473,0.48809600019352,20,90,response to chemical,BP,ACTN2;CDKN1A;NRTN;DKK3;RHOB;PIK3R1;GAS6;ITGB5;SEMA6C;PRKACB;ACSL4;DHH;FOXO4;DLL1;PDE4B;CLDN1;CGN;CTGF;ITGA3;WT1
4975,GO:0071425,0.635514917875949,0.804709508631859,1,3,hematopoietic stem cell proliferation,BP,KITLG
3404,GO:0044801,0.636096579306645,0.775076464351227,1,5,single-organism membrane fusion,BP,SERPINA5
5842,GO:1903524,0.636328137914628,0.774871075489111,1,5,positive regulation of blood circulation,BP,CTGF
4609,GO:0060837,0.636482594140717,0.803942017726339,1,3,blood vessel endothelial cell differentiation,BP,DLL1
4613,GO:0060842,0.636482594140717,0.803942017726339,1,3,arterial endothelial cell differentiation,BP,DLL1
1363,GO:0010639,0.636706140221719,0.636653262175904,3,10,negative regulation of organelle organization,BP,PLEKHH2;FHOD3;ESPN
2633,GO:0034220,0.637090660551274,0.621778193442216,3,14,ion transmembrane transport,BP,ACTN2;GAS6;PDE4B
163,GO:0001838,0.63955324196046,0.672168149946511,2,9,embryonic epithelial tube formation,BP,SDC4;PRKACB
2557,GO:0033059,0.640274634322477,0.782109380416956,1,4,cellular pigmentation,BP,MYO7A
4092,GO:0051050,0.640647082797933,0.549898607935329,6,27,positive regulation of transport,BP,ACTN2;MFGE8;PIK3R1;GAS6;SDC4;DLL1
5896,GO:1904018,0.640730710741003,0.683416337220264,2,7,positive regulation of vasculature development,BP,RHOB;DLL1
2,GO:0000003,0.642163278372913,0.51129705746917,10,46,reproduction,BP,KITLG;MFGE8;CLDN11;PRKACB;ITGB8;SERPINA5;ACSL4;DHH;ITGA3;WT1
1915,GO:0022414,0.642163278372913,0.51129705746917,10,46,reproductive process,BP,KITLG;MFGE8;CLDN11;PRKACB;ITGB8;SERPINA5;ACSL4;DHH;ITGA3;WT1
317,GO:0002573,0.642329646398389,0.674663918493771,2,8,myeloid leukocyte differentiation,BP,KITLG;PIK3R1
968,GO:0007166,0.643783975649418,0.482360057743499,18,81,cell surface receptor signaling pathway,BP,LAMA1;NRTN;DKK3;KITLG;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;PRKACB;ITGB8;DHH;FOXO4;DLL1;PDE4B;CGN;CTGF;ITGA3
1625,GO:0016301,0.643866804229454,0.546427149635465,6,27,kinase activity,MF,CDKN1A;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
1695,GO:0016772,0.643866804229454,0.546427149635465,6,27,transferase activity, transferring phosphorus-containing groups,MF,CDKN1A;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
1696,GO:0016773,0.643866804229454,0.546427149635465,6,27,phosphotransferase activity, alcohol group as acceptor,MF,CDKN1A;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
1021,GO:0007368,0.645065761540477,0.671887665954767,2,8,determination of left/right symmetry,BP,DAAM2;DLL1
1254,GO:0009855,0.645065761540477,0.671887665954767,2,8,determination of bilateral symmetry,BP,DAAM2;DLL1
3931,GO:0048839,0.645112085873355,0.615957942202692,3,13,inner ear development,BP,MYO7A;SDC4;DLL1
295,GO:0002431,0.645124848511271,0.796979856331046,1,3,Fc receptor mediated stimulatory signaling pathway,BP,PIK3R1
296,GO:0002433,0.645124848511271,0.796979856331046,1,3,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3R1
2900,GO:0038094,0.645124848511271,0.796979856331046,1,3,Fc-gamma receptor signaling pathway,BP,PIK3R1
2902,GO:0038096,0.645124848511271,0.796979856331046,1,3,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3R1
2904,GO:0038128,0.645496916010726,0.777556549913471,1,4,ERBB2 signaling pathway,BP,PIK3R1
99,GO:0001568,0.645672332321298,0.523679680901499,8,34,blood vessel development,BP,RHOB;MFGE8;LAMA5;ITGB8;FOXO4;DLL1;CTGF;WT1
4056,GO:0050905,0.646312706710953,0.796007567236578,1,3,neuromuscular process,BP,MYO7A
5185,GO:0072331,0.64673439049169,0.765490145692924,1,5,signal transduction by p53 class mediator,BP,CDKN1A
3592,GO:0045926,0.647228838698923,0.664308449284788,2,9,negative regulation of growth,BP,CDKN1A;WT1
978,GO:0007186,0.648126953320306,0.579565920085927,4,18,G-protein coupled receptor signaling pathway,BP,ACTN2;GPRASP1;PRKACB;GPSM1
10,GO:0000079,0.648454202541541,0.75677295575546,1,6,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN1A
5900,GO:1904029,0.648454202541541,0.75677295575546,1,6,regulation of cyclin-dependent protein kinase activity,BP,CDKN1A
3010,GO:0042472,0.648686613800168,0.774739035702386,1,4,inner ear morphogenesis,BP,MYO7A
6096,GO:2000273,0.65097483681831,0.77270044029083,1,4,positive regulation of receptor activity,BP,ACTN2
2394,GO:0032391,0.651036589111845,0.834774248046073,1,2,photoreceptor connecting cilium,CC,MYO7A
2816,GO:0035869,0.651036589111845,0.834774248046073,1,2,ciliary transition zone,CC,MYO7A
2393,GO:0032388,0.651081744390308,0.66572429548046,2,8,positive regulation of intracellular transport,BP,PIK3R1;GAS6
1872,GO:0021782,0.651520099133105,0.772212505456705,1,4,glial cell development,BP,DLL1
5158,GO:0072215,0.651814464220246,0.760801541245529,1,5,regulation of metanephros development,BP,WT1
1844,GO:0021510,0.651818375443081,0.791451636674904,1,3,spinal cord development,BP,DLL1
2827,GO:0035924,0.651818375443081,0.791451636674904,1,3,cellular response to vascular endothelial growth factor stimulus,BP,DLL1
1136,GO:0008307,0.652993178846453,0.790468858643584,1,3,structural constituent of muscle,MF,ACTN2
97,GO:0001558,0.653186249932313,0.604648703235614,3,14,regulation of cell growth,BP,CDKN1A;CTGF;WT1
1593,GO:0016049,0.653186249932313,0.604648703235614,3,14,cell growth,BP,CDKN1A;CTGF;WT1
1036,GO:0007431,0.653238482428776,0.770669329243096,1,4,salivary gland development,BP,LAMA5
1037,GO:0007435,0.653238482428776,0.770669329243096,1,4,salivary gland morphogenesis,BP,LAMA5
2740,GO:0035272,0.653238482428776,0.770669329243096,1,4,exocrine system development,BP,LAMA5
4502,GO:0060445,0.653238482428776,0.770669329243096,1,4,branching involved in salivary gland morphogenesis,BP,LAMA5
2668,GO:0034614,0.653354473509155,0.770564865173693,1,4,cellular response to reactive oxygen species,BP,RHOB
5084,GO:0072074,0.654045483684663,0.769941739162148,1,4,kidney mesenchyme development,BP,WT1
1501,GO:0014812,0.654172676277001,0.769826894742716,1,4,muscle cell migration,BP,FOXO4
1525,GO:0014909,0.654172676277001,0.769826894742716,1,4,smooth muscle cell migration,BP,FOXO4
5014,GO:0071702,0.654523563321986,0.497524321561187,10,47,organic substance transport,BP,MYO7A;CDKN1A;RHOB;SLC52A3;PIK3R1;GAS6;SERPINA5;ACSL4;RAB39B;UNC119
2080,GO:0030595,0.655022589298827,0.656192840576033,2,9,leukocyte chemotaxis,BP,GAS6;PDE4B
2485,GO:0032774,0.655097381696715,0.491640391809503,11,51,RNA biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
5432,GO:0097659,0.655097381696715,0.491640391809503,11,51,nucleic acid-templated transcription,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
310,GO:0002521,0.65530006182994,0.573650848477055,4,17,leukocyte differentiation,BP,KITLG;PIK3R1;GAS6;DLL1
1889,GO:0021915,0.655323947670865,0.661328668629317,2,8,neural tube development,BP,SDC4;PRKACB
1609,GO:0016192,0.656653466108495,0.490950929569246,11,48,vesicle-mediated transport,BP,ACTN2;MYO7A;MFGE8;PIK3R1;GAS6;SDC4;RIN3;CRISPLD2;RAB39B;DLL1;UNC119
1572,GO:0015849,0.657277626251026,0.767009127191317,1,4,organic acid transport,BP,ACSL4
3730,GO:0046942,0.657277626251026,0.767009127191317,1,4,carboxylic acid transport,BP,ACSL4
938,GO:0007033,0.657637880512318,0.76668041258993,1,4,vacuole organization,BP,MYO7A
1637,GO:0016338,0.657902621239386,0.645564700239895,2,11,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11;CLDN1
3578,GO:0045859,0.658159097301495,0.528371165500857,6,30,regulation of protein kinase activity,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;UNC119
3056,GO:0042692,0.658236486927177,0.547387175025906,5,22,muscle cell differentiation,BP,ACTN2;FHOD3;FOXO4;DLL1;WT1
3131,GO:0043200,0.658513855551391,0.765879574547109,1,4,response to amino acid,BP,CTGF
4097,GO:0051055,0.658679151778203,0.76572820936031,1,4,negative regulation of lipid biosynthetic process,BP,DKK3
5450,GO:0098589,0.660982806146612,0.655400428995631,2,8,membrane region,CC,SDC4;DLL1
1075,GO:0007626,0.661117308757609,0.763486379076086,1,4,locomotory behavior,BP,ESPN
226,GO:0002065,0.661403776168438,0.601681108454758,3,12,columnar/cuboidal epithelial cell differentiation,BP,MYO7A;CDKN1A;DLL1
647,GO:0005622,0.662134135980357,0.482605044685731,44,192,intracellular,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;MRO;PHLDA1;RHOJ;NUAK2;PLEKHH2;CAMSAP3;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;SDC4;PRKACB;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;ESPN;GPSM1;MARK4;TMEM163;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
4156,GO:0051234,0.662371366875912,0.455084440279934,25,110,establishment of localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;SLC52A3;MFGE8;PIK3R1;SLC25A53;LAMA5;GAS6;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;DLL1;PDE4B;CLDN1;SLC18B1;CTGF;UNC119;ITGA3
11,GO:0000082,0.663355546133733,0.742420998119991,1,6,G1/S transition of mitotic cell cycle,BP,CDKN1A
3410,GO:0044843,0.663355546133733,0.742420998119991,1,6,cell cycle G1/S phase transition,BP,CDKN1A
4345,GO:0055076,0.663363042142282,0.761406207902504,1,4,transition metal ion homeostasis,BP,PRND
1744,GO:0018108,0.66394068286688,0.588664155038048,3,16,peptidyl-tyrosine phosphorylation,BP,KITLG;GAS6;UNC119
1754,GO:0018212,0.66394068286688,0.588664155038048,3,16,peptidyl-tyrosine modification,BP,KITLG;GAS6;UNC119
843,GO:0006700,0.664030121430846,0.760785468028213,1,4,C21-steroid hormone biosynthetic process,BP,DKK3
846,GO:0006705,0.664030121430846,0.760785468028213,1,4,mineralocorticoid biosynthetic process,BP,DKK3
1116,GO:0008207,0.664030121430846,0.760785468028213,1,4,C21-steroid hormone metabolic process,BP,DKK3
1119,GO:0008212,0.664030121430846,0.760785468028213,1,4,mineralocorticoid metabolic process,BP,DKK3
1345,GO:0010566,0.664030121430846,0.760785468028213,1,4,regulation of ketone biosynthetic process,BP,DKK3
2373,GO:0032341,0.664030121430846,0.760785468028213,1,4,aldosterone metabolic process,BP,DKK3
2374,GO:0032342,0.664030121430846,0.760785468028213,1,4,aldosterone biosynthetic process,BP,DKK3
2375,GO:0032344,0.664030121430846,0.760785468028213,1,4,regulation of aldosterone metabolic process,BP,DKK3
2378,GO:0032347,0.664030121430846,0.760785468028213,1,4,regulation of aldosterone biosynthetic process,BP,DKK3
2381,GO:0032350,0.664030121430846,0.760785468028213,1,4,regulation of hormone metabolic process,BP,DKK3
2693,GO:0034754,0.664030121430846,0.760785468028213,1,4,cellular hormone metabolic process,BP,DKK3
2966,GO:0042181,0.664030121430846,0.760785468028213,1,4,ketone biosynthetic process,BP,DKK3
3004,GO:0042445,0.664030121430846,0.760785468028213,1,4,hormone metabolic process,BP,DKK3
3005,GO:0042446,0.664030121430846,0.760785468028213,1,4,hormone biosynthetic process,BP,DKK3
3622,GO:0046184,0.664030121430846,0.760785468028213,1,4,aldehyde biosynthetic process,BP,DKK3
3713,GO:0046885,0.664030121430846,0.760785468028213,1,4,regulation of hormone biosynthetic process,BP,DKK3
5267,GO:0090030,0.664030121430846,0.760785468028213,1,4,regulation of steroid hormone biosynthetic process,BP,DKK3
682,GO:0005796,0.664381283790306,0.641986693963057,2,10,Golgi lumen,CC,GAS6;SDC4
3823,GO:0048513,0.664572734189996,0.454733766486156,22,96,animal organ development,BP,ACTN2;MYO7A;CDKN1A;NRTN;DKK3;KITLG;RHOJ;PIK3R1;LAMA5;GAS6;SDC4;ITGB8;SERPINA5;CRISPLD2;FHOD3;DHH;FOXO4;DLL1;CLDN1;CTGF;ITGA3;WT1
3360,GO:0044444,0.664590406791183,0.455243343791338,34,147,cytoplasmic part,CC,ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;REEP1;GPRASP1;RHOB;PHLDA1;RHOJ;PLEKHH2;PIK3R1;SLC25A53;GAS6;ITGB5;SDC4;PRKACB;SERPINA5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;FOXO4;GPSM1;MARK4;TMEM163;DLL1;PDE4B;CTGF;UNC119;ITGA3;WT1
3044,GO:0042592,0.664675516641683,0.493460533824671,9,41,homeostatic process,BP,KITLG;PRND;PIK3R1;GAS6;PRKACB;DLL1;PDE4B;CLDN1;CTGF
663,GO:0005765,0.665229278675365,0.75966632410765,1,4,lysosomal membrane,CC,MYO7A
670,GO:0005774,0.665229278675365,0.75966632410765,1,4,vacuolar membrane,CC,MYO7A
5491,GO:0098852,0.665229278675365,0.75966632410765,1,4,lytic vacuole membrane,CC,MYO7A
777,GO:0006352,0.666389622287481,0.778990677429752,1,3,DNA-templated transcription, initiation,BP,CTGF
783,GO:0006367,0.666389622287481,0.778990677429752,1,3,transcription initiation from RNA polymerase II promoter,BP,CTGF
2918,GO:0040008,0.666467364297381,0.535895134768936,5,24,regulation of growth,BP,CDKN1A;GAS6;DLL1;CTGF;WT1
3085,GO:0042993,0.666490609005438,0.778902218738737,1,3,positive regulation of transcription factor import into nucleus,BP,PIK3R1
2662,GO:0034504,0.666511164758854,0.592818524734205,3,13,protein localization to nucleus,BP,CDKN1A;PIK3R1;GAS6
5556,GO:1900180,0.666511164758854,0.592818524734205,3,13,regulation of protein localization to nucleus,BP,CDKN1A;PIK3R1;GAS6
3245,GO:0043565,0.666732461852875,0.649300102768444,2,8,sequence-specific DNA binding,MF,FOXO4;WT1
5059,GO:0072006,0.66712479457944,0.558735436481801,4,18,nephron development,BP,LAMA5;DLL1;ITGA3;WT1
1131,GO:0008285,0.669094098163271,0.532961811280446,5,24,negative regulation of cell proliferation,BP,CDKN1A;SDC4;FOXO4;DLL1;WT1
974,GO:0007178,0.669645801027352,0.554260717379159,4,19,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,DKK3;ITGB5;CGN;ITGA3
3722,GO:0046907,0.669652877464455,0.507855450103527,7,29,intracellular transport,BP,MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;PIK3R1;GAS6
2506,GO:0032869,0.66988313671781,0.645923875688318,2,8,cellular response to insulin stimulus,BP,PIK3R1;FOXO4
3161,GO:0043266,0.66992833502311,0.755239755978608,1,4,regulation of potassium ion transport,BP,ACTN2
2696,GO:0034763,0.670517982329582,0.754679643558197,1,4,negative regulation of transmembrane transport,BP,ACTN2
2699,GO:0034766,0.670517982329582,0.754679643558197,1,4,negative regulation of ion transmembrane transport,BP,ACTN2
3780,GO:0048247,0.670808214565903,0.754403564661399,1,4,lymphocyte chemotaxis,BP,GAS6
5431,GO:0097651,0.670930323420655,0.774984004003418,1,3,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1
3946,GO:0048869,0.671187950212395,0.445535071167878,25,108,cellular developmental process,BP,ACTN2;MYO7A;CDKN1A;NRTN;RHOB;KITLG;RHOJ;CAMSAP3;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;ACSL4;FHOD3;DHH;FOXO4;GPSM1;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
4152,GO:0051222,0.672024679367162,0.643615372716686,2,8,positive regulation of protein transport,BP,PIK3R1;GAS6
1016,GO:0007346,0.672454589047946,0.624618463405562,2,13,regulation of mitotic cell cycle,BP,CDKN1A;FOXO4
4720,GO:0061333,0.672645065888399,0.632988770366678,2,10,renal tubule morphogenesis,BP,LAMA5;WT1
5088,GO:0072078,0.672645065888399,0.632988770366678,2,10,nephron tubule morphogenesis,BP,LAMA5;WT1
971,GO:0007169,0.673070276054074,0.512536261757026,6,29,transmembrane receptor protein tyrosine kinase signaling pathway,BP,NRTN;PIK3R1;MPZL1;FOXO4;DLL1;CTGF
3106,GO:0043085,0.673363305678984,0.475758816993094,10,50,positive regulation of catalytic activity,BP,ACTN2;CDKN1A;NRTN;KITLG;GAS6;SDC4;PRKACB;RIN3;CTGF;UNC119
126,GO:0001708,0.67343320277627,0.772749642491952,1,3,cell fate specification,BP,DLL1
1124,GO:0008233,0.673482904541206,0.751847324204327,1,4,peptidase activity,MF,DHH
5171,GO:0072273,0.674237962613967,0.739212088992068,1,5,metanephric nephron morphogenesis,BP,WT1
229,GO:0002068,0.674648823341195,0.75072623595227,1,4,glandular epithelial cell development,BP,DLL1
465,GO:0003309,0.674648823341195,0.75072623595227,1,4,type B pancreatic cell differentiation,BP,DLL1
466,GO:0003323,0.674648823341195,0.75072623595227,1,4,type B pancreatic cell development,BP,DLL1
2818,GO:0035883,0.674648823341195,0.75072623595227,1,4,enteroendocrine cell differentiation,BP,DLL1
856,GO:0006766,0.675065582181546,0.771282376759001,1,3,vitamin metabolic process,BP,SLC52A3
3287,GO:0044085,0.675168542525204,0.461999284035965,13,56,cellular component biogenesis,BP,ACTN2;MYO7A;PRND;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;FHOD3;ESPN;MARK4;CLDN1;CTGF
1816,GO:0019838,0.675572242525904,0.74983537390877,1,4,growth factor binding,MF,CTGF
331,GO:0002688,0.676584079962415,0.748856205728589,1,4,regulation of leukocyte chemotaxis,BP,GAS6
860,GO:0006790,0.677219795161936,0.769333854057653,1,3,sulfur compound metabolic process,BP,ACSL4
3316,GO:0044272,0.677219795161936,0.769333854057653,1,3,sulfur compound biosynthetic process,BP,ACSL4
5885,GO:1903829,0.67749298624118,0.580589838919455,3,13,positive regulation of cellular protein localization,BP,PIK3R1;GAS6;ITGA3
3484,GO:0045445,0.677583917792165,0.747885550992713,1,4,myoblast differentiation,BP,DLL1
5052,GO:0071901,0.677993465436903,0.735448302570814,1,5,negative regulation of protein serine/threonine kinase activity,BP,CDKN1A
1778,GO:0019216,0.678363243589957,0.579610199419563,3,13,regulation of lipid metabolic process,BP,DKK3;PIK3R1;DHH
2474,GO:0032729,0.678570178058159,0.746925047869704,1,4,positive regulation of interferon-gamma production,BP,PDE4B
2673,GO:0034641,0.678949329971609,0.450665975113719,15,68,cellular nitrogen compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;ITGB8;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
3137,GO:0043209,0.679151517642133,0.746357476274292,1,4,myelin sheath,CC,CLDN11
374,GO:0003008,0.679214791709315,0.460551222417283,12,55,system process,BP,ACTN2;MYO7A;SLC52A3;GAS6;ITGB5;PRKACB;ESPN;DLL1;PDE4B;CTGF;UNC119;ITGA3
1761,GO:0019003,0.679256228937389,0.726377629109763,1,6,GDP binding,MF,RHOB
1184,GO:0009100,0.679363310916296,0.746150437646049,1,4,glycoprotein metabolic process,BP,PHLDA1
5482,GO:0098797,0.679940472649847,0.581160509085993,3,12,plasma membrane protein complex,CC,ITGB5;ITGB8;ITGA3
5805,GO:1903169,0.680884180210783,0.744659599451713,1,4,regulation of calcium ion transmembrane transport,BP,PDE4B
1230,GO:0009611,0.681126727118669,0.491887456631616,7,33,response to wounding,BP,RHOB;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;CTGF
5862,GO:1903670,0.681443774698807,0.765472423943519,1,3,regulation of sprouting angiogenesis,BP,DLL1
386,GO:0003073,0.681446148527507,0.731949156732353,1,5,regulation of systemic arterial blood pressure,BP,GAS6
2539,GO:0032984,0.681783716331265,0.651573956576051,2,6,macromolecular complex disassembly,BP,ACTN2;PLEKHH2
3152,GO:0043241,0.681783716331265,0.651573956576051,2,6,protein complex disassembly,BP,ACTN2;PLEKHH2
2899,GO:0038093,0.681967818517828,0.743592938569577,1,4,Fc receptor signaling pathway,BP,PIK3R1
2901,GO:0038095,0.681967818517828,0.743592938569577,1,4,Fc-epsilon receptor signaling pathway,BP,PIK3R1
3949,GO:0048872,0.682266660226892,0.626710106200647,2,9,homeostasis of number of cells,BP,KITLG;PDE4B
5137,GO:0072175,0.682506702661705,0.618535269397026,2,11,epithelial tube formation,BP,SDC4;PRKACB
286,GO:0002376,0.683239365365795,0.456327494136512,12,54,immune system process,BP,CDKN1A;KITLG;PIK3R1;GAS6;ITGB5;SDC4;PRKACB;CRISPLD2;DLL1;PDE4B;CLDN1;ITGA3
5381,GO:0097150,0.68330658633388,0.763752142563715,1,3,neuronal stem cell population maintenance,BP,DLL1
864,GO:0006807,0.683477286356723,0.443005252195873,16,73,nitrogen compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;SDC4;ITGB8;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
630,GO:0005524,0.68546612811894,0.518256103717452,5,21,ATP binding,MF,MYO7A;NUAK2;PRKACB;ACSL4;MARK4
1253,GO:0009799,0.685918328148069,0.622621531387823,2,9,specification of symmetry,BP,DAAM2;DLL1
2667,GO:0034613,0.686498865059753,0.470032883490476,9,39,cellular protein localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;LAMA5;GAS6;ITGA3
4886,GO:0070727,0.686498865059753,0.470032883490476,9,39,cellular macromolecule localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;LAMA5;GAS6;ITGA3
2503,GO:0032845,0.687073589398672,0.738517157405056,1,4,negative regulation of homeostatic process,BP,KITLG
3960,GO:0050663,0.687824479425261,0.759535131639304,1,3,cytokine secretion,BP,GAS6
866,GO:0006810,0.6881352677708,0.427850488410823,23,103,transport,BP,ACTN2;MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;SLC52A3;MFGE8;PIK3R1;SLC25A53;GAS6;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;DLL1;PDE4B;CLDN1;SLC18B1;CTGF;UNC119
2972,GO:0042277,0.688399881298102,0.737185021024517,1,4,peptide binding,MF,PIK3R1
775,GO:0006325,0.688812940445212,0.736768982746268,1,4,chromatin organization,BP,HMGN5
1933,GO:0022857,0.688921839471063,0.560424947223228,3,16,transmembrane transporter activity,MF,SLC25A53;GAS6;SLC18B1
713,GO:0005923,0.689343094299013,0.561957259208567,3,15,bicellular tight junction,CC,CLDN11;CLDN1;CGN
4789,GO:0070160,0.689343094299013,0.561957259208567,3,15,occluding junction,CC,CLDN11;CLDN1;CGN
2231,GO:0031406,0.690083716090958,0.735485576034079,1,4,carboxylic acid binding,MF,SERPINA5
3124,GO:0043177,0.690083716090958,0.735485576034079,1,4,organic acid binding,MF,SERPINA5
2049,GO:0030424,0.690234513216384,0.722871145855264,1,5,axon,CC,NRTN
156,GO:0001822,0.691135126630752,0.507907438180639,5,24,kidney development,BP,LAMA5;SDC4;DLL1;ITGA3;WT1
5631,GO:1901564,0.691918922607631,0.5081467977986,5,23,organonitrogen compound metabolic process,BP,SLC52A3;GAS6;SDC4;ITGB8;PDE4B
2050,GO:0030425,0.693722837801409,0.619584354531337,2,8,dendrite,CC,ACTN2;PDE4B
1908,GO:0022406,0.693738391591868,0.719181761039793,1,5,membrane docking,BP,MARK4
42,GO:0000323,0.693965865343002,0.609008281358301,2,10,lytic vacuole,CC,MYO7A;SDC4
662,GO:0005764,0.693965865343002,0.609008281358301,2,10,lysosome,CC,MYO7A;SDC4
573,GO:0005112,0.694103021498404,0.753567451772474,1,3,Notch binding,MF,DLL1
3120,GO:0043167,0.695941774853948,0.420033796755644,22,97,ion binding,MF,ACTN2;MYO7A;CDKN1A;RHOB;PRND;RHOJ;NUAK2;MFGE8;GAS6;PRKACB;SERPINA5;ACSL4;CRISPLD2;RAB39B;DHH;MARK4;TMEM163;DLL1;PDE4B;CTGF;ITGA3;WT1
4319,GO:0055001,0.696149803834429,0.616821767962545,2,8,muscle cell development,BP,ACTN2;FHOD3
3433,GO:0045088,0.696333893390023,0.729096304902116,1,4,regulation of innate immune response,BP,PRKACB
3434,GO:0045089,0.696333893390023,0.729096304902116,1,4,positive regulation of innate immune response,BP,PRKACB
942,GO:0007043,0.696651597316684,0.707912517202741,1,6,cell-cell junction assembly,BP,CLDN1
353,GO:0002762,0.696929532815514,0.728480658207788,1,4,negative regulation of myeloid leukocyte differentiation,BP,PIK3R1
4719,GO:0061326,0.697877082061486,0.554403881258782,3,14,renal tubule development,BP,LAMA5;DLL1;WT1
5062,GO:0072009,0.697877082061486,0.554403881258782,3,14,nephron epithelium development,BP,LAMA5;DLL1;WT1
5090,GO:0072080,0.697877082061486,0.554403881258782,3,14,nephron tubule development,BP,LAMA5;DLL1;WT1
4376,GO:0060048,0.698185398980684,0.608638884041744,2,9,cardiac muscle contraction,BP,PDE4B;CTGF
2702,GO:0034976,0.698612329305794,0.726734913355028,1,4,response to endoplasmic reticulum stress,BP,PIK3R1
4448,GO:0060324,0.698821956510956,0.726516777649489,1,4,face development,BP,CRISPLD2
2703,GO:0035004,0.69892244248679,0.603269490500408,2,10,phosphatidylinositol 3-kinase activity,MF,KITLG;PIK3R1
3652,GO:0046488,0.69892244248679,0.603269490500408,2,10,phosphatidylinositol metabolic process,BP,KITLG;PIK3R1
3696,GO:0046834,0.69892244248679,0.603269490500408,2,10,lipid phosphorylation,BP,KITLG;PIK3R1
3702,GO:0046854,0.69892244248679,0.603269490500408,2,10,phosphatidylinositol phosphorylation,BP,KITLG;PIK3R1
3727,GO:0046934,0.69892244248679,0.603269490500408,2,10,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,KITLG;PIK3R1
4318,GO:0052813,0.69892244248679,0.603269490500408,2,10,phosphatidylinositol bisphosphate kinase activity,MF,KITLG;PIK3R1
905,GO:0006928,0.699038657312775,0.428909357377578,15,64,movement of cell or subcellular component,BP,LAMA1;ACTN2;MYO7A;NRTN;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;SEMA6C;FOXO4;PDE4B;CTGF;ITGA3
3649,GO:0046483,0.701095661146412,0.428229138921397,14,66,heterocycle metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
3432,GO:0045087,0.701131874908469,0.600690835392163,2,10,innate immune response,BP,PRKACB;CLDN1
5235,GO:0085029,0.701159495107999,0.746707506032728,1,3,extracellular matrix assembly,BP,GAS6
2659,GO:0034446,0.701329110679861,0.746540583319293,1,3,substrate adhesion-dependent cell spreading,BP,LAMA5
1361,GO:0010634,0.701354921582597,0.596829860992819,2,11,positive regulation of epithelial cell migration,BP,RHOB;ITGA3
5155,GO:0072207,0.70150873771221,0.723707775169356,1,4,metanephric epithelium development,BP,WT1
1800,GO:0019538,0.701763215176489,0.41530394050646,20,93,protein metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;PTPN7;DHH;FOXO4;MARK4;DLL1;CTGF;UNC119
1095,GO:0008083,0.701920979722841,0.541909010833933,3,18,growth factor activity,MF,NRTN;KITLG;CTGF
3294,GO:0044093,0.702486454425707,0.442501317842118,10,51,positive regulation of molecular function,BP,ACTN2;CDKN1A;NRTN;KITLG;GAS6;SDC4;PRKACB;RIN3;CTGF;UNC119
1157,GO:0008543,0.703710387700701,0.700133199933035,1,6,fibroblast growth factor receptor signaling pathway,BP,CTGF
3333,GO:0044344,0.703710387700701,0.700133199933035,1,6,cellular response to fibroblast growth factor stimulus,BP,CTGF
5025,GO:0071774,0.703710387700701,0.700133199933035,1,6,response to fibroblast growth factor,BP,CTGF
1965,GO:0030054,0.704053222156561,0.429466040094145,13,56,cell junction,CC,ACTN2;RHOB;CAMSAP3;CLDN11;PIK3R1;ITGB5;MPZL1;SDC4;TMEM163;DLL1;CLDN1;CGN;ITGA3
4255,GO:0051650,0.704328813682505,0.707780516651048,1,5,establishment of vesicle localization,BP,MYO7A
636,GO:0005546,0.704529846628732,0.72051981178515,1,4,phosphatidylinositol-4,5-bisphosphate binding,MF,ACTN2
4567,GO:0060674,0.704603104077415,0.720442118370911,1,4,placenta blood vessel development,BP,ITGB8
600,GO:0005244,0.704913256266285,0.707140165356772,1,5,voltage-gated ion channel activity,MF,GAS6
608,GO:0005261,0.704913256266285,0.707140165356772,1,5,cation channel activity,MF,GAS6
1928,GO:0022832,0.704913256266285,0.707140165356772,1,5,voltage-gated channel activity,MF,GAS6
1930,GO:0022836,0.704913256266285,0.707140165356772,1,5,gated channel activity,MF,GAS6
1932,GO:0022843,0.704913256266285,0.707140165356772,1,5,voltage-gated cation channel activity,MF,GAS6
139,GO:0001756,0.705199591571325,0.742705203585942,1,3,somitogenesis,BP,DLL1
4479,GO:0060419,0.706708508363942,0.718201275078761,1,4,heart growth,BP,WT1
4480,GO:0060420,0.706708508363942,0.718201275078761,1,4,regulation of heart growth,BP,WT1
4481,GO:0060421,0.706708508363942,0.718201275078761,1,4,positive regulation of heart growth,BP,WT1
178,GO:0001894,0.707579836874182,0.704203396422191,1,5,tissue homeostasis,BP,CTGF
1528,GO:0015031,0.708956278115354,0.459182026869379,7,34,protein transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6;RAB39B;UNC119
3821,GO:0048511,0.709008773854195,0.715735356848564,1,4,rhythmic process,BP,KITLG
1103,GO:0008150,0.709253871949288,0.549545952082901,53,228,biological_process,BP,LAMA1;ACTN2;MYO7A;CDKN1A;HMGCS2;NRTN;REEP1;GPRASP1;DKK3;RHOB;KITLG;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;DAAM2;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;UNC119;ITGA3;WT1
979,GO:0007187,0.709768167547743,0.701774691605867,1,5,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,PRKACB
980,GO:0007188,0.709768167547743,0.701774691605867,1,5,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,PRKACB
4164,GO:0051248,0.710336037755196,0.533400843048552,3,17,negative regulation of protein metabolic process,BP,CDKN1A;GAS6;SERPINA5
4902,GO:0070887,0.710423996726861,0.414839329449875,15,70,cellular response to chemical stimulus,BP,ACTN2;DKK3;RHOB;PIK3R1;GAS6;ITGB5;PRKACB;FOXO4;DLL1;PDE4B;CLDN1;CGN;CTGF;ITGA3;WT1
782,GO:0006366,0.710818261404481,0.447498239001547,8,39,transcription from RNA polymerase II promoter,BP,CDKN1A;PIK3R1;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
3855,GO:0048592,0.710860451606148,0.593776895385481,2,9,eye morphogenesis,BP,MYO7A;DLL1
1025,GO:0007389,0.711685866460604,0.502756530807252,4,21,pattern specification process,BP,PRKACB;DAAM2;DLL1;WT1
1165,GO:0008610,0.711988904290804,0.503732689907722,4,20,lipid biosynthetic process,BP,HMGCS2;DKK3;PIK3R1;DHH
5483,GO:0098801,0.712053512501549,0.699220195200908,1,5,regulation of renal system process,BP,GAS6
766,GO:0006260,0.712195624036415,0.690553350664664,1,6,DNA replication,BP,KITLG
768,GO:0006275,0.712195624036415,0.690553350664664,1,6,regulation of DNA replication,BP,KITLG
3543,GO:0045740,0.712195624036415,0.690553350664664,1,6,positive regulation of DNA replication,BP,KITLG
3549,GO:0045747,0.712580926000847,0.711868938902834,1,4,positive regulation of Notch signaling pathway,BP,DLL1
5883,GO:1903827,0.713210669954245,0.484428411358164,5,22,regulation of cellular protein localization,BP,ACTN2;CDKN1A;PIK3R1;GAS6;ITGA3
1983,GO:0030154,0.713398374068837,0.3989485800581,24,105,cell differentiation,BP,ACTN2;MYO7A;CDKN1A;NRTN;RHOB;KITLG;CAMSAP3;PIK3R1;LAMA5;GAS6;ITGB5;SDC4;SEMA6C;ACSL4;FHOD3;DHH;FOXO4;GPSM1;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
1454,GO:0010976,0.71411802723953,0.710191205045754,1,4,positive regulation of neuron projection development,BP,ITGA3
1406,GO:0010812,0.714591795604687,0.733183922990077,1,3,negative regulation of cell-substrate adhesion,BP,PIK3R1
4538,GO:0060563,0.715482859658875,0.59425137492678,2,8,neuroepithelial cell differentiation,BP,MYO7A;DLL1
3869,GO:0048639,0.715671532757561,0.583397564694713,2,10,positive regulation of developmental growth,BP,DLL1;WT1
4947,GO:0071345,0.71594254902327,0.583069777841686,2,10,cellular response to cytokine stimulus,BP,GAS6;CLDN1
1034,GO:0007422,0.716135679894771,0.68601795507947,1,6,peripheral nervous system development,BP,CLDN1
6104,GO:2000379,0.716597287682591,0.685482920912427,1,6,positive regulation of reactive oxygen species metabolic process,BP,CDKN1A
1046,GO:0007519,0.716779061963978,0.707266548882033,1,4,skeletal muscle tissue development,BP,DLL1
2617,GO:0033993,0.716805254312271,0.474832109931949,5,27,response to lipid,BP,CDKN1A;DHH;PDE4B;CLDN1;CTGF
6090,GO:2000243,0.717006178553848,0.707015741086037,1,4,positive regulation of reproductive process,BP,WT1
173,GO:0001885,0.71764712253037,0.69288857995774,1,5,endothelial cell development,BP,CLDN1
4657,GO:0061028,0.71764712253037,0.69288857995774,1,5,establishment of endothelial barrier,BP,CLDN1
5110,GO:0072111,0.718142420750254,0.692322446889425,1,5,cell proliferation involved in kidney development,BP,WT1
3476,GO:0045335,0.71899655678653,0.691344039159401,1,5,phagocytic vesicle,CC,ITGB5
3252,GO:0043588,0.719053419019392,0.505328972773514,4,15,skin development,BP,LAMA5;DLL1;CLDN1;ITGA3
2554,GO:0033036,0.719215604543511,0.411237356192364,13,59,macromolecule localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;LAMA5;GAS6;SERPINA5;ACSL4;RAB39B;UNC119;ITGA3
962,GO:0007159,0.719715747500592,0.583133938150562,2,9,leukocyte cell-cell adhesion,BP,PIK3R1;SDC4
1080,GO:0008013,0.719929242501492,0.703770893319573,1,4,beta-catenin binding,MF,FOXO4
4154,GO:0051224,0.720800829341219,0.702797262205785,1,4,negative regulation of protein transport,BP,GAS6
5599,GO:1901135,0.722455384832006,0.492591549114898,4,19,carbohydrate derivative metabolic process,BP,PHLDA1;SDC4;ITGB8;PDE4B
2939,GO:0042060,0.723287596305087,0.453396879078065,6,30,wound healing,BP,RHOB;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5
1798,GO:0019439,0.724144024385343,0.699036396295694,1,4,aromatic compound catabolic process,BP,PDE4B
2679,GO:0034655,0.724144024385343,0.699036396295694,1,4,nucleobase-containing compound catabolic process,BP,PDE4B
3314,GO:0044270,0.724144024385343,0.699036396295694,1,4,cellular nitrogen compound catabolic process,BP,PDE4B
3682,GO:0046700,0.724144024385343,0.699036396295694,1,4,heterocycle catabolic process,BP,PDE4B
5618,GO:1901361,0.724144024385343,0.699036396295694,1,4,organic cyclic compound catabolic process,BP,PDE4B
1291,GO:0010008,0.724585782446423,0.568796634271994,2,11,endosome membrane,CC,RHOB;TMEM163
3358,GO:0044440,0.724585782446423,0.568796634271994,2,11,endosomal part,CC,RHOB;TMEM163
1723,GO:0017022,0.724615024376921,0.69850318237224,1,4,myosin binding,MF,RAB39B
5481,GO:0098796,0.724659339286469,0.525123320263706,3,13,membrane protein complex,CC,ITGB5;ITGB8;ITGA3
1069,GO:0007610,0.72548940091951,0.57139228590754,2,10,behavior,BP,ESPN;ITGA3
5480,GO:0098794,0.726064596136498,0.581456679186861,2,8,postsynapse,CC,ACTN2;PDE4B
136,GO:0001750,0.72744996347036,0.719636369196458,1,3,photoreceptor outer segment,CC,MYO7A
5437,GO:0097730,0.72744996347036,0.719636369196458,1,3,non-motile cilium,CC,MYO7A
5438,GO:0097731,0.72744996347036,0.719636369196458,1,3,9+0 non-motile cilium,CC,MYO7A
5439,GO:0097733,0.72744996347036,0.719636369196458,1,3,photoreceptor cell cilium,CC,MYO7A
2045,GO:0030336,0.728526514102852,0.694042477180429,1,4,negative regulation of cell migration,BP,RHOB
6074,GO:2000146,0.728526514102852,0.694042477180429,1,4,negative regulation of cell motility,BP,RHOB
4061,GO:0050921,0.7288997710042,0.670932527414317,1,6,positive regulation of chemotaxis,BP,GAS6
2079,GO:0030593,0.72903811066659,0.679637095869653,1,5,neutrophil chemotaxis,BP,PDE4B
5002,GO:0071621,0.72903811066659,0.679637095869653,1,5,granulocyte chemotaxis,BP,PDE4B
5424,GO:0097530,0.72903811066659,0.679637095869653,1,5,granulocyte migration,BP,PDE4B
6010,GO:1990266,0.72903811066659,0.679637095869653,1,5,neutrophil migration,BP,PDE4B
1746,GO:0018130,0.729186479111401,0.406718622729701,11,54,heterocycle biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
2678,GO:0034654,0.729186479111401,0.406718622729701,11,54,nucleobase-containing compound biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
3315,GO:0044271,0.729186479111401,0.406718622729701,11,54,cellular nitrogen compound biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
2204,GO:0031294,0.729905091898524,0.692456360214124,1,4,lymphocyte costimulation,BP,PIK3R1
2205,GO:0031295,0.729905091898524,0.692456360214124,1,4,T cell costimulation,BP,PIK3R1
4041,GO:0050870,0.729905091898524,0.692456360214124,1,4,positive regulation of T cell activation,BP,PIK3R1
5792,GO:1903039,0.729905091898524,0.692456360214124,1,4,positive regulation of leukocyte cell-cell adhesion,BP,PIK3R1
1984,GO:0030155,0.729970518008711,0.451151792600571,6,24,regulation of cell adhesion,BP,LAMA1;PIK3R1;LAMA5;SDC4;DLL1;ITGA3
3273,GO:0043933,0.730398396584195,0.462368821784209,5,23,macromolecular complex subunit organization,BP,ACTN2;PRND;PLEKHH2;FHOD3;CLDN1
5033,GO:0071822,0.730398396584195,0.462368821784209,5,23,protein complex subunit organization,BP,ACTN2;PRND;PLEKHH2;FHOD3;CLDN1
525,GO:0004672,0.730886798877902,0.479368220819432,4,21,protein kinase activity,MF,CDKN1A;NUAK2;PRKACB;MARK4
2302,GO:0031981,0.73103636332375,0.445627553570973,6,28,nuclear lumen,CC,CDKN1A;MRO;PHLDA1;PRKACB;FOXO4;WT1
1044,GO:0007507,0.732925513679747,0.459267333069866,5,23,heart development,BP,ACTN2;FHOD3;DLL1;ITGA3;WT1
197,GO:0001947,0.733367058546246,0.688440662306151,1,4,heart looping,BP,DLL1
4734,GO:0061371,0.733367058546246,0.688440662306151,1,4,determination of heart left/right asymmetry,BP,DLL1
1569,GO:0015833,0.733370637322078,0.429489968490972,7,35,peptide transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6;RAB39B;UNC119
3078,GO:0042886,0.733370637322078,0.429489968490972,7,35,amide transport,BP,MYO7A;CDKN1A;RHOB;PIK3R1;GAS6;RAB39B;UNC119
1484,GO:0014066,0.733952842934618,0.557068756760566,2,11,regulation of phosphatidylinositol 3-kinase signaling,BP,KITLG;PIK3R1
4661,GO:0061035,0.733972337243898,0.673743208031388,1,5,regulation of cartilage development,BP,CTGF
2695,GO:0034762,0.73403821249557,0.560714720064068,2,10,regulation of transmembrane transport,BP,ACTN2;PDE4B
2698,GO:0034765,0.73403821249557,0.560714720064068,2,10,regulation of ion transmembrane transport,BP,ACTN2;PDE4B
2624,GO:0034109,0.734165234709074,0.687508157385293,1,4,homotypic cell-cell adhesion,BP,GAS6
1832,GO:0019903,0.734483831563125,0.6871352401553,1,4,protein phosphatase binding,MF,PIK3R1
4179,GO:0051276,0.735406926785303,0.672011696460767,1,5,chromosome organization,BP,HMGN5
3501,GO:0045604,0.736489942765118,0.684777839046025,1,4,regulation of epidermal cell differentiation,BP,DLL1
1415,GO:0010827,0.736830958222123,0.684375514019202,1,4,regulation of glucose transport,BP,PIK3R1
1416,GO:0010828,0.736830958222123,0.684375514019202,1,4,positive regulation of glucose transport,BP,PIK3R1
3628,GO:0046324,0.736830958222123,0.684375514019202,1,4,regulation of glucose import,BP,PIK3R1
3629,GO:0046326,0.736830958222123,0.684375514019202,1,4,positive regulation of glucose import,BP,PIK3R1
669,GO:0005773,0.736967116180631,0.553240628995649,2,11,vacuole,CC,MYO7A;SDC4
5016,GO:0071705,0.73799349660473,0.414250909702614,8,41,nitrogen compound transport,BP,MYO7A;CDKN1A;RHOB;SLC52A3;PIK3R1;GAS6;RAB39B;UNC119
4009,GO:0050794,0.738322309501125,0.37907163148561,38,170,regulation of cellular process,BP,LAMA1;ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;FHOD3;DHH;FOXO4;ESPN;GPSM1;MARK4;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
1344,GO:0010565,0.738895822600195,0.66776651337691,1,5,regulation of cellular ketone metabolic process,BP,DKK3
2965,GO:0042180,0.738895822600195,0.66776651337691,1,5,cellular ketone metabolic process,BP,DKK3
2332,GO:0032148,0.739038327005688,0.667592080593154,1,5,activation of protein kinase B activity,BP,GAS6
5405,GO:0097305,0.739537623281826,0.65788315684023,1,6,response to alcohol,BP,CLDN1
5092,GO:0072088,0.739693908801112,0.549754448363118,2,11,nephron epithelium morphogenesis,BP,LAMA5;WT1
5641,GO:1901615,0.740212710155391,0.552868901737213,2,10,organic hydroxy compound metabolic process,BP,HMGCS2;DKK3
3473,GO:0045321,0.740364285922858,0.43336959301892,6,29,leukocyte activation,BP,CDKN1A;PIK3R1;GAS6;SDC4;CRISPLD2;DLL1
4917,GO:0071216,0.740694311472266,0.665559048205848,1,5,cellular response to biotic stimulus,BP,PDE4B
4918,GO:0071219,0.740694311472266,0.665559048205848,1,5,cellular response to molecule of bacterial origin,BP,PDE4B
4919,GO:0071222,0.740694311472266,0.665559048205848,1,5,cellular response to lipopolysaccharide,BP,PDE4B
1797,GO:0019438,0.741998137438536,0.391228419232352,11,55,aromatic compound biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1728,GO:0017076,0.742198009071299,0.401829848488555,9,46,purine nucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
2432,GO:0032553,0.742198009071299,0.401829848488555,9,46,ribonucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
2433,GO:0032555,0.742198009071299,0.401829848488555,9,46,purine ribonucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
5328,GO:0090304,0.742301643941412,0.386772332836275,12,59,nucleic acid metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1277,GO:0009953,0.742643753630974,0.647615811679475,1,7,dorsal/ventral pattern formation,BP,PRKACB
3150,GO:0043235,0.742921855809735,0.505773544312711,3,12,receptor complex,CC,ITGB5;ITGB8;ITGA3
616,GO:0005488,0.743152263901547,0.416304239373355,48,208,binding,MF,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;NRTN;REEP1;GPRASP1;RHOB;KITLG;PRND;PHLDA1;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;MARK4;DAAM2;TMEM163;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
5698,GO:1902106,0.74321759875388,0.662439772757707,1,5,negative regulation of leukocyte differentiation,BP,PIK3R1
6008,GO:1990234,0.744262766950142,0.552449297041635,2,9,transferase complex,CC,CDKN1A;PIK3R1
4854,GO:0070482,0.745168238289861,0.539601664163325,2,12,response to oxygen levels,BP,CDKN1A;CTGF
1070,GO:0007611,0.745323073352838,0.659816960378353,1,5,learning or memory,BP,ITGA3
2919,GO:0040011,0.746513234147677,0.379322079234385,13,58,locomotion,BP,LAMA1;NRTN;RHOB;KITLG;PIK3R1;LAMA5;GAS6;SDC4;SEMA6C;FOXO4;PDE4B;CTGF;ITGA3
4799,GO:0070201,0.746530984935598,0.462626943466249,4,19,regulation of establishment of protein localization,BP,CDKN1A;PIK3R1;GAS6;ITGA3
5157,GO:0072210,0.747144291282346,0.648273817683292,1,6,metanephric nephron development,BP,WT1
2156,GO:0031018,0.747180803451509,0.657487473866107,1,5,endocrine pancreas development,BP,DLL1
888,GO:0006887,0.748062753738719,0.457796223888971,4,21,exocytosis,BP,ACTN2;GAS6;SDC4;CRISPLD2
3319,GO:0044283,0.74817120053199,0.542585707579988,2,10,small molecule biosynthetic process,BP,HMGCS2;DKK3
3299,GO:0044237,0.74865102398088,0.357933563464536,30,134,cellular metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;GPRASP1;DKK3;KITLG;PRND;PHLDA1;NUAK2;SLC52A3;CAMSAP3;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;FOXO4;MARK4;DLL1;PDE4B;CTGF;UNC119;ITGA3;WT1
3858,GO:0048598,0.748815874324485,0.411799062330238,7,33,embryonic morphogenesis,BP,MYO7A;LAMA5;ITGB5;SDC4;PRKACB;DLL1;ITGA3
1030,GO:0007411,0.749439548726102,0.488491795104316,3,15,axon guidance,BP,NRTN;PIK3R1;SEMA6C
5422,GO:0097485,0.749439548726102,0.488491795104316,3,15,neuron projection guidance,BP,NRTN;PIK3R1;SEMA6C
911,GO:0006941,0.74945890929719,0.540903433044789,2,10,striated muscle contraction,BP,PDE4B;CTGF
776,GO:0006351,0.749941618003936,0.38672312908331,10,50,transcription, DNA-templated,BP,CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
4292,GO:0051924,0.752284654411611,0.651012658547906,1,5,regulation of calcium ion transport,BP,PDE4B
3892,GO:0048699,0.752994688060243,0.379068255933129,11,51,generation of neurons,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;GAS6;SDC4;SEMA6C;ACSL4;DLL1;UNC119;ITGA3
1634,GO:0016331,0.754079195438405,0.480343000483624,3,16,morphogenesis of embryonic epithelium,BP,LAMA5;SDC4;PRKACB
596,GO:0005216,0.754896433294514,0.638232233623561,1,6,ion channel activity,MF,GAS6
1931,GO:0022838,0.754896433294514,0.638232233623561,1,6,substrate-specific channel activity,MF,GAS6
4054,GO:0050896,0.755754465932772,0.35385489133516,35,158,response to stimulus,BP,LAMA1;ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;SLC52A3;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;RIN3;ACSL4;CRISPLD2;DHH;FOXO4;GPSM1;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
1691,GO:0016746,0.755977760695758,0.6610164384467,1,4,transferase activity, transferring acyl groups,MF,HMGCS2
482,GO:0003674,0.7562120490933,0.494691192039011,53,228,molecular_function,MF,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;RHOB;KITLG;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;DAAM2;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;UNC119;ITGA3;WT1
1602,GO:0016070,0.756335082615524,0.374166658734708,11,54,RNA metabolic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
675,GO:0005783,0.756353857823164,0.426763784435746,5,26,endoplasmic reticulum,CC,REEP1;PIK3R1;GAS6;ACSL4;GPSM1
3593,GO:0045927,0.757598272800857,0.526300276105383,2,11,positive regulation of growth,BP,DLL1;WT1
3916,GO:0048762,0.757610153735308,0.475709597951599,3,16,mesenchymal cell differentiation,BP,NRTN;KITLG;LAMA5
5616,GO:1901343,0.75903289424584,0.533094495409245,2,9,negative regulation of vasculature development,BP,FOXO4;WT1
1491,GO:0014706,0.759254518528901,0.446276245950085,4,19,striated muscle tissue development,BP,ACTN2;FHOD3;DLL1;WT1
1952,GO:0030027,0.759406893296458,0.532595227950499,2,9,lamellipodium,CC,KITLG;PLEKHH2
3082,GO:0042990,0.759622800305156,0.656391298437152,1,4,regulation of transcription factor import into nucleus,BP,PIK3R1
3083,GO:0042991,0.759622800305156,0.656391298437152,1,4,transcription factor import into nucleus,BP,PIK3R1
861,GO:0006793,0.759844164426021,0.354191527347332,16,77,phosphorus metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;ACSL4;MARK4;PDE4B;CTGF;UNC119
3009,GO:0042471,0.759936739858691,0.631564405550235,1,6,ear morphogenesis,BP,MYO7A
2947,GO:0042098,0.76020789737785,0.640738237770921,1,5,T cell proliferation,BP,SDC4
2309,GO:0032006,0.760281773344619,0.640641135844888,1,5,regulation of TOR signaling,BP,GAS6
831,GO:0006644,0.760463312116013,0.522453447361306,2,11,phospholipid metabolic process,BP,KITLG;PIK3R1
832,GO:0006650,0.760463312116013,0.522453447361306,2,11,glycerophospholipid metabolic process,BP,KITLG;PIK3R1
718,GO:0005942,0.761656059094842,0.653785492382424,1,4,phosphatidylinositol 3-kinase complex,CC,PIK3R1
2193,GO:0031224,0.761826408741579,0.348565727362389,18,82,intrinsic component of membrane,CC,REEP1;KITLG;PRND;SLC52A3;CLDN11;SLC25A53;ITGB5;MPZL1;SDC4;SEMA6C;ITGB8;ACSL4;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;ITGA3
2155,GO:0031016,0.762538220681648,0.628078977601006,1,6,pancreas development,BP,DLL1
4422,GO:0060231,0.762704840346308,0.627854710650373,1,6,mesenchymal to epithelial transition,BP,WT1
5832,GO:1903506,0.762779929354628,0.371006296484456,10,50,regulation of nucleic acid-templated transcription,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
6187,GO:2001141,0.762779929354628,0.371006296484456,10,50,regulation of RNA biosynthetic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
4215,GO:0051445,0.762838581615952,0.637265381733747,1,5,regulation of meiotic cell cycle,BP,PRKACB
1276,GO:0009952,0.762883241272857,0.519183461628839,2,11,anterior/posterior pattern specification,BP,DLL1;WT1
1640,GO:0016358,0.763711530452483,0.636106062250909,1,5,dendrite development,BP,ACSL4
908,GO:0006937,0.763806559091597,0.517930742557276,2,11,regulation of muscle contraction,BP,PDE4B;CTGF
5318,GO:0090257,0.763806559091597,0.517930742557276,2,11,regulation of muscle system process,BP,PDE4B;CTGF
5124,GO:0072148,0.763924297161435,0.650856401349372,1,4,epithelial cell fate commitment,BP,DLL1
1049,GO:0007565,0.766356671268766,0.518335070196168,2,10,female pregnancy,BP,ACSL4;ITGA3
3313,GO:0044267,0.767018992834179,0.341868354148764,18,87,cellular protein metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;PTPN7;FOXO4;MARK4;DLL1;CTGF;UNC119
4116,GO:0051146,0.767172864543545,0.467605808293202,3,14,striated muscle cell differentiation,BP,ACTN2;FHOD3;WT1
1869,GO:0021700,0.767375520020792,0.621516866535019,1,6,developmental maturation,BP,CDKN1A
2187,GO:0031175,0.769404171506745,0.397617419814274,6,28,neuron projection development,BP,NRTN;CAMSAP3;PIK3R1;SEMA6C;ACSL4;ITGA3
2716,GO:0035091,0.770488885025229,0.626986163344862,1,5,phosphatidylinositol binding,MF,ACTN2
5681,GO:1901981,0.770488885025229,0.626986163344862,1,5,phosphatidylinositol phosphate binding,MF,ACTN2
5778,GO:1902936,0.770488885025229,0.626986163344862,1,5,phosphatidylinositol bisphosphate binding,MF,ACTN2
371,GO:0003002,0.772231243331865,0.452729597429938,3,18,regionalization,BP,PRKACB;DLL1;WT1
4153,GO:0051223,0.772536786382055,0.457880363941944,3,15,regulation of protein transport,BP,CDKN1A;PIK3R1;GAS6
261,GO:0002263,0.773053773535179,0.505227356581999,2,11,cell activation involved in immune response,BP,CRISPLD2;DLL1
283,GO:0002366,0.773053773535179,0.505227356581999,2,11,leukocyte activation involved in immune response,BP,CRISPLD2;DLL1
2505,GO:0032868,0.774072509929941,0.507713696813585,2,10,response to insulin,BP,PIK3R1;FOXO4
850,GO:0006732,0.774268937645994,0.637193885109339,1,4,coenzyme metabolic process,BP,ACSL4
4137,GO:0051186,0.774268937645994,0.637193885109339,1,4,cofactor metabolic process,BP,ACSL4
638,GO:0005575,0.774573741374843,1,56,240,cellular_component,CC,LAMA1;ACTN2;MYO7A;CDKN1A;FRMPD1;HMGCS2;NRTN;REEP1;GPRASP1;DKK3;RHOB;KITLG;MRO;PRND;PHLDA1;RHOJ;NUAK2;SLC52A3;PLEKHH2;CAMSAP3;MFGE8;CLDN11;PIK3R1;SLC25A53;LAMA5;GAS6;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;RIN3;ACSL4;CRISPLD2;FHOD3;RAB39B;DHH;FOXO4;ESPN;GPSM1;MARK4;DAAM2;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;UNC119;ITGA3;WT1
1460,GO:0012505,0.774770561794129,0.338131488247471,15,74,endomembrane system,CC,ACTN2;REEP1;RHOB;PIK3R1;GAS6;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;GPSM1;TMEM163;PDE4B;CTGF
5015,GO:0071704,0.774881432506987,0.32694390044075,30,137,organic substance metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;GPRASP1;DKK3;KITLG;PRND;PHLDA1;NUAK2;SLC52A3;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;DHH;FOXO4;MARK4;DLL1;PDE4B;CTGF;UNC119;ITGA3;WT1
1035,GO:0007423,0.775421773799872,0.401192676256727,5,27,sensory organ development,BP,MYO7A;RHOJ;SDC4;DLL1;WT1
6088,GO:2000241,0.775871276427147,0.505207944543775,2,10,regulation of reproductive process,BP,PRKACB;WT1
3033,GO:0042552,0.776098152412713,0.609409850531911,1,6,myelination,BP,DHH
3581,GO:0045862,0.776196707987496,0.609270992114503,1,6,positive regulation of proteolysis,BP,CTGF
2211,GO:0031326,0.776197648537035,0.349200182947937,11,56,regulation of cellular biosynthetic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
3883,GO:0048667,0.77655661008453,0.4234315686192,4,19,cell morphogenesis involved in neuron differentiation,BP,MYO7A;NRTN;PIK3R1;SEMA6C
3249,GO:0043583,0.777577670622912,0.448875081667921,3,16,ear development,BP,MYO7A;SDC4;DLL1
3752,GO:0048018,0.777804224410792,0.606999477457131,1,6,receptor agonist activity,MF,GAS6
468,GO:0003338,0.77801000516151,0.599841195100807,1,7,metanephros morphogenesis,BP,WT1
253,GO:0002237,0.779036823647891,0.493674004010707,2,12,response to molecule of bacterial origin,BP,PDE4B;CLDN1
2420,GO:0032496,0.779036823647891,0.493674004010707,2,12,response to lipopolysaccharide,BP,PDE4B;CLDN1
1158,GO:0008544,0.779054301264999,0.423792799410603,4,17,epidermis development,BP,MYO7A;LAMA5;DLL1;CTGF
2219,GO:0031344,0.779171531559673,0.49666214856324,2,11,regulation of cell projection organization,BP,ESPN;ITGA3
4161,GO:0051241,0.779295468792093,0.372634730403041,7,34,negative regulation of multicellular organismal process,BP,PIK3R1;GAS6;PRKACB;FOXO4;DLL1;PDE4B;WT1
224,GO:0002062,0.779337228313273,0.592885349493134,1,8,chondrocyte differentiation,BP,CTGF
2540,GO:0032989,0.779568654398413,0.364951727301049,8,36,cellular component morphogenesis,BP,ACTN2;MYO7A;NRTN;RHOJ;PIK3R1;LAMA5;SEMA6C;FHOD3
796,GO:0006469,0.780050218511634,0.596910672167419,1,7,negative regulation of protein kinase activity,BP,CDKN1A
2610,GO:0033673,0.780050218511634,0.596910672167419,1,7,negative regulation of kinase activity,BP,CDKN1A
4202,GO:0051348,0.780050218511634,0.596910672167419,1,7,negative regulation of transferase activity,BP,CDKN1A
2427,GO:0032535,0.78062641887813,0.45226702373378,3,13,regulation of cellular component size,BP,ACTN2;PLEKHH2;FHOD3
4199,GO:0051345,0.780912231602058,0.393148015088785,5,28,positive regulation of hydrolase activity,BP,ACTN2;NRTN;KITLG;RIN3;CTGF
4773,GO:0065008,0.781137373028153,0.326391293979263,17,82,regulation of biological quality,BP,ACTN2;CDKN1A;DKK3;RHOB;KITLG;PRND;RHOJ;PLEKHH2;PIK3R1;GAS6;PRKACB;SERPINA5;FHOD3;DLL1;PDE4B;CLDN1;CTGF
1322,GO:0010469,0.781367978764665,0.601918724890878,1,6,regulation of receptor activity,BP,ACTN2
2726,GO:0035148,0.7834017309319,0.487474996642226,2,12,tube formation,BP,SDC4;PRKACB
2977,GO:0042307,0.784137291004484,0.6079544654351,1,5,positive regulation of protein import into nucleus,BP,PIK3R1
5919,GO:1904591,0.784137291004484,0.6079544654351,1,5,positive regulation of protein import,BP,PIK3R1
1045,GO:0007517,0.78425110607881,0.410157688823238,4,21,muscle organ development,BP,LAMA5;FOXO4;DLL1;WT1
4008,GO:0050793,0.785618576736981,0.33047528590699,13,63,regulation of developmental process,BP,LAMA1;RHOB;KITLG;RHOJ;PIK3R1;LAMA5;GAS6;PRKACB;FOXO4;DLL1;CTGF;ITGA3;WT1
4672,GO:0061053,0.786004620671443,0.621062615349203,1,4,somite development,BP,DLL1
3236,GO:0043547,0.786461082853432,0.405938590196054,4,22,positive regulation of GTPase activity,BP,ACTN2;NRTN;KITLG;RIN3
3422,GO:0045055,0.78646474583407,0.438701058647984,3,15,regulated exocytosis,BP,ACTN2;GAS6;CRISPLD2
1104,GO:0008152,0.786916431328194,0.31287331318404,31,141,metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;GPRASP1;DKK3;KITLG;PRND;PHLDA1;NUAK2;SLC52A3;CAMSAP3;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;DHH;FOXO4;MARK4;DLL1;PDE4B;CTGF;UNC119;ITGA3;WT1
38,GO:0000302,0.787053015130752,0.593682908479404,1,6,response to reactive oxygen species,BP,RHOB
6064,GO:2000112,0.787066486923208,0.340296864039886,10,51,regulation of cellular macromolecule biosynthetic process,BP,CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
3074,GO:0042802,0.787443820628807,0.370555852882549,6,33,identical protein binding,MF,ACTN2;MYO7A;PLEKHH2;CLDN11;FOXO4;CLDN1
1738,GO:0017157,0.787895576561396,0.592448367637866,1,6,regulation of exocytosis,BP,SDC4
862,GO:0006796,0.788437251833837,0.321152690316922,15,75,phosphate-containing compound metabolic process,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;MARK4;PDE4B;CTGF;UNC119
4425,GO:0060249,0.788585677643664,0.59143449932249,1,6,anatomical structure homeostasis,BP,CTGF
756,GO:0006139,0.788927403488558,0.325982004215742,13,65,nucleobase-containing compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
5451,GO:0098590,0.789339433982393,0.386634477779179,5,23,plasma membrane region,CC,MYO7A;SLC52A3;DLL1;CLDN1;ITGA3
24,GO:0000166,0.790781593857457,0.340881929567222,9,47,nucleotide binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
5611,GO:1901265,0.790781593857457,0.340881929567222,9,47,nucleoside phosphate binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4;PDE4B
3612,GO:0045992,0.791718829210924,0.596977996422657,1,5,negative regulation of embryonic development,BP,PRKACB
4528,GO:0060537,0.792205560637967,0.400604983096033,4,20,muscle tissue development,BP,ACTN2;FHOD3;DLL1;WT1
500,GO:0003924,0.792705165281598,0.419570090770737,3,22,GTPase activity,MF,RHOB;RHOJ;RAB39B
2689,GO:0034703,0.793580167138066,0.584022996511363,1,6,cation channel complex,CC,PDE4B
1588,GO:0016021,0.793898648874952,0.310838528640432,17,80,integral component of membrane,CC,REEP1;KITLG;SLC52A3;CLDN11;SLC25A53;ITGB5;MPZL1;SDC4;SEMA6C;ITGB8;ACSL4;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;ITGA3
3666,GO:0046620,0.794085837422454,0.583265299382699,1,6,regulation of organ growth,BP,WT1
3667,GO:0046622,0.794085837422454,0.583265299382699,1,6,positive regulation of organ growth,BP,WT1
5300,GO:0090184,0.794107370746072,0.576154607083849,1,7,positive regulation of kidney development,BP,WT1
4005,GO:0050789,0.794225795744048,0.31452512562201,39,177,regulation of biological process,BP,LAMA1;ACTN2;CDKN1A;NRTN;REEP1;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;FHOD3;DHH;FOXO4;ESPN;GPSM1;MARK4;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
400,GO:0003143,0.794374898896655,0.593061082357924,1,5,embryonic heart tube morphogenesis,BP,DLL1
2709,GO:0035050,0.794374898896655,0.593061082357924,1,5,embryonic heart tube development,BP,DLL1
194,GO:0001942,0.794825627510688,0.608468814734766,1,4,hair follicle development,BP,LAMA5
1906,GO:0022404,0.794825627510688,0.608468814734766,1,4,molting cycle process,BP,LAMA5
1907,GO:0022405,0.794825627510688,0.608468814734766,1,4,hair cycle process,BP,LAMA5
2975,GO:0042303,0.794825627510688,0.608468814734766,1,4,molting cycle,BP,LAMA5
3049,GO:0042633,0.794825627510688,0.608468814734766,1,4,hair cycle,BP,LAMA5
622,GO:0005509,0.795445608556636,0.397634441590563,4,19,calcium ion binding,MF,ACTN2;GAS6;DHH;DLL1
5068,GO:0072028,0.796021234669604,0.46916472486087,2,12,nephron morphogenesis,BP,LAMA5;WT1
6103,GO:2000377,0.796027888023821,0.573239752407004,1,7,regulation of reactive oxygen species metabolic process,BP,CDKN1A
109,GO:0001655,0.796163396138142,0.374266167158604,5,26,urogenital system development,BP,LAMA5;SDC4;DLL1;ITGA3;WT1
5058,GO:0072001,0.796163396138142,0.374266167158604,5,26,renal system development,BP,LAMA5;SDC4;DLL1;ITGA3;WT1
2232,GO:0031410,0.796210473357887,0.320388748270716,12,59,cytoplasmic vesicle,CC,ACTN2;MYO7A;RHOB;PHLDA1;GAS6;ITGB5;SERPINA5;RIN3;CRISPLD2;TMEM163;DLL1;PDE4B
5434,GO:0097708,0.796210473357887,0.320388748270716,12,59,intracellular vesicle,CC,ACTN2;MYO7A;RHOB;PHLDA1;GAS6;ITGB5;SERPINA5;RIN3;CRISPLD2;TMEM163;DLL1;PDE4B
2224,GO:0031349,0.796288894444364,0.590214963274467,1,5,positive regulation of defense response,BP,PRKACB
3198,GO:0043412,0.796305536732337,0.309303895659964,16,79,macromolecule modification,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;HMGN5;PTPN7;FOXO4;MARK4;CTGF;UNC119
1664,GO:0016525,0.796513342538457,0.606011328039738,1,4,negative regulation of angiogenesis,BP,FOXO4
5031,GO:0071804,0.796668803599248,0.579373671284162,1,6,cellular potassium ion transport,BP,ACTN2
5032,GO:0071805,0.796668803599248,0.579373671284162,1,6,potassium ion transmembrane transport,BP,ACTN2
1359,GO:0010632,0.79712069259122,0.467541341852934,2,12,regulation of epithelial cell migration,BP,RHOB;ITGA3
1342,GO:0010563,0.7980206260706,0.463552383724218,2,13,negative regulation of phosphorus metabolic process,BP,CDKN1A;CAMSAP3
3600,GO:0045936,0.7980206260706,0.463552383724218,2,13,negative regulation of phosphate metabolic process,BP,CDKN1A;CAMSAP3
1995,GO:0030182,0.798427767114927,0.32660936528431,10,48,neuron differentiation,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;SDC4;SEMA6C;ACSL4;DLL1;UNC119;ITGA3
3393,GO:0044765,0.798569819731809,0.310948073359379,14,70,single-organism transport,BP,ACTN2;MYO7A;CDKN1A;SLC52A3;MFGE8;PIK3R1;GAS6;SDC4;SERPINA5;ACSL4;CRISPLD2;CLDN1;CTGF;UNC119
5227,GO:0072676,0.798693219399829,0.57629842442943,1,6,lymphocyte migration,BP,GAS6
4117,GO:0051147,0.798888733644345,0.468135871922401,2,11,regulation of muscle cell differentiation,BP,FOXO4;DLL1
3379,GO:0044706,0.798896902602308,0.468123749506504,2,11,multi-multicellular organism process,BP,ACSL4;ITGA3
2018,GO:0030258,0.799330076662264,0.464265124782194,2,12,lipid modification,BP,KITLG;PIK3R1
708,GO:0005913,0.799371416984255,0.585589149974861,1,5,cell-cell adherens junction,CC,CAMSAP3
849,GO:0006725,0.799407086953401,0.31259666942856,13,66,cellular aromatic compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
497,GO:0003824,0.800756716947922,0.303829650004003,16,78,catalytic activity,MF,MYO7A;CDKN1A;HMGCS2;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;PRKACB;PTPN7;ACSL4;RAB39B;DHH;MARK4;PDE4B;CGN
4254,GO:0051649,0.801300735915746,0.343157599352332,7,35,establishment of localization in cell,BP,MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;PIK3R1;GAS6
4051,GO:0050890,0.801967979579783,0.571276271212995,1,6,cognition,BP,ITGA3
1357,GO:0010629,0.802367615348142,0.352486009740544,6,30,negative regulation of gene expression,BP,CDKN1A;DKK3;GAS6;ITGB8;CTGF;WT1
4160,GO:0051240,0.802749219227634,0.325040749217484,9,48,positive regulation of multicellular organismal process,BP,RHOB;KITLG;PIK3R1;GAS6;DLL1;PDE4B;CTGF;ITGA3;WT1
3383,GO:0044711,0.803119913822101,0.36309791250894,5,28,single-organism biosynthetic process,BP,HMGCS2;DKK3;PIK3R1;DHH;CTGF
742,GO:0006081,0.803228234095569,0.569327692963252,1,6,cellular aldehyde metabolic process,BP,DKK3
133,GO:0001738,0.803895047073492,0.595075108751192,1,4,morphogenesis of a polarized epithelium,BP,LAMA5
3627,GO:0046323,0.804127441923934,0.57834808083647,1,5,glucose import,BP,PIK3R1
5946,GO:1904950,0.804677752126725,0.577501952547138,1,5,negative regulation of establishment of protein localization,BP,GAS6
174,GO:0001889,0.804782604925596,0.577340539418514,1,5,liver development,BP,CLDN1
4651,GO:0061008,0.804782604925596,0.577340539418514,1,5,hepaticobiliary system development,BP,CLDN1
3165,GO:0043270,0.804936429818612,0.559458258920302,1,7,positive regulation of ion transport,BP,ACTN2
257,GO:0002252,0.805220903928197,0.409816346425264,3,16,immune effector process,BP,PIK3R1;CRISPLD2;DLL1
1945,GO:0030001,0.80527540900784,0.379782200094697,4,22,metal ion transport,BP,ACTN2;GAS6;PDE4B;CTGF
483,GO:0003676,0.805866679469159,0.411003404530319,3,15,nucleic acid binding,MF,HMGN5;FOXO4;WT1
3880,GO:0048663,0.805966697709764,0.575513324172337,1,5,neuron fate commitment,BP,DLL1
4195,GO:0051321,0.805997653958841,0.565014253664191,1,6,meiotic cell cycle,BP,PRKACB
2858,GO:0036094,0.806460612150019,0.315042879337984,10,52,small molecule binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;SERPINA5;ACSL4;RAB39B;MARK4;PDE4B
1228,GO:0009605,0.806488234676687,0.310479633104958,11,57,response to external stimulus,BP,CDKN1A;NRTN;NUAK2;PIK3R1;GAS6;SEMA6C;ACSL4;FOXO4;PDE4B;CLDN1;UNC119
1040,GO:0007492,0.806529258208261,0.564181280361374,1,6,endoderm development,BP,ITGB5
5277,GO:0090087,0.80722300458726,0.406894721497548,3,16,regulation of peptide transport,BP,CDKN1A;PIK3R1;GAS6
2169,GO:0031090,0.80755074209943,0.318733576855932,9,48,organelle membrane,CC,MYO7A;HMGCS2;REEP1;RHOB;SLC25A53;SERPINA5;ACSL4;GPSM1;TMEM163
52,GO:0000904,0.807592149436699,0.360467363822045,5,24,cell morphogenesis involved in differentiation,BP,MYO7A;NRTN;PIK3R1;LAMA5;SEMA6C
3309,GO:0044260,0.807685192424386,0.286733075480119,24,113,cellular macromolecule metabolic process,BP,ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;PTPN7;FOXO4;MARK4;DLL1;CTGF;UNC119;ITGA3;WT1
219,GO:0002040,0.808823491487198,0.571071396015503,1,5,sprouting angiogenesis,BP,DLL1
1233,GO:0009617,0.809036914482032,0.44697748180007,2,13,response to bacterium,BP,PDE4B;CLDN1
265,GO:0002283,0.809124772992007,0.560091012769649,1,6,neutrophil activation involved in immune response,BP,CRISPLD2
301,GO:0002446,0.809124772992007,0.560091012769649,1,6,neutrophil mediated immunity,BP,CRISPLD2
2864,GO:0036230,0.809124772992007,0.560091012769649,1,6,granulocyte activation,BP,CRISPLD2
2954,GO:0042119,0.809124772992007,0.560091012769649,1,6,neutrophil activation,BP,CRISPLD2
3178,GO:0043312,0.809124772992007,0.560091012769649,1,6,neutrophil degranulation,BP,CRISPLD2
4101,GO:0051090,0.809313310283456,0.559792377263246,1,6,regulation of sequence-specific DNA binding transcription factor activity,BP,GAS6
3123,GO:0043170,0.809477130620022,0.284029742417959,26,122,macromolecule metabolic process,BP,ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;DHH;FOXO4;MARK4;DLL1;CTGF;UNC119;ITGA3;WT1
2782,GO:0035639,0.809699936041137,0.32203651207263,8,44,purine ribonucleoside triphosphate binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;ACSL4;RAB39B;MARK4
5738,GO:1902578,0.81002096545202,0.292122157250425,16,78,single-organism localization,BP,ACTN2;MYO7A;CDKN1A;SLC52A3;MFGE8;PIK3R1;LAMA5;GAS6;SDC4;SERPINA5;ACSL4;CRISPLD2;CLDN1;CTGF;UNC119;ITGA3
577,GO:0005126,0.810486233606113,0.447429400195066,2,12,cytokine receptor binding,MF,KITLG;PIK3R1
1913,GO:0022411,0.810897118008578,0.465650211389602,2,8,cellular component disassembly,BP,ACTN2;PLEKHH2
4096,GO:0051054,0.811129542223335,0.54427995522638,1,8,positive regulation of DNA metabolic process,BP,KITLG
5350,GO:0090596,0.811627795249082,0.443009302499823,2,13,sensory organ morphogenesis,BP,MYO7A;DLL1
3922,GO:0048806,0.812747933686558,0.547007935495989,1,7,genitalia development,BP,WT1
2500,GO:0032835,0.813186785308164,0.553610755770018,1,6,glomerulus development,BP,WT1
4742,GO:0061437,0.813186785308164,0.553610755770018,1,6,renal system vasculature development,BP,WT1
4745,GO:0061440,0.813186785308164,0.553610755770018,1,6,kidney vasculature development,BP,WT1
5064,GO:0072012,0.813186785308164,0.553610755770018,1,6,glomerulus vasculature development,BP,WT1
5108,GO:0072109,0.813186785308164,0.553610755770018,1,6,glomerular mesangium development,BP,WT1
2579,GO:0033218,0.813435105581767,0.56379913682106,1,5,amide binding,MF,PIK3R1
3524,GO:0045665,0.815686239289527,0.560202589389794,1,5,negative regulation of neuron differentiation,BP,DLL1
3895,GO:0048705,0.815858354779708,0.536576486517029,1,8,skeletal system morphogenesis,BP,CTGF
3166,GO:0043271,0.817095775987729,0.547281632723736,1,6,negative regulation of ion transport,BP,ACTN2
69,GO:0001071,0.817273079986054,0.444168538168899,2,10,nucleic acid binding transcription factor activity,MF,FOXO4;WT1
488,GO:0003700,0.817273079986054,0.444168538168899,2,10,transcription factor activity, sequence-specific DNA binding,MF,FOXO4;WT1
1450,GO:0010959,0.818004017161255,0.439033332569314,2,11,regulation of metal ion transport,BP,ACTN2;PDE4B
967,GO:0007165,0.818573206484344,0.272739461712644,28,132,signal transduction,BP,LAMA1;ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;RIN3;DHH;FOXO4;GPSM1;DLL1;PDE4B;CGN;CTGF;UNC119;ITGA3
913,GO:0006950,0.818701621077809,0.290473891901864,12,64,response to stress,BP,CDKN1A;RHOB;NUAK2;SLC52A3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;FOXO4;CLDN1;CTGF
3300,GO:0044238,0.818724894099288,0.272493958520067,28,130,primary metabolic process,BP,ACTN2;CDKN1A;HMGCS2;NRTN;DKK3;KITLG;PRND;PHLDA1;NUAK2;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;PTPN7;ACSL4;DHH;FOXO4;MARK4;DLL1;PDE4B;CTGF;UNC119;ITGA3;WT1
2062,GO:0030510,0.819215737001987,0.554500650517152,1,5,regulation of BMP signaling pathway,BP,ITGA3
1626,GO:0016303,0.820047898584912,0.535048489893264,1,7,1-phosphatidylinositol-3-kinase activity,MF,PIK3R1
2857,GO:0036092,0.820047898584912,0.535048489893264,1,7,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3R1
4317,GO:0052742,0.820047898584912,0.535048489893264,1,7,phosphatidylinositol kinase activity,MF,PIK3R1
780,GO:0006357,0.820371213459547,0.315857745876729,7,38,regulation of transcription from RNA polymerase II promoter,BP,CDKN1A;PIK3R1;HMGN5;FOXO4;DLL1;ITGA3;WT1
889,GO:0006888,0.820601322280514,0.569131115355682,1,4,ER to Golgi vesicle-mediated transport,BP,GAS6
1831,GO:0019902,0.823603400306832,0.547302614288555,1,5,phosphatase binding,MF,PIK3R1
1004,GO:0007268,0.82360911539006,0.519513535236954,1,9,chemical synaptic transmission,BP,UNC119
5501,GO:0098916,0.82360911539006,0.519513535236954,1,9,anterograde trans-synaptic signaling,BP,UNC119
5520,GO:0099536,0.82360911539006,0.519513535236954,1,9,synaptic signaling,BP,UNC119
5521,GO:0099537,0.82360911539006,0.519513535236954,1,9,trans-synaptic signaling,BP,UNC119
4149,GO:0051216,0.823767408221501,0.424044467744778,2,13,cartilage development,BP,ITGB8;CTGF
2813,GO:0035850,0.824258777977588,0.528001418897201,1,7,epithelial cell differentiation involved in kidney development,BP,WT1
1321,GO:0010468,0.824608832090989,0.283218420721027,12,61,regulation of gene expression,BP,CDKN1A;DKK3;PIK3R1;GAS6;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
795,GO:0006468,0.825281851551273,0.281987394096823,12,63,protein phosphorylation,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;MARK4;CTGF;UNC119
5423,GO:0097529,0.826106041230127,0.524874681102871,1,7,myeloid leukocyte migration,BP,PDE4B
4266,GO:0051716,0.826794645135197,0.263408784016007,31,144,cellular response to stimulus,BP,LAMA1;ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;SLC52A3;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;RIN3;DHH;FOXO4;GPSM1;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
3860,GO:0048608,0.828585619206747,0.327144604367209,5,28,reproductive structure development,BP,KITLG;ITGB8;SERPINA5;DHH;WT1
4749,GO:0061458,0.828585619206747,0.327144604367209,5,28,reproductive system development,BP,KITLG;ITGB8;SERPINA5;DHH;WT1
2688,GO:0034702,0.828755280274352,0.520352221278076,1,7,ion channel complex,CC,PDE4B
5732,GO:1902495,0.828755280274352,0.520352221278076,1,7,transmembrane transporter complex,CC,PDE4B
6012,GO:1990351,0.828755280274352,0.520352221278076,1,7,transporter complex,CC,PDE4B
3471,GO:0045296,0.828981115595651,0.538309408807758,1,5,cadherin binding,MF,CGN
649,GO:0005634,0.829074978208063,0.281177919914953,11,55,nucleus,CC,CDKN1A;RHOB;MRO;PHLDA1;NUAK2;PIK3R1;LAMA5;PRKACB;HMGN5;FOXO4;WT1
1900,GO:0022008,0.829262397457375,0.280927138464016,11,55,neurogenesis,BP,MYO7A;NRTN;CAMSAP3;PIK3R1;GAS6;SDC4;SEMA6C;ACSL4;DLL1;UNC119;ITGA3
3317,GO:0044281,0.82971389366405,0.326265583565968,5,27,small molecule metabolic process,BP,HMGCS2;DKK3;SLC52A3;ACSL4;PDE4B
4748,GO:0061448,0.830060046605317,0.369201357228455,3,18,connective tissue development,BP,ITGB8;CTGF;WT1
1909,GO:0022407,0.830836437772308,0.418619379712579,2,11,regulation of cell-cell adhesion,BP,PIK3R1;SDC4
4093,GO:0051051,0.83108687287336,0.369199913870383,3,17,negative regulation of transport,BP,ACTN2;GAS6;UNC119
3906,GO:0048732,0.831121550595885,0.325044695461037,5,26,gland development,BP,DKK3;LAMA5;SERPINA5;CLDN1;WT1
2511,GO:0032879,0.831725436274325,0.264167425780963,16,78,regulation of localization,BP,LAMA1;ACTN2;CDKN1A;REEP1;RHOB;KITLG;MFGE8;PIK3R1;LAMA5;GAS6;SDC4;FOXO4;DLL1;PDE4B;UNC119;ITGA3
1826,GO:0019897,0.831801563497957,0.522612900777478,1,6,extrinsic component of plasma membrane,CC,MFGE8
1268,GO:0009898,0.832141670735968,0.532933443705172,1,5,cytoplasmic side of plasma membrane,CC,PTPN7
5447,GO:0098562,0.832141670735968,0.532933443705172,1,5,cytoplasmic side of membrane,CC,PTPN7
1162,GO:0008593,0.832336233070494,0.521689335559454,1,6,regulation of Notch signaling pathway,BP,DLL1
1206,GO:0009187,0.832348146521313,0.51414553975314,1,7,cyclic nucleotide metabolic process,BP,PDE4B
4132,GO:0051179,0.832514477106499,0.255193041403374,29,134,localization,BP,LAMA1;ACTN2;MYO7A;CDKN1A;NRTN;REEP1;GPRASP1;RHOB;KITLG;SLC52A3;MFGE8;PIK3R1;SLC25A53;LAMA5;GAS6;SDC4;SERPINA5;RIN3;ACSL4;CRISPLD2;RAB39B;FOXO4;DLL1;PDE4B;CLDN1;SLC18B1;CTGF;UNC119;ITGA3
665,GO:0005768,0.833171335540597,0.361774823978953,3,20,endosome,CC,RHOB;RIN3;TMEM163
1486,GO:0014069,0.833670111020386,0.53030900807917,1,5,postsynaptic density,CC,PDE4B
2361,GO:0032279,0.833670111020386,0.53030900807917,1,5,asymmetric synapse,CC,PDE4B
5503,GO:0098984,0.833670111020386,0.53030900807917,1,5,neuron to neuron synapse,CC,PDE4B
5524,GO:0099572,0.833670111020386,0.53030900807917,1,5,postsynaptic specialization,CC,PDE4B
822,GO:0006631,0.833750946749218,0.519236245258502,1,6,fatty acid metabolic process,BP,ACSL4
1934,GO:0022890,0.834211962798779,0.505380263931794,1,8,inorganic cation transmembrane transporter activity,MF,GAS6
3704,GO:0046873,0.834211962798779,0.505380263931794,1,8,metal ion transmembrane transporter activity,MF,GAS6
2089,GO:0030667,0.83477250201814,0.504393329142898,1,8,secretory granule membrane,CC,SERPINA5
4370,GO:0060039,0.835060915523469,0.527906745211596,1,5,pericardium development,BP,WT1
3369,GO:0044459,0.835243970099737,0.264120995811443,14,66,plasma membrane part,CC,MYO7A;SLC52A3;MFGE8;ITGB5;MPZL1;SDC4;ITGB8;SERPINA5;PTPN7;DLL1;PDE4B;CLDN1;SLC18B1;ITGA3
868,GO:0006812,0.835722878978646,0.333332318409965,4,24,cation transport,BP,ACTN2;GAS6;PDE4B;CTGF
792,GO:0006461,0.835938734272541,0.334997087284594,4,22,protein complex assembly,BP,ACTN2;PRND;FHOD3;CLDN1
4771,GO:0065003,0.835938734272541,0.334997087284594,4,22,macromolecular complex assembly,BP,ACTN2;PRND;FHOD3;CLDN1
4817,GO:0070271,0.835938734272541,0.334997087284594,4,22,protein complex biogenesis,BP,ACTN2;PRND;FHOD3;CLDN1
2590,GO:0033365,0.837000987272686,0.359997054812329,3,17,protein localization to organelle,BP,CDKN1A;PIK3R1;GAS6
3908,GO:0048738,0.837552173256373,0.360940121403447,3,16,cardiac muscle tissue development,BP,ACTN2;FHOD3;WT1
5455,GO:0098602,0.83794347213756,0.30342656825831,6,29,single organism cell adhesion,BP,CAMSAP3;PIK3R1;LAMA5;GAS6;ITGB5;SDC4
2130,GO:0030863,0.838465765809864,0.415194237113821,2,9,cortical cytoskeleton,CC,ACTN2;PLEKHH2
2131,GO:0030864,0.838465765809864,0.415194237113821,2,9,cortical actin cytoskeleton,CC,ACTN2;PLEKHH2
4450,GO:0060326,0.838497715603991,0.402832667218552,2,12,cell chemotaxis,BP,GAS6;PDE4B
3354,GO:0044433,0.840278345232371,0.296079081836904,6,36,cytoplasmic vesicle part,CC,ACTN2;RHOB;GAS6;SERPINA5;CRISPLD2;TMEM163
1029,GO:0007409,0.840296611621484,0.35481079970919,3,17,axonogenesis,BP,NRTN;PIK3R1;SEMA6C
1633,GO:0016328,0.840421901404789,0.494327030243039,1,8,lateral plasma membrane,CC,CLDN1
4405,GO:0060135,0.840785415565026,0.506832158825775,1,6,maternal process involved in female pregnancy,BP,ITGA3
3897,GO:0048708,0.841345061512026,0.505830232282036,1,6,astrocyte differentiation,BP,DLL1
2917,GO:0040007,0.841382334072694,0.307105839938978,5,30,growth,BP,CDKN1A;GAS6;DLL1;CTGF;WT1
779,GO:0006355,0.841435079548046,0.272663745368724,9,49,regulation of transcription, DNA-templated,BP,CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
5367,GO:0097060,0.841458963491355,0.516677925325402,1,5,synaptic membrane,CC,ITGA3
2222,GO:0031347,0.841739450198254,0.505122801616885,1,6,regulation of defense response,BP,PRKACB
869,GO:0006813,0.842060799702379,0.496928191237364,1,7,potassium ion transport,BP,ACTN2
4091,GO:0051049,0.842071282701389,0.26712235393848,10,53,regulation of transport,BP,ACTN2;CDKN1A;REEP1;MFGE8;PIK3R1;GAS6;SDC4;DLL1;PDE4B;UNC119
4772,GO:0065007,0.842948924442184,0.254716255712814,40,183,biological regulation,BP,LAMA1;ACTN2;CDKN1A;NRTN;REEP1;GPRASP1;DKK3;RHOB;KITLG;PRND;RHOJ;NUAK2;PLEKHH2;CAMSAP3;MFGE8;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;RIN3;FHOD3;DHH;FOXO4;ESPN;GPSM1;MARK4;DLL1;PDE4B;CLDN1;CGN;CTGF;UNC119;ITGA3;WT1
3874,GO:0048645,0.843028681388978,0.485363711291698,1,9,animal organ formation,BP,WT1
3996,GO:0050768,0.843118058173422,0.502641038587272,1,6,negative regulation of neurogenesis,BP,DLL1
4168,GO:0051252,0.843400737122854,0.265293088130458,10,53,regulation of RNA metabolic process,BP,ACTN2;CDKN1A;DKK3;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
2921,GO:0040013,0.845368480733407,0.498559803545959,1,6,negative regulation of locomotion,BP,RHOB
4177,GO:0051271,0.845368480733407,0.498559803545959,1,6,negative regulation of cellular component movement,BP,RHOB
1783,GO:0019221,0.845382674954045,0.485303706814401,1,8,cytokine-mediated signaling pathway,BP,GAS6
5845,GO:1903532,0.845580566526057,0.484940091816327,1,8,positive regulation of secretion by cell,BP,SDC4
1960,GO:0030041,0.846158305211469,0.525846617945809,1,4,actin filament polymerization,BP,FHOD3
2117,GO:0030833,0.846158305211469,0.525846617945809,1,4,regulation of actin filament polymerization,BP,FHOD3
2121,GO:0030837,0.846158305211469,0.525846617945809,1,4,negative regulation of actin filament polymerization,BP,FHOD3
2217,GO:0031333,0.846158305211469,0.525846617945809,1,4,negative regulation of protein complex assembly,BP,FHOD3
2355,GO:0032272,0.846158305211469,0.525846617945809,1,4,negative regulation of protein polymerization,BP,FHOD3
1351,GO:0010605,0.846980988429395,0.278035947621916,7,39,negative regulation of macromolecule metabolic process,BP,CDKN1A;DKK3;GAS6;ITGB8;SERPINA5;CTGF;WT1
699,GO:0005886,0.847324778242128,0.236337873286229,30,137,plasma membrane,CC,ACTN2;MYO7A;FRMPD1;RHOB;KITLG;PRND;RHOJ;SLC52A3;PLEKHH2;MFGE8;CLDN11;PIK3R1;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;PTPN7;RAB39B;DHH;GPSM1;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;ITGA3
3349,GO:0044428,0.847353078361548,0.287770784633227,6,32,nuclear part,CC,CDKN1A;MRO;PHLDA1;PRKACB;FOXO4;WT1
2664,GO:0034599,0.847383341962517,0.487209054146223,1,7,cellular response to oxidative stress,BP,RHOB
4348,GO:0055082,0.847616020375198,0.340209476348067,3,19,cellular chemical homeostasis,BP,PRND;PIK3R1;GAS6
3745,GO:0048010,0.848402404031682,0.485324360317114,1,7,vascular endothelial growth factor receptor signaling pathway,BP,PIK3R1
4645,GO:0060993,0.849382311166499,0.379617453968628,2,14,kidney morphogenesis,BP,LAMA5;WT1
3856,GO:0048593,0.849412535922926,0.483448475461612,1,7,camera-type eye morphogenesis,BP,DLL1
5731,GO:1902494,0.850513693736434,0.385799574480373,2,11,catalytic complex,CC,CDKN1A;PIK3R1
5299,GO:0090183,0.85208343677084,0.47283048996929,1,8,regulation of kidney development,BP,WT1
6079,GO:2000181,0.852588321808146,0.496414923309489,1,5,negative regulation of blood vessel morphogenesis,BP,FOXO4
2512,GO:0032880,0.852781029422294,0.292044127728353,5,27,regulation of protein localization,BP,ACTN2;CDKN1A;PIK3R1;GAS6;ITGA3
5231,GO:0080090,0.853076458027985,0.233944556311531,17,88,regulation of primary metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;DHH;FOXO4;DLL1;CTGF;UNC119;ITGA3;WT1
3843,GO:0048562,0.853565939406735,0.374653283614316,2,13,embryonic organ morphogenesis,BP,MYO7A;DLL1
1782,GO:0019220,0.854027346446027,0.254322217233203,9,52,regulation of phosphate metabolic process,BP,CDKN1A;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;CTGF;UNC119
4131,GO:0051174,0.854027346446027,0.254322217233203,9,52,regulation of phosphorus metabolic process,BP,CDKN1A;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;CTGF;UNC119
122,GO:0001704,0.854034171361358,0.376498184436833,2,12,formation of primary germ layer,BP,ITGB5;ITGA3
1348,GO:0010595,0.854360422269746,0.468514771548051,1,8,positive regulation of endothelial cell migration,BP,RHOB
377,GO:0003013,0.854445833313784,0.303737290520564,4,25,circulatory system process,BP,GAS6;DLL1;PDE4B;CTGF
1081,GO:0008015,0.854445833313784,0.303737290520564,4,25,blood circulation,BP,GAS6;DLL1;PDE4B;CTGF
101,GO:0001570,0.854726792361492,0.481174972044506,1,6,vasculogenesis,BP,WT1
3950,GO:0048878,0.85719727938185,0.283922499636129,5,29,chemical homeostasis,BP,PRND;PIK3R1;GAS6;PRKACB;CLDN1
3494,GO:0045596,0.857940762198674,0.323404282306062,3,19,negative regulation of cell differentiation,BP,PIK3R1;FOXO4;DLL1
3976,GO:0050708,0.858119854805024,0.466951227612077,1,7,regulation of protein secretion,BP,GAS6
4674,GO:0061061,0.858132576479031,0.271243262060753,6,33,muscle structure development,BP,ACTN2;LAMA5;FHOD3;FOXO4;DLL1;WT1
1098,GO:0008104,0.858885831330964,0.24018794881086,11,56,protein localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;RHOB;PIK3R1;LAMA5;GAS6;RAB39B;UNC119;ITGA3
2119,GO:0030835,0.858901564647215,0.502397519157395,1,4,negative regulation of actin filament depolymerization,BP,PLEKHH2
3153,GO:0043242,0.858901564647215,0.502397519157395,1,4,negative regulation of protein complex disassembly,BP,PLEKHH2
5671,GO:1901880,0.858901564647215,0.502397519157395,1,4,negative regulation of protein depolymerization,BP,PLEKHH2
189,GO:0001934,0.859074251920716,0.259110491242101,7,43,positive regulation of protein phosphorylation,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
2986,GO:0042327,0.859074251920716,0.259110491242101,7,43,positive regulation of phosphorylation,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
4253,GO:0051648,0.860367711322502,0.462594062732534,1,7,vesicle localization,BP,MYO7A
5279,GO:0090092,0.860461487226135,0.362586291744162,2,13,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,DKK3;ITGA3
3352,GO:0044431,0.860547114314633,0.317897382251288,3,20,Golgi apparatus part,CC,GAS6;SDC4;GPSM1
1630,GO:0016323,0.860555182318355,0.462228798092221,1,7,basolateral plasma membrane,CC,ITGA3
833,GO:0006661,0.860700535075023,0.456283277275773,1,8,phosphatidylinositol biosynthetic process,BP,PIK3R1
3417,GO:0045017,0.860700535075023,0.456283277275773,1,8,glycerolipid biosynthetic process,BP,PIK3R1
3648,GO:0046474,0.860700535075023,0.456283277275773,1,8,glycerophospholipid biosynthetic process,BP,PIK3R1
3868,GO:0048638,0.86159077238397,0.358368469977017,2,14,regulation of developmental growth,BP,DLL1;WT1
2330,GO:0032103,0.861615577511033,0.454491200052397,1,8,positive regulation of response to external stimulus,BP,GAS6
213,GO:0002009,0.861672574999812,0.265921234435434,6,33,morphogenesis of an epithelium,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;WT1
3568,GO:0045833,0.861988360376467,0.459426768869047,1,7,negative regulation of lipid metabolic process,BP,DKK3
631,GO:0005525,0.862840622101647,0.310440439706231,3,24,GTP binding,MF,RHOB;RHOJ;RAB39B
1760,GO:0019001,0.862840622101647,0.310440439706231,3,24,guanyl nucleotide binding,MF,RHOB;RHOJ;RAB39B
2430,GO:0032549,0.862840622101647,0.310440439706231,3,24,ribonucleoside binding,MF,RHOB;RHOJ;RAB39B
2431,GO:0032550,0.862840622101647,0.310440439706231,3,24,purine ribonucleoside binding,MF,RHOB;RHOJ;RAB39B
2435,GO:0032561,0.862840622101647,0.310440439706231,3,24,guanyl ribonucleotide binding,MF,RHOB;RHOJ;RAB39B
3347,GO:0044425,0.862893757740658,0.215656166408256,24,109,membrane part,CC,MYO7A;REEP1;KITLG;PRND;SLC52A3;MFGE8;CLDN11;PIK3R1;SLC25A53;ITGB5;MPZL1;SDC4;SEMA6C;ITGB8;SERPINA5;PTPN7;ACSL4;GPSM1;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;ITGA3
2191,GO:0031214,0.863069900938767,0.451628741676081,1,8,biomineral tissue development,BP,GAS6
4794,GO:0070167,0.863069900938767,0.451628741676081,1,8,regulation of biomineral tissue development,BP,GAS6
3363,GO:0044448,0.863925307834218,0.366227808935288,2,10,cell cortex part,CC,ACTN2;PLEKHH2
2283,GO:0031929,0.864203808375783,0.45506134917553,1,7,TOR signaling,BP,GAS6
3531,GO:0045682,0.86442679594998,0.462411089022248,1,6,regulation of epidermis development,BP,DLL1
3008,GO:0042470,0.86478606698058,0.461700760308698,1,6,melanosome,CC,MYO7A
3917,GO:0048770,0.86478606698058,0.461700760308698,1,6,pigment granule,CC,MYO7A
1129,GO:0008283,0.864793857514133,0.234722215227496,10,56,cell proliferation,BP,CDKN1A;KITLG;LAMA5;GAS6;SDC4;HMGN5;FOXO4;DLL1;CTGF;WT1
3218,GO:0043491,0.865702530730111,0.452084468563878,1,7,protein kinase B signaling,BP,GAS6
793,GO:0006464,0.865756680899119,0.219964803973549,15,78,cellular protein modification process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;FOXO4;MARK4;CTGF;UNC119
2863,GO:0036211,0.865756680899119,0.219964803973549,15,78,protein modification process,BP,ACTN2;CDKN1A;NRTN;KITLG;PRND;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;PTPN7;FOXO4;MARK4;CTGF;UNC119
3100,GO:0043065,0.866222303160539,0.352302485594905,2,13,positive regulation of apoptotic process,BP,RHOB;CTGF
3576,GO:0045844,0.866675327995526,0.450141834629941,1,7,positive regulation of striated muscle tissue development,BP,DLL1
3867,GO:0048636,0.866675327995526,0.450141834629941,1,7,positive regulation of muscle organ development,BP,DLL1
5669,GO:1901863,0.866675327995526,0.450141834629941,1,7,positive regulation of muscle tissue development,BP,DLL1
5485,GO:0098805,0.868003484211288,0.246509247639293,7,41,whole membrane,CC,MYO7A;RHOB;SDC4;SERPINA5;ACSL4;TMEM163;DLL1
1483,GO:0014065,0.868081463714296,0.346738420167734,2,14,phosphatidylinositol 3-kinase signaling,BP,KITLG;PIK3R1
3749,GO:0048015,0.868081463714296,0.346738420167734,2,14,phosphatidylinositol-mediated signaling,BP,KITLG;PIK3R1
3751,GO:0048017,0.868081463714296,0.346738420167734,2,14,inositol lipid-mediated signaling,BP,KITLG;PIK3R1
51,GO:0000902,0.868159479625334,0.257159981260119,6,31,cell morphogenesis,BP,MYO7A;NRTN;RHOJ;PIK3R1;LAMA5;SEMA6C
1171,GO:0008645,0.868388111237043,0.446701366651832,1,7,hexose transport,BP,PIK3R1
1564,GO:0015749,0.868388111237043,0.446701366651832,1,7,monosaccharide transport,BP,PIK3R1
1565,GO:0015758,0.868388111237043,0.446701366651832,1,7,glucose transport,BP,PIK3R1
2570,GO:0033138,0.868732002022275,0.446007473018678,1,7,positive regulation of peptidyl-serine phosphorylation,BP,GAS6
1356,GO:0010628,0.869063938000814,0.233215235706217,9,50,positive regulation of gene expression,BP,PIK3R1;GAS6;ITGB8;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
16,GO:0000139,0.869146371999848,0.439475435723506,1,8,Golgi membrane,CC,GPSM1
490,GO:0003712,0.869147867119328,0.445166947563276,1,7,transcription cofactor activity,MF,ACTN2
4258,GO:0051656,0.869417055008655,0.434595168242701,1,9,establishment of organelle localization,BP,MYO7A
2354,GO:0032271,0.869450155084683,0.463774094178088,1,5,regulation of protein polymerization,BP,FHOD3
3108,GO:0043087,0.871242043425678,0.277692673642023,4,24,regulation of GTPase activity,BP,ACTN2;NRTN;KITLG;RIN3
1971,GO:0030097,0.871826347586337,0.27861341832497,4,22,hemopoiesis,BP,KITLG;PIK3R1;GAS6;DLL1
1293,GO:0010035,0.872144365614051,0.339333981574757,2,14,response to inorganic substance,BP,RHOB;CLDN1
1784,GO:0019222,0.872472599127889,0.20547535084355,19,97,regulation of metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;DHH;FOXO4;DLL1;CTGF;UNC119;ITGA3;WT1
2200,GO:0031253,0.872523143313186,0.446123393140615,1,6,cell projection membrane,CC,ITGA3
2230,GO:0031401,0.87271516393463,0.238551978225036,7,44,positive regulation of protein modification process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
4650,GO:0061005,0.872856819138817,0.431895873177361,1,8,cell differentiation involved in kidney development,BP,WT1
1781,GO:0019219,0.873447375586884,0.218870263646073,11,60,regulation of nucleobase-containing compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
4128,GO:0051171,0.873447375586884,0.218870263646073,11,60,regulation of nitrogen compound metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;HMGN5;FOXO4;DLL1;ITGA3;WT1
4115,GO:0051145,0.874379657188322,0.428749138574998,1,8,smooth muscle cell differentiation,BP,FOXO4
1337,GO:0010557,0.874442434662768,0.236824676382911,7,41,positive regulation of macromolecule biosynthetic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;CTGF;WT1
1320,GO:0010467,0.875297796114247,0.213331545753721,12,64,gene expression,BP,CDKN1A;DKK3;PIK3R1;GAS6;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;CTGF;ITGA3;WT1
1137,GO:0008324,0.876072846169543,0.420882169715777,1,9,cation transmembrane transporter activity,MF,GAS6
5054,GO:0071944,0.876168857480612,0.198005134043572,30,139,cell periphery,CC,ACTN2;MYO7A;FRMPD1;RHOB;KITLG;PRND;RHOJ;SLC52A3;PLEKHH2;MFGE8;CLDN11;PIK3R1;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;PTPN7;RAB39B;DHH;GPSM1;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;ITGA3
4105,GO:0051094,0.876863025495924,0.232843487088798,7,42,positive regulation of developmental process,BP,RHOB;KITLG;GAS6;DLL1;CTGF;ITGA3;WT1
1948,GO:0030010,0.876889880469227,0.429231268224975,1,7,establishment of cell polarity,BP,MARK4
3381,GO:0044708,0.877443115406673,0.422353967657184,1,8,single-organism behavior,BP,ITGA3
1636,GO:0016337,0.877942616005547,0.252749972904038,5,27,single organismal cell-cell adhesion,BP,CAMSAP3;PIK3R1;GAS6;ITGB5;SDC4
1810,GO:0019725,0.87828694709425,0.287745518503097,3,20,cellular homeostasis,BP,PRND;PIK3R1;GAS6
4428,GO:0060255,0.878417717962244,0.199362686718737,17,89,regulation of macromolecule metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;SERPINA5;HMGN5;FOXO4;DLL1;CTGF;UNC119;ITGA3;WT1
3830,GO:0048522,0.879576404135058,0.195616501988894,19,100,positive regulation of cellular process,BP,ACTN2;CDKN1A;RHOB;KITLG;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;HMGN5;FOXO4;ESPN;MARK4;DLL1;CLDN1;CTGF;UNC119;ITGA3;WT1
5620,GO:1901363,0.87994815325809,0.206681863921418,12,64,heterocyclic compound binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;HMGN5;ACSL4;RAB39B;FOXO4;MARK4;PDE4B;WT1
372,GO:0003006,0.881023807861757,0.245369938653261,5,31,developmental process involved in reproduction,BP,KITLG;ITGB8;SERPINA5;DHH;WT1
1689,GO:0016740,0.881077910327088,0.22774299775055,7,38,transferase activity,MF,CDKN1A;HMGCS2;KITLG;NUAK2;PIK3R1;PRKACB;MARK4
1919,GO:0022604,0.881580050191019,0.413576365192248,1,8,regulation of cell morphogenesis,BP,RHOJ
950,GO:0007067,0.883271458121345,0.405589568891394,1,9,mitotic nuclear division,BP,MARK4
2984,GO:0042325,0.883544169556564,0.216216196113688,8,48,regulation of phosphorylation,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;CTGF;UNC119
188,GO:0001933,0.883938732882506,0.404146641158198,1,9,negative regulation of protein phosphorylation,BP,CDKN1A
2229,GO:0031400,0.883938732882506,0.404146641158198,1,9,negative regulation of protein modification process,BP,CDKN1A
1262,GO:0009892,0.885050565251107,0.21466342291412,8,45,negative regulation of metabolic process,BP,CDKN1A;DKK3;CAMSAP3;GAS6;ITGB8;SERPINA5;CTGF;WT1
171,GO:0001882,0.88513468527934,0.271534791475368,3,25,nucleoside binding,MF,RHOB;RHOJ;RAB39B
172,GO:0001883,0.88513468527934,0.271534791475368,3,25,purine nucleoside binding,MF,RHOB;RHOJ;RAB39B
3382,GO:0044710,0.885150576287407,0.194607437392231,14,74,single-organism metabolic process,BP,ACTN2;HMGCS2;NRTN;DKK3;KITLG;SLC52A3;PIK3R1;GAS6;SDC4;ITGB8;ACSL4;DHH;PDE4B;CTGF
1543,GO:0015267,0.885507994486525,0.400735751218573,1,9,channel activity,MF,GAS6
1925,GO:0022803,0.885507994486525,0.400735751218573,1,9,passive transmembrane transporter activity,MF,GAS6
1229,GO:0009607,0.886123721666144,0.308299338237032,2,17,response to biotic stimulus,BP,PDE4B;CLDN1
3136,GO:0043207,0.886123721666144,0.308299338237032,2,17,response to external biotic stimulus,BP,PDE4B;CLDN1
4265,GO:0051707,0.886123721666144,0.308299338237032,2,17,response to other organism,BP,PDE4B;CLDN1
5093,GO:0072089,0.886593815584132,0.408441269501185,1,7,stem cell proliferation,BP,KITLG
924,GO:0006979,0.886664317890116,0.398206529340037,1,9,response to oxidative stress,BP,RHOB
1388,GO:0010721,0.887237384693672,0.401298669750074,1,8,negative regulation of cell development,BP,DLL1
2126,GO:0030856,0.887303899333333,0.401152372776942,1,8,regulation of epithelial cell differentiation,BP,DLL1
110,GO:0001656,0.888610040774991,0.390505404411125,1,10,metanephros development,BP,WT1
358,GO:0002791,0.889970365718377,0.39524926738975,1,8,regulation of peptide secretion,BP,GAS6
3774,GO:0048193,0.890266574170257,0.408206860450456,1,6,Golgi vesicle transport,BP,GAS6
2199,GO:0031252,0.890754974860905,0.308782448358345,2,12,cell leading edge,CC,KITLG;PLEKHH2
1827,GO:0019898,0.891114026233457,0.308076632249382,2,12,extrinsic component of membrane,CC,MFGE8;PIK3R1
3091,GO:0043025,0.891227921127773,0.398169000967039,1,7,neuronal cell body,CC,ACSL4
309,GO:0002520,0.891568233947993,0.243613459976213,4,24,immune system development,BP,KITLG;PIK3R1;GAS6;DLL1
3835,GO:0048534,0.891568233947993,0.243613459976213,4,24,hematopoietic or lymphoid organ development,BP,KITLG;PIK3R1;GAS6;DLL1
5233,GO:0080135,0.894062132407456,0.29422157986291,2,16,regulation of cellular response to stress,BP,PIK3R1;CTGF
263,GO:0002275,0.894578790602529,0.384866295246318,1,8,myeloid cell activation involved in immune response,BP,CRISPLD2
300,GO:0002444,0.894578790602529,0.384866295246318,1,8,myeloid leukocyte mediated immunity,BP,CRISPLD2
3176,GO:0043299,0.894578790602529,0.384866295246318,1,8,leukocyte degranulation,BP,CRISPLD2
1453,GO:0010975,0.894875079731412,0.384190700391586,1,8,regulation of neuron projection development,BP,ITGA3
4925,GO:0071248,0.895892638709627,0.381862917218152,1,8,cellular response to metal ion,BP,CLDN1
1628,GO:0016310,0.896678577800902,0.181944000819571,12,67,phosphorylation,BP,ACTN2;CDKN1A;NRTN;KITLG;NUAK2;PIK3R1;GAS6;SDC4;PRKACB;MARK4;CTGF;UNC119
56,GO:0000975,0.897195771333209,0.384588974709118,1,7,regulatory region DNA binding,MF,WT1
68,GO:0001067,0.897195771333209,0.384588974709118,1,7,regulatory region nucleic acid binding,MF,WT1
3295,GO:0044212,0.897195771333209,0.384588974709118,1,7,transcription regulatory region DNA binding,MF,WT1
2997,GO:0042391,0.897346903150142,0.374173660142617,1,9,regulation of membrane potential,BP,ACTN2
1350,GO:0010604,0.897676512346832,0.176289112930306,14,77,positive regulation of macromolecule metabolic process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;CTGF;UNC119;ITGA3;WT1
1587,GO:0016020,0.898317376442766,0.171701786299147,36,166,membrane,CC,LAMA1;ACTN2;MYO7A;FRMPD1;HMGCS2;REEP1;RHOB;KITLG;PRND;RHOJ;SLC52A3;PLEKHH2;MFGE8;CLDN11;PIK3R1;SLC25A53;ITGB5;MPZL1;SDC4;SEMA6C;PRKACB;ITGB8;SERPINA5;PTPN7;ACSL4;RAB39B;DHH;GPSM1;TMEM163;DLL1;PDE4B;CLDN1;SLC18B1;CGN;CTGF;ITGA3
1911,GO:0022409,0.898768129534799,0.380942238880519,1,7,positive regulation of cell-cell adhesion,BP,PIK3R1
1172,GO:0008654,0.898794872928029,0.370819115697169,1,9,phospholipid biosynthetic process,BP,PIK3R1
652,GO:0005654,0.898833163603552,0.230221325259296,4,25,nucleoplasm,CC,CDKN1A;PRKACB;FOXO4;WT1
1170,GO:0008643,0.901704398979525,0.368337479778471,1,8,carbohydrate transport,BP,PIK3R1
3845,GO:0048565,0.902636029135309,0.366131798433607,1,8,digestive tract development,BP,CDKN1A
4358,GO:0055123,0.902636029135309,0.366131798433607,1,8,digestive system development,BP,CDKN1A
906,GO:0006935,0.902763904220123,0.209357894426151,5,31,chemotaxis,BP,NRTN;PIK3R1;GAS6;SEMA6C;PDE4B
2987,GO:0042330,0.902763904220123,0.209357894426151,5,31,taxis,BP,NRTN;PIK3R1;GAS6;SEMA6C;PDE4B
187,GO:0001932,0.903607184180187,0.190241082775419,7,45,regulation of protein phosphorylation,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
5383,GO:0097159,0.904545451209134,0.1703249825895,12,66,organic cyclic compound binding,MF,MYO7A;RHOB;RHOJ;NUAK2;PRKACB;HMGN5;ACSL4;RAB39B;FOXO4;MARK4;PDE4B;WT1
1529,GO:0015075,0.905056046086836,0.352640106176734,1,10,ion transmembrane transporter activity,MF,GAS6
1176,GO:0009057,0.905336568544085,0.274768784753875,2,14,macromolecule catabolic process,BP,GPRASP1;SDC4
228,GO:0002067,0.905478814911366,0.359334831764572,1,8,glandular epithelial cell differentiation,BP,DLL1
3903,GO:0048729,0.906877986122162,0.185958620148005,7,41,tissue morphogenesis,BP,RHOB;LAMA5;SDC4;PRKACB;DLL1;ITGA3;WT1
1977,GO:0030111,0.906899349694734,0.269773044330478,2,15,regulation of Wnt signaling pathway,BP,DKK3;ITGA3
4252,GO:0051641,0.907028919506426,0.172639466474562,10,53,cellular localization,BP,ACTN2;MYO7A;CDKN1A;REEP1;GPRASP1;RHOB;PIK3R1;LAMA5;GAS6;ITGA3
4306,GO:0051960,0.907199798539507,0.235099214804582,3,20,regulation of nervous system development,BP,PRKACB;DLL1;ITGA3
1022,GO:0007369,0.907303404856131,0.270685302605291,2,14,gastrulation,BP,ITGB5;ITGA3
4251,GO:0051640,0.908301798079966,0.344792631929966,1,10,organelle localization,BP,MYO7A
125,GO:0001707,0.908497756539773,0.352003946971617,1,8,mesoderm formation,BP,ITGA3
3799,GO:0048332,0.908497756539773,0.352003946971617,1,8,mesoderm morphogenesis,BP,ITGA3
5633,GO:1901566,0.909363460889,0.339481910674016,1,11,organonitrogen compound biosynthetic process,BP,SDC4
1251,GO:0009792,0.910197150726957,0.210637295185922,4,24,embryo development ending in birth or egg hatching,BP,SDC4;PRKACB;ACSL4;DLL1
5558,GO:1900182,0.910292913821475,0.347587973640443,1,8,positive regulation of protein localization to nucleus,BP,PIK3R1
2985,GO:0042326,0.910311929549674,0.339865388479419,1,10,negative regulation of phosphorylation,BP,CDKN1A
299,GO:0002443,0.911100702215007,0.341286256180667,1,9,leukocyte mediated immunity,BP,CRISPLD2
3632,GO:0046330,0.911110066790973,0.337894376198875,1,10,positive regulation of JNK cascade,BP,CTGF
3493,GO:0045595,0.911326879630249,0.177917548187975,7,44,regulation of cell differentiation,BP,KITLG;PIK3R1;GAS6;FOXO4;DLL1;CTGF;ITGA3
1341,GO:0010562,0.911502818598628,0.176990328114431,7,47,positive regulation of phosphorus metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
3601,GO:0045937,0.911502818598628,0.176990328114431,7,47,positive regulation of phosphate metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
3525,GO:0045666,0.912031897155251,0.338972468959798,1,9,positive regulation of neuron differentiation,BP,ITGA3
706,GO:0005911,0.91220623996155,0.193527224374566,5,30,cell-cell junction,CC,CAMSAP3;CLDN11;PIK3R1;CLDN1;CGN
1261,GO:0009891,0.912493660886068,0.175998297315954,7,44,positive regulation of biosynthetic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;CTGF;WT1
2569,GO:0033135,0.913235212394023,0.340255462654645,1,8,regulation of peptidyl-serine phosphorylation,BP,GAS6
2228,GO:0031399,0.913637315287984,0.173679364636335,7,46,regulation of protein modification process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
4171,GO:0051258,0.913941790969316,0.344139006758086,1,7,protein polymerization,BP,FHOD3
2331,GO:0032147,0.914080728032487,0.251884486174989,2,17,activation of protein kinase activity,BP,GAS6;PRKACB
3012,GO:0042475,0.914984155733022,0.3315583091779,1,9,odontogenesis of dentin-containing tooth,BP,LAMA5
4089,GO:0051047,0.915071156467526,0.327985939119536,1,10,positive regulation of secretion,BP,SDC4
1347,GO:0010594,0.915312227320286,0.33072689857844,1,9,regulation of endothelial cell migration,BP,RHOB
4753,GO:0061564,0.915971313258106,0.218110166767774,3,20,axon development,BP,NRTN;PIK3R1;SEMA6C
1082,GO:0008016,0.916031978654947,0.24898459781183,2,16,regulation of heart contraction,BP,PDE4B;CTGF
2525,GO:0032940,0.916143016534306,0.184584907903186,5,35,secretion by cell,BP,ACTN2;GAS6;SDC4;CRISPLD2;CTGF
3523,GO:0045664,0.916508308670576,0.249422913737811,2,15,regulation of neuron differentiation,BP,DLL1;ITGA3
2951,GO:0042110,0.917239852028792,0.249540326855987,2,14,T cell activation,BP,PIK3R1;SDC4
1042,GO:0007498,0.917459245435412,0.325247880222616,1,9,mesoderm development,BP,ITGA3
972,GO:0007173,0.919359930144593,0.317010951093857,1,10,epidermal growth factor receptor signaling pathway,BP,PIK3R1
2903,GO:0038127,0.919359930144593,0.317010951093857,1,10,ERBB signaling pathway,BP,PIK3R1
3735,GO:0046982,0.920367698878734,0.241012780228915,2,15,protein heterodimerization activity,MF,PIK3R1;ITGA3
1801,GO:0019637,0.92118268074442,0.206048699015766,3,22,organophosphate metabolic process,BP,KITLG;PIK3R1;PDE4B
1279,GO:0009966,0.921423529393613,0.142318656219382,13,74,regulation of signal transduction,BP,ACTN2;GPRASP1;DKK3;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;CTGF;ITGA3
4924,GO:0071241,0.921706922806322,0.314208019593319,1,9,cellular response to inorganic substance,BP,CLDN1
2208,GO:0031323,0.922359971446212,0.135825943510852,17,92,regulation of cellular metabolic process,BP,ACTN2;CDKN1A;DKK3;KITLG;CAMSAP3;PIK3R1;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;FOXO4;DLL1;CTGF;UNC119;ITGA3;WT1
5274,GO:0090066,0.922379268125956,0.205349203301068,3,20,regulation of anatomical structure size,BP,ACTN2;PLEKHH2;FHOD3
1935,GO:0022891,0.922719728675294,0.305564081766522,1,11,substrate-specific transmembrane transporter activity,MF,GAS6
1936,GO:0022892,0.922719728675294,0.305564081766522,1,11,substrate-specific transporter activity,MF,GAS6
2541,GO:0032990,0.923914750390782,0.202244472444877,3,20,cell part morphogenesis,BP,NRTN;PIK3R1;SEMA6C
3925,GO:0048812,0.923914750390782,0.202244472444877,3,20,neuron projection morphogenesis,BP,NRTN;PIK3R1;SEMA6C
3942,GO:0048858,0.923914750390782,0.202244472444877,3,20,cell projection morphogenesis,BP,NRTN;PIK3R1;SEMA6C
74,GO:0001101,0.924225014884751,0.2298027645808,2,17,response to acid chemical,BP,CLDN1;CTGF
965,GO:0007163,0.924758467054683,0.306105406644172,1,9,establishment or maintenance of cell polarity,BP,MARK4
2866,GO:0036293,0.926460604942217,0.295595956610744,1,11,response to decreased oxygen levels,BP,CTGF
4972,GO:0071407,0.9268895210743,0.225057472779481,2,16,cellular response to organic cyclic compound,BP,PDE4B;WT1
5456,GO:0098609,0.927384647291555,0.151655422503822,7,41,cell-cell adhesion,BP,CAMSAP3;CLDN11;PIK3R1;GAS6;ITGB5;SDC4;CLDN1
3075,GO:0042803,0.927391955865189,0.222702525781085,2,17,protein homodimerization activity,MF,ACTN2;MYO7A
4019,GO:0050808,0.927415465835962,0.298927805664204,1,9,synapse organization,BP,RAB39B
5278,GO:0090090,0.927671187443908,0.302421163330332,1,8,negative regulation of canonical Wnt signaling pathway,BP,DKK3
3146,GO:0043231,0.927957208756515,0.124553943798689,22,111,intracellular membrane-bounded organelle,CC,MYO7A;CDKN1A;HMGCS2;REEP1;RHOB;MRO;PHLDA1;NUAK2;PIK3R1;SLC25A53;LAMA5;GAS6;SDC4;PRKACB;SERPINA5;HMGN5;ACSL4;RAB39B;FOXO4;GPSM1;CTGF;WT1
3826,GO:0048518,0.928025986115391,0.124774879854403,21,111,positive regulation of biological process,BP,ACTN2;CDKN1A;RHOB;KITLG;MFGE8;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;HMGN5;FOXO4;ESPN;MARK4;DLL1;PDE4B;CLDN1;CTGF;UNC119;ITGA3;WT1
3850,GO:0048583,0.928288202503731,0.130118835007468,14,79,regulation of response to stimulus,BP,ACTN2;GPRASP1;DKK3;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;PDE4B;CTGF;ITGA3
676,GO:0005788,0.928298216215098,0.290617378919623,1,11,endoplasmic reticulum lumen,CC,GAS6
4060,GO:0050920,0.92909941008099,0.291051775796871,1,10,regulation of chemotaxis,BP,GAS6
1815,GO:0019827,0.9291458021832,0.294189770789635,1,9,stem cell population maintenance,BP,DLL1
5469,GO:0098727,0.9291458021832,0.294189770789635,1,9,maintenance of cell number,BP,DLL1
1918,GO:0022603,0.929784280208073,0.160337393142464,5,34,regulation of anatomical structure morphogenesis,BP,RHOB;RHOJ;FOXO4;DLL1;WT1
3013,GO:0042476,0.930205836248435,0.288004851242968,1,10,odontogenesis,BP,LAMA5
3847,GO:0048568,0.930631629108211,0.186808944251546,3,22,embryonic organ development,BP,MYO7A;KITLG;DLL1
404,GO:0003156,0.930889799338949,0.283500413302531,1,11,regulation of animal organ formation,BP,WT1
883,GO:0006875,0.930947164668022,0.285951496743592,1,10,cellular metal ion homeostasis,BP,PRND
3384,GO:0044712,0.931098311031065,0.288780999107306,1,9,single-organism catabolic process,BP,PDE4B
262,GO:0002274,0.931268032844861,0.288307652183377,1,9,myeloid leukocyte activation,BP,CRISPLD2
995,GO:0007254,0.931355280683489,0.282209948203872,1,11,JNK cascade,BP,CTGF
3630,GO:0046328,0.931355280683489,0.282209948203872,1,11,regulation of JNK cascade,BP,CTGF
2353,GO:0032270,0.931608891789119,0.142938617602202,7,48,positive regulation of cellular protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
3164,GO:0043269,0.931748931037507,0.212760144803004,2,17,regulation of ion transport,BP,ACTN2;PDE4B
551,GO:0004872,0.931819037568319,0.169159585700988,4,25,receptor activity,MF,ITGB5;SDC4;ITGB8;CLDN1
4395,GO:0060089,0.931819037568319,0.169159585700988,4,25,molecular transducer activity,MF,ITGB5;SDC4;ITGB8;CLDN1
3583,GO:0045892,0.931962534291006,0.184801490081231,3,21,negative regulation of transcription, DNA-templated,BP,DKK3;GAS6;WT1
5755,GO:1902679,0.931962534291006,0.184801490081231,3,21,negative regulation of RNA biosynthetic process,BP,DKK3;GAS6;WT1
5833,GO:1903507,0.931962534291006,0.184801490081231,3,21,negative regulation of nucleic acid-templated transcription,BP,DKK3;GAS6;WT1
2351,GO:0032268,0.932474647199223,0.137123405109025,8,53,regulation of cellular protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;SERPINA5;CTGF;UNC119
2510,GO:0032874,0.9327223569228,0.278398038136842,1,11,positive regulation of stress-activated MAPK cascade,BP,CTGF
4826,GO:0070304,0.9327223569228,0.278398038136842,1,11,positive regulation of stress-activated protein kinase signaling cascade,BP,CTGF
987,GO:0007219,0.933807500999193,0.281162687877086,1,9,Notch signaling pathway,BP,DLL1
1611,GO:0016202,0.933996821302032,0.2774017453538,1,10,regulation of striated muscle tissue development,BP,DLL1
3865,GO:0048634,0.933996821302032,0.2774017453538,1,10,regulation of muscle organ development,BP,DLL1
5667,GO:1901861,0.933996821302032,0.2774017453538,1,10,regulation of muscle tissue development,BP,DLL1
1358,GO:0010631,0.934178166867353,0.20830518873808,2,16,epithelial cell migration,BP,RHOB;ITGA3
2542,GO:0032991,0.934406548426196,0.12269865116476,13,65,macromolecular complex,CC,LAMA1;MYO7A;CDKN1A;PIK3R1;LAMA5;ITGB5;PRKACB;ITGB8;SERPINA5;ESPN;PDE4B;CGN;ITGA3
1813,GO:0019752,0.934563677751842,0.27901205413882,1,9,carboxylic acid metabolic process,BP,ACSL4
2489,GO:0032787,0.934563677751842,0.27901205413882,1,9,monocarboxylic acid metabolic process,BP,ACSL4
379,GO:0003015,0.935311249623299,0.204472861599062,2,17,heart process,BP,PDE4B;CTGF
4375,GO:0060047,0.935311249623299,0.204472861599062,2,17,heart contraction,BP,PDE4B;CTGF
3156,GO:0043254,0.936615571640155,0.277215464230029,1,8,regulation of protein complex assembly,BP,FHOD3
758,GO:0006163,0.936744254123431,0.26955253089469,1,10,purine nucleotide metabolic process,BP,PDE4B
854,GO:0006753,0.936744254123431,0.26955253089469,1,10,nucleoside phosphate metabolic process,BP,PDE4B
1189,GO:0009117,0.936744254123431,0.26955253089469,1,10,nucleotide metabolic process,BP,PDE4B
1197,GO:0009150,0.936744254123431,0.26955253089469,1,10,purine ribonucleotide metabolic process,BP,PDE4B
1212,GO:0009259,0.936744254123431,0.26955253089469,1,10,ribonucleotide metabolic process,BP,PDE4B
1807,GO:0019693,0.936744254123431,0.26955253089469,1,10,ribose phosphate metabolic process,BP,PDE4B
4350,GO:0055086,0.936744254123431,0.26955253089469,1,10,nucleobase-containing small molecule metabolic process,BP,PDE4B
5203,GO:0072521,0.936744254123431,0.26955253089469,1,10,purine-containing compound metabolic process,BP,PDE4B
681,GO:0005794,0.937534710007975,0.146178540736276,5,33,Golgi apparatus,CC,GAS6;SDC4;RAB39B;GPSM1;CTGF
3495,GO:0045597,0.938283008973291,0.153982985981113,4,30,positive regulation of cell differentiation,BP,KITLG;GAS6;CTGF;ITGA3
1217,GO:0009306,0.938799701659557,0.263585123858232,1,10,protein secretion,BP,GAS6
5287,GO:0090132,0.93995755078203,0.193435294385224,2,17,epithelium migration,BP,RHOB;ITGA3
3197,GO:0043410,0.940337321933704,0.163979712352288,3,26,positive regulation of MAPK cascade,BP,KITLG;GAS6;CTGF
4163,GO:0051247,0.942345316341893,0.123860810952018,7,49,positive regulation of protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;CTGF;UNC119
4162,GO:0051246,0.94278051196712,0.119218087459748,8,54,regulation of protein metabolic process,BP,CDKN1A;KITLG;GAS6;SDC4;PRKACB;SERPINA5;CTGF;UNC119
1554,GO:0015672,0.942785773204526,0.251767994471908,1,10,monovalent inorganic cation transport,BP,ACTN2
1281,GO:0009968,0.942806457828004,0.1357659701061,5,34,negative regulation of signal transduction,BP,GPRASP1;DKK3;GAS6;PRKACB;ITGA3
1294,GO:0010038,0.945139439968422,0.242147330194871,1,11,response to metal ion,BP,CLDN1
64,GO:0000989,0.945268793838786,0.247330400541015,1,9,transcription factor activity, transcription factor binding,MF,ACTN2
1270,GO:0009913,0.945618691136154,0.185218794677323,2,13,epidermal cell differentiation,BP,MYO7A;DLL1
1994,GO:0030178,0.945785936969766,0.245736944634056,1,9,negative regulation of Wnt signaling pathway,BP,DKK3
5844,GO:1903531,0.945890080491457,0.242327973391869,1,10,negative regulation of secretion by cell,BP,GAS6
4487,GO:0060429,0.945951171836701,0.111173362117898,9,54,epithelium development,BP,MYO7A;CDKN1A;RHOB;LAMA5;SDC4;PRKACB;DLL1;CLDN1;WT1
5285,GO:0090130,0.94738269140481,0.174256800405998,2,18,tissue migration,BP,RHOB;ITGA3
2173,GO:0031098,0.948113383076518,0.230977462921942,1,12,stress-activated protein kinase signaling cascade,BP,CTGF
2508,GO:0032872,0.948113383076518,0.230977462921942,1,12,regulation of stress-activated MAPK cascade,BP,CTGF
4209,GO:0051403,0.948113383076518,0.230977462921942,1,12,stress-activated MAPK cascade,BP,CTGF
4824,GO:0070302,0.948113383076518,0.230977462921942,1,12,regulation of stress-activated protein kinase signaling cascade,BP,CTGF
743,GO:0006082,0.949065555796956,0.232441662617555,1,10,organic acid metabolic process,BP,ACSL4
3203,GO:0043436,0.949065555796956,0.232441662617555,1,10,oxoacid metabolic process,BP,ACSL4
3736,GO:0046983,0.949655034564571,0.131119911116606,4,29,protein dimerization activity,MF,ACTN2;MYO7A;PIK3R1;ITGA3
3321,GO:0044297,0.950135800942716,0.229054492545905,1,10,cell body,CC,ACSL4
5843,GO:1903530,0.950161082353787,0.16643114059924,2,19,regulation of secretion by cell,BP,GAS6;SDC4
5637,GO:1901575,0.950349921319265,0.144015069440394,3,22,organic substance catabolic process,BP,GPRASP1;SDC4;PDE4B
2213,GO:0031328,0.950351705039327,0.114134229142245,6,42,positive regulation of cellular biosynthetic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;WT1
4970,GO:0071396,0.950781848007408,0.164854390648029,2,19,cellular response to lipid,BP,PDE4B;CLDN1
3604,GO:0045944,0.950820944218567,0.128314033577254,4,30,positive regulation of transcription from RNA polymerase II promoter,BP,PIK3R1;FOXO4;DLL1;WT1
142,GO:0001763,0.951268032433714,0.164430110812896,2,18,morphogenesis of a branching structure,BP,LAMA5;WT1
3914,GO:0048754,0.951268032433714,0.164430110812896,2,18,branching morphogenesis of an epithelial tube,BP,LAMA5;WT1
4687,GO:0061138,0.951268032433714,0.164430110812896,2,18,morphogenesis of a branching epithelium,BP,LAMA5;WT1
958,GO:0007154,0.951469975102037,0.0881543970024959,28,142,cell communication,BP,LAMA1;ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;RIN3;DHH;FOXO4;GPSM1;DLL1;PDE4B;CGN;CTGF;UNC119;ITGA3
1289,GO:0010001,0.951474122459985,0.222372875501103,1,11,glial cell differentiation,BP,DLL1
2940,GO:0042063,0.951474122459985,0.222372875501103,1,11,gliogenesis,BP,DLL1
175,GO:0001890,0.952438905766228,0.221666583925108,1,10,placenta development,BP,ITGB8
87,GO:0001503,0.952586552914806,0.161041934031664,2,18,ossification,BP,DHH;CTGF
1367,GO:0010646,0.953731549354866,0.0901659902784817,13,77,regulation of cell communication,BP,ACTN2;GPRASP1;DKK3;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;CTGF;ITGA3
5232,GO:0080134,0.95381167416155,0.13447967178453,3,25,regulation of response to stress,BP,PIK3R1;PRKACB;CTGF
2125,GO:0030855,0.953893718999536,0.107885682006978,6,39,epithelial cell differentiation,BP,MYO7A;CDKN1A;LAMA5;DLL1;CLDN1;WT1
6065,GO:2000113,0.954323603905434,0.13429314647858,3,23,negative regulation of cellular macromolecule biosynthetic process,BP,DKK3;GAS6;WT1
5840,GO:1903522,0.954568175325721,0.155104395698746,2,19,regulation of blood circulation,BP,PDE4B;CTGF
4872,GO:0070647,0.955237334025947,0.210147994888619,1,11,protein modification by small protein conjugation or removal,BP,FOXO4
63,GO:0000988,0.955889744301242,0.210330410637055,1,10,transcription factor activity, protein binding,MF,ACTN2
4159,GO:0051239,0.956225704351965,0.0860855988967178,13,74,regulation of multicellular organismal process,BP,LAMA1;RHOB;KITLG;PIK3R1;LAMA5;GAS6;PRKACB;FOXO4;DLL1;PDE4B;CTGF;ITGA3;WT1
5734,GO:1902532,0.957019198283681,0.204223544874225,1,11,negative regulation of intracellular signal transduction,BP,ITGA3
2209,GO:0031324,0.957182123194354,0.101066173922729,6,41,negative regulation of cellular metabolic process,BP,CDKN1A;DKK3;CAMSAP3;GAS6;SERPINA5;WT1
5340,GO:0090407,0.957726703942322,0.198379112165098,1,13,organophosphate biosynthetic process,BP,PIK3R1
2061,GO:0030509,0.957976256484815,0.201003389605754,1,11,BMP signaling pathway,BP,ITGA3
5023,GO:0071772,0.957976256484815,0.201003389605754,1,11,response to BMP,BP,ITGA3
5024,GO:0071773,0.957976256484815,0.201003389605754,1,11,cellular response to BMP stimulus,BP,ITGA3
1742,GO:0018105,0.957982133274926,0.200983532189851,1,11,peptidyl-serine phosphorylation,BP,GAS6
1752,GO:0018209,0.957982133274926,0.200983532189851,1,11,peptidyl-serine modification,BP,GAS6
4169,GO:0051253,0.958930423935332,0.123456190984186,3,23,negative regulation of RNA metabolic process,BP,DKK3;GAS6;WT1
1407,GO:0010817,0.959920973367755,0.192514927301482,1,12,regulation of hormone levels,BP,DKK3
881,GO:0006873,0.960270862233071,0.189770460114764,1,13,cellular ion homeostasis,BP,PRND
1946,GO:0030003,0.960270862233071,0.189770460114764,1,13,cellular cation homeostasis,BP,PRND
357,GO:0002790,0.961273122193642,0.187856436999722,1,12,peptide secretion,BP,GAS6
1941,GO:0023052,0.961376959147261,0.0722036684494665,28,143,signaling,BP,LAMA1;ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;RIN3;DHH;FOXO4;GPSM1;DLL1;PDE4B;CGN;CTGF;UNC119;ITGA3
3376,GO:0044700,0.961376959147261,0.0722036684494665,28,143,single organism signaling,BP,LAMA1;ACTN2;CDKN1A;NRTN;GPRASP1;DKK3;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;LAMA5;GAS6;ITGB5;MPZL1;SDC4;PRKACB;ITGB8;RIN3;DHH;FOXO4;GPSM1;DLL1;PDE4B;CGN;CTGF;UNC119;ITGA3
4090,GO:0051048,0.96176976332128,0.18796234924343,1,11,negative regulation of secretion,BP,GAS6
3088,GO:0043009,0.962035911998952,0.115977653804043,3,23,chordate embryonic development,BP,SDC4;PRKACB;DLL1
1263,GO:0009893,0.96299930407272,0.0732542502491784,14,84,positive regulation of metabolic process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;ITGB8;HMGN5;FOXO4;DLL1;CTGF;UNC119;ITGA3;WT1
1940,GO:0023051,0.963165446560196,0.0739028835206281,13,79,regulation of signaling,BP,ACTN2;GPRASP1;DKK3;RHOB;KITLG;RHOJ;PIK3R1;GAS6;PRKACB;GPSM1;DLL1;CTGF;ITGA3
1260,GO:0009890,0.963378785865122,0.112228818979758,3,24,negative regulation of biosynthetic process,BP,DKK3;GAS6;WT1
1338,GO:0010558,0.963378785865122,0.112228818979758,3,24,negative regulation of macromolecule biosynthetic process,BP,DKK3;GAS6;WT1
2212,GO:0031327,0.963378785865122,0.112228818979758,3,24,negative regulation of cellular biosynthetic process,BP,DKK3;GAS6;WT1
373,GO:0003007,0.963421674054779,0.180331636504774,1,12,heart morphogenesis,BP,DLL1
576,GO:0005125,0.964122849346756,0.176349268648203,1,13,cytokine activity,MF,KITLG
4607,GO:0060828,0.964148873085827,0.177749309394558,1,12,regulation of canonical Wnt signaling pathway,BP,DKK3
5449,GO:0098588,0.964329678640255,0.0863027616833628,6,44,bounding membrane of organelle,CC,MYO7A;RHOB;SERPINA5;ACSL4;GPSM1;TMEM163
1599,GO:0016055,0.966330912130967,0.122542305618245,2,20,Wnt signaling pathway,BP,DKK3;ITGA3
5537,GO:0198738,0.966330912130967,0.122542305618245,2,20,cell-cell signaling by wnt,BP,DKK3;ITGA3
3584,GO:0045893,0.96652045890452,0.0865932133272527,5,38,positive regulation of transcription, DNA-templated,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
5756,GO:1902680,0.96652045890452,0.0865932133272527,5,38,positive regulation of RNA biosynthetic process,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
5834,GO:1903508,0.96652045890452,0.0865932133272527,5,38,positive regulation of nucleic acid-templated transcription,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
5471,GO:0098742,0.966636699960278,0.122289736872947,2,19,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;CLDN1
23,GO:0000165,0.966933870209585,0.0853819625526283,5,40,MAPK cascade,BP,ACTN2;NRTN;KITLG;GAS6;CTGF
550,GO:0004871,0.96695049154119,0.102608588104628,3,26,signal transducer activity,MF,PIK3R1;GAS6;SDC4
3995,GO:0050767,0.967580967024404,0.119593077051462,2,19,regulation of neurogenesis,BP,DLL1;ITGA3
3598,GO:0045934,0.967962639601797,0.100434092641809,3,25,negative regulation of nucleobase-containing compound metabolic process,BP,DKK3;GAS6;WT1
35,GO:0000280,0.968026963863269,0.162220021228584,1,13,nuclear division,BP,MARK4
3790,GO:0048285,0.968026963863269,0.162220021228584,1,13,organelle fission,BP,MARK4
3852,GO:0048585,0.968102395506503,0.0831682132730766,5,38,negative regulation of response to stimulus,BP,GPRASP1;DKK3;GAS6;PRKACB;ITGA3
3854,GO:0048589,0.968159767811457,0.116793016507808,2,21,developmental growth,BP,DLL1;WT1
3281,GO:0044057,0.969297474910918,0.0963747085684322,3,27,regulation of system process,BP,GAS6;PDE4B;CTGF
1003,GO:0007267,0.969443347817664,0.0754165693418099,6,47,cell-cell signaling,BP,DKK3;MPZL1;DHH;DLL1;UNC119;ITGA3
3449,GO:0045165,0.969505354972055,0.112916787744581,2,21,cell fate commitment,BP,DLL1;WT1
4921,GO:0071229,0.970149303522211,0.154292250432391,1,13,cellular response to acid chemical,BP,CLDN1
85,GO:0001501,0.970554420522858,0.109863241759712,2,21,skeletal system development,BP,ITGB8;CTGF
5733,GO:1902531,0.971403815210592,0.0684236807976295,7,50,regulation of intracellular signal transduction,BP,RHOB;KITLG;RHOJ;PIK3R1;GAS6;CTGF;ITGA3
2210,GO:0031325,0.971868206760422,0.059217820716967,12,77,positive regulation of cellular metabolic process,BP,CDKN1A;KITLG;PIK3R1;GAS6;SDC4;PRKACB;HMGN5;FOXO4;DLL1;CTGF;UNC119;WT1
3599,GO:0045935,0.971974521219535,0.0702985484239904,6,45,positive regulation of nucleobase-containing compound metabolic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;WT1
4130,GO:0051173,0.971974521219535,0.0702985484239904,6,45,positive regulation of nitrogen compound metabolic process,BP,KITLG;PIK3R1;HMGN5;FOXO4;DLL1;WT1
1748,GO:0018193,0.972229323974518,0.0885768263749016,3,28,peptidyl-amino acid modification,BP,KITLG;GAS6;UNC119
3234,GO:0043542,0.972981620155265,0.144756816393298,1,12,endothelial cell migration,BP,RHOB
4170,GO:0051254,0.973291500315954,0.0715423890410616,5,39,positive regulation of RNA metabolic process,BP,PIK3R1;HMGN5;FOXO4;DLL1;WT1
3720,GO:0046903,0.973492877854643,0.0709533902067828,5,40,secretion,BP,ACTN2;GAS6;SDC4;CRISPLD2;CTGF
4088,GO:0051046,0.974166361790113,0.098688105742566,2,22,regulation of secretion,BP,GAS6;SDC4
4129,GO:0051172,0.974852094845719,0.0822713385257472,3,26,negative regulation of nitrogen compound metabolic process,BP,DKK3;GAS6;WT1
2670,GO:0034622,0.975029700653893,0.138182062775444,1,11,cellular macromolecular complex assembly,BP,FHOD3
3260,GO:0043623,0.975029700653893,0.138182062775444,1,11,cellular protein complex assembly,BP,FHOD3
3193,GO:0043406,0.975686958083383,0.131577471391702,1,14,positive regulation of MAP kinase activity,BP,KITLG
914,GO:0006952,0.975752105778888,0.0942876119117626,2,21,defense response,BP,PRKACB;CLDN1
3195,GO:0043408,0.975802303699529,0.0787261490234015,3,30,regulation of MAPK cascade,BP,KITLG;GAS6;CTGF
2885,GO:0038023,0.976213850575502,0.129450492138607,1,14,signaling receptor activity,MF,SDC4
3997,GO:0050769,0.976395155428982,0.129789978093954,1,13,positive regulation of neurogenesis,BP,ITGA3
1922,GO:0022612,0.976483635749828,0.130700676412469,1,12,gland morphogenesis,BP,LAMA5
4339,GO:0055065,0.978469429709473,0.120172290030074,1,14,metal ion homeostasis,BP,PRND
106,GO:0001649,0.978505729609879,0.120020576939841,1,14,osteoblast differentiation,BP,DHH
4308,GO:0051962,0.980042156446571,0.113525022447913,1,14,positive regulation of nervous system development,BP,ITGA3
114,GO:0001664,0.981285554259052,0.106608539297154,1,16,G-protein coupled receptor binding,MF,REEP1
5958,GO:1905114,0.981734327820353,0.0745788235566806,2,23,cell surface receptor signaling pathway involved in cell-cell signaling,BP,DKK3;ITGA3
1938,GO:0023014,0.982529512452701,0.0496101850297514,5,43,signal transduction by protein phosphorylation,BP,ACTN2;NRTN;KITLG;GAS6;CTGF
1369,GO:0010648,0.982605017446372,0.0497070215341319,5,40,negative regulation of cell communication,BP,GPRASP1;DKK3;GAS6;PRKACB;ITGA3
1943,GO:0023057,0.982605017446372,0.0497070215341319,5,40,negative regulation of signaling,BP,GPRASP1;DKK3;GAS6;PRKACB;ITGA3
4435,GO:0060284,0.983112132345144,0.0700259376455563,2,23,regulation of cell development,BP,DLL1;ITGA3
1387,GO:0010720,0.984125350507879,0.0947091959106504,1,15,positive regulation of cell development,BP,ITGA3
5051,GO:0071900,0.984566054319342,0.0646099115454366,2,25,regulation of protein serine/threonine kinase activity,BP,CDKN1A;KITLG
3851,GO:0048584,0.984778540426304,0.0395758292254862,7,54,positive regulation of response to stimulus,BP,KITLG;PIK3R1;GAS6;PRKACB;DLL1;PDE4B;CTGF
1981,GO:0030139,0.986908548873918,0.0805654621631973,1,17,endocytic vesicle,CC,ITGB5
1461,GO:0012506,0.98737366092867,0.0546928259242824,2,26,vesicle membrane,CC,SERPINA5;TMEM163
2084,GO:0030659,0.98737366092867,0.0546928259242824,2,26,cytoplasmic vesicle membrane,CC,SERPINA5;TMEM163
14,GO:0000122,0.987682144032905,0.0779508577244272,1,15,negative regulation of transcription from RNA polymerase II promoter,BP,WT1
4347,GO:0055080,0.987766525201121,0.076442231251626,1,17,cation homeostasis,BP,PRND
5475,GO:0098771,0.987766525201121,0.076442231251626,1,17,inorganic ion homeostasis,BP,PRND
5053,GO:0071902,0.988973701408907,0.0700817252603016,1,18,positive regulation of protein serine/threonine kinase activity,BP,KITLG
4387,GO:0060070,0.989315799118652,0.0687944962240892,1,17,canonical Wnt signaling pathway,BP,DKK3
4446,GO:0060322,0.989715618420022,0.0466170289059859,2,24,head development,BP,CRISPLD2;DLL1
5735,GO:1902533,0.990125025862223,0.0370332833619451,3,34,positive regulation of intracellular signal transduction,BP,KITLG;GAS6;CTGF
1257,GO:0009887,0.99114542836468,0.0276558108414171,5,44,animal organ morphogenesis,BP,MYO7A;LAMA5;DLL1;CTGF;WT1
4012,GO:0050801,0.991439224660874,0.0574498986827397,1,18,ion homeostasis,BP,PRND
2766,GO:0035556,0.9920627930816,0.0196917668755073,11,78,intracellular signal transduction,BP,ACTN2;CDKN1A;NRTN;RHOB;KITLG;RHOJ;NUAK2;PIK3R1;GAS6;CTGF;ITGA3
3192,GO:0043405,0.992381150329062,0.0520813486249554,1,19,regulation of MAP kinase activity,BP,KITLG
6047,GO:2000027,0.992556741718628,0.0511255699123717,1,19,regulation of organ morphogenesis,BP,WT1
2328,GO:0032101,0.99265651875314,0.051224777900366,1,17,regulation of response to external stimulus,BP,GAS6
1175,GO:0009056,0.994050406262127,0.0244315671539925,3,30,catabolic process,BP,GPRASP1;SDC4;PDE4B
1280,GO:0009967,0.994070226017501,0.0193979041802861,5,48,positive regulation of signal transduction,BP,KITLG;PIK3R1;GAS6;DLL1;CTGF
1368,GO:0010647,0.994070226017501,0.0193979041802861,5,48,positive regulation of cell communication,BP,KITLG;PIK3R1;GAS6;DLL1;CTGF
1942,GO:0023056,0.994070226017501,0.0193979041802861,5,48,positive regulation of signaling,BP,KITLG;PIK3R1;GAS6;DLL1;CTGF
3303,GO:0044248,0.994776294250287,0.0266329154813533,2,24,cellular catabolic process,BP,GPRASP1;PDE4B
1033,GO:0007420,0.997396637422611,0.0215982694257689,1,21,brain development,BP,DLL1
1032,GO:0007417,0.999638964716073,0.00396223103016422,1,27,central nervous system development,BP,DLL1
5968,GO:1905330,0.999999999999999,0.0857716146507738,0,10,regulation of morphogenesis of an epithelium,BP,
1423,GO:0010862,1,0.211088109521904,0,6,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
4466,GO:0060389,1,0.211088109521904,0,6,pathway-restricted SMAD protein phosphorylation,BP,
4469,GO:0060393,1,0.211088109521904,0,6,regulation of pathway-restricted SMAD protein phosphorylation,BP,
1,GO:0000002,1,0.749336515652812,0,1,mitochondrial genome maintenance,BP,
3,GO:0000018,1,0.849407889468112,0,1,regulation of DNA recombination,BP,
4,GO:0000041,1,0.50499599248856,0,3,transition metal ion transport,BP,
5,GO:0000045,1,0.817600888298876,0,1,autophagosome assembly,BP,
7,GO:0000070,1,0.853347594896784,0,1,mitotic sister chromatid segregation,BP,
13,GO:0000118,1,0.6837505749659,0,1,histone deacetylase complex,CC,
15,GO:0000132,1,0.941285075943011,0,1,establishment of mitotic spindle orientation,BP,
17,GO:0000145,1,0.817600888298876,0,1,exocyst,CC,
19,GO:0000149,1,0.667375753190344,0,2,SNARE binding,MF,
20,GO:0000151,1,0.529563814783185,0,2,ubiquitin ligase complex,CC,
21,GO:0000155,1,0.763757722401656,0,1,phosphorelay sensor kinase activity,MF,
22,GO:0000160,1,0.763757722401656,0,1,phosphorelay signal transduction system,BP,
25,GO:0000185,1,0.88243496779377,0,1,activation of MAPKKK activity,BP,
26,GO:0000186,1,0.532885810478924,0,3,activation of MAPKK activity,BP,
27,GO:0000187,1,0.129958476365752,0,8,activation of MAPK activity,BP,
28,GO:0000188,1,0.800672150482427,0,1,inactivation of MAPK activity,BP,
29,GO:0000209,1,0.322080852912668,0,3,protein polyubiquitination,BP,
31,GO:0000228,1,0.6837505749659,0,1,nuclear chromosome,CC,
32,GO:0000242,1,0.847576173811789,0,1,pericentriolar material,CC,
33,GO:0000271,1,0.478476681596556,0,3,polysaccharide biosynthetic process,BP,
36,GO:0000281,1,0.681433432009857,0,1,mitotic cytokinesis,BP,
39,GO:0000303,1,0.725126756103963,0,1,response to superoxide,BP,
40,GO:0000305,1,0.725126756103963,0,1,response to oxygen radical,BP,
45,GO:0000790,1,0.6837505749659,0,1,nuclear chromatin,CC,
46,GO:0000792,1,0.749714102664732,0,1,heterochromatin,CC,
47,GO:0000803,1,0.6837505749659,0,1,sex chromosome,CC,
48,GO:0000805,1,0.6837505749659,0,1,X chromosome,CC,
49,GO:0000806,1,0.6837505749659,0,1,Y chromosome,CC,
50,GO:0000819,1,0.853347594896784,0,1,sister chromatid segregation,BP,
57,GO:0000976,1,0.761153424935427,0,1,transcription regulatory region sequence-specific DNA binding,MF,
58,GO:0000977,1,0.761153424935427,0,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,
59,GO:0000979,1,0.761153424935427,0,1,RNA polymerase II core promoter sequence-specific DNA binding,MF,
62,GO:0000983,1,0.814984680586157,0,1,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,
65,GO:0001012,1,0.761153424935427,0,1,RNA polymerase II regulatory region DNA binding,MF,
66,GO:0001046,1,0.761153424935427,0,1,core promoter sequence-specific DNA binding,MF,
67,GO:0001047,1,0.395772503319265,0,3,core promoter binding,MF,
70,GO:0001076,1,0.170920704818504,0,5,transcription factor activity, RNA polymerase II transcription factor binding,MF,
72,GO:0001078,1,0.761153424935427,0,1,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
73,GO:0001085,1,0.761153424935427,0,1,RNA polymerase II transcription factor binding,MF,
75,GO:0001102,1,0.761153424935427,0,1,RNA polymerase II activating transcription factor binding,MF,
76,GO:0001104,1,0.401905153320802,0,3,RNA polymerase II transcription cofactor activity,MF,
77,GO:0001105,1,0.777790771548319,0,1,RNA polymerase II transcription coactivator activity,MF,
78,GO:0001106,1,0.51824679977071,0,2,RNA polymerase II transcription corepressor activity,MF,
79,GO:0001134,1,0.730053612763015,0,1,transcription factor activity, transcription factor recruiting,MF,
80,GO:0001135,1,0.730053612763015,0,1,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
81,GO:0001190,1,0.459292252369848,0,2,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
82,GO:0001191,1,0.235964632069206,0,4,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
83,GO:0001227,1,0.761153424935427,0,1,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
88,GO:0001504,1,0.936826423682637,0,1,neurotransmitter uptake,BP,
89,GO:0001505,1,0.678228619833455,0,3,regulation of neurotransmitter levels,BP,
90,GO:0001508,1,0.519110774387841,0,2,action potential,BP,
91,GO:0001516,1,0.703978953100515,0,2,prostaglandin biosynthetic process,BP,
94,GO:0001533,1,0.149604617026572,0,5,cornified envelope,CC,
96,GO:0001556,1,0.962412700305168,0,1,oocyte maturation,BP,
98,GO:0001562,1,0.898270644003197,0,1,response to protozoan,BP,
100,GO:0001569,1,0.581639125984066,0,3,branching involved in blood vessel morphogenesis,BP,
104,GO:0001609,1,0.782385944864048,0,1,G-protein coupled adenosine receptor activity,MF,
107,GO:0001653,1,0.718207300668576,0,1,peptide receptor activity,MF,
113,GO:0001659,1,0.782385944864048,0,1,temperature homeostasis,BP,
115,GO:0001666,1,0.0914200589837822,0,10,response to hypoxia,BP,
120,GO:0001701,1,0.00595785695801265,0,16,in utero embryonic development,BP,
121,GO:0001702,1,0.326487747216859,0,3,gastrulation with mouth forming second,BP,
123,GO:0001705,1,0.733087029820149,0,1,ectoderm formation,BP,
128,GO:0001710,1,0.850452765079241,0,1,mesodermal cell fate commitment,BP,
129,GO:0001712,1,0.733087029820149,0,1,ectodermal cell fate commitment,BP,
130,GO:0001715,1,0.733087029820149,0,1,ectodermal cell fate specification,BP,
131,GO:0001726,1,0.345529047734131,0,3,ruffle,CC,
132,GO:0001736,1,0.484688036404671,0,2,establishment of planar polarity,BP,
134,GO:0001741,1,0.6837505749659,0,1,XY body,CC,
135,GO:0001743,1,0.753597902783621,0,1,optic placode formation,BP,
141,GO:0001759,1,0.329309659784805,0,7,organ induction,BP,
144,GO:0001771,1,0.727489805589545,0,1,immunological synapse formation,BP,
155,GO:0001821,1,0.828354528958696,0,1,histamine secretion,BP,
158,GO:0001824,1,0.749714102664732,0,1,blastocyst development,BP,
159,GO:0001832,1,0.749714102664732,0,1,blastocyst growth,BP,
160,GO:0001833,1,0.749714102664732,0,1,inner cell mass cell proliferation,BP,
161,GO:0001836,1,0.655311057413809,0,2,release of cytochrome c from mitochondria,BP,
162,GO:0001837,1,0.0674116272126241,0,9,epithelial to mesenchymal transition,BP,
164,GO:0001839,1,0.906752862467527,0,1,neural plate morphogenesis,BP,
165,GO:0001840,1,0.906752862467527,0,1,neural plate development,BP,
167,GO:0001842,1,0.725126756103963,0,1,neural fold formation,BP,
169,GO:0001844,1,0.839760482627469,0,1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
176,GO:0001892,1,0.145739618537109,0,7,embryonic placenta development,BP,
177,GO:0001893,1,0.321092862006917,0,4,maternal placenta development,BP,
179,GO:0001895,1,0.570096592216055,0,2,retina homeostasis,BP,
180,GO:0001906,1,0.652140740773466,0,2,cell killing,BP,
181,GO:0001909,1,0.784473242465539,0,1,leukocyte mediated cytotoxicity,BP,
182,GO:0001913,1,0.784473242465539,0,1,T cell mediated cytotoxicity,BP,
184,GO:0001927,1,0.817600888298876,0,1,exocyst assembly,BP,
185,GO:0001928,1,0.817600888298876,0,1,regulation of exocyst assembly,BP,
186,GO:0001931,1,0.727489805589545,0,1,uropod,CC,
190,GO:0001935,1,0.153604284146506,0,7,endothelial cell proliferation,BP,
191,GO:0001936,1,0.153604284146506,0,7,regulation of endothelial cell proliferation,BP,
192,GO:0001938,1,0.153604284146506,0,7,positive regulation of endothelial cell proliferation,BP,
193,GO:0001941,1,0.665895859294542,0,2,postsynaptic membrane organization,BP,
196,GO:0001945,1,0.713574905533741,0,1,lymph vessel development,BP,
202,GO:0001958,1,0.514447661618388,0,3,endochondral ossification,BP,
206,GO:0001963,1,0.936826423682637,0,1,synaptic transmission, dopaminergic,BP,
209,GO:0001973,1,0.782385944864048,0,1,adenosine receptor signaling pathway,BP,
210,GO:0001974,1,0.622287440234298,0,3,blood vessel remodeling,BP,
212,GO:0001990,1,0.828354528958696,0,1,regulation of systemic arterial blood pressure by hormone,BP,
214,GO:0002011,1,0.0996757356898776,0,7,morphogenesis of an epithelial sheet,BP,
216,GO:0002026,1,0.832024114860243,0,1,regulation of the force of heart contraction,BP,
217,GO:0002027,1,0.224697820790223,0,5,regulation of heart rate,BP,
218,GO:0002028,1,0.374289876316622,0,3,regulation of sodium ion transport,BP,
220,GO:0002042,1,0.421091420510704,0,2,cell migration involved in sprouting angiogenesis,BP,
221,GO:0002043,1,0.850452765079241,0,1,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
222,GO:0002052,1,0.59183921579231,0,1,positive regulation of neuroblast proliferation,BP,
223,GO:0002053,1,0.51631739437111,0,2,positive regulation of mesenchymal cell proliferation,BP,
232,GO:0002072,1,0.662592268986548,0,1,optic cup morphogenesis involved in camera-type eye development,BP,
234,GO:0002082,1,0.780567658291826,0,1,regulation of oxidative phosphorylation,BP,
236,GO:0002087,1,0.782385944864048,0,1,regulation of respiratory gaseous exchange by neurological system process,BP,
237,GO:0002088,1,0.180647198438906,0,7,lens development in camera-type eye,BP,
238,GO:0002089,1,0.850452765079241,0,1,lens morphogenesis in camera-type eye,BP,
242,GO:0002159,1,0.783719200454775,0,1,desmosome assembly,BP,
243,GO:0002193,1,0.59183921579231,0,1,MAML1-RBP-Jkappa- ICN1 complex,CC,
244,GO:0002200,1,0.849407889468112,0,1,somatic diversification of immune receptors,BP,
245,GO:0002204,1,0.849407889468112,0,1,somatic recombination of immunoglobulin genes involved in immune response,BP,
246,GO:0002208,1,0.849407889468112,0,1,somatic diversification of immunoglobulins involved in immune response,BP,
249,GO:0002221,1,0.728085055754081,0,1,pattern recognition receptor signaling pathway,BP,
251,GO:0002224,1,0.728085055754081,0,1,toll-like receptor signaling pathway,BP,
252,GO:0002228,1,0.784473242465539,0,1,natural killer cell mediated immunity,BP,
254,GO:0002244,1,0.29623564089164,0,4,hematopoietic progenitor cell differentiation,BP,
255,GO:0002250,1,0.296811456620828,0,5,adaptive immune response,BP,
256,GO:0002251,1,0.840429863359978,0,1,organ or tissue specific immune response,BP,
259,GO:0002260,1,0.655311057413809,0,2,lymphocyte homeostasis,BP,
264,GO:0002279,1,0.561913766641372,0,2,mast cell activation involved in immune response,BP,
267,GO:0002286,1,0.596385859464224,0,2,T cell activation involved in immune response,BP,
268,GO:0002287,1,0.761153424935427,0,1,alpha-beta T cell activation involved in immune response,BP,
269,GO:0002292,1,0.761153424935427,0,1,T cell differentiation involved in immune response,BP,
270,GO:0002293,1,0.761153424935427,0,1,alpha-beta T cell differentiation involved in immune response,BP,
271,GO:0002294,1,0.761153424935427,0,1,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
272,GO:0002295,1,0.761153424935427,0,1,T-helper cell lineage commitment,BP,
276,GO:0002318,1,0.741010011526507,0,1,myeloid progenitor cell differentiation,BP,
277,GO:0002320,1,0.502546403706452,0,2,lymphoid progenitor cell differentiation,BP,
278,GO:0002323,1,0.784473242465539,0,1,natural killer cell activation involved in immune response,BP,
279,GO:0002328,1,0.59183921579231,0,1,pro-B cell differentiation,BP,
281,GO:0002360,1,0.761153424935427,0,1,T cell lineage commitment,BP,
282,GO:0002363,1,0.761153424935427,0,1,alpha-beta T cell lineage commitment,BP,
285,GO:0002374,1,0.662592268986548,0,1,cytokine secretion involved in immune response,BP,
287,GO:0002377,1,0.849407889468112,0,1,immunoglobulin production,BP,
288,GO:0002381,1,0.849407889468112,0,1,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
289,GO:0002385,1,0.840429863359978,0,1,mucosal immune response,BP,
290,GO:0002386,1,0.840429863359978,0,1,immune response in mucosal-associated lymphoid tissue,BP,
292,GO:0002414,1,0.840429863359978,0,1,immunoglobulin transcytosis in epithelial cells,BP,
293,GO:0002415,1,0.840429863359978,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
297,GO:0002437,1,0.59183921579231,0,1,inflammatory response to antigenic stimulus,BP,
302,GO:0002448,1,0.561913766641372,0,2,mast cell mediated immunity,BP,
303,GO:0002449,1,0.665819623780898,0,2,lymphocyte mediated immunity,BP,
304,GO:0002456,1,0.784473242465539,0,1,T cell mediated immunity,BP,
305,GO:0002460,1,0.597510358801524,0,3,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
311,GO:0002523,1,0.741010011526507,0,1,leukocyte migration involved in inflammatory response,BP,
312,GO:0002526,1,0.34650097274217,0,4,acute inflammatory response,BP,
313,GO:0002544,1,0.850380627707629,0,1,chronic inflammatory response,BP,
314,GO:0002548,1,0.720171426197999,0,2,monocyte chemotaxis,BP,
315,GO:0002551,1,0.832024114860243,0,1,mast cell chemotaxis,BP,
316,GO:0002562,1,0.849407889468112,0,1,somatic diversification of immune receptors via germline recombination within a single locus,BP,
319,GO:0002637,1,0.849407889468112,0,1,regulation of immunoglobulin production,BP,
320,GO:0002639,1,0.849407889468112,0,1,positive regulation of immunoglobulin production,BP,
321,GO:0002673,1,0.528198301770273,0,2,regulation of acute inflammatory response,BP,
322,GO:0002674,1,0.782385944864048,0,1,negative regulation of acute inflammatory response,BP,
323,GO:0002675,1,0.676247599336564,0,1,positive regulation of acute inflammatory response,BP,
324,GO:0002679,1,0.676247599336564,0,1,respiratory burst involved in defense response,BP,
329,GO:0002686,1,0.782385944864048,0,1,negative regulation of leukocyte migration,BP,
336,GO:0002697,1,0.562106718008584,0,2,regulation of immune effector process,BP,
337,GO:0002699,1,0.562106718008584,0,2,positive regulation of immune effector process,BP,
338,GO:0002700,1,0.562106718008584,0,2,regulation of production of molecular mediator of immune response,BP,
339,GO:0002702,1,0.562106718008584,0,2,positive regulation of production of molecular mediator of immune response,BP,
340,GO:0002703,1,0.849407889468112,0,1,regulation of leukocyte mediated immunity,BP,
341,GO:0002705,1,0.849407889468112,0,1,positive regulation of leukocyte mediated immunity,BP,
342,GO:0002706,1,0.849407889468112,0,1,regulation of lymphocyte mediated immunity,BP,
343,GO:0002708,1,0.849407889468112,0,1,positive regulation of lymphocyte mediated immunity,BP,
344,GO:0002712,1,0.849407889468112,0,1,regulation of B cell mediated immunity,BP,
345,GO:0002714,1,0.849407889468112,0,1,positive regulation of B cell mediated immunity,BP,
346,GO:0002718,1,0.662592268986548,0,1,regulation of cytokine production involved in immune response,BP,
347,GO:0002720,1,0.662592268986548,0,1,positive regulation of cytokine production involved in immune response,BP,
348,GO:0002739,1,0.662592268986548,0,1,regulation of cytokine secretion involved in immune response,BP,
349,GO:0002741,1,0.662592268986548,0,1,positive regulation of cytokine secretion involved in immune response,BP,
360,GO:0002793,1,0.396312795165059,0,3,positive regulation of peptide secretion,BP,
361,GO:0002819,1,0.849407889468112,0,1,regulation of adaptive immune response,BP,
362,GO:0002821,1,0.849407889468112,0,1,positive regulation of adaptive immune response,BP,
363,GO:0002822,1,0.849407889468112,0,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
364,GO:0002824,1,0.849407889468112,0,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
365,GO:0002831,1,0.768189760920054,0,1,regulation of response to biotic stimulus,BP,
366,GO:0002833,1,0.768189760920054,0,1,positive regulation of response to biotic stimulus,BP,
367,GO:0002889,1,0.849407889468112,0,1,regulation of immunoglobulin mediated immune response,BP,
368,GO:0002891,1,0.849407889468112,0,1,positive regulation of immunoglobulin mediated immune response,BP,
369,GO:0002931,1,0.813104792706398,0,1,response to ischemia,BP,
370,GO:0002934,1,0.783719200454775,0,1,desmosome organization,BP,
375,GO:0003009,1,0.780567658291826,0,1,skeletal muscle contraction,BP,
380,GO:0003016,1,0.536808086812008,0,2,respiratory system process,BP,
381,GO:0003018,1,0.15599030630525,0,9,vascular process in circulatory system,BP,
382,GO:0003044,1,0.828354528958696,0,1,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
383,GO:0003062,1,0.763757722401656,0,1,regulation of heart rate by chemical signal,BP,
384,GO:0003064,1,0.763757722401656,0,1,regulation of heart rate by hormone,BP,
387,GO:0003085,1,0.793380151163482,0,1,negative regulation of systemic arterial blood pressure,BP,
391,GO:0003096,1,0.718774331523076,0,1,renal sodium ion transport,BP,
392,GO:0003100,1,0.828354528958696,0,1,regulation of systemic arterial blood pressure by endothelin,BP,
394,GO:0003128,1,0.850452765079241,0,1,heart field specification,BP,
395,GO:0003129,1,0.650932589184655,0,2,heart induction,BP,
396,GO:0003130,1,0.650932589184655,0,2,BMP signaling pathway involved in heart induction,BP,
397,GO:0003133,1,0.650932589184655,0,2,endodermal-mesodermal cell signaling,BP,
398,GO:0003134,1,0.650932589184655,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
399,GO:0003139,1,0.850452765079241,0,1,secondary heart field specification,BP,
401,GO:0003148,1,0.77086581613867,0,2,outflow tract septum morphogenesis,BP,
402,GO:0003149,1,0.850452765079241,0,1,membranous septum morphogenesis,BP,
403,GO:0003151,1,0.321675138775885,0,5,outflow tract morphogenesis,BP,
405,GO:0003157,1,0.458123943077997,0,2,endocardium development,BP,
408,GO:0003160,1,0.59183921579231,0,1,endocardium morphogenesis,BP,
409,GO:0003161,1,0.59183921579231,0,1,cardiac conduction system development,BP,
410,GO:0003162,1,0.59183921579231,0,1,atrioventricular node development,BP,
411,GO:0003169,1,0.59183921579231,0,1,coronary vein morphogenesis,BP,
412,GO:0003170,1,0.141030825947634,0,7,heart valve development,BP,
413,GO:0003171,1,0.214745839889995,0,5,atrioventricular valve development,BP,
414,GO:0003174,1,0.347417976419997,0,3,mitral valve development,BP,
415,GO:0003175,1,0.761153424935427,0,1,tricuspid valve development,BP,
416,GO:0003176,1,0.502546403706452,0,2,aortic valve development,BP,
417,GO:0003177,1,0.318168911863837,0,4,pulmonary valve development,BP,
418,GO:0003179,1,0.141030825947634,0,7,heart valve morphogenesis,BP,
419,GO:0003180,1,0.502546403706452,0,2,aortic valve morphogenesis,BP,
420,GO:0003181,1,0.214745839889995,0,5,atrioventricular valve morphogenesis,BP,
421,GO:0003183,1,0.347417976419997,0,3,mitral valve morphogenesis,BP,
422,GO:0003184,1,0.318168911863837,0,4,pulmonary valve morphogenesis,BP,
423,GO:0003186,1,0.761153424935427,0,1,tricuspid valve morphogenesis,BP,
424,GO:0003188,1,0.365170071596194,0,3,heart valve formation,BP,
425,GO:0003190,1,0.365170071596194,0,3,atrioventricular valve formation,BP,
426,GO:0003192,1,0.449392614686304,0,2,mitral valve formation,BP,
427,GO:0003195,1,0.761153424935427,0,1,tricuspid valve formation,BP,
428,GO:0003197,1,0.156238502506386,0,7,endocardial cushion development,BP,
429,GO:0003198,1,0.336870593112022,0,4,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
430,GO:0003203,1,0.184701458826466,0,6,endocardial cushion morphogenesis,BP,
431,GO:0003205,1,0.0447641549019661,0,11,cardiac chamber development,BP,
432,GO:0003206,1,0.0783913912808667,0,9,cardiac chamber morphogenesis,BP,
433,GO:0003207,1,0.59183921579231,0,1,cardiac chamber formation,BP,
434,GO:0003208,1,0.48142933547353,0,2,cardiac ventricle morphogenesis,BP,
435,GO:0003209,1,0.17723342050398,0,5,cardiac atrium morphogenesis,BP,
436,GO:0003211,1,0.59183921579231,0,1,cardiac ventricle formation,BP,
437,GO:0003213,1,0.390781339218915,0,2,cardiac right atrium morphogenesis,BP,
438,GO:0003214,1,0.59183921579231,0,1,cardiac left ventricle morphogenesis,BP,
439,GO:0003215,1,0.59183921579231,0,1,cardiac right ventricle morphogenesis,BP,
440,GO:0003219,1,0.59183921579231,0,1,cardiac right ventricle formation,BP,
441,GO:0003222,1,0.59183921579231,0,1,ventricular trabecula myocardium morphogenesis,BP,
442,GO:0003228,1,0.780622506963867,0,1,atrial cardiac muscle tissue development,BP,
443,GO:0003229,1,0.59183921579231,0,1,ventricular cardiac muscle tissue development,BP,
444,GO:0003230,1,0.17723342050398,0,5,cardiac atrium development,BP,
445,GO:0003231,1,0.0901154411031359,0,8,cardiac ventricle development,BP,
446,GO:0003241,1,0.59183921579231,0,1,growth involved in heart morphogenesis,BP,
447,GO:0003256,1,0.59183921579231,0,1,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
448,GO:0003264,1,0.59183921579231,0,1,regulation of cardioblast proliferation,BP,
449,GO:0003266,1,0.59183921579231,0,1,regulation of secondary heart field cardioblast proliferation,BP,
450,GO:0003270,1,0.59183921579231,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
451,GO:0003272,1,0.242763624603807,0,5,endocardial cushion formation,BP,
452,GO:0003273,1,0.59183921579231,0,1,cell migration involved in endocardial cushion formation,BP,
453,GO:0003274,1,0.775827451160419,0,1,endocardial cushion fusion,BP,
454,GO:0003279,1,0.0580973841845895,0,10,cardiac septum development,BP,
455,GO:0003281,1,0.0901154411031359,0,8,ventricular septum development,BP,
456,GO:0003283,1,0.589784909170825,0,2,atrial septum development,BP,
457,GO:0003284,1,0.775827451160419,0,1,septum primum development,BP,
458,GO:0003289,1,0.775827451160419,0,1,atrial septum primum morphogenesis,BP,
459,GO:0003298,1,0.828354528958696,0,1,physiological muscle hypertrophy,BP,
460,GO:0003300,1,0.828354528958696,0,1,cardiac muscle hypertrophy,BP,
461,GO:0003301,1,0.828354528958696,0,1,physiological cardiac muscle hypertrophy,BP,
462,GO:0003306,1,0.50661191352048,0,2,Wnt signaling pathway involved in heart development,BP,
463,GO:0003307,1,0.766038155162373,0,1,regulation of Wnt signaling pathway involved in heart development,BP,
464,GO:0003308,1,0.766038155162373,0,1,negative regulation of Wnt signaling pathway involved in heart development,BP,
467,GO:0003337,1,0.580630022112622,0,3,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
469,GO:0003339,1,0.683588900267456,0,2,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
470,GO:0003344,1,0.281935616193067,0,3,pericardium morphogenesis,BP,
471,GO:0003348,1,0.458123943077997,0,2,cardiac endothelial cell differentiation,BP,
472,GO:0003365,1,0.639456775809035,0,1,establishment of cell polarity involved in ameboidal cell migration,BP,
473,GO:0003382,1,0.889012027115443,0,1,epithelial cell morphogenesis,BP,
474,GO:0003401,1,0.52928711799253,0,3,axis elongation,BP,
475,GO:0003402,1,0.662592268986548,0,1,planar cell polarity pathway involved in axis elongation,BP,
476,GO:0003408,1,0.662592268986548,0,1,optic cup formation involved in camera-type eye development,BP,
477,GO:0003413,1,0.962412700305168,0,1,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
478,GO:0003416,1,0.962412700305168,0,1,endochondral bone growth,BP,
479,GO:0003417,1,0.962412700305168,0,1,growth plate cartilage development,BP,
480,GO:0003418,1,0.962412700305168,0,1,growth plate cartilage chondrocyte differentiation,BP,
481,GO:0003419,1,0.962412700305168,0,1,growth plate cartilage chondrocyte proliferation,BP,
487,GO:0003696,1,0.814984680586157,0,1,satellite DNA binding,MF,
489,GO:0003707,1,0.698454611733275,0,1,steroid hormone receptor activity,MF,
492,GO:0003714,1,0.29669364984174,0,4,transcription corepressor activity,MF,
494,GO:0003725,1,0.727489805589545,0,1,double-stranded RNA binding,MF,
498,GO:0003841,1,0.73462101006065,0,1,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
499,GO:0003873,1,0.710564000841808,0,1,6-phosphofructo-2-kinase activity,MF,
504,GO:0004175,1,0.560051758415791,0,2,endopeptidase activity,MF,
505,GO:0004252,1,0.560051758415791,0,2,serine-type endopeptidase activity,MF,
506,GO:0004312,1,0.604707407962162,0,1,fatty acid synthase activity,MF,
507,GO:0004313,1,0.604707407962162,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
508,GO:0004314,1,0.604707407962162,0,1,[acyl-carrier-protein] S-malonyltransferase activity,MF,
509,GO:0004315,1,0.604707407962162,0,1,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
510,GO:0004316,1,0.604707407962162,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
511,GO:0004317,1,0.604707407962162,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
512,GO:0004319,1,0.604707407962162,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
513,GO:0004320,1,0.604707407962162,0,1,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
514,GO:0004331,1,0.710564000841808,0,1,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
515,GO:0004375,1,0.733962171685514,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
516,GO:0004379,1,0.688189150954661,0,1,glycylpeptide N-tetradecanoyltransferase activity,MF,
517,GO:0004383,1,0.545370950726175,0,2,guanylate cyclase activity,MF,
518,GO:0004407,1,0.6837505749659,0,1,histone deacetylase activity,MF,
520,GO:0004454,1,0.807301335691128,0,1,ketohexokinase activity,MF,
522,GO:0004603,1,0.897954377332652,0,1,phenylethanolamine N-methyltransferase activity,MF,
523,GO:0004620,1,0.782385944864048,0,1,phospholipase activity,MF,
524,GO:0004629,1,0.782385944864048,0,1,phospholipase C activity,MF,
526,GO:0004673,1,0.763757722401656,0,1,protein histidine kinase activity,MF,
528,GO:0004675,1,0.775827451160419,0,1,transmembrane receptor protein serine/threonine kinase activity,MF,
531,GO:0004697,1,0.753910584400672,0,1,protein kinase C activity,MF,
532,GO:0004702,1,0.529385762292155,0,3,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
533,GO:0004707,1,0.852042669196423,0,1,MAP kinase activity,MF,
534,GO:0004709,1,0.802878249889337,0,1,MAP kinase kinase kinase activity,MF,
535,GO:0004712,1,0.781006884258256,0,1,protein serine/threonine/tyrosine kinase activity,MF,
536,GO:0004713,1,0.326873487946437,0,6,protein tyrosine kinase activity,MF,
537,GO:0004714,1,0.533189335576637,0,2,transmembrane receptor protein tyrosine kinase activity,MF,
538,GO:0004716,1,0.728085055754081,0,1,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
541,GO:0004745,1,0.766038155162373,0,1,retinol dehydrogenase activity,MF,
542,GO:0004842,1,0.168035136617011,0,5,ubiquitin-protein transferase activity,MF,
546,GO:0004862,1,0.801649544056734,0,1,cAMP-dependent protein kinase inhibitor activity,MF,
552,GO:0004879,1,0.698454611733275,0,1,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,
553,GO:0004888,1,0.0588915350910521,0,11,transmembrane signaling receptor activity,MF,
554,GO:0004930,1,0.166459062372658,0,7,G-protein coupled receptor activity,MF,
555,GO:0004935,1,0.636999731039707,0,2,adrenergic receptor activity,MF,
556,GO:0004936,1,0.636999731039707,0,2,alpha-adrenergic receptor activity,MF,
557,GO:0004938,1,0.636999731039707,0,2,alpha2-adrenergic receptor activity,MF,
558,GO:0005024,1,0.775827451160419,0,1,transforming growth factor beta-activated receptor activity,MF,
559,GO:0005025,1,0.775827451160419,0,1,transforming growth factor beta receptor activity, type I,MF,
560,GO:0005057,1,0.384015554564667,0,4,signal transducer activity, downstream of receptor,MF,
568,GO:0005104,1,0.761555378669057,0,3,fibroblast growth factor receptor binding,MF,
569,GO:0005105,1,0.892838741202228,0,1,type 1 fibroblast growth factor receptor binding,MF,
570,GO:0005109,1,0.0826291631652209,0,10,frizzled binding,MF,
571,GO:0005110,1,0.662592268986548,0,1,frizzled-2 binding,MF,
572,GO:0005111,1,0.840250794004666,0,2,type 2 fibroblast growth factor receptor binding,MF,
575,GO:0005115,1,0.662592268986548,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
578,GO:0005127,1,0.849407889468112,0,1,ciliary neurotrophic factor receptor binding,MF,
579,GO:0005146,1,0.730053612763015,0,1,leukemia inhibitory factor receptor binding,MF,
580,GO:0005154,1,0.57946390993134,0,2,epidermal growth factor receptor binding,MF,
583,GO:0005160,1,0.228545340458534,0,6,transforming growth factor beta receptor binding,MF,
584,GO:0005161,1,0.557316858545686,0,2,platelet-derived growth factor receptor binding,MF,
588,GO:0005172,1,0.715318261416419,0,1,vascular endothelial growth factor receptor binding,MF,
591,GO:0005179,1,0.607676253776734,0,3,hormone activity,MF,
593,GO:0005200,1,0.293121397955656,0,3,structural constituent of cytoskeleton,MF,
597,GO:0005225,1,0.834203192552595,0,1,volume-sensitive anion channel activity,MF,
598,GO:0005242,1,0.605258026216555,0,2,inward rectifier potassium channel activity,MF,
599,GO:0005243,1,0.476383191440494,0,3,gap junction channel activity,MF,
602,GO:0005246,1,0.842019572243639,0,1,calcium channel regulator activity,MF,
603,GO:0005249,1,0.369566479446413,0,4,voltage-gated potassium channel activity,MF,
604,GO:0005250,1,0.698328250039281,0,1,A-type (transient outward) potassium channel activity,MF,
605,GO:0005251,1,0.670973560062049,0,2,delayed rectifier potassium channel activity,MF,
606,GO:0005253,1,0.834203192552595,0,1,anion channel activity,MF,
607,GO:0005254,1,0.834203192552595,0,1,chloride channel activity,MF,
610,GO:0005267,1,0.369566479446413,0,4,potassium channel activity,MF,
611,GO:0005351,1,0.754585539747771,0,1,sugar:proton symporter activity,MF,
612,GO:0005355,1,0.821374167469034,0,1,glucose transmembrane transporter activity,MF,
613,GO:0005381,1,0.653878742254595,0,2,iron ion transmembrane transporter activity,MF,
614,GO:0005402,1,0.754585539747771,0,1,cation:sugar symporter activity,MF,
615,GO:0005484,1,0.788402850719053,0,1,SNAP receptor activity,MF,
617,GO:0005496,1,0.698454611733275,0,1,steroid binding,MF,
618,GO:0005499,1,0.698454611733275,0,1,vitamin D binding,MF,
620,GO:0005506,1,0.784501226927412,0,1,iron ion binding,MF,
623,GO:0005513,1,0.790066751337715,0,1,detection of calcium ion,BP,
628,GO:0005521,1,0.67497188939156,0,1,lamin binding,MF,
629,GO:0005522,1,0.704992319915139,0,1,profilin binding,MF,
633,GO:0005540,1,0.842657135531074,0,1,hyaluronic acid binding,MF,
635,GO:0005544,1,0.847146262734248,0,1,calcium-dependent phospholipid binding,MF,
637,GO:0005547,1,0.781006884258256,0,1,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
650,GO:0005635,1,0.526312607351094,0,3,nuclear envelope,CC,
651,GO:0005641,1,0.850380627707629,0,1,nuclear envelope lumen,CC,
653,GO:0005667,1,0.411622390128097,0,3,transcription factor complex,CC,
664,GO:0005766,1,0.652920314241421,0,2,primary lysosome,CC,
668,GO:0005771,1,0.784473242465539,0,1,multivesicular body,CC,
672,GO:0005776,1,0.674504211245608,0,2,autophagosome,CC,
678,GO:0005790,1,0.834203192552595,0,1,smooth endoplasmic reticulum,CC,
679,GO:0005791,1,0.828354528958696,0,1,rough endoplasmic reticulum,CC,
680,GO:0005793,1,0.813104792706398,0,1,endoplasmic reticulum-Golgi intermediate compartment,CC,
683,GO:0005798,1,0.704992319915139,0,1,Golgi-associated vesicle,CC,
685,GO:0005802,1,0.609586403399773,0,2,trans-Golgi network,CC,
692,GO:0005859,1,0.634601131053728,0,1,muscle myosin complex,CC,
695,GO:0005876,1,0.722881072054875,0,2,spindle microtubule,CC,
696,GO:0005881,1,0.714643631752963,0,2,cytoplasmic microtubule,CC,
697,GO:0005882,1,0.67497188939156,0,1,intermediate filament,CC,
702,GO:0005901,1,0.694582335858129,0,1,caveola,CC,
705,GO:0005905,1,0.428109430328062,0,3,clathrin-coated pit,CC,
710,GO:0005916,1,0.711185484621141,0,1,fascia adherens,CC,
711,GO:0005921,1,0.395171804424807,0,4,gap junction,CC,
712,GO:0005922,1,0.395171804424807,0,4,connexin complex,CC,
720,GO:0005944,1,0.676247599336564,0,1,phosphatidylinositol 3-kinase complex, class IB,CC,
722,GO:0005960,1,0.733962171685514,0,1,glycine cleavage complex,CC,
723,GO:0005975,1,0.095626266235064,0,9,carbohydrate metabolic process,BP,
724,GO:0005976,1,0.478476681596556,0,3,polysaccharide metabolic process,BP,
725,GO:0005977,1,0.781006884258256,0,1,glycogen metabolic process,BP,
726,GO:0005978,1,0.781006884258256,0,1,glycogen biosynthetic process,BP,
727,GO:0005979,1,0.781006884258256,0,1,regulation of glycogen biosynthetic process,BP,
728,GO:0005996,1,0.158368067618458,0,7,monosaccharide metabolic process,BP,
729,GO:0006000,1,0.572881559912366,0,2,fructose metabolic process,BP,
730,GO:0006001,1,0.807301335691128,0,1,fructose catabolic process,BP,
731,GO:0006003,1,0.710564000841808,0,1,fructose 2,6-bisphosphate metabolic process,BP,
732,GO:0006006,1,0.197454075614848,0,6,glucose metabolic process,BP,
733,GO:0006007,1,0.553813046047101,0,2,glucose catabolic process,BP,
739,GO:0006029,1,0.766038155162373,0,1,proteoglycan metabolic process,BP,
741,GO:0006073,1,0.781006884258256,0,1,cellular glucan metabolic process,BP,
744,GO:0006084,1,0.604707407962162,0,1,acetyl-CoA metabolic process,BP,
745,GO:0006089,1,0.780567658291826,0,1,lactate metabolic process,BP,
746,GO:0006090,1,0.553813046047101,0,2,pyruvate metabolic process,BP,
747,GO:0006091,1,0.317180547105888,0,4,generation of precursor metabolites and energy,BP,
748,GO:0006094,1,0.749336515652812,0,1,gluconeogenesis,BP,
749,GO:0006096,1,0.553813046047101,0,2,glycolytic process,BP,
750,GO:0006109,1,0.29610618358941,0,5,regulation of carbohydrate metabolic process,BP,
751,GO:0006110,1,0.780567658291826,0,1,regulation of glycolytic process,BP,
752,GO:0006111,1,0.749336515652812,0,1,regulation of gluconeogenesis,BP,
753,GO:0006112,1,0.781006884258256,0,1,energy reserve metabolic process,BP,
754,GO:0006113,1,0.780567658291826,0,1,fermentation,BP,
755,GO:0006119,1,0.780567658291826,0,1,oxidative phosphorylation,BP,
757,GO:0006140,1,0.242756792244459,0,6,regulation of nucleotide metabolic process,BP,
759,GO:0006164,1,0.433433333151153,0,4,purine nucleotide biosynthetic process,BP,
760,GO:0006165,1,0.553813046047101,0,2,nucleoside diphosphate phosphorylation,BP,
761,GO:0006171,1,0.828354528958696,0,1,cAMP biosynthetic process,BP,
762,GO:0006182,1,0.524492013104965,0,3,cGMP biosynthetic process,BP,
767,GO:0006261,1,0.652766003058323,0,2,DNA-dependent DNA replication,BP,
769,GO:0006281,1,0.830446040247913,0,2,DNA repair,BP,
770,GO:0006282,1,0.941285075943011,0,1,regulation of DNA repair,BP,
771,GO:0006304,1,0.738574234795428,0,1,DNA modification,BP,
772,GO:0006305,1,0.738574234795428,0,1,DNA alkylation,BP,
773,GO:0006306,1,0.738574234795428,0,1,DNA methylation,BP,
774,GO:0006310,1,0.849407889468112,0,1,DNA recombination,BP,
778,GO:0006354,1,0.753597902783621,0,1,DNA-templated transcription, elongation,BP,
781,GO:0006359,1,0.789606292109108,0,1,regulation of transcription from RNA polymerase III promoter,BP,
784,GO:0006368,1,0.753597902783621,0,1,transcription elongation from RNA polymerase II promoter,BP,
785,GO:0006383,1,0.789606292109108,0,1,transcription from RNA polymerase III promoter,BP,
787,GO:0006401,1,0.387755779325457,0,3,RNA catabolic process,BP,
788,GO:0006402,1,0.387755779325457,0,3,mRNA catabolic process,BP,
789,GO:0006412,1,0.496235265868628,0,3,translation,BP,
790,GO:0006417,1,0.496235265868628,0,3,regulation of translation,BP,
791,GO:0006457,1,0.962412700305168,0,1,protein folding,BP,
798,GO:0006473,1,0.730053612763015,0,1,protein acetylation,BP,
799,GO:0006475,1,0.730053612763015,0,1,internal protein amino acid acetylation,BP,
800,GO:0006476,1,0.6837505749659,0,1,protein deacetylation,BP,
801,GO:0006479,1,0.843650774888678,0,1,protein methylation,BP,
802,GO:0006486,1,0.787775492853738,0,1,protein glycosylation,BP,
803,GO:0006493,1,0.787775492853738,0,1,protein O-linked glycosylation,BP,
805,GO:0006498,1,0.688189150954661,0,1,N-terminal protein lipidation,BP,
806,GO:0006499,1,0.688189150954661,0,1,N-terminal protein myristoylation,BP,
809,GO:0006511,1,0.311651581428465,0,4,ubiquitin-dependent protein catabolic process,BP,
811,GO:0006520,1,0.733962171685514,0,1,cellular amino acid metabolic process,BP,
812,GO:0006544,1,0.733962171685514,0,1,glycine metabolic process,BP,
813,GO:0006546,1,0.733962171685514,0,1,glycine catabolic process,BP,
814,GO:0006575,1,0.604707407962162,0,1,cellular modified amino acid metabolic process,BP,
815,GO:0006582,1,0.662592268986548,0,1,melanin metabolic process,BP,
816,GO:0006584,1,0.64443816079087,0,2,catecholamine metabolic process,BP,
823,GO:0006633,1,0.424337754127046,0,3,fatty acid biosynthetic process,BP,
824,GO:0006635,1,0.584485373100561,0,2,fatty acid beta-oxidation,BP,
825,GO:0006636,1,0.703978953100515,0,2,unsaturated fatty acid biosynthetic process,BP,
838,GO:0006690,1,0.703978953100515,0,2,icosanoid metabolic process,BP,
839,GO:0006692,1,0.703978953100515,0,2,prostanoid metabolic process,BP,
840,GO:0006693,1,0.703978953100515,0,2,prostaglandin metabolic process,BP,
844,GO:0006702,1,0.730656633467999,0,1,androgen biosynthetic process,BP,
851,GO:0006733,1,0.553813046047101,0,2,oxidoreduction coenzyme metabolic process,BP,
852,GO:0006734,1,0.553813046047101,0,2,NADH metabolic process,BP,
853,GO:0006735,1,0.710564000841808,0,1,NADH regeneration,BP,
855,GO:0006757,1,0.553813046047101,0,2,ATP generation from ADP,BP,
859,GO:0006775,1,0.698454611733275,0,1,fat-soluble vitamin metabolic process,BP,
863,GO:0006801,1,0.599987783631036,0,2,superoxide metabolic process,BP,
865,GO:0006809,1,0.646375496778584,0,2,nitric oxide biosynthetic process,BP,
870,GO:0006814,1,0.374289876316622,0,3,sodium ion transport,BP,
873,GO:0006821,1,0.598935555469529,0,2,chloride transport,BP,
874,GO:0006826,1,0.50499599248856,0,3,iron ion transport,BP,
875,GO:0006835,1,0.782385944864048,0,1,dicarboxylic acid transport,BP,
876,GO:0006836,1,0.678228619833455,0,3,neurotransmitter transport,BP,
878,GO:0006862,1,0.86195591591415,0,1,nucleotide transport,BP,
879,GO:0006865,1,0.782385944864048,0,1,amino acid transport,BP,
882,GO:0006874,1,0.18734193551637,0,6,cellular calcium ion homeostasis,BP,
885,GO:0006879,1,0.60194213563973,0,2,cellular iron ion homeostasis,BP,
886,GO:0006885,1,0.489034437441904,0,4,regulation of pH,BP,
890,GO:0006890,1,0.769896520332264,0,1,retrograde vesicle-mediated transport, Golgi to ER,BP,
891,GO:0006891,1,0.769896520332264,0,1,intra-Golgi vesicle-mediated transport,BP,
892,GO:0006892,1,0.806923924153747,0,1,post-Golgi vesicle-mediated transport,BP,
895,GO:0006904,1,0.614426666394382,0,3,vesicle docking involved in exocytosis,BP,
896,GO:0006906,1,0.44849449631527,0,4,vesicle fusion,BP,
901,GO:0006914,1,0.0381182522054902,0,11,autophagy,BP,
903,GO:0006919,1,0.839760482627469,0,1,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
904,GO:0006924,1,0.781006884258256,0,1,activation-induced cell death of T cells,BP,
909,GO:0006939,1,0.208528020588989,0,7,smooth muscle contraction,BP,
910,GO:0006940,1,0.410935768902583,0,4,regulation of smooth muscle contraction,BP,
915,GO:0006954,1,0.0212628859825262,0,13,inflammatory response,BP,
917,GO:0006959,1,0.491573459016696,0,2,humoral immune response,BP,
921,GO:0006975,1,0.852042669196423,0,1,DNA damage induced protein phosphorylation,BP,
927,GO:0007005,1,0.429565810339217,0,4,mitochondrion organization,BP,
928,GO:0007006,1,0.839760482627469,0,1,mitochondrial membrane organization,BP,
932,GO:0007016,1,0.670370234134071,0,1,cytoskeletal anchoring at plasma membrane,BP,
934,GO:0007020,1,0.847576173811789,0,1,microtubule nucleation,BP,
936,GO:0007030,1,0.560534968294878,0,1,Golgi organization,BP,
937,GO:0007032,1,0.784473242465539,0,1,endosome organization,BP,
947,GO:0007051,1,0.853347594896784,0,1,spindle organization,BP,
948,GO:0007052,1,0.853347594896784,0,1,mitotic spindle organization,BP,
949,GO:0007059,1,0.853347594896784,0,1,chromosome segregation,BP,
951,GO:0007080,1,0.853347594896784,0,1,mitotic metaphase plate congression,BP,
952,GO:0007088,1,0.304974736727912,0,6,regulation of mitotic nuclear division,BP,
955,GO:0007098,1,0.678926723930427,0,2,centrosome cycle,BP,
956,GO:0007126,1,0.287802956910327,0,4,meiotic nuclear division,BP,
957,GO:0007140,1,0.822375713756337,0,1,male meiosis,BP,
960,GO:0007156,1,0.100399936820391,0,6,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
961,GO:0007157,1,0.507732529777402,0,2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
966,GO:0007164,1,0.484688036404671,0,2,establishment of tissue polarity,BP,
970,GO:0007168,1,0.690941304389812,0,2,receptor guanylyl cyclase signaling pathway,BP,
973,GO:0007176,1,0.497351785793601,0,3,regulation of epidermal growth factor-activated receptor activity,BP,
976,GO:0007182,1,0.850452765079241,0,1,common-partner SMAD protein phosphorylation,BP,
977,GO:0007184,1,0.652766003058323,0,2,SMAD protein import into nucleus,BP,
981,GO:0007189,1,0.529144208457412,0,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
982,GO:0007193,1,0.782385944864048,0,1,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
984,GO:0007202,1,0.849948042925311,0,1,activation of phospholipase C activity,BP,
985,GO:0007204,1,0.373755055396668,0,4,positive regulation of cytosolic calcium ion concentration,BP,
986,GO:0007205,1,0.828354528958696,0,1,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
989,GO:0007221,1,0.59183921579231,0,1,positive regulation of transcription of Notch receptor target,BP,
990,GO:0007223,1,0.662592268986548,0,1,Wnt signaling pathway, calcium modulating pathway,BP,
993,GO:0007249,1,0.351057653571451,0,4,I-kappaB kinase/NF-kappaB signaling,BP,
994,GO:0007252,1,0.781006884258256,0,1,I-kappaB phosphorylation,BP,
996,GO:0007257,1,0.362570400876512,0,3,activation of JUN kinase activity,BP,
997,GO:0007259,1,0.365064734570266,0,3,JAK-STAT cascade,BP,
998,GO:0007260,1,0.619506013751581,0,2,tyrosine phosphorylation of STAT protein,BP,
999,GO:0007263,1,0.760556996405447,0,1,nitric oxide mediated signal transduction,BP,
1005,GO:0007269,1,0.724367006107158,0,2,neurotransmitter secretion,BP,
1006,GO:0007270,1,0.732665504584577,0,2,neuron-neuron synaptic transmission,BP,
1013,GO:0007292,1,0.53564375971815,0,3,female gamete generation,BP,
1026,GO:0007398,1,0.733087029820149,0,1,ectoderm development,BP,
1028,GO:0007405,1,0.502117148532651,0,2,neuroblast proliferation,BP,
1031,GO:0007416,1,0.231933492238512,0,5,synapse assembly,BP,
1038,GO:0007440,1,0.59183921579231,0,1,foregut morphogenesis,BP,
1039,GO:0007442,1,0.662592268986548,0,1,hindgut morphogenesis,BP,
1041,GO:0007494,1,0.662592268986548,0,1,midgut development,BP,
1043,GO:0007500,1,0.850452765079241,0,1,mesodermal cell fate determination,BP,
1050,GO:0007566,1,0.534637881377078,0,2,embryo implantation,BP,
1051,GO:0007567,1,0.828354528958696,0,1,parturition,BP,
1055,GO:0007585,1,0.443695598616083,0,3,respiratory gaseous exchange,BP,
1056,GO:0007586,1,0.471105520908653,0,3,digestion,BP,
1057,GO:0007588,1,0.403535639463561,0,4,excretion,BP,
1058,GO:0007589,1,0.157246800326896,0,7,body fluid secretion,BP,
1059,GO:0007595,1,0.51138829804362,0,2,lactation,BP,
1065,GO:0007603,1,0.688189150954661,0,1,phototransduction, visible light,BP,
1067,GO:0007606,1,0.787775492853738,0,1,sensory perception of chemical stimulus,BP,
1068,GO:0007608,1,0.787775492853738,0,1,sensory perception of smell,BP,
1071,GO:0007612,1,0.652176178221349,0,2,learning,BP,
1073,GO:0007622,1,0.782385944864048,0,1,rhythmic behavior,BP,
1074,GO:0007623,1,0.782385944864048,0,1,circadian rhythm,BP,
1076,GO:0007628,1,0.670370234134071,0,1,adult walking behavior,BP,
1077,GO:0007631,1,0.781943571206073,0,1,feeding behavior,BP,
1078,GO:0007638,1,0.781943571206073,0,1,mechanosensory behavior,BP,
1079,GO:0008009,1,0.923408743724329,0,1,chemokine activity,MF,
1087,GO:0008045,1,0.906752862467527,0,1,motor neuron axon guidance,BP,
1091,GO:0008074,1,0.545370950726175,0,2,guanylate cyclase complex, soluble,CC,
1092,GO:0008076,1,0.369566479446413,0,4,voltage-gated potassium channel complex,CC,
1093,GO:0008078,1,0.906752862467527,0,1,mesodermal cell migration,BP,
1096,GO:0008091,1,0.225053907625481,0,3,spectrin,CC,
1099,GO:0008105,1,0.855530641430602,0,1,asymmetric protein localization,BP,
1101,GO:0008138,1,0.800672150482427,0,1,protein tyrosine/serine/threonine phosphatase activity,MF,
1102,GO:0008144,1,0.604707407962162,0,1,drug binding,MF,
1106,GO:0008168,1,0.897954377332652,0,1,methyltransferase activity,MF,
1107,GO:0008170,1,0.897954377332652,0,1,N-methyltransferase activity,MF,
1108,GO:0008180,1,0.639456775809035,0,1,COP9 signalosome,CC,
1109,GO:0008194,1,0.787775492853738,0,1,UDP-glycosyltransferase activity,MF,
1110,GO:0008198,1,0.784501226927412,0,1,ferrous iron binding,MF,
1111,GO:0008199,1,0.784501226927412,0,1,ferric iron binding,MF,
1112,GO:0008200,1,0.718774331523076,0,1,ion channel inhibitor activity,MF,
1117,GO:0008209,1,0.730656633467999,0,1,androgen metabolic process,BP,
1120,GO:0008213,1,0.843650774888678,0,1,protein alkylation,BP,
1123,GO:0008227,1,0.636999731039707,0,2,G-protein coupled amine receptor activity,MF,
1125,GO:0008236,1,0.560051758415791,0,2,serine-type peptidase activity,MF,
1126,GO:0008238,1,0.698761896207821,0,1,exopeptidase activity,MF,
1139,GO:0008344,1,0.627624931861197,0,2,adult locomotory behavior,BP,
1141,GO:0008361,1,0.268547298653836,0,5,regulation of cell size,BP,
1143,GO:0008374,1,0.73462101006065,0,1,O-acyltransferase activity,MF,
1144,GO:0008375,1,0.787775492853738,0,1,acetylglucosaminyltransferase activity,MF,
1145,GO:0008378,1,0.787775492853738,0,1,galactosyltransferase activity,MF,
1149,GO:0008434,1,0.698454611733275,0,1,calcitriol receptor activity,MF,
1150,GO:0008443,1,0.710564000841808,0,1,phosphofructokinase activity,MF,
1151,GO:0008499,1,0.787775492853738,0,1,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
1152,GO:0008506,1,0.754585539747771,0,1,sucrose:proton symporter activity,MF,
1153,GO:0008509,1,0.834203192552595,0,1,anion transmembrane transporter activity,MF,
1154,GO:0008515,1,0.754585539747771,0,1,sucrose transmembrane transporter activity,MF,
1155,GO:0008528,1,0.718207300668576,0,1,G-protein coupled peptide receptor activity,MF,
1156,GO:0008532,1,0.787775492853738,0,1,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1164,GO:0008603,1,0.801649544056734,0,1,cAMP-dependent protein kinase regulator activity,MF,
1168,GO:0008631,1,0.781006884258256,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
1169,GO:0008637,1,0.655311057413809,0,2,apoptotic mitochondrial changes,BP,
1173,GO:0008757,1,0.897954377332652,0,1,S-adenosylmethionine-dependent methyltransferase activity,MF,
1174,GO:0009055,1,0.733962171685514,0,1,electron carrier activity,MF,
1179,GO:0009060,1,0.780567658291826,0,1,aerobic respiration,BP,
1180,GO:0009062,1,0.584485373100561,0,2,fatty acid catabolic process,BP,
1181,GO:0009063,1,0.733962171685514,0,1,cellular amino acid catabolic process,BP,
1182,GO:0009069,1,0.733962171685514,0,1,serine family amino acid metabolic process,BP,
1183,GO:0009071,1,0.733962171685514,0,1,serine family amino acid catabolic process,BP,
1187,GO:0009110,1,0.698454611733275,0,1,vitamin biosynthetic process,BP,
1188,GO:0009116,1,0.704992319915139,0,1,nucleoside metabolic process,BP,
1190,GO:0009119,1,0.704992319915139,0,1,ribonucleoside metabolic process,BP,
1191,GO:0009123,1,0.553813046047101,0,2,nucleoside monophosphate metabolic process,BP,
1192,GO:0009126,1,0.553813046047101,0,2,purine nucleoside monophosphate metabolic process,BP,
1193,GO:0009132,1,0.553813046047101,0,2,nucleoside diphosphate metabolic process,BP,
1194,GO:0009135,1,0.553813046047101,0,2,purine nucleoside diphosphate metabolic process,BP,
1195,GO:0009141,1,0.38903932195749,0,3,nucleoside triphosphate metabolic process,BP,
1196,GO:0009144,1,0.38903932195749,0,3,purine nucleoside triphosphate metabolic process,BP,
1198,GO:0009152,1,0.433433333151153,0,4,purine ribonucleotide biosynthetic process,BP,
1200,GO:0009161,1,0.553813046047101,0,2,ribonucleoside monophosphate metabolic process,BP,
1201,GO:0009165,1,0.433433333151153,0,4,nucleotide biosynthetic process,BP,
1203,GO:0009167,1,0.553813046047101,0,2,purine ribonucleoside monophosphate metabolic process,BP,
1204,GO:0009179,1,0.553813046047101,0,2,purine ribonucleoside diphosphate metabolic process,BP,
1205,GO:0009185,1,0.553813046047101,0,2,ribonucleoside diphosphate metabolic process,BP,
1207,GO:0009190,1,0.433433333151153,0,4,cyclic nucleotide biosynthetic process,BP,
1208,GO:0009199,1,0.38903932195749,0,3,ribonucleoside triphosphate metabolic process,BP,
1209,GO:0009205,1,0.38903932195749,0,3,purine ribonucleoside triphosphate metabolic process,BP,
1211,GO:0009250,1,0.781006884258256,0,1,glucan biosynthetic process,BP,
1213,GO:0009260,1,0.433433333151153,0,4,ribonucleotide biosynthetic process,BP,
1226,GO:0009584,1,0.688189150954661,0,1,detection of visible light,BP,
1227,GO:0009593,1,0.790066751337715,0,1,detection of chemical stimulus,BP,
1231,GO:0009612,1,0.258103349594084,0,6,response to mechanical stimulus,BP,
1232,GO:0009615,1,0.596441580518449,0,3,response to virus,BP,
1234,GO:0009620,1,0.832024114860243,0,1,response to fungus,BP,
1239,GO:0009712,1,0.64443816079087,0,2,catechol-containing compound metabolic process,BP,
1240,GO:0009713,1,0.897954377332652,0,1,catechol-containing compound biosynthetic process,BP,
1244,GO:0009744,1,0.807301335691128,0,1,response to sucrose,BP,
1247,GO:0009750,1,0.807301335691128,0,1,response to fructose,BP,
1248,GO:0009755,1,0.428976908541838,0,3,hormone-mediated signaling pathway,BP,
1264,GO:0009894,1,0.00182811351443668,0,20,regulation of catabolic process,BP,
1265,GO:0009895,1,0.0810094717935734,0,8,negative regulation of catabolic process,BP,
1266,GO:0009896,1,0.0278590148875888,0,12,positive regulation of catabolic process,BP,
1269,GO:0009912,1,0.405425054735677,0,2,auditory receptor cell fate commitment,BP,
1271,GO:0009914,1,0.0946164276247027,0,9,hormone transport,BP,
1272,GO:0009925,1,0.784501226927412,0,1,basal plasma membrane,CC,
1273,GO:0009946,1,0.941285075943011,0,1,proximal/distal axis specification,BP,
1275,GO:0009950,1,0.871622561621531,0,1,dorsal/ventral axis specification,BP,
1282,GO:0009975,1,0.545370950726175,0,2,cyclase activity,MF,
1285,GO:0009988,1,0.727489805589545,0,1,cell-cell recognition,BP,
1287,GO:0009994,1,0.53564375971815,0,3,oocyte differentiation,BP,
1288,GO:0009996,1,0.733087029820149,0,1,negative regulation of cell fate specification,BP,
1290,GO:0010002,1,0.59183921579231,0,1,cardioblast differentiation,BP,
1295,GO:0010039,1,0.60194213563973,0,2,response to iron ion,BP,
1296,GO:0010043,1,0.807301335691128,0,1,response to zinc ion,BP,
1297,GO:0010092,1,0.431839788872931,0,6,specification of animal organ identity,BP,
1298,GO:0010159,1,0.850452765079241,0,1,specification of animal organ position,BP,
1301,GO:0010193,1,0.828354528958696,0,1,response to ozone,BP,
1304,GO:0010226,1,0.694582335858129,0,1,response to lithium ion,BP,
1307,GO:0010259,1,0.828354528958696,0,1,multicellular organism aging,BP,
1313,GO:0010453,1,0.622856267383487,0,2,regulation of cell fate commitment,BP,
1314,GO:0010454,1,0.733087029820149,0,1,negative regulation of cell fate commitment,BP,
1315,GO:0010459,1,0.670370234134071,0,1,negative regulation of heart rate,BP,
1316,GO:0010460,1,0.828354528958696,0,1,positive regulation of heart rate,BP,
1317,GO:0010463,1,0.240941139356028,0,5,mesenchymal cell proliferation,BP,
1318,GO:0010464,1,0.438207360650783,0,3,regulation of mesenchymal cell proliferation,BP,
1323,GO:0010470,1,0.733087029820149,0,1,regulation of gastrulation,BP,
1324,GO:0010498,1,0.260693326345889,0,5,proteasomal protein catabolic process,BP,
1325,GO:0010506,1,0.0764014259175609,0,9,regulation of autophagy,BP,
1326,GO:0010507,1,0.386708239584471,0,3,negative regulation of autophagy,BP,
1327,GO:0010508,1,0.280652727360634,0,5,positive regulation of autophagy,BP,
1328,GO:0010511,1,0.780266268444755,0,1,regulation of phosphatidylinositol biosynthetic process,BP,
1329,GO:0010512,1,0.780266268444755,0,1,negative regulation of phosphatidylinositol biosynthetic process,BP,
1330,GO:0010517,1,0.849948042925311,0,1,regulation of phospholipase activity,BP,
1331,GO:0010518,1,0.849948042925311,0,1,positive regulation of phospholipase activity,BP,
1332,GO:0010522,1,0.790066751337715,0,1,regulation of calcium ion transport into cytosol,BP,
1333,GO:0010523,1,0.790066751337715,0,1,negative regulation of calcium ion transport into cytosol,BP,
1334,GO:0010543,1,0.780266268444755,0,1,regulation of platelet activation,BP,
1335,GO:0010544,1,0.780266268444755,0,1,negative regulation of platelet activation,BP,
1339,GO:0010559,1,0.811111303766348,0,1,regulation of glycoprotein biosynthetic process,BP,
1340,GO:0010561,1,0.811111303766348,0,1,negative regulation of glycoprotein biosynthetic process,BP,
1346,GO:0010586,1,0.898270644003197,0,1,miRNA metabolic process,BP,
1349,GO:0010596,1,0.59183921579231,0,1,negative regulation of endothelial cell migration,BP,
1352,GO:0010608,1,0.464346770459469,0,4,posttranscriptional regulation of gene expression,BP,
1353,GO:0010611,1,0.828354528958696,0,1,regulation of cardiac muscle hypertrophy,BP,
1354,GO:0010613,1,0.828354528958696,0,1,positive regulation of cardiac muscle hypertrophy,BP,
1360,GO:0010633,1,0.59183921579231,0,1,negative regulation of epithelial cell migration,BP,
1364,GO:0010640,1,0.780266268444755,0,1,regulation of platelet-derived growth factor receptor signaling pathway,BP,
1365,GO:0010642,1,0.780266268444755,0,1,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
1366,GO:0010644,1,0.790066751337715,0,1,cell communication by electrical coupling,BP,
1370,GO:0010649,1,0.790066751337715,0,1,regulation of cell communication by electrical coupling,BP,
1371,GO:0010656,1,0.599987783631036,0,2,negative regulation of muscle cell apoptotic process,BP,
1372,GO:0010657,1,0.599987783631036,0,2,muscle cell apoptotic process,BP,
1373,GO:0010658,1,0.725126756103963,0,1,striated muscle cell apoptotic process,BP,
1374,GO:0010660,1,0.599987783631036,0,2,regulation of muscle cell apoptotic process,BP,
1375,GO:0010662,1,0.725126756103963,0,1,regulation of striated muscle cell apoptotic process,BP,
1376,GO:0010664,1,0.725126756103963,0,1,negative regulation of striated muscle cell apoptotic process,BP,
1377,GO:0010668,1,0.733087029820149,0,1,ectodermal cell differentiation,BP,
1378,GO:0010675,1,0.381182763628878,0,4,regulation of cellular carbohydrate metabolic process,BP,
1379,GO:0010676,1,0.510508396423162,0,3,positive regulation of cellular carbohydrate metabolic process,BP,
1380,GO:0010677,1,0.780567658291826,0,1,negative regulation of cellular carbohydrate metabolic process,BP,
1381,GO:0010700,1,0.636999731039707,0,2,negative regulation of norepinephrine secretion,BP,
1384,GO:0010715,1,0.733567890553574,0,1,regulation of extracellular matrix disassembly,BP,
1385,GO:0010717,1,0.349674017857538,0,3,regulation of epithelial to mesenchymal transition,BP,
1386,GO:0010718,1,0.349674017857538,0,3,positive regulation of epithelial to mesenchymal transition,BP,
1389,GO:0010724,1,0.761153424935427,0,1,regulation of definitive erythrocyte differentiation,BP,
1390,GO:0010746,1,0.781006884258256,0,1,regulation of plasma membrane long-chain fatty acid transport,BP,
1391,GO:0010748,1,0.781006884258256,0,1,negative regulation of plasma membrane long-chain fatty acid transport,BP,
1394,GO:0010763,1,0.781006884258256,0,1,positive regulation of fibroblast migration,BP,
1395,GO:0010765,1,0.781006884258256,0,1,positive regulation of sodium ion transport,BP,
1396,GO:0010766,1,0.718774331523076,0,1,negative regulation of sodium ion transport,BP,
1397,GO:0010769,1,0.330378846917229,0,4,regulation of cell morphogenesis involved in differentiation,BP,
1398,GO:0010770,1,0.871622561621531,0,1,positive regulation of cell morphogenesis involved in differentiation,BP,
1399,GO:0010771,1,0.57689958345257,0,2,negative regulation of cell morphogenesis involved in differentiation,BP,
1400,GO:0010799,1,0.359968806372189,0,3,regulation of peptidyl-threonine phosphorylation,BP,
1401,GO:0010800,1,0.359968806372189,0,3,positive regulation of peptidyl-threonine phosphorylation,BP,
1408,GO:0010818,1,0.446884477519981,0,2,T cell chemotaxis,BP,
1409,GO:0010819,1,0.662592268986548,0,1,regulation of T cell chemotaxis,BP,
1410,GO:0010820,1,0.662592268986548,0,1,positive regulation of T cell chemotaxis,BP,
1411,GO:0010821,1,0.655311057413809,0,2,regulation of mitochondrion organization,BP,
1412,GO:0010822,1,0.839760482627469,0,1,positive regulation of mitochondrion organization,BP,
1413,GO:0010823,1,0.781006884258256,0,1,negative regulation of mitochondrion organization,BP,
1414,GO:0010824,1,0.769896520332264,0,1,regulation of centrosome duplication,BP,
1417,GO:0010830,1,0.59183921579231,0,1,regulation of myotube differentiation,BP,
1418,GO:0010832,1,0.59183921579231,0,1,negative regulation of myotube differentiation,BP,
1419,GO:0010837,1,0.467674222013895,0,3,regulation of keratinocyte proliferation,BP,
1420,GO:0010838,1,0.941285075943011,0,1,positive regulation of keratinocyte proliferation,BP,
1421,GO:0010839,1,0.49737543589536,0,2,negative regulation of keratinocyte proliferation,BP,
1424,GO:0010863,1,0.849948042925311,0,1,positive regulation of phospholipase C activity,BP,
1425,GO:0010869,1,0.828354528958696,0,1,regulation of receptor biosynthetic process,BP,
1426,GO:0010870,1,0.828354528958696,0,1,positive regulation of receptor biosynthetic process,BP,
1428,GO:0010880,1,0.790066751337715,0,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1429,GO:0010881,1,0.790066751337715,0,1,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
1430,GO:0010882,1,0.790066751337715,0,1,regulation of cardiac muscle contraction by calcium ion signaling,BP,
1431,GO:0010893,1,0.560461161423182,0,2,positive regulation of steroid biosynthetic process,BP,
1433,GO:0010896,1,0.676247599336564,0,1,regulation of triglyceride catabolic process,BP,
1434,GO:0010897,1,0.676247599336564,0,1,negative regulation of triglyceride catabolic process,BP,
1435,GO:0010906,1,0.381182763628878,0,4,regulation of glucose metabolic process,BP,
1436,GO:0010907,1,0.510508396423162,0,3,positive regulation of glucose metabolic process,BP,
1437,GO:0010917,1,0.839760482627469,0,1,negative regulation of mitochondrial membrane potential,BP,
1439,GO:0010922,1,0.766038155162373,0,1,positive regulation of phosphatase activity,BP,
1443,GO:0010935,1,0.662592268986548,0,1,regulation of macrophage cytokine production,BP,
1451,GO:0010962,1,0.781006884258256,0,1,regulation of glucan biosynthetic process,BP,
1455,GO:0010977,1,0.57689958345257,0,2,negative regulation of neuron projection development,BP,
1456,GO:0010979,1,0.698454611733275,0,1,regulation of vitamin D 24-hydroxylase activity,BP,
1457,GO:0010980,1,0.698454611733275,0,1,positive regulation of vitamin D 24-hydroxylase activity,BP,
1458,GO:0010996,1,0.781943571206073,0,1,response to auditory stimulus,BP,
1463,GO:0014004,1,0.762752220991701,0,1,microglia differentiation,BP,
1464,GO:0014005,1,0.762752220991701,0,1,microglia development,BP,
1465,GO:0014009,1,0.59183921579231,0,1,glial cell proliferation,BP,
1466,GO:0014013,1,0.196455403605463,0,5,regulation of gliogenesis,BP,
1467,GO:0014014,1,0.59183921579231,0,1,negative regulation of gliogenesis,BP,
1468,GO:0014015,1,0.278329711756256,0,4,positive regulation of gliogenesis,BP,
1473,GO:0014037,1,0.478064104336451,0,3,Schwann cell differentiation,BP,
1474,GO:0014044,1,0.606769107287404,0,2,Schwann cell development,BP,
1475,GO:0014045,1,0.62421465567788,0,2,establishment of endothelial blood-brain barrier,BP,
1476,GO:0014046,1,0.936826423682637,0,1,dopamine secretion,BP,
1477,GO:0014047,1,0.782385944864048,0,1,glutamate secretion,BP,
1478,GO:0014048,1,0.782385944864048,0,1,regulation of glutamate secretion,BP,
1479,GO:0014050,1,0.782385944864048,0,1,negative regulation of glutamate secretion,BP,
1480,GO:0014059,1,0.936826423682637,0,1,regulation of dopamine secretion,BP,
1481,GO:0014060,1,0.636999731039707,0,2,regulation of epinephrine secretion,BP,
1482,GO:0014061,1,0.636999731039707,0,2,regulation of norepinephrine secretion,BP,
1485,GO:0014068,1,0.57407693564143,0,2,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
1489,GO:0014701,1,0.790066751337715,0,1,junctional sarcoplasmic reticulum membrane,CC,
1490,GO:0014704,1,0.483177844492258,0,2,intercalated disc,CC,
1492,GO:0014719,1,0.855530641430602,0,1,skeletal muscle satellite cell activation,BP,
1493,GO:0014728,1,0.780567658291826,0,1,regulation of the force of skeletal muscle contraction,BP,
1494,GO:0014731,1,0.60593023544219,0,1,spectrin-associated cytoskeleton,CC,
1495,GO:0014732,1,0.780567658291826,0,1,skeletal muscle atrophy,BP,
1496,GO:0014733,1,0.780567658291826,0,1,regulation of skeletal muscle adaptation,BP,
1497,GO:0014742,1,0.828354528958696,0,1,positive regulation of muscle hypertrophy,BP,
1498,GO:0014743,1,0.828354528958696,0,1,regulation of muscle hypertrophy,BP,
1500,GO:0014808,1,0.790066751337715,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1502,GO:0014819,1,0.780567658291826,0,1,regulation of skeletal muscle contraction,BP,
1503,GO:0014820,1,0.828354528958696,0,1,tonic smooth muscle contraction,BP,
1504,GO:0014821,1,0.775778269639768,0,2,phasic smooth muscle contraction,BP,
1505,GO:0014823,1,0.635734690589842,0,2,response to activity,BP,
1506,GO:0014824,1,0.828354528958696,0,1,artery smooth muscle contraction,BP,
1507,GO:0014826,1,0.828354528958696,0,1,vein smooth muscle contraction,BP,
1508,GO:0014829,1,0.716302039052923,0,2,vascular smooth muscle contraction,BP,
1509,GO:0014834,1,0.626593131137752,0,2,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
1510,GO:0014854,1,0.780567658291826,0,1,response to inactivity,BP,
1511,GO:0014855,1,0.460977367221894,0,2,striated muscle cell proliferation,BP,
1512,GO:0014862,1,0.780567658291826,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
1513,GO:0014866,1,0.634601131053728,0,1,skeletal myofibril assembly,BP,
1514,GO:0014870,1,0.780567658291826,0,1,response to muscle inactivity,BP,
1515,GO:0014874,1,0.780567658291826,0,1,response to stimulus involved in regulation of muscle adaptation,BP,
1516,GO:0014877,1,0.780567658291826,0,1,response to muscle inactivity involved in regulation of muscle adaptation,BP,
1517,GO:0014883,1,0.780567658291826,0,1,transition between fast and slow fiber,BP,
1518,GO:0014888,1,0.780567658291826,0,1,striated muscle adaptation,BP,
1519,GO:0014889,1,0.780567658291826,0,1,muscle atrophy,BP,
1520,GO:0014891,1,0.780567658291826,0,1,striated muscle atrophy,BP,
1521,GO:0014894,1,0.780567658291826,0,1,response to denervation involved in regulation of muscle adaptation,BP,
1522,GO:0014896,1,0.828354528958696,0,1,muscle hypertrophy,BP,
1523,GO:0014897,1,0.828354528958696,0,1,striated muscle hypertrophy,BP,
1524,GO:0014902,1,0.59183921579231,0,1,myotube differentiation,BP,
1530,GO:0015077,1,0.369566479446413,0,4,monovalent inorganic cation transmembrane transporter activity,MF,
1531,GO:0015079,1,0.369566479446413,0,4,potassium ion transmembrane transporter activity,MF,
1533,GO:0015091,1,0.784501226927412,0,1,ferric iron transmembrane transporter activity,MF,
1534,GO:0015095,1,0.871848704734727,0,1,magnesium ion transmembrane transporter activity,MF,
1535,GO:0015103,1,0.834203192552595,0,1,inorganic anion transmembrane transporter activity,MF,
1536,GO:0015108,1,0.834203192552595,0,1,chloride transmembrane transporter activity,MF,
1537,GO:0015144,1,0.61915588803758,0,2,carbohydrate transmembrane transporter activity,MF,
1538,GO:0015145,1,0.821374167469034,0,1,monosaccharide transmembrane transporter activity,MF,
1539,GO:0015149,1,0.821374167469034,0,1,hexose transmembrane transporter activity,MF,
1540,GO:0015154,1,0.754585539747771,0,1,disaccharide transmembrane transporter activity,MF,
1541,GO:0015157,1,0.754585539747771,0,1,oligosaccharide transmembrane transporter activity,MF,
1542,GO:0015232,1,0.741464194934762,0,1,heme transporter activity,MF,
1544,GO:0015271,1,0.698328250039281,0,1,outward rectifier potassium channel activity,MF,
1545,GO:0015276,1,0.605258026216555,0,2,ligand-gated ion channel activity,MF,
1546,GO:0015291,1,0.754585539747771,0,1,secondary active transmembrane transporter activity,MF,
1547,GO:0015293,1,0.754585539747771,0,1,symporter activity,MF,
1548,GO:0015294,1,0.754585539747771,0,1,solute:cation symporter activity,MF,
1549,GO:0015295,1,0.754585539747771,0,1,solute:proton symporter activity,MF,
1555,GO:0015682,1,0.784501226927412,0,1,ferric iron transport,BP,
1556,GO:0015684,1,0.784501226927412,0,1,ferrous iron transport,BP,
1557,GO:0015693,1,0.871848704734727,0,1,magnesium ion transport,BP,
1558,GO:0015696,1,0.775778269639768,0,2,ammonium transport,BP,
1559,GO:0015698,1,0.598935555469529,0,2,inorganic anion transport,BP,
1562,GO:0015732,1,0.828354528958696,0,1,prostaglandin transport,BP,
1563,GO:0015748,1,0.86195591591415,0,1,organophosphate ester transport,BP,
1566,GO:0015766,1,0.754585539747771,0,1,disaccharide transport,BP,
1567,GO:0015770,1,0.754585539747771,0,1,sucrose transport,BP,
1568,GO:0015772,1,0.754585539747771,0,1,oligosaccharide transport,BP,
1570,GO:0015837,1,0.38612818293433,0,5,amine transport,BP,
1571,GO:0015844,1,0.495188342036156,0,4,monoamine transport,BP,
1573,GO:0015850,1,0.379038915418721,0,5,organic hydroxy compound transport,BP,
1574,GO:0015858,1,0.782385944864048,0,1,nucleoside transport,BP,
1575,GO:0015865,1,0.86195591591415,0,1,purine nucleotide transport,BP,
1576,GO:0015868,1,0.86195591591415,0,1,purine ribonucleotide transport,BP,
1577,GO:0015872,1,0.936826423682637,0,1,dopamine transport,BP,
1578,GO:0015874,1,0.636999731039707,0,2,norepinephrine transport,BP,
1579,GO:0015886,1,0.741464194934762,0,1,heme transport,BP,
1582,GO:0015909,1,0.781006884258256,0,1,long-chain fatty acid transport,BP,
1583,GO:0015911,1,0.781006884258256,0,1,plasma membrane long-chain fatty acid transport,BP,
1584,GO:0015931,1,0.673891493834439,0,2,nucleobase-containing compound transport,BP,
1585,GO:0015939,1,0.604707407962162,0,1,pantothenate metabolic process,BP,
1586,GO:0015980,1,0.44853792169098,0,3,energy derivation by oxidation of organic compounds,BP,
1590,GO:0016042,1,0.306853254218086,0,4,lipid catabolic process,BP,
1592,GO:0016048,1,0.782385944864048,0,1,detection of temperature stimulus,BP,
1595,GO:0016051,1,0.35716035325295,0,4,carbohydrate biosynthetic process,BP,
1596,GO:0016052,1,0.446054970520777,0,3,carbohydrate catabolic process,BP,
1597,GO:0016053,1,0.424337754127046,0,3,organic acid biosynthetic process,BP,
1598,GO:0016054,1,0.427728004181613,0,3,organic acid catabolic process,BP,
1600,GO:0016056,1,0.688189150954661,0,1,rhodopsin mediated signaling pathway,BP,
1601,GO:0016064,1,0.849407889468112,0,1,immunoglobulin mediated immune response,BP,
1603,GO:0016071,1,0.387755779325457,0,3,mRNA metabolic process,BP,
1604,GO:0016079,1,0.847146262734248,0,1,synaptic vesicle exocytosis,BP,
1608,GO:0016176,1,0.780266268444755,0,1,superoxide-generating NADPH oxidase activator activity,MF,
1612,GO:0016209,1,0.749336515652812,0,1,antioxidant activity,MF,
1613,GO:0016236,1,0.192740527615478,0,6,macroautophagy,BP,
1614,GO:0016239,1,0.504359396252862,0,3,positive regulation of macroautophagy,BP,
1615,GO:0016241,1,0.192740527615478,0,6,regulation of macroautophagy,BP,
1616,GO:0016242,1,0.386708239584471,0,3,negative regulation of macroautophagy,BP,
1617,GO:0016247,1,0.604576111047567,0,2,channel regulator activity,MF,
1618,GO:0016248,1,0.718774331523076,0,1,channel inhibitor activity,MF,
1619,GO:0016264,1,0.700420857160719,0,2,gap junction assembly,BP,
1620,GO:0016266,1,0.787775492853738,0,1,O-glycan processing,BP,
1621,GO:0016295,1,0.604707407962162,0,1,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
1622,GO:0016296,1,0.604707407962162,0,1,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
1623,GO:0016297,1,0.604707407962162,0,1,acyl-[acyl-carrier-protein] hydrolase activity,MF,
1624,GO:0016298,1,0.782385944864048,0,1,lipase activity,MF,
1627,GO:0016307,1,0.498450633860005,0,2,phosphatidylinositol phosphate kinase activity,MF,
1632,GO:0016327,1,0.741765538889623,0,2,apicolateral plasma membrane,CC,
1635,GO:0016332,1,0.730311826899045,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
1638,GO:0016339,1,0.516568996354587,0,2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
1639,GO:0016342,1,0.492938323459123,0,2,catenin complex,CC,
1641,GO:0016361,1,0.775827451160419,0,1,activin receptor activity, type I,MF,
1642,GO:0016363,1,0.670370234134071,0,1,nuclear matrix,CC,
1643,GO:0016407,1,0.604707407962162,0,1,acetyltransferase activity,MF,
1644,GO:0016410,1,0.688189150954661,0,1,N-acyltransferase activity,MF,
1645,GO:0016411,1,0.73462101006065,0,1,acylglycerol O-acyltransferase activity,MF,
1646,GO:0016417,1,0.604707407962162,0,1,S-acyltransferase activity,MF,
1647,GO:0016418,1,0.604707407962162,0,1,S-acetyltransferase activity,MF,
1648,GO:0016419,1,0.604707407962162,0,1,S-malonyltransferase activity,MF,
1649,GO:0016420,1,0.604707407962162,0,1,malonyltransferase activity,MF,
1650,GO:0016441,1,0.850452765079241,0,1,posttranscriptional gene silencing,BP,
1651,GO:0016444,1,0.849407889468112,0,1,somatic cell DNA recombination,BP,
1652,GO:0016445,1,0.849407889468112,0,1,somatic diversification of immunoglobulins,BP,
1653,GO:0016447,1,0.849407889468112,0,1,somatic recombination of immunoglobulin gene segments,BP,
1654,GO:0016458,1,0.850452765079241,0,1,gene silencing,BP,
1656,GO:0016460,1,0.634601131053728,0,1,myosin II complex,CC,
1660,GO:0016480,1,0.789606292109108,0,1,negative regulation of transcription from RNA polymerase III promoter,BP,
1661,GO:0016482,1,0.559267784073669,0,2,cytosolic transport,BP,
1663,GO:0016491,1,0.251780666657492,0,4,oxidoreductase activity,MF,
1665,GO:0016528,1,0.790066751337715,0,1,sarcoplasm,CC,
1666,GO:0016529,1,0.790066751337715,0,1,sarcoplasmic reticulum,CC,
1668,GO:0016567,1,0.0597199660799722,0,10,protein ubiquitination,BP,
1670,GO:0016570,1,0.498159341642912,0,2,histone modification,BP,
1671,GO:0016573,1,0.730053612763015,0,1,histone acetylation,BP,
1672,GO:0016575,1,0.6837505749659,0,1,histone deacetylation,BP,
1674,GO:0016580,1,0.6837505749659,0,1,Sin3 complex,CC,
1675,GO:0016594,1,0.733962171685514,0,1,glycine binding,MF,
1676,GO:0016597,1,0.549124329519052,0,2,amino acid binding,MF,
1677,GO:0016600,1,0.694582335858129,0,1,flotillin complex,CC,
1679,GO:0016605,1,0.670370234134071,0,1,PML body,CC,
1681,GO:0016614,1,0.462175208104496,0,2,oxidoreductase activity, acting on CH-OH group of donors,MF,
1682,GO:0016616,1,0.462175208104496,0,2,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1683,GO:0016627,1,0.604707407962162,0,1,oxidoreductase activity, acting on the CH-CH group of donors,MF,
1684,GO:0016628,1,0.604707407962162,0,1,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
1685,GO:0016638,1,0.733962171685514,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
1686,GO:0016642,1,0.733962171685514,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
1687,GO:0016667,1,0.749336515652812,0,1,oxidoreductase activity, acting on a sulfur group of donors,MF,
1688,GO:0016684,1,0.749336515652812,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1690,GO:0016741,1,0.897954377332652,0,1,transferase activity, transferring one-carbon groups,MF,
1692,GO:0016747,1,0.303380629931338,0,3,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
1693,GO:0016757,1,0.787775492853738,0,1,transferase activity, transferring glycosyl groups,MF,
1694,GO:0016758,1,0.787775492853738,0,1,transferase activity, transferring hexosyl groups,MF,
1697,GO:0016775,1,0.763757722401656,0,1,phosphotransferase activity, nitrogenous group as acceptor,MF,
1700,GO:0016790,1,0.604707407962162,0,1,thiolester hydrolase activity,MF,
1702,GO:0016805,1,0.698761896207821,0,1,dipeptidase activity,MF,
1703,GO:0016810,1,0.6837505749659,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
1704,GO:0016811,1,0.6837505749659,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
1707,GO:0016829,1,0.239395228600341,0,4,lyase activity,MF,
1708,GO:0016835,1,0.604707407962162,0,1,carbon-oxygen lyase activity,MF,
1709,GO:0016836,1,0.604707407962162,0,1,hydro-lyase activity,MF,
1710,GO:0016849,1,0.545370950726175,0,2,phosphorus-oxygen lyase activity,MF,
1711,GO:0016853,1,0.850380627707629,0,1,isomerase activity,MF,
1712,GO:0016860,1,0.850380627707629,0,1,intramolecular oxidoreductase activity,MF,
1717,GO:0016936,1,0.887923397179303,0,1,galactoside binding,MF,
1718,GO:0016941,1,0.718207300668576,0,1,natriuretic peptide receptor activity,MF,
1719,GO:0017002,1,0.775827451160419,0,1,activin-activated receptor activity,MF,
1722,GO:0017017,1,0.800672150482427,0,1,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
1727,GO:0017053,1,0.761153424935427,0,1,transcriptional repressor complex,CC,
1729,GO:0017081,1,0.718774331523076,0,1,chloride channel regulator activity,MF,
1734,GO:0017145,1,0.369273641872246,0,3,stem cell division,BP,
1735,GO:0017147,1,0.559481610903871,0,2,Wnt-protein binding,MF,
1736,GO:0017148,1,0.636701371256347,0,2,negative regulation of translation,BP,
1737,GO:0017156,1,0.500577483645589,0,2,calcium ion regulated exocytosis,BP,
1739,GO:0017158,1,0.500577483645589,0,2,regulation of calcium ion-dependent exocytosis,BP,
1740,GO:0017171,1,0.560051758415791,0,2,serine hydrolase activity,MF,
1741,GO:0018008,1,0.688189150954661,0,1,N-terminal peptidyl-glycine N-myristoylation,BP,
1743,GO:0018107,1,0.215880817914508,0,5,peptidyl-threonine phosphorylation,BP,
1745,GO:0018125,1,0.843650774888678,0,1,peptidyl-cysteine methylation,BP,
1747,GO:0018146,1,0.787775492853738,0,1,keratan sulfate biosynthetic process,BP,
1749,GO:0018198,1,0.843650774888678,0,1,peptidyl-cysteine modification,BP,
1750,GO:0018201,1,0.688189150954661,0,1,peptidyl-glycine modification,BP,
1751,GO:0018205,1,0.730053612763015,0,1,peptidyl-lysine modification,BP,
1753,GO:0018210,1,0.215880817914508,0,5,peptidyl-threonine modification,BP,
1755,GO:0018377,1,0.688189150954661,0,1,protein myristoylation,BP,
1756,GO:0018393,1,0.730053612763015,0,1,internal peptidyl-lysine acetylation,BP,
1757,GO:0018394,1,0.730053612763015,0,1,peptidyl-lysine acetylation,BP,
1759,GO:0018958,1,0.42563112836692,0,3,phenol-containing compound metabolic process,BP,
1766,GO:0019107,1,0.688189150954661,0,1,myristoyltransferase activity,MF,
1767,GO:0019171,1,0.604707407962162,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
1768,GO:0019199,1,0.412486537226133,0,3,transmembrane receptor protein kinase activity,MF,
1769,GO:0019200,1,0.572881559912366,0,2,carbohydrate kinase activity,MF,
1770,GO:0019203,1,0.710564000841808,0,1,carbohydrate phosphatase activity,MF,
1772,GO:0019208,1,0.766038155162373,0,1,phosphatase regulator activity,MF,
1775,GO:0019211,1,0.766038155162373,0,1,phosphatase activator activity,MF,
1776,GO:0019213,1,0.6837505749659,0,1,deacetylase activity,MF,
1777,GO:0019215,1,0.67497188939156,0,1,intermediate filament binding,MF,
1779,GO:0019217,1,0.781006884258256,0,1,regulation of fatty acid metabolic process,BP,
1785,GO:0019226,1,0.495737533689608,0,2,transmission of nerve impulse,BP,
1786,GO:0019229,1,0.410203829268266,0,4,regulation of vasoconstriction,BP,
1787,GO:0019233,1,0.542078580678341,0,3,sensory perception of pain,BP,
1788,GO:0019318,1,0.158368067618458,0,7,hexose metabolic process,BP,
1789,GO:0019319,1,0.749336515652812,0,1,hexose biosynthetic process,BP,
1790,GO:0019320,1,0.446054970520777,0,3,hexose catabolic process,BP,
1791,GO:0019362,1,0.553813046047101,0,2,pyridine nucleotide metabolic process,BP,
1792,GO:0019369,1,0.850380627707629,0,1,arachidonic acid metabolic process,BP,
1793,GO:0019371,1,0.850380627707629,0,1,cyclooxygenase pathway,BP,
1794,GO:0019395,1,0.584485373100561,0,2,fatty acid oxidation,BP,
1795,GO:0019430,1,0.725126756103963,0,1,removal of superoxide radicals,BP,
1796,GO:0019433,1,0.676247599336564,0,1,triglyceride catabolic process,BP,
1799,GO:0019464,1,0.733962171685514,0,1,glycine decarboxylation via glycine cleavage system,BP,
1802,GO:0019659,1,0.780567658291826,0,1,glucose catabolic process to lactate,BP,
1803,GO:0019660,1,0.780567658291826,0,1,glycolytic fermentation,BP,
1804,GO:0019661,1,0.780567658291826,0,1,glucose catabolic process to lactate via pyruvate,BP,
1805,GO:0019674,1,0.553813046047101,0,2,NAD metabolic process,BP,
1806,GO:0019682,1,0.807301335691128,0,1,glyceraldehyde-3-phosphate metabolic process,BP,
1808,GO:0019722,1,0.469785110077193,0,4,calcium-mediated signaling,BP,
1809,GO:0019724,1,0.849407889468112,0,1,B cell mediated immunity,BP,
1811,GO:0019730,1,0.832024114860243,0,1,antimicrobial humoral response,BP,
1812,GO:0019748,1,0.662592268986548,0,1,secondary metabolic process,BP,
1814,GO:0019787,1,0.168035136617011,0,5,ubiquitin-like protein transferase activity,MF,
1818,GO:0019842,1,0.307682401139751,0,3,vitamin binding,MF,
1821,GO:0019869,1,0.718774331523076,0,1,chloride channel inhibitor activity,MF,
1825,GO:0019894,1,0.560534968294878,0,1,kinesin binding,MF,
1834,GO:0019905,1,0.667375753190344,0,2,syntaxin binding,MF,
1836,GO:0019932,1,0.355897227385471,0,5,second-messenger-mediated signaling,BP,
1837,GO:0019934,1,0.760556996405447,0,1,cGMP-mediated signaling,BP,
1838,GO:0019935,1,0.760556996405447,0,1,cyclic-nucleotide-mediated signaling,BP,
1839,GO:0019941,1,0.311651581428465,0,4,modification-dependent protein catabolic process,BP,
1841,GO:0019955,1,0.775827451160419,0,1,cytokine binding,MF,
1842,GO:0020037,1,0.563108477678154,0,2,heme binding,MF,
1843,GO:0021502,1,0.725126756103963,0,1,neural fold elevation formation,BP,
1845,GO:0021515,1,0.59183921579231,0,1,cell differentiation in spinal cord,BP,
1847,GO:0021533,1,0.855530641430602,0,1,cell differentiation in hindbrain,BP,
1848,GO:0021536,1,0.182930282643326,0,7,diencephalon development,BP,
1849,GO:0021537,1,0.275165494070301,0,5,telencephalon development,BP,
1850,GO:0021543,1,0.644410022118507,0,2,pallium development,BP,
1851,GO:0021544,1,0.906752862467527,0,1,subpallium development,BP,
1858,GO:0021681,1,0.855530641430602,0,1,cerebellar granular layer development,BP,
1859,GO:0021683,1,0.855530641430602,0,1,cerebellar granular layer morphogenesis,BP,
1860,GO:0021684,1,0.855530641430602,0,1,cerebellar granular layer formation,BP,
1870,GO:0021707,1,0.855530641430602,0,1,cerebellar granule cell differentiation,BP,
1871,GO:0021772,1,0.662592268986548,0,1,olfactory bulb development,BP,
1873,GO:0021784,1,0.936826423682637,0,1,postganglionic parasympathetic fiber development,BP,
1874,GO:0021797,1,0.753597902783621,0,1,forebrain anterior/posterior pattern specification,BP,
1875,GO:0021798,1,0.906752862467527,0,1,forebrain dorsal/ventral pattern formation,BP,
1876,GO:0021846,1,0.775477357112509,0,2,cell proliferation in forebrain,BP,
1877,GO:0021871,1,0.262510155606668,0,6,forebrain regionalization,BP,
1878,GO:0021872,1,0.451206990255904,0,3,forebrain generation of neurons,BP,
1879,GO:0021877,1,0.753597902783621,0,1,forebrain neuron fate commitment,BP,
1880,GO:0021879,1,0.451206990255904,0,3,forebrain neuron differentiation,BP,
1881,GO:0021881,1,0.753597902783621,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
1882,GO:0021884,1,0.600297692341274,0,2,forebrain neuron development,BP,
1883,GO:0021885,1,0.728085055754081,0,1,forebrain cell migration,BP,
1884,GO:0021889,1,0.662592268986548,0,1,olfactory bulb interneuron differentiation,BP,
1885,GO:0021891,1,0.662592268986548,0,1,olfactory bulb interneuron development,BP,
1886,GO:0021898,1,0.753597902783621,0,1,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
1887,GO:0021903,1,0.906752862467527,0,1,rostrocaudal neural tube patterning,BP,
1890,GO:0021952,1,0.670370234134071,0,1,central nervous system projection neuron axonogenesis,BP,
1891,GO:0021953,1,0.172605092476874,0,7,central nervous system neuron differentiation,BP,
1892,GO:0021954,1,0.400993278718928,0,3,central nervous system neuron development,BP,
1893,GO:0021955,1,0.670370234134071,0,1,central nervous system neuron axonogenesis,BP,
1894,GO:0021978,1,0.650932589184655,0,2,telencephalon regionalization,BP,
1895,GO:0021983,1,0.182930282643326,0,7,pituitary gland development,BP,
1896,GO:0021984,1,0.5061424921696,0,3,adenohypophysis development,BP,
1897,GO:0021987,1,0.711185484621141,0,1,cerebral cortex development,BP,
1898,GO:0021988,1,0.662592268986548,0,1,olfactory lobe development,BP,
1899,GO:0021999,1,0.753597902783621,0,1,neural plate anterior/posterior regionalization,BP,
1901,GO:0022009,1,0.62421465567788,0,2,central nervous system vasculogenesis,BP,
1902,GO:0022011,1,0.606769107287404,0,2,myelination in peripheral nervous system,BP,
1904,GO:0022400,1,0.688189150954661,0,1,regulation of rhodopsin mediated signaling pathway,BP,
1912,GO:0022410,1,0.782385944864048,0,1,circadian sleep/wake cycle process,BP,
1916,GO:0022600,1,0.471105520908653,0,3,digestive system process,BP,
1923,GO:0022614,1,0.727489805589545,0,1,membrane to membrane docking,BP,
1924,GO:0022617,1,0.508539533724445,0,2,extracellular matrix disassembly,BP,
1926,GO:0022804,1,0.754585539747771,0,1,active transmembrane transporter activity,MF,
1927,GO:0022829,1,0.476383191440494,0,3,wide pore channel activity,MF,
1929,GO:0022834,1,0.605258026216555,0,2,ligand-gated channel activity,MF,
1939,GO:0023019,1,0.906752862467527,0,1,signal transduction involved in regulation of gene expression,BP,
1944,GO:0023061,1,0.0675010449197061,0,11,signal release,BP,
1947,GO:0030004,1,0.591548703543027,0,3,cellular monovalent inorganic cation homeostasis,BP,
1956,GO:0030032,1,0.853129851663623,0,1,lamellipodium assembly,BP,
1967,GO:0030056,1,0.665308550780754,0,1,hemidesmosome,CC,
1968,GO:0030057,1,0.109769140218771,0,6,desmosome,CC,
1969,GO:0030072,1,0.464126284518413,0,4,peptide hormone secretion,BP,
1970,GO:0030073,1,0.561511797727282,0,3,insulin secretion,BP,
1979,GO:0030135,1,0.123384736547515,0,7,coated vesicle,CC,
1980,GO:0030136,1,0.123384736547515,0,7,clathrin-coated vesicle,CC,
1985,GO:0030157,1,0.718774331523076,0,1,pancreatic juice secretion,BP,
1986,GO:0030159,1,0.753597902783621,0,1,receptor signaling complex scaffold activity,MF,
1988,GO:0030163,1,0.0837067169424556,0,9,protein catabolic process,BP,
1989,GO:0030165,1,0.559481610903871,0,2,PDZ domain binding,MF,
1991,GO:0030170,1,0.733962171685514,0,1,pyridoxal phosphate binding,MF,
1993,GO:0030177,1,0.120927854129109,0,9,positive regulation of Wnt signaling pathway,BP,
1997,GO:0030185,1,0.828354528958696,0,1,nitric oxide transport,BP,
1998,GO:0030193,1,0.516168134235673,0,3,regulation of blood coagulation,BP,
1999,GO:0030195,1,0.516168134235673,0,3,negative regulation of blood coagulation,BP,
2002,GO:0030212,1,0.608707925787425,0,2,hyaluronan metabolic process,BP,
2003,GO:0030213,1,0.780266268444755,0,1,hyaluronan biosynthetic process,BP,
2004,GO:0030216,1,0.0298543110092987,0,9,keratinocyte differentiation,BP,
2005,GO:0030217,1,0.178237452352815,0,6,T cell differentiation,BP,
2006,GO:0030218,1,0.499483772935288,0,3,erythrocyte differentiation,BP,
2007,GO:0030219,1,0.761153424935427,0,1,megakaryocyte differentiation,BP,
2008,GO:0030220,1,0.761153424935427,0,1,platelet formation,BP,
2009,GO:0030224,1,0.850452765079241,0,1,monocyte differentiation,BP,
2010,GO:0030225,1,0.471996267911207,0,3,macrophage differentiation,BP,
2012,GO:0030235,1,0.781006884258256,0,1,nitric-oxide synthase regulator activity,MF,
2013,GO:0030237,1,0.730656633467999,0,1,female sex determination,BP,
2016,GO:0030241,1,0.634601131053728,0,1,skeletal muscle myosin thick filament assembly,BP,
2017,GO:0030246,1,0.887923397179303,0,1,carbohydrate binding,MF,
2021,GO:0030276,1,0.847146262734248,0,1,clathrin binding,MF,
2022,GO:0030278,1,0.053060753766191,0,10,regulation of ossification,BP,
2023,GO:0030279,1,0.59183921579231,0,1,negative regulation of ossification,BP,
2024,GO:0030280,1,0.67497188939156,0,1,structural constituent of epidermis,MF,
2025,GO:0030282,1,0.20185121060264,0,6,bone mineralization,BP,
2030,GO:0030307,1,0.45533615789651,0,4,positive regulation of cell growth,BP,
2032,GO:0030309,1,0.787775492853738,0,1,poly-N-acetyllactosamine metabolic process,BP,
2033,GO:0030311,1,0.787775492853738,0,1,poly-N-acetyllactosamine biosynthetic process,BP,
2034,GO:0030314,1,0.790066751337715,0,1,junctional membrane complex,CC,
2040,GO:0030326,1,0.11844343056268,0,8,embryonic limb morphogenesis,BP,
2053,GO:0030431,1,0.782385944864048,0,1,sleep,BP,
2054,GO:0030432,1,0.936826423682637,0,1,peristalsis,BP,
2055,GO:0030485,1,0.865219391210355,0,1,smooth muscle contractile fiber,CC,
2056,GO:0030496,1,0.697246881652823,0,2,midbody,CC,
2057,GO:0030500,1,0.20185121060264,0,6,regulation of bone mineralization,BP,
2058,GO:0030501,1,0.20185121060264,0,6,positive regulation of bone mineralization,BP,
2059,GO:0030506,1,0.279686788486634,0,3,ankyrin binding,MF,
2063,GO:0030512,1,0.838635604722482,0,1,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
2064,GO:0030513,1,0.502546403706452,0,2,positive regulation of BMP signaling pathway,BP,
2065,GO:0030514,1,0.312078803662644,0,3,negative regulation of BMP signaling pathway,BP,
2066,GO:0030516,1,0.57689958345257,0,2,regulation of axon extension,BP,
2067,GO:0030517,1,0.57689958345257,0,2,negative regulation of axon extension,BP,
2068,GO:0030522,1,0.698454611733275,0,1,intracellular receptor signaling pathway,BP,
2069,GO:0030529,1,0.528101695200463,0,2,intracellular ribonucleoprotein complex,CC,
2070,GO:0030534,1,0.627624931861197,0,2,adult behavior,BP,
2071,GO:0030538,1,0.941285075943011,0,1,embryonic genitalia morphogenesis,BP,
2073,GO:0030540,1,0.352641610470151,0,4,female genitalia development,BP,
2081,GO:0030641,1,0.591548703543027,0,3,regulation of cellular pH,BP,
2082,GO:0030656,1,0.698454611733275,0,1,regulation of vitamin metabolic process,BP,
2085,GO:0030660,1,0.704992319915139,0,1,Golgi-associated vesicle membrane,CC,
2086,GO:0030662,1,0.419830348613364,0,3,coated vesicle membrane,CC,
2087,GO:0030665,1,0.419830348613364,0,3,clathrin-coated vesicle membrane,CC,
2088,GO:0030666,1,0.0527646871591979,0,12,endocytic vesicle membrane,CC,
2090,GO:0030669,1,0.536610387123389,0,2,clathrin-coated endocytic vesicle membrane,CC,
2091,GO:0030670,1,0.374325658339819,0,4,phagocytic vesicle membrane,CC,
2093,GO:0030673,1,0.782385944864048,0,1,axolemma,CC,
2096,GO:0030728,1,0.763405242997684,0,1,ovulation,BP,
2097,GO:0030742,1,0.740751940389523,0,2,GTP-dependent protein binding,MF,
2098,GO:0030799,1,0.31267974917891,0,5,regulation of cyclic nucleotide metabolic process,BP,
2099,GO:0030800,1,0.828354528958696,0,1,negative regulation of cyclic nucleotide metabolic process,BP,
2100,GO:0030801,1,0.378806021993844,0,4,positive regulation of cyclic nucleotide metabolic process,BP,
2101,GO:0030802,1,0.571549327879466,0,3,regulation of cyclic nucleotide biosynthetic process,BP,
2102,GO:0030803,1,0.828354528958696,0,1,negative regulation of cyclic nucleotide biosynthetic process,BP,
2103,GO:0030804,1,0.690941304389812,0,2,positive regulation of cyclic nucleotide biosynthetic process,BP,
2104,GO:0030808,1,0.571549327879466,0,3,regulation of nucleotide biosynthetic process,BP,
2105,GO:0030809,1,0.828354528958696,0,1,negative regulation of nucleotide biosynthetic process,BP,
2106,GO:0030810,1,0.690941304389812,0,2,positive regulation of nucleotide biosynthetic process,BP,
2107,GO:0030814,1,0.662540798119578,0,3,regulation of cAMP metabolic process,BP,
2108,GO:0030815,1,0.828354528958696,0,1,negative regulation of cAMP metabolic process,BP,
2109,GO:0030816,1,0.832024114860243,0,1,positive regulation of cAMP metabolic process,BP,
2110,GO:0030817,1,0.828354528958696,0,1,regulation of cAMP biosynthetic process,BP,
2111,GO:0030818,1,0.828354528958696,0,1,negative regulation of cAMP biosynthetic process,BP,
2112,GO:0030823,1,0.456542286868747,0,3,regulation of cGMP metabolic process,BP,
2113,GO:0030825,1,0.456542286868747,0,3,positive regulation of cGMP metabolic process,BP,
2114,GO:0030826,1,0.690941304389812,0,2,regulation of cGMP biosynthetic process,BP,
2115,GO:0030828,1,0.690941304389812,0,2,positive regulation of cGMP biosynthetic process,BP,
2122,GO:0030849,1,0.6837505749659,0,1,autosome,CC,
2123,GO:0030850,1,0.224334300077913,0,5,prostate gland development,BP,
2124,GO:0030851,1,0.761153424935427,0,1,granulocyte differentiation,BP,
2128,GO:0030858,1,0.150154976416079,0,7,positive regulation of epithelial cell differentiation,BP,
2129,GO:0030859,1,0.480964539241892,0,2,polarized epithelial cell differentiation,BP,
2132,GO:0030865,1,0.704992319915139,0,1,cortical cytoskeleton organization,BP,
2133,GO:0030866,1,0.704992319915139,0,1,cortical actin cytoskeleton organization,BP,
2134,GO:0030868,1,0.834203192552595,0,1,smooth endoplasmic reticulum membrane,CC,
2135,GO:0030877,1,0.753597902783621,0,1,beta-catenin destruction complex,CC,
2136,GO:0030878,1,0.853364031216559,0,2,thyroid gland development,BP,
2137,GO:0030879,1,0.0431314599608668,0,11,mammary gland development,BP,
2141,GO:0030900,1,0.0148909772548869,0,15,forebrain development,BP,
2142,GO:0030901,1,0.449227785515024,0,3,midbrain development,BP,
2144,GO:0030903,1,0.662592268986548,0,1,notochord development,BP,
2145,GO:0030910,1,0.753597902783621,0,1,olfactory placode formation,BP,
2146,GO:0030916,1,0.853364031216559,0,2,otic vesicle formation,BP,
2147,GO:0030917,1,0.906752862467527,0,1,midbrain-hindbrain boundary development,BP,
2148,GO:0030947,1,0.672975237355323,0,2,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2149,GO:0030949,1,0.672975237355323,0,2,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2153,GO:0031000,1,0.790066751337715,0,1,response to caffeine,BP,
2157,GO:0031023,1,0.678926723930427,0,2,microtubule organizing center organization,BP,
2159,GO:0031033,1,0.634601131053728,0,1,myosin filament organization,BP,
2160,GO:0031034,1,0.634601131053728,0,1,myosin filament assembly,BP,
2161,GO:0031045,1,0.847146262734248,0,1,dense core granule,CC,
2162,GO:0031047,1,0.850452765079241,0,1,gene silencing by RNA,BP,
2163,GO:0031050,1,0.850452765079241,0,1,dsRNA fragmentation,BP,
2164,GO:0031056,1,0.730053612763015,0,1,regulation of histone modification,BP,
2165,GO:0031058,1,0.730053612763015,0,1,positive regulation of histone modification,BP,
2166,GO:0031069,1,0.556656233076134,0,2,hair follicle morphogenesis,BP,
2167,GO:0031072,1,0.782385944864048,0,1,heat shock protein binding,MF,
2168,GO:0031076,1,0.35119216794222,0,4,embryonic camera-type eye development,BP,
2176,GO:0031102,1,0.741010011526507,0,1,neuron projection regeneration,BP,
2177,GO:0031103,1,0.741010011526507,0,1,axon regeneration,BP,
2178,GO:0031109,1,0.722881072054875,0,2,microtubule polymerization or depolymerization,BP,
2179,GO:0031110,1,0.853347594896784,0,1,regulation of microtubule polymerization or depolymerization,BP,
2180,GO:0031112,1,0.853347594896784,0,1,positive regulation of microtubule polymerization or depolymerization,BP,
2181,GO:0031113,1,0.853347594896784,0,1,regulation of microtubule polymerization,BP,
2182,GO:0031116,1,0.853347594896784,0,1,positive regulation of microtubule polymerization,BP,
2183,GO:0031122,1,0.638156901527024,0,2,cytoplasmic microtubule organization,BP,
2184,GO:0031128,1,0.207421956856366,0,9,developmental induction,BP,
2185,GO:0031133,1,0.855530641430602,0,1,regulation of axon diameter,BP,
2188,GO:0031177,1,0.604707407962162,0,1,phosphopantetheine binding,MF,
2189,GO:0031201,1,0.788402850719053,0,1,SNARE complex,CC,
2192,GO:0031223,1,0.781943571206073,0,1,auditory behavior,BP,
2196,GO:0031232,1,0.784501226927412,0,1,extrinsic component of external side of plasma membrane,CC,
2197,GO:0031234,1,0.526919379053173,0,2,extrinsic component of cytoplasmic side of plasma membrane,CC,
2198,GO:0031235,1,0.60593023544219,0,1,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
2201,GO:0031254,1,0.727489805589545,0,1,cell trailing edge,CC,
2202,GO:0031256,1,0.558838667903679,0,2,leading edge membrane,CC,
2214,GO:0031329,1,0.00496000808792176,0,17,regulation of cellular catabolic process,BP,
2215,GO:0031330,1,0.135192008333231,0,6,negative regulation of cellular catabolic process,BP,
2218,GO:0031334,1,0.519974617113514,0,3,positive regulation of protein complex assembly,BP,
2223,GO:0031348,1,0.568852189409995,0,2,negative regulation of defense response,BP,
2225,GO:0031365,1,0.688189150954661,0,1,N-terminal protein amino acid modification,BP,
2226,GO:0031396,1,0.629174328088141,0,2,regulation of protein ubiquitination,BP,
2227,GO:0031398,1,0.629174328088141,0,2,positive regulation of protein ubiquitination,BP,
2233,GO:0031424,1,0.149604617026572,0,5,keratinization,BP,
2235,GO:0031434,1,0.802878249889337,0,1,mitogen-activated protein kinase kinase binding,MF,
2241,GO:0031503,1,0.592160443815491,0,2,protein complex localization,BP,
2243,GO:0031528,1,0.727489805589545,0,1,microvillus membrane,CC,
2244,GO:0031529,1,0.898270644003197,0,1,ruffle organization,BP,
2245,GO:0031532,1,0.720740381129714,0,3,actin cytoskeleton reorganization,BP,
2249,GO:0031581,1,0.665308550780754,0,1,hemidesmosome assembly,BP,
2250,GO:0031583,1,0.828354528958696,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
2251,GO:0031588,1,0.749336515652812,0,1,nucleotide-activated protein kinase complex,CC,
2253,GO:0031624,1,0.665337439618267,0,1,ubiquitin conjugating enzyme binding,MF,
2255,GO:0031638,1,0.800794052075968,0,1,zymogen activation,BP,
2256,GO:0031639,1,0.800794052075968,0,1,plasminogen activation,BP,
2257,GO:0031640,1,0.832024114860243,0,1,killing of cells of other organism,BP,
2258,GO:0031641,1,0.781006884258256,0,1,regulation of myelination,BP,
2259,GO:0031644,1,0.542078580678341,0,3,regulation of neurological system process,BP,
2261,GO:0031648,1,0.766038155162373,0,1,protein destabilization,BP,
2262,GO:0031657,1,0.734866748417631,0,2,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2263,GO:0031659,1,0.734866748417631,0,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2264,GO:0031663,1,0.59924978774064,0,2,lipopolysaccharide-mediated signaling pathway,BP,
2265,GO:0031664,1,0.768189760920054,0,1,regulation of lipopolysaccharide-mediated signaling pathway,BP,
2266,GO:0031666,1,0.768189760920054,0,1,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
2272,GO:0031683,1,0.782385944864048,0,1,G-protein beta/gamma-subunit complex binding,MF,
2273,GO:0031690,1,0.838425043082162,0,1,adrenergic receptor binding,MF,
2274,GO:0031694,1,0.838425043082162,0,1,alpha-2A adrenergic receptor binding,MF,
2275,GO:0031705,1,0.828354528958696,0,1,bombesin receptor binding,MF,
2276,GO:0031707,1,0.828354528958696,0,1,endothelin A receptor binding,MF,
2277,GO:0031708,1,0.828354528958696,0,1,endothelin B receptor binding,MF,
2278,GO:0031731,1,0.923408743724329,0,1,CCR6 chemokine receptor binding,MF,
2284,GO:0031932,1,0.551214759448113,0,2,TORC2 complex,CC,
2288,GO:0031945,1,0.730656633467999,0,1,positive regulation of glucocorticoid metabolic process,BP,
2291,GO:0031948,1,0.730656633467999,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
2292,GO:0031952,1,0.780266268444755,0,1,regulation of protein autophosphorylation,BP,
2293,GO:0031954,1,0.780266268444755,0,1,positive regulation of protein autophosphorylation,BP,
2299,GO:0031970,1,0.850380627707629,0,1,organelle envelope lumen,CC,
2306,GO:0031994,1,0.665308550780754,0,1,insulin-like growth factor I binding,MF,
2307,GO:0031998,1,0.781006884258256,0,1,regulation of fatty acid beta-oxidation,BP,
2308,GO:0031999,1,0.781006884258256,0,1,negative regulation of fatty acid beta-oxidation,BP,
2310,GO:0032007,1,0.510458969002767,0,2,negative regulation of TOR signaling,BP,
2312,GO:0032026,1,0.768189760920054,0,1,response to magnesium ion,BP,
2313,GO:0032029,1,0.560534968294878,0,1,myosin tail binding,MF,
2314,GO:0032036,1,0.560534968294878,0,1,myosin heavy chain binding,MF,
2315,GO:0032042,1,0.749336515652812,0,1,mitochondrial DNA metabolic process,BP,
2316,GO:0032052,1,0.698454611733275,0,1,bile acid binding,MF,
2317,GO:0032055,1,0.749336515652812,0,1,negative regulation of translation in response to stress,BP,
2318,GO:0032069,1,0.781006884258256,0,1,regulation of nuclease activity,BP,
2319,GO:0032070,1,0.781006884258256,0,1,regulation of deoxyribonuclease activity,BP,
2320,GO:0032071,1,0.781006884258256,0,1,regulation of endodeoxyribonuclease activity,BP,
2321,GO:0032075,1,0.781006884258256,0,1,positive regulation of nuclease activity,BP,
2322,GO:0032077,1,0.781006884258256,0,1,positive regulation of deoxyribonuclease activity,BP,
2323,GO:0032079,1,0.781006884258256,0,1,positive regulation of endodeoxyribonuclease activity,BP,
2324,GO:0032088,1,0.725126756103963,0,1,negative regulation of NF-kappaB transcription factor activity,BP,
2325,GO:0032091,1,0.484020016506115,0,3,negative regulation of protein binding,BP,
2326,GO:0032092,1,0.350408267742044,0,4,positive regulation of protein binding,BP,
2327,GO:0032094,1,0.781006884258256,0,1,response to food,BP,
2329,GO:0032102,1,0.0697688123196376,0,9,negative regulation of response to external stimulus,BP,
2340,GO:0032225,1,0.936826423682637,0,1,regulation of synaptic transmission, dopaminergic,BP,
2341,GO:0032228,1,0.782385944864048,0,1,regulation of synaptic transmission, GABAergic,BP,
2342,GO:0032229,1,0.782385944864048,0,1,negative regulation of synaptic transmission, GABAergic,BP,
2345,GO:0032239,1,0.782385944864048,0,1,regulation of nucleobase-containing compound transport,BP,
2346,GO:0032241,1,0.782385944864048,0,1,positive regulation of nucleobase-containing compound transport,BP,
2347,GO:0032242,1,0.782385944864048,0,1,regulation of nucleoside transport,BP,
2348,GO:0032244,1,0.782385944864048,0,1,positive regulation of nucleoside transport,BP,
2349,GO:0032252,1,0.676247599336564,0,1,secretory granule localization,BP,
2350,GO:0032259,1,0.55834969093341,0,3,methylation,BP,
2356,GO:0032273,1,0.853347594896784,0,1,positive regulation of protein polymerization,BP,
2357,GO:0032274,1,0.763405242997684,0,1,gonadotropin secretion,BP,
2358,GO:0032276,1,0.763405242997684,0,1,regulation of gonadotropin secretion,BP,
2359,GO:0032277,1,0.763405242997684,0,1,negative regulation of gonadotropin secretion,BP,
2360,GO:0032278,1,0.763405242997684,0,1,positive regulation of gonadotropin secretion,BP,
2362,GO:0032287,1,0.781006884258256,0,1,peripheral nervous system myelin maintenance,BP,
2363,GO:0032292,1,0.606769107287404,0,2,peripheral nervous system axon ensheathment,BP,
2364,GO:0032303,1,0.828354528958696,0,1,regulation of icosanoid secretion,BP,
2365,GO:0032305,1,0.828354528958696,0,1,positive regulation of icosanoid secretion,BP,
2366,GO:0032306,1,0.828354528958696,0,1,regulation of prostaglandin secretion,BP,
2367,GO:0032308,1,0.828354528958696,0,1,positive regulation of prostaglandin secretion,BP,
2368,GO:0032309,1,0.828354528958696,0,1,icosanoid secretion,BP,
2369,GO:0032310,1,0.828354528958696,0,1,prostaglandin secretion,BP,
2371,GO:0032331,1,0.850452765079241,0,1,negative regulation of chondrocyte differentiation,BP,
2372,GO:0032332,1,0.768189760920054,0,1,positive regulation of chondrocyte differentiation,BP,
2377,GO:0032346,1,0.560461161423182,0,2,positive regulation of aldosterone metabolic process,BP,
2380,GO:0032349,1,0.560461161423182,0,2,positive regulation of aldosterone biosynthetic process,BP,
2383,GO:0032352,1,0.560461161423182,0,2,positive regulation of hormone metabolic process,BP,
2385,GO:0032354,1,0.59183921579231,0,1,response to follicle-stimulating hormone,BP,
2387,GO:0032364,1,0.730311826899045,0,1,oxygen homeostasis,BP,
2388,GO:0032368,1,0.495478867338016,0,3,regulation of lipid transport,BP,
2389,GO:0032369,1,0.781006884258256,0,1,negative regulation of lipid transport,BP,
2390,GO:0032370,1,0.635734690589842,0,2,positive regulation of lipid transport,BP,
2395,GO:0032400,1,0.658754890982925,0,2,melanosome localization,BP,
2396,GO:0032401,1,0.658754890982925,0,2,establishment of melanosome localization,BP,
2397,GO:0032402,1,0.658754890982925,0,2,melanosome transport,BP,
2405,GO:0032418,1,0.561913766641372,0,2,lysosome localization,BP,
2409,GO:0032427,1,0.704992319915139,0,1,GBD domain binding,MF,
2410,GO:0032433,1,0.834203192552595,0,1,filopodium tip,CC,
2411,GO:0032434,1,0.415383885417359,0,3,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
2412,GO:0032436,1,0.518721889976232,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
2413,GO:0032438,1,0.87844991147751,0,1,melanosome organization,BP,
2414,GO:0032446,1,0.0597199660799722,0,10,protein modification by small protein conjugation,BP,
2416,GO:0032459,1,0.839760482627469,0,1,regulation of protein oligomerization,BP,
2417,GO:0032461,1,0.839760482627469,0,1,positive regulation of protein oligomerization,BP,
2418,GO:0032479,1,0.663672125770882,0,1,regulation of type I interferon production,BP,
2419,GO:0032495,1,0.59183921579231,0,1,response to muramyl dipeptide,BP,
2424,GO:0032506,1,0.681433432009857,0,1,cytokinetic process,BP,
2425,GO:0032507,1,0.522661227069333,0,2,maintenance of protein location in cell,BP,
2426,GO:0032526,1,0.0858805883214274,0,10,response to retinoic acid,BP,
2428,GO:0032536,1,0.62421465567788,0,2,regulation of cell projection size,BP,
2429,GO:0032542,1,0.749336515652812,0,1,sulfiredoxin activity,MF,
2436,GO:0032570,1,0.813104792706398,0,1,response to progesterone,BP,
2438,GO:0032585,1,0.784473242465539,0,1,multivesicular body membrane,CC,
2439,GO:0032587,1,0.715318261416419,0,1,ruffle membrane,CC,
2440,GO:0032589,1,0.782385944864048,0,1,neuron projection membrane,CC,
2441,GO:0032602,1,0.503361512000019,0,2,chemokine production,BP,
2442,GO:0032605,1,0.763405242997684,0,1,hepatocyte growth factor production,BP,
2443,GO:0032606,1,0.663672125770882,0,1,type I interferon production,BP,
2445,GO:0032610,1,0.923408743724329,0,1,interleukin-1 alpha production,BP,
2446,GO:0032611,1,0.662592268986548,0,1,interleukin-1 beta production,BP,
2450,GO:0032633,1,0.449392614686304,0,2,interleukin-4 production,BP,
2452,GO:0032637,1,0.662592268986548,0,1,interleukin-8 production,BP,
2454,GO:0032642,1,0.503361512000019,0,2,regulation of chemokine production,BP,
2455,GO:0032646,1,0.763405242997684,0,1,regulation of hepatocyte growth factor production,BP,
2457,GO:0032650,1,0.923408743724329,0,1,regulation of interleukin-1 alpha production,BP,
2458,GO:0032651,1,0.662592268986548,0,1,regulation of interleukin-1 beta production,BP,
2462,GO:0032673,1,0.761153424935427,0,1,regulation of interleukin-4 production,BP,
2464,GO:0032677,1,0.662592268986548,0,1,regulation of interleukin-8 production,BP,
2466,GO:0032686,1,0.763405242997684,0,1,negative regulation of hepatocyte growth factor production,BP,
2470,GO:0032713,1,0.761153424935427,0,1,negative regulation of interleukin-4 production,BP,
2473,GO:0032722,1,0.662592268986548,0,1,positive regulation of chemokine production,BP,
2475,GO:0032730,1,0.923408743724329,0,1,positive regulation of interleukin-1 alpha production,BP,
2476,GO:0032731,1,0.662592268986548,0,1,positive regulation of interleukin-1 beta production,BP,
2477,GO:0032732,1,0.61139307884054,0,2,positive regulation of interleukin-1 production,BP,
2479,GO:0032755,1,0.662592268986548,0,1,positive regulation of interleukin-6 production,BP,
2480,GO:0032757,1,0.662592268986548,0,1,positive regulation of interleukin-8 production,BP,
2482,GO:0032762,1,0.832024114860243,0,1,mast cell cytokine production,BP,
2483,GO:0032768,1,0.509738996595777,0,3,regulation of monooxygenase activity,BP,
2484,GO:0032770,1,0.731372175333709,0,2,positive regulation of monooxygenase activity,BP,
2486,GO:0032781,1,0.941285075943011,0,1,positive regulation of ATPase activity,BP,
2487,GO:0032784,1,0.753597902783621,0,1,regulation of DNA-templated transcription, elongation,BP,
2488,GO:0032785,1,0.753597902783621,0,1,negative regulation of DNA-templated transcription, elongation,BP,
2490,GO:0032794,1,0.541614449917901,0,2,GTPase activating protein binding,MF,
2491,GO:0032795,1,0.782385944864048,0,1,heterotrimeric G-protein binding,MF,
2492,GO:0032800,1,0.828354528958696,0,1,receptor biosynthetic process,BP,
2494,GO:0032808,1,0.941285075943011,0,1,lacrimal gland development,BP,
2495,GO:0032811,1,0.636999731039707,0,2,negative regulation of epinephrine secretion,BP,
2504,GO:0032846,1,0.468434168613049,0,3,positive regulation of homeostatic process,BP,
2509,GO:0032873,1,0.781006884258256,0,1,negative regulation of stress-activated MAPK cascade,BP,
2513,GO:0032881,1,0.608707925787425,0,2,regulation of polysaccharide metabolic process,BP,
2514,GO:0032885,1,0.608707925787425,0,2,regulation of polysaccharide biosynthetic process,BP,
2516,GO:0032890,1,0.504701157466161,0,3,regulation of organic acid transport,BP,
2517,GO:0032891,1,0.610368083398472,0,2,negative regulation of organic acid transport,BP,
2518,GO:0032892,1,0.828354528958696,0,1,positive regulation of organic acid transport,BP,
2519,GO:0032898,1,0.782385944864048,0,1,neurotrophin production,BP,
2520,GO:0032899,1,0.782385944864048,0,1,regulation of neurotrophin production,BP,
2521,GO:0032900,1,0.782385944864048,0,1,negative regulation of neurotrophin production,BP,
2522,GO:0032924,1,0.444810208568044,0,4,activin receptor signaling pathway,BP,
2523,GO:0032925,1,0.584287425142307,0,3,regulation of activin receptor signaling pathway,BP,
2524,GO:0032926,1,0.621198377089134,0,2,negative regulation of activin receptor signaling pathway,BP,
2526,GO:0032941,1,0.528106954152329,0,3,secretion by tissue,BP,
2531,GO:0032947,1,0.753597902783621,0,1,protein complex scaffold,MF,
2538,GO:0032982,1,0.634601131053728,0,1,myosin filament,CC,
2543,GO:0033002,1,0.106903354166249,0,9,muscle cell proliferation,BP,
2544,GO:0033010,1,0.741010011526507,0,1,paranodal junction,CC,
2545,GO:0033017,1,0.790066751337715,0,1,sarcoplasmic reticulum membrane,CC,
2546,GO:0033018,1,0.790066751337715,0,1,sarcoplasmic reticulum lumen,CC,
2556,GO:0033044,1,0.730053612763015,0,1,regulation of chromosome organization,BP,
2558,GO:0033077,1,0.235834714608662,0,5,T cell differentiation in thymus,BP,
2559,GO:0033079,1,0.62078556105748,0,2,immature T cell proliferation,BP,
2560,GO:0033080,1,0.62078556105748,0,2,immature T cell proliferation in thymus,BP,
2561,GO:0033081,1,0.850452765079241,0,1,regulation of T cell differentiation in thymus,BP,
2562,GO:0033083,1,0.850452765079241,0,1,regulation of immature T cell proliferation,BP,
2563,GO:0033084,1,0.850452765079241,0,1,regulation of immature T cell proliferation in thymus,BP,
2564,GO:0033085,1,0.850452765079241,0,1,negative regulation of T cell differentiation in thymus,BP,
2565,GO:0033087,1,0.850452765079241,0,1,negative regulation of immature T cell proliferation,BP,
2566,GO:0033088,1,0.850452765079241,0,1,negative regulation of immature T cell proliferation in thymus,BP,
2567,GO:0033093,1,0.649253369305073,0,2,Weibel-Palade body,CC,
2571,GO:0033139,1,0.730053612763015,0,1,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2572,GO:0033141,1,0.730053612763015,0,1,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2576,GO:0033162,1,0.688674490385899,0,2,melanosome membrane,CC,
2577,GO:0033173,1,0.780567658291826,0,1,calcineurin-NFAT signaling cascade,BP,
2580,GO:0033267,1,0.411661474534371,0,3,axon part,CC,
2581,GO:0033268,1,0.670370234134071,0,1,node of Ranvier,CC,
2582,GO:0033270,1,0.670370234134071,0,1,paranode region of axon,CC,
2585,GO:0033278,1,0.51631739437111,0,2,cell proliferation in midbrain,BP,
2586,GO:0033280,1,0.5054717456525,0,2,response to vitamin D,BP,
2589,GO:0033363,1,0.87844991147751,0,1,secretory granule organization,BP,
2591,GO:0033483,1,0.730311826899045,0,1,gas homeostasis,BP,
2593,GO:0033549,1,0.800672150482427,0,1,MAP kinase phosphatase activity,MF,
2595,GO:0033558,1,0.6837505749659,0,1,protein deacetylase activity,MF,
2596,GO:0033559,1,0.703978953100515,0,2,unsaturated fatty acid metabolic process,BP,
2598,GO:0033563,1,0.906752862467527,0,1,dorsal/ventral axon guidance,BP,
2599,GO:0033572,1,0.784501226927412,0,1,transferrin transport,BP,
2600,GO:0033574,1,0.601949199928911,0,2,response to testosterone,BP,
2601,GO:0033598,1,0.662592268986548,0,1,mammary gland epithelial cell proliferation,BP,
2602,GO:0033603,1,0.936826423682637,0,1,positive regulation of dopamine secretion,BP,
2603,GO:0033604,1,0.529144208457412,0,3,negative regulation of catecholamine secretion,BP,
2604,GO:0033605,1,0.936826423682637,0,1,positive regulation of catecholamine secretion,BP,
2605,GO:0033612,1,0.360371721138142,0,4,receptor serine/threonine kinase binding,MF,
2606,GO:0033613,1,0.761153424935427,0,1,activating transcription factor binding,MF,
2607,GO:0033627,1,0.385395170855992,0,3,cell adhesion mediated by integrin,BP,
2608,GO:0033628,1,0.540700129456301,0,2,regulation of cell adhesion mediated by integrin,BP,
2609,GO:0033631,1,0.715318261416419,0,1,cell-cell adhesion mediated by integrin,BP,
2612,GO:0033687,1,0.766038155162373,0,1,osteoblast proliferation,BP,
2613,GO:0033688,1,0.766038155162373,0,1,regulation of osteoblast proliferation,BP,
2614,GO:0033690,1,0.766038155162373,0,1,positive regulation of osteoblast proliferation,BP,
2615,GO:0033692,1,0.614589324949419,0,2,cellular polysaccharide biosynthetic process,BP,
2620,GO:0034101,1,0.499483772935288,0,3,erythrocyte homeostasis,BP,
2621,GO:0034103,1,0.526953090754819,0,2,regulation of tissue remodeling,BP,
2622,GO:0034104,1,0.755771665883275,0,1,negative regulation of tissue remodeling,BP,
2623,GO:0034105,1,0.698454611733275,0,1,positive regulation of tissue remodeling,BP,
2625,GO:0034113,1,0.351016848807005,0,3,heterotypic cell-cell adhesion,BP,
2626,GO:0034114,1,0.725126756103963,0,1,regulation of heterotypic cell-cell adhesion,BP,
2627,GO:0034116,1,0.725126756103963,0,1,positive regulation of heterotypic cell-cell adhesion,BP,
2628,GO:0034121,1,0.728085055754081,0,1,regulation of toll-like receptor signaling pathway,BP,
2629,GO:0034122,1,0.728085055754081,0,1,negative regulation of toll-like receptor signaling pathway,BP,
2632,GO:0034219,1,0.821374167469034,0,1,carbohydrate transmembrane transport,BP,
2634,GO:0034236,1,0.801649544056734,0,1,protein kinase A catalytic subunit binding,MF,
2635,GO:0034243,1,0.753597902783621,0,1,regulation of transcription elongation from RNA polymerase II promoter,BP,
2636,GO:0034244,1,0.753597902783621,0,1,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
2637,GO:0034248,1,0.496235265868628,0,3,regulation of cellular amide metabolic process,BP,
2638,GO:0034249,1,0.636701371256347,0,2,negative regulation of cellular amide metabolic process,BP,
2639,GO:0034260,1,0.390215752691291,0,3,negative regulation of GTPase activity,BP,
2641,GO:0034285,1,0.807301335691128,0,1,response to disaccharide,BP,
2647,GO:0034340,1,0.662592268986548,0,1,response to type I interferon,BP,
2652,GO:0034390,1,0.828354528958696,0,1,smooth muscle cell apoptotic process,BP,
2653,GO:0034391,1,0.828354528958696,0,1,regulation of smooth muscle cell apoptotic process,BP,
2654,GO:0034392,1,0.828354528958696,0,1,negative regulation of smooth muscle cell apoptotic process,BP,
2656,GO:0034399,1,0.670370234134071,0,1,nuclear periphery,CC,
2657,GO:0034405,1,0.781006884258256,0,1,response to fluid shear stress,BP,
2658,GO:0034440,1,0.584485373100561,0,2,lipid oxidation,BP,
2660,GO:0034452,1,0.560534968294878,0,1,dynactin binding,MF,
2663,GO:0034505,1,0.856552884009832,0,1,tooth mineralization,BP,
2671,GO:0034629,1,0.817600888298876,0,1,cellular protein complex localization,BP,
2672,GO:0034637,1,0.614589324949419,0,2,cellular carbohydrate biosynthetic process,BP,
2680,GO:0034660,1,0.898270644003197,0,1,ncRNA metabolic process,BP,
2684,GO:0034694,1,0.646375496778584,0,2,response to prostaglandin,BP,
2685,GO:0034695,1,0.781006884258256,0,1,response to prostaglandin E,BP,
2686,GO:0034696,1,0.828354528958696,0,1,response to prostaglandin F,BP,
2691,GO:0034705,1,0.369566479446413,0,4,potassium channel complex,CC,
2692,GO:0034707,1,0.834203192552595,0,1,chloride channel complex,CC,
2694,GO:0034755,1,0.834203192552595,0,1,iron ion transmembrane transport,BP,
2704,GO:0035005,1,0.498450633860005,0,2,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
2706,GO:0035019,1,0.435751252433886,0,4,somatic stem cell population maintenance,BP,
2711,GO:0035054,1,0.766038155162373,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
2712,GO:0035065,1,0.730053612763015,0,1,regulation of histone acetylation,BP,
2713,GO:0035066,1,0.730053612763015,0,1,positive regulation of histone acetylation,BP,
2714,GO:0035088,1,0.480964539241892,0,2,establishment or maintenance of apical/basal cell polarity,BP,
2715,GO:0035089,1,0.480964539241892,0,2,establishment of apical/basal cell polarity,BP,
2717,GO:0035094,1,0.828354528958696,0,1,response to nicotine,BP,
2718,GO:0035107,1,0.111110736737287,0,9,appendage morphogenesis,BP,
2719,GO:0035108,1,0.111110736737287,0,9,limb morphogenesis,BP,
2720,GO:0035112,1,0.941285075943011,0,1,genitalia morphogenesis,BP,
2721,GO:0035113,1,0.11844343056268,0,8,embryonic appendage morphogenesis,BP,
2722,GO:0035115,1,0.745353356214418,0,2,embryonic forelimb morphogenesis,BP,
2723,GO:0035116,1,0.33758894298319,0,5,embryonic hindlimb morphogenesis,BP,
2724,GO:0035136,1,0.745353356214418,0,2,forelimb morphogenesis,BP,
2725,GO:0035137,1,0.33758894298319,0,5,hindlimb morphogenesis,BP,
2727,GO:0035150,1,0.15599030630525,0,9,regulation of tube size,BP,
2729,GO:0035194,1,0.850452765079241,0,1,posttranscriptional gene silencing by RNA,BP,
2730,GO:0035195,1,0.850452765079241,0,1,gene silencing by miRNA,BP,
2731,GO:0035196,1,0.850452765079241,0,1,production of miRNAs involved in gene silencing by miRNA,BP,
2734,GO:0035249,1,0.782385944864048,0,1,synaptic transmission, glutamatergic,BP,
2735,GO:0035250,1,0.787775492853738,0,1,UDP-galactosyltransferase activity,MF,
2736,GO:0035257,1,0.698454611733275,0,1,nuclear hormone receptor binding,MF,
2737,GO:0035264,1,0.475129723939441,0,3,multicellular organism growth,BP,
2743,GO:0035296,1,0.15599030630525,0,9,regulation of tube diameter,BP,
2745,GO:0035304,1,0.782385944864048,0,1,regulation of protein dephosphorylation,BP,
2747,GO:0035306,1,0.598624338976455,0,2,positive regulation of dephosphorylation,BP,
2748,GO:0035307,1,0.782385944864048,0,1,positive regulation of protein dephosphorylation,BP,
2749,GO:0035313,1,0.494922819797838,0,3,wound healing, spreading of epidermal cells,BP,
2751,GO:0035329,1,0.639456775809035,0,1,hippo signaling,BP,
2758,GO:0035411,1,0.733087029820149,0,1,catenin import into nucleus,BP,
2759,GO:0035412,1,0.733087029820149,0,1,regulation of catenin import into nucleus,BP,
2760,GO:0035418,1,0.566183657895701,0,2,protein localization to synapse,BP,
2761,GO:0035428,1,0.821374167469034,0,1,hexose transmembrane transport,BP,
2764,GO:0035493,1,0.788402850719053,0,1,SNARE complex assembly,BP,
2767,GO:0035567,1,0.300858340595105,0,4,non-canonical Wnt signaling pathway,BP,
2768,GO:0035577,1,0.652920314241421,0,2,azurophil granule membrane,CC,
2769,GO:0035579,1,0.487479448914371,0,3,specific granule membrane,CC,
2770,GO:0035580,1,0.784473242465539,0,1,specific granule lumen,CC,
2771,GO:0035584,1,0.923408743724329,0,1,calcium-mediated signaling using intracellular calcium source,BP,
2772,GO:0035586,1,0.782385944864048,0,1,purinergic receptor activity,MF,
2773,GO:0035587,1,0.782385944864048,0,1,purinergic receptor signaling pathway,BP,
2774,GO:0035588,1,0.782385944864048,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
2776,GO:0035601,1,0.6837505749659,0,1,protein deacylation,BP,
2777,GO:0035624,1,0.636999731039707,0,2,receptor transactivation,BP,
2778,GO:0035625,1,0.636999731039707,0,2,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
2779,GO:0035630,1,0.766038155162373,0,1,bone mineralization involved in bone maturation,BP,
2780,GO:0035635,1,0.694582335858129,0,1,entry of bacterium into host cell,BP,
2781,GO:0035637,1,0.0742151066640092,0,9,multicellular organismal signaling,BP,
2784,GO:0035646,1,0.87844991147751,0,1,endosome to melanosome transport,BP,
2785,GO:0035650,1,0.87844991147751,0,1,AP-1 adaptor complex binding,MF,
2786,GO:0035651,1,0.87844991147751,0,1,AP-3 adaptor complex binding,MF,
2787,GO:0035655,1,0.608707925787425,0,2,interleukin-18-mediated signaling pathway,BP,
2788,GO:0035659,1,0.855530641430602,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
2791,GO:0035710,1,0.761153424935427,0,1,CD4-positive, alpha-beta T cell activation,BP,
2792,GO:0035728,1,0.760110775581285,0,1,response to hepatocyte growth factor,BP,
2793,GO:0035729,1,0.760110775581285,0,1,cellular response to hepatocyte growth factor stimulus,BP,
2794,GO:0035747,1,0.676247599336564,0,1,natural killer cell chemotaxis,BP,
2796,GO:0035767,1,0.59183921579231,0,1,endothelial cell chemotaxis,BP,
2797,GO:0035787,1,0.780266268444755,0,1,cell migration involved in kidney development,BP,
2798,GO:0035788,1,0.780266268444755,0,1,cell migration involved in metanephros development,BP,
2799,GO:0035789,1,0.780266268444755,0,1,metanephric mesenchymal cell migration,BP,
2800,GO:0035791,1,0.780266268444755,0,1,platelet-derived growth factor receptor-beta signaling pathway,BP,
2801,GO:0035793,1,0.780266268444755,0,1,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
2802,GO:0035794,1,0.839760482627469,0,1,positive regulation of mitochondrial membrane permeability,BP,
2805,GO:0035809,1,0.594244500784469,0,2,regulation of urine volume,BP,
2806,GO:0035810,1,0.594244500784469,0,2,positive regulation of urine volume,BP,
2807,GO:0035812,1,0.463842714461611,0,3,renal sodium excretion,BP,
2808,GO:0035813,1,0.463842714461611,0,3,regulation of renal sodium excretion,BP,
2809,GO:0035814,1,0.782385944864048,0,1,negative regulation of renal sodium excretion,BP,
2810,GO:0035815,1,0.594244500784469,0,2,positive regulation of renal sodium excretion,BP,
2811,GO:0035821,1,0.832024114860243,0,1,modification of morphology or physiology of other organism,BP,
2812,GO:0035844,1,0.850452765079241,0,1,cloaca development,BP,
2814,GO:0035855,1,0.761153424935427,0,1,megakaryocyte development,BP,
2815,GO:0035859,1,0.749336515652812,0,1,Seh1-associated complex,CC,
2817,GO:0035878,1,0.665308550780754,0,1,nail development,BP,
2819,GO:0035886,1,0.460765373521377,0,2,vascular smooth muscle cell differentiation,BP,
2820,GO:0035900,1,0.898270644003197,0,1,response to isolation stress,BP,
2822,GO:0035904,1,0.309500178880308,0,4,aorta development,BP,
2823,GO:0035907,1,0.814984680586157,0,1,dorsal aorta development,BP,
2824,GO:0035909,1,0.309500178880308,0,4,aorta morphogenesis,BP,
2825,GO:0035912,1,0.814984680586157,0,1,dorsal aorta morphogenesis,BP,
2826,GO:0035914,1,0.59183921579231,0,1,skeletal muscle cell differentiation,BP,
2828,GO:0035929,1,0.768189760920054,0,1,steroid hormone secretion,BP,
2829,GO:0035930,1,0.768189760920054,0,1,corticosteroid hormone secretion,BP,
2830,GO:0035931,1,0.768189760920054,0,1,mineralocorticoid secretion,BP,
2831,GO:0035932,1,0.768189760920054,0,1,aldosterone secretion,BP,
2832,GO:0035939,1,0.814984680586157,0,1,microsatellite binding,MF,
2835,GO:0035970,1,0.800672150482427,0,1,peptidyl-threonine dephosphorylation,BP,
2838,GO:0035989,1,0.850452765079241,0,1,tendon development,BP,
2839,GO:0035990,1,0.850452765079241,0,1,tendon cell differentiation,BP,
2840,GO:0035992,1,0.850452765079241,0,1,tendon formation,BP,
2841,GO:0035993,1,0.850452765079241,0,1,deltoid tuberosity development,BP,
2842,GO:0035994,1,0.828354528958696,0,1,response to muscle stretch,BP,
2843,GO:0036003,1,0.442362255833277,0,2,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
2844,GO:0036010,1,0.727489805589545,0,1,protein localization to endosome,BP,
2852,GO:0036035,1,0.755771665883275,0,1,osteoclast development,BP,
2854,GO:0036075,1,0.514447661618388,0,3,replacement ossification,BP,
2855,GO:0036089,1,0.681433432009857,0,1,cleavage furrow formation,BP,
2856,GO:0036091,1,0.749336515652812,0,1,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
2859,GO:0036118,1,0.725126756103963,0,1,hyaluranon cable assembly,BP,
2860,GO:0036151,1,0.73462101006065,0,1,phosphatidylcholine acyl-chain remodeling,BP,
2861,GO:0036152,1,0.73462101006065,0,1,phosphatidylethanolamine acyl-chain remodeling,BP,
2862,GO:0036166,1,0.780266268444755,0,1,phenotypic switching,BP,
2865,GO:0036257,1,0.784473242465539,0,1,multivesicular body organization,BP,
2867,GO:0036294,1,0.229786268727168,0,5,cellular response to decreased oxygen levels,BP,
2869,GO:0036304,1,0.814984680586157,0,1,umbilical cord morphogenesis,BP,
2872,GO:0036342,1,0.662592268986548,0,1,post-anal tail morphogenesis,BP,
2873,GO:0036344,1,0.761153424935427,0,1,platelet morphogenesis,BP,
2875,GO:0036461,1,0.87844991147751,0,1,BLOC-2 complex binding,MF,
2876,GO:0036465,1,0.724367006107158,0,2,synaptic vesicle recycling,BP,
2877,GO:0036473,1,0.781006884258256,0,1,cell death in response to oxidative stress,BP,
2879,GO:0036490,1,0.749336515652812,0,1,regulation of translation in response to endoplasmic reticulum stress,BP,
2880,GO:0036514,1,0.662592268986548,0,1,dopaminergic neuron axon guidance,BP,
2881,GO:0036515,1,0.662592268986548,0,1,serotonergic neuron axon guidance,BP,
2882,GO:0036517,1,0.662592268986548,0,1,chemoattraction of serotonergic neuron axon,BP,
2883,GO:0036518,1,0.662592268986548,0,1,chemorepulsion of dopaminergic neuron axon,BP,
2884,GO:0038001,1,0.780266268444755,0,1,paracrine signaling,BP,
2886,GO:0038028,1,0.738574234795428,0,1,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
2887,GO:0038030,1,0.352762343768439,0,3,non-canonical Wnt signaling pathway via MAPK cascade,BP,
2888,GO:0038031,1,0.484688036404671,0,2,non-canonical Wnt signaling pathway via JNK cascade,BP,
2890,GO:0038060,1,0.760556996405447,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
2891,GO:0038061,1,0.781006884258256,0,1,NIK/NF-kappaB signaling,BP,
2892,GO:0038062,1,0.733567890553574,0,1,protein tyrosine kinase collagen receptor activity,MF,
2893,GO:0038063,1,0.733567890553574,0,1,collagen-activated tyrosine kinase receptor signaling pathway,BP,
2894,GO:0038064,1,0.733567890553574,0,1,collagen receptor activity,MF,
2895,GO:0038065,1,0.733567890553574,0,1,collagen-activated signaling pathway,BP,
2896,GO:0038066,1,0.675516485569067,0,2,p38MAPK cascade,BP,
2897,GO:0038083,1,0.733567890553574,0,1,peptidyl-tyrosine autophosphorylation,BP,
2905,GO:0038132,1,0.665308550780754,0,1,neuregulin binding,MF,
2907,GO:0038179,1,0.760110775581285,0,1,neurotrophin signaling pathway,BP,
2908,GO:0038181,1,0.698454611733275,0,1,bile acid receptor activity,MF,
2909,GO:0038183,1,0.698454611733275,0,1,bile acid signaling pathway,BP,
2910,GO:0038186,1,0.698454611733275,0,1,lithocholic acid receptor activity,MF,
2911,GO:0038201,1,0.551214759448113,0,2,TOR complex,CC,
2912,GO:0038202,1,0.749336515652812,0,1,TORC1 signaling,BP,
2913,GO:0038203,1,0.736743667269758,0,1,TORC2 signaling,BP,
2915,GO:0039706,1,0.650932589184655,0,2,co-receptor binding,MF,
2916,GO:0040001,1,0.941285075943011,0,1,establishment of mitotic spindle localization,BP,
2922,GO:0040014,1,0.475129723939441,0,3,regulation of multicellular organism growth,BP,
2924,GO:0040018,1,0.670370234134071,0,1,positive regulation of multicellular organism growth,BP,
2925,GO:0040019,1,0.276540973287721,0,5,positive regulation of embryonic development,BP,
2926,GO:0040020,1,0.351286469667283,0,3,regulation of meiotic nuclear division,BP,
2927,GO:0040029,1,0.850452765079241,0,1,regulation of gene expression, epigenetic,BP,
2929,GO:0040036,1,0.483071218279717,0,2,regulation of fibroblast growth factor receptor signaling pathway,BP,
2930,GO:0040037,1,0.483071218279717,0,2,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
2931,GO:0042033,1,0.662592268986548,0,1,chemokine biosynthetic process,BP,
2932,GO:0042035,1,0.353062617769002,0,4,regulation of cytokine biosynthetic process,BP,
2933,GO:0042036,1,0.580301260184215,0,2,negative regulation of cytokine biosynthetic process,BP,
2934,GO:0042044,1,0.828354528958696,0,1,fluid transport,BP,
2935,GO:0042045,1,0.828354528958696,0,1,epithelial fluid transport,BP,
2936,GO:0042056,1,0.372633539760017,0,5,chemoattractant activity,MF,
2937,GO:0042058,1,0.309643766372757,0,5,regulation of epidermal growth factor receptor signaling pathway,BP,
2938,GO:0042059,1,0.802878249889337,0,1,negative regulation of epidermal growth factor receptor signaling pathway,BP,
2941,GO:0042074,1,0.382354724014539,0,3,cell migration involved in gastrulation,BP,
2942,GO:0042088,1,0.898270644003197,0,1,T-helper 1 type immune response,BP,
2943,GO:0042089,1,0.353062617769002,0,4,cytokine biosynthetic process,BP,
2944,GO:0042093,1,0.761153424935427,0,1,T-helper cell differentiation,BP,
2945,GO:0042095,1,0.761153424935427,0,1,interferon-gamma biosynthetic process,BP,
2946,GO:0042097,1,0.761153424935427,0,1,interleukin-4 biosynthetic process,BP,
2949,GO:0042107,1,0.353062617769002,0,4,cytokine metabolic process,BP,
2950,GO:0042108,1,0.464228454873716,0,3,positive regulation of cytokine biosynthetic process,BP,
2953,GO:0042116,1,0.662592268986548,0,1,macrophage activation,BP,
2958,GO:0042147,1,0.769896520332264,0,1,retrograde transport, endosome to Golgi,BP,
2962,GO:0042171,1,0.73462101006065,0,1,lysophosphatidic acid acyltransferase activity,MF,
2964,GO:0042176,1,0.147680779212172,0,6,regulation of protein catabolic process,BP,
2968,GO:0042222,1,0.923408743724329,0,1,interleukin-1 biosynthetic process,BP,
2969,GO:0042246,1,0.347060685397931,0,4,tissue regeneration,BP,
2970,GO:0042249,1,0.662592268986548,0,1,establishment of planar polarity of embryonic epithelium,BP,
2971,GO:0042267,1,0.784473242465539,0,1,natural killer cell mediated cytotoxicity,BP,
2973,GO:0042278,1,0.704992319915139,0,1,purine nucleoside metabolic process,BP,
2974,GO:0042297,1,0.781943571206073,0,1,vocal learning,BP,
2979,GO:0042310,1,0.353979005436789,0,5,vasoconstriction,BP,
2980,GO:0042311,1,0.782385944864048,0,1,vasodilation,BP,
2981,GO:0042313,1,0.828354528958696,0,1,protein kinase C deactivation,BP,
2982,GO:0042321,1,0.782385944864048,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
2983,GO:0042323,1,0.782385944864048,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
2988,GO:0042339,1,0.787775492853738,0,1,keratan sulfate metabolic process,BP,
2989,GO:0042345,1,0.725126756103963,0,1,regulation of NF-kappaB import into nucleus,BP,
2990,GO:0042347,1,0.725126756103963,0,1,negative regulation of NF-kappaB import into nucleus,BP,
2991,GO:0042348,1,0.725126756103963,0,1,NF-kappaB import into nucleus,BP,
2992,GO:0042359,1,0.698454611733275,0,1,vitamin D metabolic process,BP,
2993,GO:0042362,1,0.698454611733275,0,1,fat-soluble vitamin biosynthetic process,BP,
2994,GO:0042368,1,0.698454611733275,0,1,vitamin D biosynthetic process,BP,
2995,GO:0042379,1,0.923408743724329,0,1,chemokine receptor binding,MF,
2996,GO:0042383,1,0.711185484621141,0,1,sarcolemma,CC,
2998,GO:0042414,1,0.897954377332652,0,1,epinephrine metabolic process,BP,
2999,GO:0042417,1,0.718207300668576,0,1,dopamine metabolic process,BP,
3000,GO:0042418,1,0.897954377332652,0,1,epinephrine biosynthetic process,BP,
3001,GO:0042423,1,0.897954377332652,0,1,catecholamine biosynthetic process,BP,
3002,GO:0042438,1,0.662592268986548,0,1,melanin biosynthetic process,BP,
3003,GO:0042440,1,0.662592268986548,0,1,pigment metabolic process,BP,
3011,GO:0042474,1,0.828354528958696,0,1,middle ear morphogenesis,BP,
3014,GO:0042481,1,0.416587060164222,0,5,regulation of odontogenesis,BP,
3015,GO:0042482,1,0.542242651098154,0,3,positive regulation of odontogenesis,BP,
3016,GO:0042487,1,0.589678144715651,0,3,regulation of odontogenesis of dentin-containing tooth,BP,
3019,GO:0042492,1,0.687227117442492,0,1,gamma-delta T cell differentiation,BP,
3021,GO:0042501,1,0.730053612763015,0,1,serine phosphorylation of STAT protein,BP,
3022,GO:0042503,1,0.619506013751581,0,2,tyrosine phosphorylation of Stat3 protein,BP,
3023,GO:0042508,1,0.730053612763015,0,1,tyrosine phosphorylation of Stat1 protein,BP,
3024,GO:0042509,1,0.619506013751581,0,2,regulation of tyrosine phosphorylation of STAT protein,BP,
3025,GO:0042510,1,0.730053612763015,0,1,regulation of tyrosine phosphorylation of Stat1 protein,BP,
3026,GO:0042511,1,0.730053612763015,0,1,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
3027,GO:0042516,1,0.619506013751581,0,2,regulation of tyrosine phosphorylation of Stat3 protein,BP,
3028,GO:0042517,1,0.619506013751581,0,2,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
3029,GO:0042531,1,0.619506013751581,0,2,positive regulation of tyrosine phosphorylation of STAT protein,BP,
3032,GO:0042551,1,0.670370234134071,0,1,neuron maturation,BP,
3034,GO:0042554,1,0.828354528958696,0,1,superoxide anion generation,BP,
3038,GO:0042581,1,0.381177521771608,0,4,specific granule,CC,
3039,GO:0042582,1,0.652920314241421,0,2,azurophil granule,CC,
3040,GO:0042583,1,0.832024114860243,0,1,chromaffin granule,CC,
3041,GO:0042587,1,0.604707407962162,0,1,glycogen granule,CC,
3042,GO:0042588,1,0.843650774888678,0,1,zymogen granule,CC,
3048,GO:0042629,1,0.561913766641372,0,2,mast cell granule,CC,
3050,GO:0042634,1,0.662592268986548,0,1,regulation of hair cycle,BP,
3051,GO:0042635,1,0.662592268986548,0,1,positive regulation of hair cycle,BP,
3052,GO:0042640,1,0.662592268986548,0,1,anagen,BP,
3053,GO:0042659,1,0.733087029820149,0,1,regulation of cell fate specification,BP,
3054,GO:0042665,1,0.733087029820149,0,1,regulation of ectodermal cell fate specification,BP,
3055,GO:0042666,1,0.733087029820149,0,1,negative regulation of ectodermal cell fate specification,BP,
3058,GO:0042695,1,0.662592268986548,0,1,thelarche,BP,
3061,GO:0042730,1,0.800794052075968,0,1,fibrinolysis,BP,
3062,GO:0042733,1,0.282593467716724,0,4,embryonic digit morphogenesis,BP,
3063,GO:0042734,1,0.782385944864048,0,1,presynaptic membrane,CC,
3064,GO:0042742,1,0.768025523124241,0,2,defense response to bacterium,BP,
3065,GO:0042745,1,0.782385944864048,0,1,circadian sleep/wake cycle,BP,
3066,GO:0042748,1,0.782385944864048,0,1,circadian sleep/wake cycle, non-REM sleep,BP,
3067,GO:0042749,1,0.782385944864048,0,1,regulation of circadian sleep/wake cycle,BP,
3068,GO:0042752,1,0.782385944864048,0,1,regulation of circadian rhythm,BP,
3069,GO:0042754,1,0.782385944864048,0,1,negative regulation of circadian rhythm,BP,
3073,GO:0042787,1,0.500407991984192,0,2,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3076,GO:0042813,1,0.559481610903871,0,2,Wnt-activated receptor activity,MF,
3077,GO:0042832,1,0.898270644003197,0,1,defense response to protozoan,BP,
3080,GO:0042974,1,0.698454611733275,0,1,retinoic acid receptor binding,MF,
3084,GO:0042992,1,0.725126756103963,0,1,negative regulation of transcription factor import into nucleus,BP,
3094,GO:0043029,1,0.655311057413809,0,2,T cell homeostasis,BP,
3095,GO:0043030,1,0.662592268986548,0,1,regulation of macrophage activation,BP,
3096,GO:0043032,1,0.662592268986548,0,1,positive regulation of macrophage activation,BP,
3098,GO:0043043,1,0.496235265868628,0,3,peptide biosynthetic process,BP,
3110,GO:0043113,1,0.711185484621141,0,1,receptor clustering,BP,
3111,GO:0043114,1,0.718207300668576,0,1,regulation of vascular permeability,BP,
3112,GO:0043122,1,0.351057653571451,0,4,regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3113,GO:0043123,1,0.641691812313783,0,2,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3114,GO:0043124,1,0.549747838911486,0,2,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3119,GO:0043161,1,0.311651581428465,0,4,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
3125,GO:0043179,1,0.828354528958696,0,1,rhythmic excitation,BP,
3126,GO:0043184,1,0.715318261416419,0,1,vascular endothelial growth factor receptor 2 binding,MF,
3127,GO:0043194,1,0.670370234134071,0,1,axon initial segment,CC,
3128,GO:0043195,1,0.616170925542981,0,2,terminal bouton,CC,
3130,GO:0043198,1,0.673830352346191,0,1,dendritic shaft,CC,
3132,GO:0043201,1,0.749336515652812,0,1,response to leucine,BP,
3134,GO:0043203,1,0.670370234134071,0,1,axon hillock,CC,
3135,GO:0043204,1,0.633541893109308,0,1,perikaryon,CC,
3138,GO:0043217,1,0.781006884258256,0,1,myelin maintenance,BP,
3139,GO:0043218,1,0.741010011526507,0,1,compact myelin,CC,
3140,GO:0043220,1,0.741010011526507,0,1,Schmidt-Lanterman incisure,CC,
3157,GO:0043255,1,0.454948935330503,0,3,regulation of carbohydrate biosynthetic process,BP,
3167,GO:0043276,1,0.181883681001111,0,5,anoikis,BP,
3169,GO:0043279,1,0.653897348227705,0,2,response to alkaloid,BP,
3173,GO:0043295,1,0.850380627707629,0,1,glutathione binding,MF,
3177,GO:0043303,1,0.561913766641372,0,2,mast cell degranulation,BP,
3179,GO:0043316,1,0.784473242465539,0,1,cytotoxic T cell degranulation,BP,
3180,GO:0043320,1,0.784473242465539,0,1,natural killer cell degranulation,BP,
3181,GO:0043325,1,0.781006884258256,0,1,phosphatidylinositol-3,4-bisphosphate binding,MF,
3182,GO:0043330,1,0.817600888298876,0,1,response to exogenous dsRNA,BP,
3183,GO:0043331,1,0.582776247784627,0,3,response to dsRNA,BP,
3184,GO:0043367,1,0.761153424935427,0,1,CD4-positive, alpha-beta T cell differentiation,BP,
3185,GO:0043368,1,0.761153424935427,0,1,positive T cell selection,BP,
3186,GO:0043369,1,0.761153424935427,0,1,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
3187,GO:0043373,1,0.761153424935427,0,1,CD4-positive, alpha-beta T cell lineage commitment,BP,
3188,GO:0043392,1,0.814984680586157,0,1,negative regulation of DNA binding,BP,
3189,GO:0043393,1,0.205780900016309,0,6,regulation of protein binding,BP,
3190,GO:0043401,1,0.428976908541838,0,3,steroid hormone mediated signaling pathway,BP,
3191,GO:0043403,1,0.626593131137752,0,2,skeletal muscle tissue regeneration,BP,
3194,GO:0043407,1,0.492279770856842,0,3,negative regulation of MAP kinase activity,BP,
3196,GO:0043409,1,0.278254585696884,0,5,negative regulation of MAPK cascade,BP,
3199,GO:0043413,1,0.787775492853738,0,1,macromolecule glycosylation,BP,
3200,GO:0043414,1,0.622488898498417,0,2,macromolecule methylation,BP,
3204,GO:0043455,1,0.662592268986548,0,1,regulation of secondary metabolic process,BP,
3205,GO:0043457,1,0.575732336943012,0,2,regulation of cellular respiration,BP,
3206,GO:0043462,1,0.941285075943011,0,1,regulation of ATPase activity,BP,
3207,GO:0043465,1,0.780567658291826,0,1,regulation of fermentation,BP,
3208,GO:0043467,1,0.44853792169098,0,3,regulation of generation of precursor metabolites and energy,BP,
3209,GO:0043470,1,0.780567658291826,0,1,regulation of carbohydrate catabolic process,BP,
3211,GO:0043476,1,0.87844991147751,0,1,pigment accumulation,BP,
3212,GO:0043482,1,0.87844991147751,0,1,cellular pigment accumulation,BP,
3214,GO:0043485,1,0.87844991147751,0,1,endosome to pigment granule transport,BP,
3215,GO:0043487,1,0.731372175333709,0,2,regulation of RNA stability,BP,
3216,GO:0043488,1,0.731372175333709,0,2,regulation of mRNA stability,BP,
3217,GO:0043489,1,0.936826423682637,0,1,RNA stabilization,BP,
3219,GO:0043500,1,0.646010841297154,0,2,muscle adaptation,BP,
3220,GO:0043501,1,0.780567658291826,0,1,skeletal muscle adaptation,BP,
3221,GO:0043502,1,0.646010841297154,0,2,regulation of muscle adaptation,BP,
3222,GO:0043506,1,0.227414300287828,0,5,regulation of JUN kinase activity,BP,
3223,GO:0043507,1,0.227414300287828,0,5,positive regulation of JUN kinase activity,BP,
3224,GO:0043516,1,0.839760482627469,0,1,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
3225,GO:0043517,1,0.839760482627469,0,1,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
3226,GO:0043523,1,0.345379016658196,0,6,regulation of neuron apoptotic process,BP,
3227,GO:0043524,1,0.345379016658196,0,6,negative regulation of neuron apoptotic process,BP,
3229,GO:0043532,1,0.639456775809035,0,1,angiostatin binding,MF,
3230,GO:0043534,1,0.161020228677082,0,5,blood vessel endothelial cell migration,BP,
3231,GO:0043535,1,0.358652658935451,0,3,regulation of blood vessel endothelial cell migration,BP,
3232,GO:0043536,1,0.608707925787425,0,2,positive regulation of blood vessel endothelial cell migration,BP,
3233,GO:0043537,1,0.59183921579231,0,1,negative regulation of blood vessel endothelial cell migration,BP,
3235,GO:0043543,1,0.501408967118874,0,2,protein acylation,BP,
3241,GO:0043552,1,0.780266268444755,0,1,positive regulation of phosphatidylinositol 3-kinase activity,BP,
3242,GO:0043555,1,0.749336515652812,0,1,regulation of translation in response to stress,BP,
3246,GO:0043567,1,0.766038155162373,0,1,regulation of insulin-like growth factor receptor signaling pathway,BP,
3247,GO:0043569,1,0.766038155162373,0,1,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
3248,GO:0043576,1,0.782385944864048,0,1,regulation of respiratory gaseous exchange,BP,
3250,GO:0043584,1,0.588530561595628,0,2,nose development,BP,
3251,GO:0043585,1,0.781943571206073,0,1,nose morphogenesis,BP,
3254,GO:0043604,1,0.496235265868628,0,3,amide biosynthetic process,BP,
3255,GO:0043616,1,0.467674222013895,0,3,keratinocyte proliferation,BP,
3256,GO:0043618,1,0.442362255833277,0,2,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
3257,GO:0043619,1,0.749336515652812,0,1,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3258,GO:0043620,1,0.442362255833277,0,2,regulation of DNA-templated transcription in response to stress,BP,
3259,GO:0043621,1,0.560534968294878,0,1,protein self-association,MF,
3263,GO:0043632,1,0.311651581428465,0,4,modification-dependent macromolecule catabolic process,BP,
3264,GO:0043679,1,0.515757355644357,0,3,axon terminus,CC,
3266,GO:0043696,1,0.780266268444755,0,1,dedifferentiation,BP,
3267,GO:0043697,1,0.780266268444755,0,1,cell dedifferentiation,BP,
3268,GO:0043900,1,0.331599636480048,0,4,regulation of multi-organism process,BP,
3269,GO:0043901,1,0.962412700305168,0,1,negative regulation of multi-organism process,BP,
3270,GO:0043902,1,0.344986397100729,0,3,positive regulation of multi-organism process,BP,
3271,GO:0043903,1,0.59183921579231,0,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,
3272,GO:0043931,1,0.766038155162373,0,1,ossification involved in bone maturation,BP,
3275,GO:0043966,1,0.730053612763015,0,1,histone H3 acetylation,BP,
3276,GO:0043974,1,0.730053612763015,0,1,histone H3-K27 acetylation,BP,
3277,GO:0044028,1,0.738574234795428,0,1,DNA hypomethylation,BP,
3278,GO:0044029,1,0.738574234795428,0,1,hypomethylation of CpG island,BP,
3279,GO:0044030,1,0.738574234795428,0,1,regulation of DNA methylation,BP,
3280,GO:0044042,1,0.781006884258256,0,1,glucan metabolic process,BP,
3282,GO:0044058,1,0.676231336708854,0,2,regulation of digestive system process,BP,
3283,GO:0044060,1,0.370694480069297,0,3,regulation of endocrine process,BP,
3284,GO:0044062,1,0.463842714461611,0,3,regulation of excretion,BP,
3285,GO:0044065,1,0.782385944864048,0,1,regulation of respiratory system process,BP,
3286,GO:0044070,1,0.420004806755683,0,4,regulation of anion transport,BP,
3289,GO:0044088,1,0.817600888298876,0,1,regulation of vacuole organization,BP,
3291,GO:0044090,1,0.817600888298876,0,1,positive regulation of vacuole organization,BP,
3292,GO:0044091,1,0.711185484621141,0,1,membrane biogenesis,BP,
3301,GO:0044242,1,0.393819444537025,0,3,cellular lipid catabolic process,BP,
3307,GO:0044257,1,0.128229257678018,0,8,cellular protein catabolic process,BP,
3310,GO:0044262,1,0.169186302552799,0,7,cellular carbohydrate metabolic process,BP,
3311,GO:0044264,1,0.614589324949419,0,2,cellular polysaccharide metabolic process,BP,
3312,GO:0044265,1,0.0479920957068675,0,11,cellular macromolecule catabolic process,BP,
3318,GO:0044282,1,0.188442067238326,0,6,small molecule catabolic process,BP,
3320,GO:0044291,1,0.356696578335597,0,3,cell-cell contact zone,CC,
3322,GO:0044304,1,0.52358968328039,0,2,main axon,CC,
3323,GO:0044306,1,0.412242993998045,0,4,neuron projection terminus,CC,
3325,GO:0044319,1,0.361630446594202,0,4,wound healing, spreading of cells,BP,
3326,GO:0044320,1,0.763405242997684,0,1,cellular response to leptin stimulus,BP,
3327,GO:0044321,1,0.631762713585514,0,2,response to leptin,BP,
3329,GO:0044331,1,0.470119254499318,0,2,cell-cell adhesion mediated by cadherin,BP,
3330,GO:0044338,1,0.871622561621531,0,1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
3331,GO:0044339,1,0.871622561621531,0,1,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
3332,GO:0044340,1,0.871622561621531,0,1,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
3335,GO:0044364,1,0.832024114860243,0,1,disruption of cells of other organism,BP,
3338,GO:0044390,1,0.665337439618267,0,1,ubiquitin-like protein conjugating enzyme binding,MF,
3361,GO:0044445,1,0.545370950726175,0,2,cytosolic part,CC,
3367,GO:0044454,1,0.6837505749659,0,1,nuclear chromosome part,CC,
3372,GO:0044550,1,0.662592268986548,0,1,secondary metabolite biosynthetic process,BP,
3373,GO:0044557,1,0.782385944864048,0,1,relaxation of smooth muscle,BP,
3385,GO:0044723,1,0.095626266235064,0,9,single-organism carbohydrate metabolic process,BP,
3386,GO:0044724,1,0.446054970520777,0,3,single-organism carbohydrate catabolic process,BP,
3387,GO:0044728,1,0.738574234795428,0,1,DNA methylation or demethylation,BP,
3390,GO:0044752,1,0.813104792706398,0,1,response to human chorionic gonadotropin,BP,
3394,GO:0044766,1,0.585805457600735,0,2,multi-organism transport,BP,
3402,GO:0044798,1,0.698454611733275,0,1,nuclear transcription factor complex,CC,
3411,GO:0044848,1,0.662592268986548,0,1,biological phase,BP,
3412,GO:0044851,1,0.662592268986548,0,1,hair cycle phase,BP,
3413,GO:0044853,1,0.492938323459123,0,2,plasma membrane raft,CC,
3416,GO:0045009,1,0.688674490385899,0,2,chitosome,CC,
3418,GO:0045022,1,0.727489805589545,0,1,early endosome to late endosome transport,BP,
3421,GO:0045054,1,0.784473242465539,0,1,constitutive secretory pathway,BP,
3423,GO:0045056,1,0.840429863359978,0,1,transcytosis,BP,
3424,GO:0045058,1,0.522158333787442,0,2,T cell selection,BP,
3425,GO:0045061,1,0.687227117442492,0,1,thymic T cell selection,BP,
3426,GO:0045069,1,0.59183921579231,0,1,regulation of viral genome replication,BP,
3427,GO:0045070,1,0.59183921579231,0,1,positive regulation of viral genome replication,BP,
3428,GO:0045072,1,0.761153424935427,0,1,regulation of interferon-gamma biosynthetic process,BP,
3429,GO:0045073,1,0.662592268986548,0,1,regulation of chemokine biosynthetic process,BP,
3430,GO:0045078,1,0.761153424935427,0,1,positive regulation of interferon-gamma biosynthetic process,BP,
3431,GO:0045080,1,0.662592268986548,0,1,positive regulation of chemokine biosynthetic process,BP,
3435,GO:0045103,1,0.67497188939156,0,1,intermediate filament-based process,BP,
3436,GO:0045104,1,0.67497188939156,0,1,intermediate filament cytoskeleton organization,BP,
3437,GO:0045109,1,0.67497188939156,0,1,intermediate filament organization,BP,
3438,GO:0045110,1,0.67497188939156,0,1,intermediate filament bundle assembly,BP,
3439,GO:0045111,1,0.67497188939156,0,1,intermediate filament cytoskeleton,CC,
3440,GO:0045117,1,0.828354528958696,0,1,azole transport,BP,
3442,GO:0045123,1,0.676247599336564,0,1,cellular extravasation,BP,
3443,GO:0045124,1,0.755771665883275,0,1,regulation of bone resorption,BP,
3444,GO:0045125,1,0.849948042925311,0,1,bioactive lipid receptor activity,MF,
3445,GO:0045136,1,0.662592268986548,0,1,development of secondary sexual characteristics,BP,
3447,GO:0045161,1,0.670370234134071,0,1,neuronal ion channel clustering,BP,
3448,GO:0045162,1,0.670370234134071,0,1,clustering of voltage-gated sodium channels,BP,
3455,GO:0045185,1,0.522661227069333,0,2,maintenance of protein location,BP,
3456,GO:0045187,1,0.782385944864048,0,1,regulation of circadian sleep/wake cycle, sleep,BP,
3457,GO:0045188,1,0.782385944864048,0,1,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
3458,GO:0045190,1,0.849407889468112,0,1,isotype switching,BP,
3459,GO:0045191,1,0.849407889468112,0,1,regulation of isotype switching,BP,
3460,GO:0045197,1,0.480964539241892,0,2,establishment or maintenance of epithelial cell apical/basal polarity,BP,
3461,GO:0045198,1,0.480964539241892,0,2,establishment of epithelial cell apical/basal polarity,BP,
3464,GO:0045211,1,0.232099429119126,0,4,postsynaptic membrane,CC,
3469,GO:0045294,1,0.55654904567109,0,2,alpha-catenin binding,MF,
3470,GO:0045295,1,0.492938323459123,0,2,gamma-catenin binding,MF,
3474,GO:0045333,1,0.575732336943012,0,2,cellular respiration,BP,
3475,GO:0045334,1,0.536610387123389,0,2,clathrin-coated endocytic vesicle,CC,
3477,GO:0045360,1,0.923408743724329,0,1,regulation of interleukin-1 biosynthetic process,BP,
3478,GO:0045362,1,0.923408743724329,0,1,positive regulation of interleukin-1 biosynthetic process,BP,
3479,GO:0045402,1,0.761153424935427,0,1,regulation of interleukin-4 biosynthetic process,BP,
3480,GO:0045403,1,0.761153424935427,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
3481,GO:0045428,1,0.646375496778584,0,2,regulation of nitric oxide biosynthetic process,BP,
3482,GO:0045429,1,0.646375496778584,0,2,positive regulation of nitric oxide biosynthetic process,BP,
3483,GO:0045444,1,0.129905969379985,0,8,fat cell differentiation,BP,
3486,GO:0045453,1,0.637025861979739,0,2,bone resorption,BP,
3488,GO:0045494,1,0.727702188042,0,1,photoreceptor cell maintenance,BP,
3489,GO:0045505,1,0.560534968294878,0,1,dynein intermediate chain binding,MF,
3490,GO:0045576,1,0.561913766641372,0,2,mast cell activation,BP,
3491,GO:0045580,1,0.850452765079241,0,1,regulation of T cell differentiation,BP,
3492,GO:0045581,1,0.850452765079241,0,1,negative regulation of T cell differentiation,BP,
3496,GO:0045598,1,0.182858914741012,0,6,regulation of fat cell differentiation,BP,
3497,GO:0045599,1,0.378049058434135,0,3,negative regulation of fat cell differentiation,BP,
3498,GO:0045600,1,0.489803627245487,0,3,positive regulation of fat cell differentiation,BP,
3499,GO:0045601,1,0.320190660403983,0,4,regulation of endothelial cell differentiation,BP,
3500,GO:0045603,1,0.320190660403983,0,4,positive regulation of endothelial cell differentiation,BP,
3503,GO:0045606,1,0.34953505954392,0,3,positive regulation of epidermal cell differentiation,BP,
3506,GO:0045616,1,0.412100360849637,0,2,regulation of keratinocyte differentiation,BP,
3507,GO:0045618,1,0.412100360849637,0,2,positive regulation of keratinocyte differentiation,BP,
3509,GO:0045620,1,0.850452765079241,0,1,negative regulation of lymphocyte differentiation,BP,
3518,GO:0045646,1,0.761153424935427,0,1,regulation of erythrocyte differentiation,BP,
3519,GO:0045649,1,0.730053612763015,0,1,regulation of macrophage differentiation,BP,
3520,GO:0045651,1,0.730053612763015,0,1,positive regulation of macrophage differentiation,BP,
3526,GO:0045667,1,0.0815403901394402,0,9,regulation of osteoblast differentiation,BP,
3527,GO:0045668,1,0.59183921579231,0,1,negative regulation of osteoblast differentiation,BP,
3528,GO:0045669,1,0.140268791465621,0,8,positive regulation of osteoblast differentiation,BP,
3533,GO:0045684,1,0.229920182926449,0,4,positive regulation of epidermis development,BP,
3534,GO:0045685,1,0.278329711756256,0,4,regulation of glial cell differentiation,BP,
3535,GO:0045686,1,0.59183921579231,0,1,negative regulation of glial cell differentiation,BP,
3536,GO:0045687,1,0.278329711756256,0,4,positive regulation of glial cell differentiation,BP,
3537,GO:0045725,1,0.781006884258256,0,1,positive regulation of glycogen biosynthetic process,BP,
3538,GO:0045730,1,0.676247599336564,0,1,respiratory burst,BP,
3539,GO:0045732,1,0.185186674616365,0,5,positive regulation of protein catabolic process,BP,
3541,GO:0045737,1,0.487671443777913,0,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
3542,GO:0045739,1,0.941285075943011,0,1,positive regulation of DNA repair,BP,
3544,GO:0045741,1,0.497351785793601,0,3,positive regulation of epidermal growth factor-activated receptor activity,BP,
3545,GO:0045742,1,0.387189658710626,0,4,positive regulation of epidermal growth factor receptor signaling pathway,BP,
3547,GO:0045745,1,0.832024114860243,0,1,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
3548,GO:0045746,1,0.590256239238641,0,2,negative regulation of Notch signaling pathway,BP,
3552,GO:0045776,1,0.620076211955058,0,2,negative regulation of blood pressure,BP,
3553,GO:0045777,1,0.782385944864048,0,1,positive regulation of blood pressure,BP,
3554,GO:0045778,1,0.0916182977160368,0,9,positive regulation of ossification,BP,
3555,GO:0045779,1,0.755771665883275,0,1,negative regulation of bone resorption,BP,
3559,GO:0045792,1,0.781006884258256,0,1,negative regulation of cell size,BP,
3560,GO:0045793,1,0.828354528958696,0,1,positive regulation of cell size,BP,
3563,GO:0045820,1,0.780567658291826,0,1,negative regulation of glycolytic process,BP,
3564,GO:0045822,1,0.352558086320212,0,3,negative regulation of heart contraction,BP,
3566,GO:0045824,1,0.728085055754081,0,1,negative regulation of innate immune response,BP,
3567,GO:0045830,1,0.849407889468112,0,1,positive regulation of isotype switching,BP,
3569,GO:0045834,1,0.252894702739275,0,5,positive regulation of lipid metabolic process,BP,
3570,GO:0045835,1,0.730053612763015,0,1,negative regulation of meiotic nuclear division,BP,
3571,GO:0045836,1,0.483071218279717,0,2,positive regulation of meiotic nuclear division,BP,
3572,GO:0045837,1,0.839760482627469,0,1,negative regulation of membrane potential,BP,
3573,GO:0045839,1,0.616074156900826,0,2,negative regulation of mitotic nuclear division,BP,
3574,GO:0045840,1,0.584983875937069,0,3,positive regulation of mitotic nuclear division,BP,
3575,GO:0045843,1,0.430945821794874,0,4,negative regulation of striated muscle tissue development,BP,
3577,GO:0045851,1,0.591548703543027,0,3,pH reduction,BP,
3585,GO:0045907,1,0.654264833544254,0,2,positive regulation of vasoconstriction,BP,
3586,GO:0045911,1,0.849407889468112,0,1,positive regulation of DNA recombination,BP,
3587,GO:0045912,1,0.780567658291826,0,1,negative regulation of carbohydrate metabolic process,BP,
3588,GO:0045913,1,0.397092339235338,0,4,positive regulation of carbohydrate metabolic process,BP,
3589,GO:0045920,1,0.59183921579231,0,1,negative regulation of exocytosis,BP,
3591,GO:0045922,1,0.781006884258256,0,1,negative regulation of fatty acid metabolic process,BP,
3595,GO:0045931,1,0.550156070614326,0,4,positive regulation of mitotic cell cycle,BP,
3596,GO:0045932,1,0.441916925314083,0,3,negative regulation of muscle contraction,BP,
3603,GO:0045940,1,0.560461161423182,0,2,positive regulation of steroid metabolic process,BP,
3605,GO:0045955,1,0.59183921579231,0,1,negative regulation of calcium ion-dependent exocytosis,BP,
3606,GO:0045980,1,0.646010841297154,0,2,negative regulation of nucleotide metabolic process,BP,
3607,GO:0045981,1,0.294367972064395,0,5,positive regulation of nucleotide metabolic process,BP,
3608,GO:0045986,1,0.655423550143836,0,2,negative regulation of smooth muscle contraction,BP,
3609,GO:0045987,1,0.828354528958696,0,1,positive regulation of smooth muscle contraction,BP,
3610,GO:0045988,1,0.528198301770273,0,2,negative regulation of striated muscle contraction,BP,
3614,GO:0046031,1,0.553813046047101,0,2,ADP metabolic process,BP,
3615,GO:0046034,1,0.553813046047101,0,2,ATP metabolic process,BP,
3616,GO:0046039,1,0.704992319915139,0,1,GTP metabolic process,BP,
3618,GO:0046068,1,0.345880614839141,0,4,cGMP metabolic process,BP,
3619,GO:0046128,1,0.704992319915139,0,1,purine ribonucleoside metabolic process,BP,
3620,GO:0046148,1,0.662592268986548,0,1,pigment biosynthetic process,BP,
3623,GO:0046189,1,0.594437042540646,0,2,phenol-containing compound biosynthetic process,BP,
3624,GO:0046209,1,0.646375496778584,0,2,nitric oxide metabolic process,BP,
3625,GO:0046320,1,0.781006884258256,0,1,regulation of fatty acid oxidation,BP,
3626,GO:0046322,1,0.781006884258256,0,1,negative regulation of fatty acid oxidation,BP,
3631,GO:0046329,1,0.781006884258256,0,1,negative regulation of JNK cascade,BP,
3634,GO:0046332,1,0.446139292264866,0,3,SMAD binding,MF,
3635,GO:0046364,1,0.749336515652812,0,1,monosaccharide biosynthetic process,BP,
3636,GO:0046365,1,0.446054970520777,0,3,monosaccharide catabolic process,BP,
3637,GO:0046390,1,0.433433333151153,0,4,ribose phosphate biosynthetic process,BP,
3638,GO:0046394,1,0.424337754127046,0,3,carboxylic acid biosynthetic process,BP,
3639,GO:0046395,1,0.427728004181613,0,3,carboxylic acid catabolic process,BP,
3640,GO:0046425,1,0.365064734570266,0,3,regulation of JAK-STAT cascade,BP,
3641,GO:0046427,1,0.365064734570266,0,3,positive regulation of JAK-STAT cascade,BP,
3643,GO:0046456,1,0.703978953100515,0,2,icosanoid biosynthetic process,BP,
3644,GO:0046457,1,0.703978953100515,0,2,prostanoid biosynthetic process,BP,
3645,GO:0046461,1,0.676247599336564,0,1,neutral lipid catabolic process,BP,
3646,GO:0046464,1,0.676247599336564,0,1,acylglycerol catabolic process,BP,
3647,GO:0046470,1,0.73462101006065,0,1,phosphatidylcholine metabolic process,BP,
3651,GO:0046487,1,0.733962171685514,0,1,glyoxylate metabolic process,BP,
3653,GO:0046496,1,0.553813046047101,0,2,nicotinamide nucleotide metabolic process,BP,
3654,GO:0046503,1,0.676247599336564,0,1,glycerolipid catabolic process,BP,
3656,GO:0046532,1,0.59183921579231,0,1,regulation of photoreceptor cell differentiation,BP,
3657,GO:0046533,1,0.59183921579231,0,1,negative regulation of photoreceptor cell differentiation,BP,
3658,GO:0046541,1,0.941285075943011,0,1,saliva secretion,BP,
3659,GO:0046543,1,0.662592268986548,0,1,development of secondary female sexual characteristics,BP,
3665,GO:0046605,1,0.769896520332264,0,1,regulation of centrosome cycle,BP,
3669,GO:0046629,1,0.687227117442492,0,1,gamma-delta T cell activation,BP,
3670,GO:0046631,1,0.761153424935427,0,1,alpha-beta T cell activation,BP,
3671,GO:0046632,1,0.761153424935427,0,1,alpha-beta T cell differentiation,BP,
3676,GO:0046676,1,0.763405242997684,0,1,negative regulation of insulin secretion,BP,
3677,GO:0046677,1,0.813104792706398,0,1,response to antibiotic,BP,
3680,GO:0046686,1,0.781006884258256,0,1,response to cadmium ion,BP,
3681,GO:0046697,1,0.412755643975972,0,3,decidualization,BP,
3683,GO:0046717,1,0.647520428700189,0,2,acid secretion,BP,
3685,GO:0046777,1,0.264312153802995,0,5,protein autophosphorylation,BP,
3686,GO:0046785,1,0.722881072054875,0,2,microtubule polymerization,BP,
3687,GO:0046789,1,0.763405242997684,0,1,host cell surface receptor binding,MF,
3688,GO:0046794,1,0.688189150954661,0,1,transport of virus,BP,
3689,GO:0046812,1,0.763405242997684,0,1,host cell surface binding,MF,
3697,GO:0046835,1,0.572881559912366,0,2,carbohydrate phosphorylation,BP,
3699,GO:0046849,1,0.637025861979739,0,2,bone remodeling,BP,
3700,GO:0046850,1,0.755771665883275,0,1,regulation of bone remodeling,BP,
3701,GO:0046851,1,0.755771665883275,0,1,negative regulation of bone remodeling,BP,
3705,GO:0046875,1,0.481480933049558,0,2,ephrin receptor binding,MF,
3706,GO:0046877,1,0.941285075943011,0,1,regulation of saliva secretion,BP,
3707,GO:0046879,1,0.0946164276247027,0,9,hormone secretion,BP,
3708,GO:0046880,1,0.763405242997684,0,1,regulation of follicle-stimulating hormone secretion,BP,
3709,GO:0046881,1,0.763405242997684,0,1,positive regulation of follicle-stimulating hormone secretion,BP,
3710,GO:0046882,1,0.763405242997684,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
3711,GO:0046883,1,0.0946164276247027,0,9,regulation of hormone secretion,BP,
3712,GO:0046884,1,0.763405242997684,0,1,follicle-stimulating hormone secretion,BP,
3714,GO:0046886,1,0.560461161423182,0,2,positive regulation of hormone biosynthetic process,BP,
3715,GO:0046887,1,0.484231079010745,0,3,positive regulation of hormone secretion,BP,
3716,GO:0046888,1,0.14226547099708,0,7,negative regulation of hormone secretion,BP,
3717,GO:0046889,1,0.436593981076676,0,3,positive regulation of lipid biosynthetic process,BP,
3719,GO:0046902,1,0.839760482627469,0,1,regulation of mitochondrial membrane permeability,BP,
3721,GO:0046906,1,0.563108477678154,0,2,tetrapyrrole binding,MF,
3725,GO:0046915,1,0.653878742254595,0,2,transition metal ion transmembrane transporter activity,MF,
3729,GO:0046939,1,0.553813046047101,0,2,nucleotide phosphorylation,BP,
3734,GO:0046965,1,0.698454611733275,0,1,retinoid X receptor binding,MF,
3737,GO:0047117,1,0.604707407962162,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
3738,GO:0047144,1,0.73462101006065,0,1,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
3739,GO:0047451,1,0.604707407962162,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
3743,GO:0048008,1,0.592358086537479,0,2,platelet-derived growth factor receptor signaling pathway,BP,
3746,GO:0048011,1,0.760110775581285,0,1,neurotrophin TRK receptor signaling pathway,BP,
3747,GO:0048012,1,0.760110775581285,0,1,hepatocyte growth factor receptor signaling pathway,BP,
3748,GO:0048013,1,0.640499735096423,0,2,ephrin receptor signaling pathway,BP,
3750,GO:0048016,1,0.646010841297154,0,2,inositol phosphate-mediated signaling,BP,
3753,GO:0048020,1,0.923408743724329,0,1,CCR chemokine receptor binding,MF,
3754,GO:0048021,1,0.662592268986548,0,1,regulation of melanin biosynthetic process,BP,
3755,GO:0048022,1,0.662592268986548,0,1,negative regulation of melanin biosynthetic process,BP,
3756,GO:0048037,1,0.442681824260904,0,2,cofactor binding,MF,
3758,GO:0048048,1,0.280216746929506,0,4,embryonic eye morphogenesis,BP,
3762,GO:0048103,1,0.369273641872246,0,3,somatic stem cell division,BP,
3766,GO:0048167,1,0.472078802501887,0,3,regulation of synaptic plasticity,BP,
3767,GO:0048168,1,0.898270644003197,0,1,regulation of neuronal synaptic plasticity,BP,
3768,GO:0048169,1,0.898270644003197,0,1,regulation of long-term neuronal synaptic plasticity,BP,
3769,GO:0048175,1,0.763405242997684,0,1,hepatocyte growth factor biosynthetic process,BP,
3770,GO:0048176,1,0.763405242997684,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
3771,GO:0048178,1,0.763405242997684,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
3772,GO:0048179,1,0.775827451160419,0,1,activin receptor complex,CC,
3773,GO:0048185,1,0.621198377089134,0,2,activin binding,MF,
3776,GO:0048237,1,0.828354528958696,0,1,rough endoplasmic reticulum lumen,CC,
3777,GO:0048241,1,0.636999731039707,0,2,epinephrine transport,BP,
3778,GO:0048242,1,0.636999731039707,0,2,epinephrine secretion,BP,
3779,GO:0048243,1,0.636999731039707,0,2,norepinephrine secretion,BP,
3781,GO:0048251,1,0.634601131053728,0,1,elastic fiber assembly,BP,
3782,GO:0048255,1,0.936826423682637,0,1,mRNA stabilization,BP,
3784,GO:0048260,1,0.784501226927412,0,1,positive regulation of receptor-mediated endocytosis,BP,
3786,GO:0048262,1,0.775827451160419,0,1,determination of dorsal/ventral asymmetry,BP,
3787,GO:0048263,1,0.775827451160419,0,1,determination of dorsal identity,BP,
3788,GO:0048278,1,0.614426666394382,0,3,vesicle docking,BP,
3789,GO:0048284,1,0.44849449631527,0,4,organelle fusion,BP,
3791,GO:0048286,1,0.455027966060659,0,4,lung alveolus development,BP,
3792,GO:0048289,1,0.849407889468112,0,1,isotype switching to IgE isotypes,BP,
3793,GO:0048293,1,0.849407889468112,0,1,regulation of isotype switching to IgE isotypes,BP,
3794,GO:0048295,1,0.849407889468112,0,1,positive regulation of isotype switching to IgE isotypes,BP,
3795,GO:0048306,1,0.790066751337715,0,1,calcium-dependent protein binding,MF,
3796,GO:0048318,1,0.753597902783621,0,1,axial mesoderm development,BP,
3797,GO:0048319,1,0.753597902783621,0,1,axial mesoderm morphogenesis,BP,
3798,GO:0048320,1,0.753597902783621,0,1,axial mesoderm formation,BP,
3801,GO:0048339,1,0.662592268986548,0,1,paraxial mesoderm development,BP,
3802,GO:0048340,1,0.662592268986548,0,1,paraxial mesoderm morphogenesis,BP,
3803,GO:0048341,1,0.662592268986548,0,1,paraxial mesoderm formation,BP,
3804,GO:0048382,1,0.906752862467527,0,1,mesendoderm development,BP,
3805,GO:0048389,1,0.850452765079241,0,1,intermediate mesoderm development,BP,
3806,GO:0048390,1,0.850452765079241,0,1,intermediate mesoderm morphogenesis,BP,
3807,GO:0048391,1,0.850452765079241,0,1,intermediate mesoderm formation,BP,
3808,GO:0048392,1,0.850452765079241,0,1,intermediate mesodermal cell differentiation,BP,
3809,GO:0048407,1,0.780266268444755,0,1,platelet-derived growth factor binding,MF,
3813,GO:0048477,1,0.53564375971815,0,3,oogenesis,BP,
3814,GO:0048483,1,0.936826423682637,0,1,autonomic nervous system development,BP,
3815,GO:0048484,1,0.936826423682637,0,1,enteric nervous system development,BP,
3816,GO:0048485,1,0.936826423682637,0,1,sympathetic nervous system development,BP,
3817,GO:0048486,1,0.936826423682637,0,1,parasympathetic nervous system development,BP,
3818,GO:0048488,1,0.847146262734248,0,1,synaptic vesicle endocytosis,BP,
3819,GO:0048489,1,0.56736982560807,0,3,synaptic vesicle transport,BP,
3822,GO:0048512,1,0.782385944864048,0,1,circadian behavior,BP,
3828,GO:0048520,1,0.781943571206073,0,1,positive regulation of behavior,BP,
3829,GO:0048521,1,0.782385944864048,0,1,negative regulation of behavior,BP,
3832,GO:0048524,1,0.59183921579231,0,1,positive regulation of viral process,BP,
3833,GO:0048531,1,0.787775492853738,0,1,beta-1,3-galactosyltransferase activity,MF,
3836,GO:0048536,1,0.941285075943011,0,1,spleen development,BP,
3837,GO:0048537,1,0.849731904516401,0,1,mucosal-associated lymphoid tissue development,BP,
3838,GO:0048538,1,0.941285075943011,0,1,thymus development,BP,
3839,GO:0048541,1,0.849731904516401,0,1,Peyer's patch development,BP,
3841,GO:0048546,1,0.24224697371671,0,5,digestive tract morphogenesis,BP,
3842,GO:0048557,1,0.941285075943011,0,1,embryonic digestive tract morphogenesis,BP,
3846,GO:0048566,1,0.735749345071057,0,2,embryonic digestive tract development,BP,
3849,GO:0048570,1,0.662592268986548,0,1,notochord morphogenesis,BP,
3853,GO:0048588,1,0.348429593195969,0,4,developmental cell growth,BP,
3857,GO:0048596,1,0.373663251579423,0,3,embryonic camera-type eye morphogenesis,BP,
3859,GO:0048599,1,0.53564375971815,0,3,oocyte development,BP,
3866,GO:0048635,1,0.430945821794874,0,4,negative regulation of muscle organ development,BP,
3870,GO:0048640,1,0.489776900965475,0,3,negative regulation of developmental growth,BP,
3873,GO:0048644,1,0.126509366164852,0,6,muscle organ morphogenesis,BP,
3876,GO:0048659,1,0.23668866513886,0,7,smooth muscle cell proliferation,BP,
3877,GO:0048660,1,0.23668866513886,0,7,regulation of smooth muscle cell proliferation,BP,
3878,GO:0048661,1,0.345239769367755,0,5,positive regulation of smooth muscle cell proliferation,BP,
3879,GO:0048662,1,0.718207300668576,0,1,negative regulation of smooth muscle cell proliferation,BP,
3884,GO:0048668,1,0.871622561621531,0,1,collateral sprouting,BP,
3885,GO:0048669,1,0.871622561621531,0,1,collateral sprouting in absence of injury,BP,
3886,GO:0048670,1,0.871622561621531,0,1,regulation of collateral sprouting,BP,
3887,GO:0048672,1,0.871622561621531,0,1,positive regulation of collateral sprouting,BP,
3888,GO:0048675,1,0.57689958345257,0,2,axon extension,BP,
3889,GO:0048678,1,0.741010011526507,0,1,response to axon injury,BP,
3890,GO:0048696,1,0.871622561621531,0,1,regulation of collateral sprouting in absence of injury,BP,
3891,GO:0048697,1,0.871622561621531,0,1,positive regulation of collateral sprouting in absence of injury,BP,
3893,GO:0048701,1,0.850452765079241,0,1,embryonic cranial skeleton morphogenesis,BP,
3894,GO:0048704,1,0.463118674478579,0,3,embryonic skeletal system morphogenesis,BP,
3896,GO:0048706,1,0.30517063901501,0,4,embryonic skeletal system development,BP,
3898,GO:0048709,1,0.450343867420196,0,2,oligodendrocyte differentiation,BP,
3899,GO:0048710,1,0.278329711756256,0,4,regulation of astrocyte differentiation,BP,
3900,GO:0048711,1,0.278329711756256,0,4,positive regulation of astrocyte differentiation,BP,
3901,GO:0048713,1,0.59183921579231,0,1,regulation of oligodendrocyte differentiation,BP,
3902,GO:0048715,1,0.59183921579231,0,1,negative regulation of oligodendrocyte differentiation,BP,
3904,GO:0048730,1,0.556656233076134,0,2,epidermis morphogenesis,BP,
3907,GO:0048736,1,0.0727539675105128,0,10,appendage development,BP,
3909,GO:0048739,1,0.538961871903561,0,2,cardiac muscle fiber development,BP,
3910,GO:0048745,1,0.664486153777512,0,2,smooth muscle tissue development,BP,
3911,GO:0048747,1,0.538961871903561,0,2,muscle fiber development,BP,
3912,GO:0048752,1,0.941285075943011,0,1,semicircular canal morphogenesis,BP,
3913,GO:0048753,1,0.87844991147751,0,1,pigment granule organization,BP,
3915,GO:0048757,1,0.87844991147751,0,1,pigment granule maturation,BP,
3918,GO:0048771,1,0.273986183872599,0,6,tissue remodeling,BP,
3919,GO:0048786,1,0.782385944864048,0,1,presynaptic active zone,CC,
3920,GO:0048791,1,0.847146262734248,0,1,calcium ion-regulated exocytosis of neurotransmitter,BP,
3921,GO:0048799,1,0.766038155162373,0,1,animal organ maturation,BP,
3923,GO:0048807,1,0.941285075943011,0,1,female genitalia morphogenesis,BP,
3924,GO:0048808,1,0.941285075943011,0,1,male genitalia morphogenesis,BP,
3926,GO:0048813,1,0.575812861095436,0,2,dendrite morphogenesis,BP,
3927,GO:0048814,1,0.673830352346191,0,1,regulation of dendrite morphogenesis,BP,
3928,GO:0048818,1,0.662592268986548,0,1,positive regulation of hair follicle maturation,BP,
3929,GO:0048819,1,0.662592268986548,0,1,regulation of hair follicle maturation,BP,
3930,GO:0048820,1,0.662592268986548,0,1,hair follicle maturation,BP,
3932,GO:0048841,1,0.57689958345257,0,2,regulation of axon extension involved in axon guidance,BP,
3933,GO:0048843,1,0.57689958345257,0,2,negative regulation of axon extension involved in axon guidance,BP,
3934,GO:0048844,1,0.203823419928594,0,6,artery morphogenesis,BP,
3935,GO:0048845,1,0.421091420510704,0,2,venous blood vessel morphogenesis,BP,
3936,GO:0048846,1,0.57689958345257,0,2,axon extension involved in axon guidance,BP,
3937,GO:0048850,1,0.662592268986548,0,1,hypophysis morphogenesis,BP,
3938,GO:0048852,1,0.662592268986548,0,1,diencephalon morphogenesis,BP,
3939,GO:0048853,1,0.600297692341274,0,2,forebrain morphogenesis,BP,
3940,GO:0048854,1,0.425612428307208,0,3,brain morphogenesis,BP,
3943,GO:0048861,1,0.730053612763015,0,1,leukemia inhibitory factor signaling pathway,BP,
3951,GO:0050000,1,0.853347594896784,0,1,chromosome localization,BP,
3952,GO:0050220,1,0.850380627707629,0,1,prostaglandin-E synthase activity,MF,
3953,GO:0050308,1,0.710564000841808,0,1,sugar-phosphatase activity,MF,
3955,GO:0050431,1,0.775827451160419,0,1,transforming growth factor beta binding,MF,
3956,GO:0050432,1,0.495188342036156,0,4,catecholamine secretion,BP,
3957,GO:0050433,1,0.495188342036156,0,4,regulation of catecholamine secretion,BP,
3958,GO:0050661,1,0.604707407962162,0,1,NADP binding,MF,
3959,GO:0050662,1,0.604707407962162,0,1,coenzyme binding,MF,
3964,GO:0050673,1,0.0178688281060605,0,15,epithelial cell proliferation,BP,
3965,GO:0050674,1,0.941285075943011,0,1,urothelial cell proliferation,BP,
3966,GO:0050675,1,0.941285075943011,0,1,regulation of urothelial cell proliferation,BP,
3967,GO:0050677,1,0.941285075943011,0,1,positive regulation of urothelial cell proliferation,BP,
3968,GO:0050678,1,0.0178688281060605,0,15,regulation of epithelial cell proliferation,BP,
3969,GO:0050679,1,0.0458417567748245,0,12,positive regulation of epithelial cell proliferation,BP,
3970,GO:0050680,1,0.228731502708195,0,5,negative regulation of epithelial cell proliferation,BP,
3972,GO:0050702,1,0.662592268986548,0,1,interleukin-1 beta secretion,BP,
3974,GO:0050706,1,0.662592268986548,0,1,regulation of interleukin-1 beta secretion,BP,
3980,GO:0050714,1,0.508043677060236,0,2,positive regulation of protein secretion,BP,
3981,GO:0050715,1,0.662592268986548,0,1,positive regulation of cytokine secretion,BP,
3982,GO:0050716,1,0.662592268986548,0,1,positive regulation of interleukin-1 secretion,BP,
3983,GO:0050718,1,0.662592268986548,0,1,positive regulation of interleukin-1 beta secretion,BP,
3984,GO:0050719,1,0.923408743724329,0,1,interleukin-1 alpha biosynthetic process,BP,
3985,GO:0050721,1,0.923408743724329,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
3986,GO:0050726,1,0.923408743724329,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
3987,GO:0050727,1,0.252225864930811,0,4,regulation of inflammatory response,BP,
3988,GO:0050728,1,0.568852189409995,0,2,negative regulation of inflammatory response,BP,
3989,GO:0050729,1,0.446884477519981,0,2,positive regulation of inflammatory response,BP,
3992,GO:0050755,1,0.662592268986548,0,1,chemokine metabolic process,BP,
3998,GO:0050770,1,0.49272666775098,0,3,regulation of axonogenesis,BP,
3999,GO:0050771,1,0.57689958345257,0,2,negative regulation of axonogenesis,BP,
4000,GO:0050772,1,0.871622561621531,0,1,positive regulation of axonogenesis,BP,
4001,GO:0050773,1,0.408808294031399,0,3,regulation of dendrite development,BP,
4003,GO:0050777,1,0.728085055754081,0,1,negative regulation of immune response,BP,
4007,GO:0050792,1,0.59183921579231,0,1,regulation of viral process,BP,
4010,GO:0050795,1,0.611102992053434,0,2,regulation of behavior,BP,
4011,GO:0050796,1,0.561511797727282,0,3,regulation of insulin secretion,BP,
4013,GO:0050802,1,0.782385944864048,0,1,circadian sleep/wake cycle, sleep,BP,
4014,GO:0050803,1,0.336248716275123,0,4,regulation of synapse structure or activity,BP,
4015,GO:0050804,1,0.311074729364813,0,6,modulation of synaptic transmission,BP,
4016,GO:0050805,1,0.782385944864048,0,1,negative regulation of synaptic transmission,BP,
4017,GO:0050806,1,0.66884849281921,0,2,positive regulation of synaptic transmission,BP,
4018,GO:0050807,1,0.336248716275123,0,4,regulation of synapse organization,BP,
4022,GO:0050818,1,0.516168134235673,0,3,regulation of coagulation,BP,
4023,GO:0050819,1,0.516168134235673,0,3,negative regulation of coagulation,BP,
4025,GO:0050829,1,0.832024114860243,0,1,defense response to Gram-negative bacterium,BP,
4026,GO:0050830,1,0.832024114860243,0,1,defense response to Gram-positive bacterium,BP,
4027,GO:0050832,1,0.832024114860243,0,1,defense response to fungus,BP,
4030,GO:0050848,1,0.616035976950467,0,2,regulation of calcium-mediated signaling,BP,
4031,GO:0050849,1,0.616035976950467,0,2,negative regulation of calcium-mediated signaling,BP,
4034,GO:0050853,1,0.760110775581285,0,1,B cell receptor signaling pathway,BP,
4043,GO:0050872,1,0.941285075943011,0,1,white fat cell differentiation,BP,
4046,GO:0050879,1,0.780567658291826,0,1,multicellular organismal movement,BP,
4047,GO:0050880,1,0.15599030630525,0,9,regulation of blood vessel size,BP,
4048,GO:0050881,1,0.780567658291826,0,1,musculoskeletal movement,BP,
4050,GO:0050886,1,0.305999574483009,0,4,endocrine process,BP,
4053,GO:0050892,1,0.698454611733275,0,1,intestinal absorption,BP,
4057,GO:0050906,1,0.782385944864048,0,1,detection of stimulus involved in sensory perception,BP,
4058,GO:0050918,1,0.315600451309773,0,6,positive chemotaxis,BP,
4059,GO:0050919,1,0.662592268986548,0,1,negative chemotaxis,BP,
4062,GO:0050922,1,0.339769469679004,0,3,negative regulation of chemotaxis,BP,
4063,GO:0050926,1,0.79962699665812,0,2,regulation of positive chemotaxis,BP,
4064,GO:0050927,1,0.79962699665812,0,2,positive regulation of positive chemotaxis,BP,
4065,GO:0050930,1,0.79962699665812,0,2,induction of positive chemotaxis,BP,
4069,GO:0050951,1,0.782385944864048,0,1,sensory perception of temperature stimulus,BP,
4073,GO:0050961,1,0.782385944864048,0,1,detection of temperature stimulus involved in sensory perception,BP,
4074,GO:0050965,1,0.782385944864048,0,1,detection of temperature stimulus involved in sensory perception of pain,BP,
4075,GO:0050994,1,0.306853254218086,0,4,regulation of lipid catabolic process,BP,
4076,GO:0050995,1,0.41136468479531,0,3,negative regulation of lipid catabolic process,BP,
4077,GO:0050996,1,0.749336515652812,0,1,positive regulation of lipid catabolic process,BP,
4079,GO:0050999,1,0.781006884258256,0,1,regulation of nitric-oxide synthase activity,BP,
4080,GO:0051000,1,0.781006884258256,0,1,positive regulation of nitric-oxide synthase activity,BP,
4084,GO:0051018,1,0.801649544056734,0,1,protein kinase A binding,MF,
4086,GO:0051040,1,0.766038155162373,0,1,regulation of calcium-independent cell-cell adhesion,BP,
4087,GO:0051042,1,0.766038155162373,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
4095,GO:0051053,1,0.962412700305168,0,1,negative regulation of DNA metabolic process,BP,
4102,GO:0051091,1,0.331989606638969,0,4,positive regulation of sequence-specific DNA binding transcription factor activity,BP,
4103,GO:0051092,1,0.662592268986548,0,1,positive regulation of NF-kappaB transcription factor activity,BP,
4106,GO:0051098,1,0.120454942238601,0,8,regulation of binding,BP,
4107,GO:0051099,1,0.350408267742044,0,4,positive regulation of binding,BP,
4108,GO:0051100,1,0.393357011997545,0,4,negative regulation of binding,BP,
4109,GO:0051101,1,0.594280291489348,0,2,regulation of DNA binding,BP,
4110,GO:0051117,1,0.817600888298876,0,1,ATPase binding,MF,
4111,GO:0051119,1,0.61915588803758,0,2,sugar transmembrane transporter activity,MF,
4119,GO:0051149,1,0.301480156990948,0,5,positive regulation of muscle cell differentiation,BP,
4122,GO:0051153,1,0.163253664110016,0,6,regulation of striated muscle cell differentiation,BP,
4123,GO:0051154,1,0.330185582895113,0,3,negative regulation of striated muscle cell differentiation,BP,
4124,GO:0051155,1,0.501270678492504,0,3,positive regulation of striated muscle cell differentiation,BP,
4134,GO:0051181,1,0.741464194934762,0,1,cofactor transport,BP,
4136,GO:0051184,1,0.741464194934762,0,1,cofactor transporter activity,MF,
4139,GO:0051193,1,0.780567658291826,0,1,regulation of cofactor metabolic process,BP,
4140,GO:0051194,1,0.780567658291826,0,1,positive regulation of cofactor metabolic process,BP,
4141,GO:0051195,1,0.780567658291826,0,1,negative regulation of cofactor metabolic process,BP,
4142,GO:0051196,1,0.780567658291826,0,1,regulation of coenzyme metabolic process,BP,
4143,GO:0051197,1,0.780567658291826,0,1,positive regulation of coenzyme metabolic process,BP,
4144,GO:0051198,1,0.780567658291826,0,1,negative regulation of coenzyme metabolic process,BP,
4145,GO:0051204,1,0.839760482627469,0,1,protein insertion into mitochondrial membrane,BP,
4147,GO:0051208,1,0.790066751337715,0,1,sequestering of calcium ion,BP,
4148,GO:0051209,1,0.790066751337715,0,1,release of sequestered calcium ion into cytosol,BP,
4151,GO:0051220,1,0.781006884258256,0,1,cytoplasmic sequestering of protein,BP,
4157,GO:0051235,1,0.411804646991332,0,3,maintenance of location,BP,
4158,GO:0051238,1,0.790066751337715,0,1,sequestering of metal ion,BP,
4180,GO:0051279,1,0.790066751337715,0,1,regulation of release of sequestered calcium ion into cytosol,BP,
4181,GO:0051280,1,0.790066751337715,0,1,negative regulation of release of sequestered calcium ion into cytosol,BP,
4182,GO:0051282,1,0.790066751337715,0,1,regulation of sequestering of calcium ion,BP,
4183,GO:0051283,1,0.790066751337715,0,1,negative regulation of sequestering of calcium ion,BP,
4184,GO:0051284,1,0.790066751337715,0,1,positive regulation of sequestering of calcium ion,BP,
4187,GO:0051293,1,0.941285075943011,0,1,establishment of spindle localization,BP,
4188,GO:0051294,1,0.941285075943011,0,1,establishment of spindle orientation,BP,
4189,GO:0051297,1,0.678926723930427,0,2,centrosome organization,BP,
4190,GO:0051298,1,0.769896520332264,0,1,centrosome duplication,BP,
4193,GO:0051303,1,0.853347594896784,0,1,establishment of chromosome localization,BP,
4194,GO:0051310,1,0.853347594896784,0,1,metaphase plate congression,BP,
4198,GO:0051341,1,0.421203532979011,0,4,regulation of oxidoreductase activity,BP,
4203,GO:0051353,1,0.421203532979011,0,4,positive regulation of oxidoreductase activity,BP,
4205,GO:0051379,1,0.636999731039707,0,2,epinephrine binding,MF,
4208,GO:0051402,1,0.345379016658196,0,6,neuron apoptotic process,BP,
4211,GO:0051427,1,0.671917646117334,0,2,hormone receptor binding,MF,
4212,GO:0051428,1,0.962412700305168,0,1,peptide hormone receptor binding,MF,
4213,GO:0051438,1,0.629174328088141,0,2,regulation of ubiquitin-protein transferase activity,BP,
4214,GO:0051443,1,0.629174328088141,0,2,positive regulation of ubiquitin-protein transferase activity,BP,
4216,GO:0051446,1,0.483071218279717,0,2,positive regulation of meiotic cell cycle,BP,
4218,GO:0051452,1,0.591548703543027,0,3,intracellular pH reduction,BP,
4219,GO:0051453,1,0.591548703543027,0,3,regulation of intracellular pH,BP,
4220,GO:0051480,1,0.270457038657825,0,5,regulation of cytosolic calcium ion concentration,BP,
4221,GO:0051482,1,0.828354528958696,0,1,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
4230,GO:0051541,1,0.811111303766348,0,1,elastin metabolic process,BP,
4231,GO:0051542,1,0.811111303766348,0,1,elastin biosynthetic process,BP,
4232,GO:0051543,1,0.811111303766348,0,1,regulation of elastin biosynthetic process,BP,
4233,GO:0051545,1,0.811111303766348,0,1,negative regulation of elastin biosynthetic process,BP,
4234,GO:0051546,1,0.763233483481036,0,2,keratinocyte migration,BP,
4235,GO:0051547,1,0.763233483481036,0,2,regulation of keratinocyte migration,BP,
4236,GO:0051549,1,0.763233483481036,0,2,positive regulation of keratinocyte migration,BP,
4237,GO:0051580,1,0.936826423682637,0,1,regulation of neurotransmitter uptake,BP,
4238,GO:0051583,1,0.936826423682637,0,1,dopamine uptake involved in synaptic transmission,BP,
4239,GO:0051584,1,0.936826423682637,0,1,regulation of dopamine uptake involved in synaptic transmission,BP,
4240,GO:0051588,1,0.936826423682637,0,1,regulation of neurotransmitter transport,BP,
4242,GO:0051592,1,0.366323349014035,0,4,response to calcium ion,BP,
4243,GO:0051601,1,0.817600888298876,0,1,exocyst localization,BP,
4244,GO:0051602,1,0.831713918892199,0,1,response to electrical stimulus,BP,
4245,GO:0051603,1,0.260693326345889,0,5,proteolysis involved in cellular protein catabolic process,BP,
4248,GO:0051607,1,0.839760482627469,0,1,defense response to virus,BP,
4249,GO:0051608,1,0.828354528958696,0,1,histamine transport,BP,
4256,GO:0051651,1,0.522661227069333,0,2,maintenance of location in cell,BP,
4257,GO:0051653,1,0.941285075943011,0,1,spindle localization,BP,
4259,GO:0051668,1,0.711185484621141,0,1,localization within membrane,BP,
4261,GO:0051693,1,0.225053907625481,0,3,actin filament capping,BP,
4267,GO:0051721,1,0.781006884258256,0,1,protein phosphatase 2A binding,MF,
4269,GO:0051767,1,0.764632542658883,0,2,nitric-oxide synthase biosynthetic process,BP,
4270,GO:0051769,1,0.764632542658883,0,2,regulation of nitric-oxide synthase biosynthetic process,BP,
4271,GO:0051770,1,0.923408743724329,0,1,positive regulation of nitric-oxide synthase biosynthetic process,BP,
4272,GO:0051771,1,0.828354528958696,0,1,negative regulation of nitric-oxide synthase biosynthetic process,BP,
4273,GO:0051781,1,0.707130535652027,0,2,positive regulation of cell division,BP,
4274,GO:0051783,1,0.104686683952909,0,9,regulation of nuclear division,BP,
4275,GO:0051784,1,0.448538880751944,0,3,negative regulation of nuclear division,BP,
4276,GO:0051785,1,0.280539415608869,0,5,positive regulation of nuclear division,BP,
4277,GO:0051797,1,0.662592268986548,0,1,regulation of hair follicle development,BP,
4278,GO:0051798,1,0.662592268986548,0,1,positive regulation of hair follicle development,BP,
4282,GO:0051881,1,0.839760482627469,0,1,regulation of mitochondrial membrane potential,BP,
4283,GO:0051884,1,0.662592268986548,0,1,regulation of timing of anagen,BP,
4284,GO:0051885,1,0.662592268986548,0,1,positive regulation of timing of anagen,BP,
4289,GO:0051899,1,0.632055329788492,0,2,membrane depolarization,BP,
4293,GO:0051926,1,0.790066751337715,0,1,negative regulation of calcium ion transport,BP,
4294,GO:0051928,1,0.780266268444755,0,1,positive regulation of calcium ion transport,BP,
4295,GO:0051930,1,0.542078580678341,0,3,regulation of sensory perception of pain,BP,
4296,GO:0051931,1,0.542078580678341,0,3,regulation of sensory perception,BP,
4297,GO:0051932,1,0.782385944864048,0,1,synaptic transmission, GABAergic,BP,
4298,GO:0051934,1,0.936826423682637,0,1,catecholamine uptake involved in synaptic transmission,BP,
4299,GO:0051937,1,0.495188342036156,0,4,catecholamine transport,BP,
4300,GO:0051940,1,0.936826423682637,0,1,regulation of catecholamine uptake involved in synaptic transmission,BP,
4301,GO:0051952,1,0.38612818293433,0,5,regulation of amine transport,BP,
4302,GO:0051953,1,0.412776807921165,0,4,negative regulation of amine transport,BP,
4303,GO:0051954,1,0.936826423682637,0,1,positive regulation of amine transport,BP,
4304,GO:0051955,1,0.782385944864048,0,1,regulation of amino acid transport,BP,
4305,GO:0051956,1,0.782385944864048,0,1,negative regulation of amino acid transport,BP,
4309,GO:0051963,1,0.474939097815659,0,3,regulation of synapse assembly,BP,
4310,GO:0051964,1,0.662592268986548,0,1,negative regulation of synapse assembly,BP,
4311,GO:0051965,1,0.855530641430602,0,1,positive regulation of synapse assembly,BP,
4312,GO:0051966,1,0.782385944864048,0,1,regulation of synaptic transmission, glutamatergic,BP,
4313,GO:0051967,1,0.782385944864048,0,1,negative regulation of synaptic transmission, glutamatergic,BP,
4316,GO:0052652,1,0.433433333151153,0,4,cyclic purine nucleotide metabolic process,BP,
4324,GO:0055008,1,0.174947021849143,0,5,cardiac muscle tissue morphogenesis,BP,
4325,GO:0055009,1,0.780622506963867,0,1,atrial cardiac muscle tissue morphogenesis,BP,
4326,GO:0055010,1,0.59183921579231,0,1,ventricular cardiac muscle tissue morphogenesis,BP,
4328,GO:0055017,1,0.380834359528135,0,3,cardiac muscle tissue growth,BP,
4329,GO:0055018,1,0.850452765079241,0,1,regulation of cardiac muscle fiber development,BP,
4330,GO:0055020,1,0.850452765079241,0,1,positive regulation of cardiac muscle fiber development,BP,
4331,GO:0055021,1,0.380834359528135,0,3,regulation of cardiac muscle tissue growth,BP,
4332,GO:0055023,1,0.380834359528135,0,3,positive regulation of cardiac muscle tissue growth,BP,
4333,GO:0055024,1,0.114104909944094,0,8,regulation of cardiac muscle tissue development,BP,
4334,GO:0055025,1,0.228882308344835,0,5,positive regulation of cardiac muscle tissue development,BP,
4335,GO:0055026,1,0.507836459659238,0,3,negative regulation of cardiac muscle tissue development,BP,
4336,GO:0055037,1,0.211074115687214,0,6,recycling endosome,CC,
4337,GO:0055038,1,0.428745411476554,0,4,recycling endosome membrane,CC,
4338,GO:0055056,1,0.821374167469034,0,1,D-glucose transmembrane transporter activity,MF,
4340,GO:0055067,1,0.206563851864204,0,7,monovalent inorganic cation homeostasis,BP,
4342,GO:0055072,1,0.464727686889581,0,3,iron ion homeostasis,BP,
4343,GO:0055074,1,0.18734193551637,0,6,calcium ion homeostasis,BP,
4344,GO:0055075,1,0.763757722401656,0,1,potassium ion homeostasis,BP,
4346,GO:0055078,1,0.463842714461611,0,3,sodium ion homeostasis,BP,
4351,GO:0055088,1,0.749336515652812,0,1,lipid homeostasis,BP,
4352,GO:0055090,1,0.749336515652812,0,1,acylglycerol homeostasis,BP,
4354,GO:0055114,1,0.0776566332924633,0,8,oxidation-reduction process,BP,
4356,GO:0055118,1,0.528198301770273,0,2,negative regulation of cardiac muscle contraction,BP,
4359,GO:0055131,1,0.763757722401656,0,1,C3HC4-type RING finger domain binding,MF,
4360,GO:0060019,1,0.669081615201052,0,2,radial glial cell differentiation,BP,
4361,GO:0060021,1,0.322564375287693,0,4,palate development,BP,
4362,GO:0060024,1,0.828354528958696,0,1,rhythmic synaptic transmission,BP,
4363,GO:0060026,1,0.662592268986548,0,1,convergent extension,BP,
4364,GO:0060027,1,0.662592268986548,0,1,convergent extension involved in gastrulation,BP,
4365,GO:0060028,1,0.662592268986548,0,1,convergent extension involved in axis elongation,BP,
4366,GO:0060029,1,0.662592268986548,0,1,convergent extension involved in organogenesis,BP,
4367,GO:0060031,1,0.662592268986548,0,1,mediolateral intercalation,BP,
4368,GO:0060037,1,0.431724680092803,0,4,pharyngeal system development,BP,
4369,GO:0060038,1,0.460977367221894,0,2,cardiac muscle cell proliferation,BP,
4373,GO:0060043,1,0.460977367221894,0,2,regulation of cardiac muscle cell proliferation,BP,
4374,GO:0060045,1,0.460977367221894,0,2,positive regulation of cardiac muscle cell proliferation,BP,
4377,GO:0060054,1,0.589368864602241,0,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,
4378,GO:0060056,1,0.698454611733275,0,1,mammary gland involution,BP,
4379,GO:0060057,1,0.698454611733275,0,1,apoptotic process involved in mammary gland involution,BP,
4380,GO:0060058,1,0.698454611733275,0,1,positive regulation of apoptotic process involved in mammary gland involution,BP,
4381,GO:0060061,1,0.871622561621531,0,1,Spemann organizer formation,BP,
4382,GO:0060064,1,0.871622561621531,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
4383,GO:0060065,1,0.441603246691018,0,3,uterus development,BP,
4384,GO:0060066,1,0.855530641430602,0,1,oviduct development,BP,
4385,GO:0060067,1,0.662592268986548,0,1,cervix development,BP,
4386,GO:0060068,1,0.481360515150838,0,2,vagina development,BP,
4388,GO:0060071,1,0.484688036404671,0,2,Wnt signaling pathway, planar cell polarity pathway,BP,
4389,GO:0060075,1,0.793380151163482,0,1,regulation of resting membrane potential,BP,
4391,GO:0060078,1,0.66884849281921,0,2,regulation of postsynaptic membrane potential,BP,
4392,GO:0060079,1,0.66884849281921,0,2,excitatory postsynaptic potential,BP,
4393,GO:0060087,1,0.782385944864048,0,1,relaxation of vascular smooth muscle,BP,
4400,GO:0060120,1,0.405425054735677,0,2,inner ear receptor cell fate commitment,BP,
4402,GO:0060126,1,0.730656633467999,0,1,somatotropin secreting cell differentiation,BP,
4403,GO:0060128,1,0.694211506670186,0,2,corticotropin hormone secreting cell differentiation,BP,
4404,GO:0060129,1,0.5061424921696,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
4407,GO:0060137,1,0.828354528958696,0,1,maternal process involved in parturition,BP,
4408,GO:0060147,1,0.850452765079241,0,1,regulation of posttranscriptional gene silencing,BP,
4409,GO:0060148,1,0.850452765079241,0,1,positive regulation of posttranscriptional gene silencing,BP,
4410,GO:0060155,1,0.87844991147751,0,1,platelet dense granule organization,BP,
4411,GO:0060157,1,0.662592268986548,0,1,urinary bladder development,BP,
4412,GO:0060170,1,0.560534968294878,0,1,ciliary membrane,CC,
4413,GO:0060173,1,0.0727539675105128,0,10,limb development,BP,
4414,GO:0060174,1,0.820256354365096,0,2,limb bud formation,BP,
4415,GO:0060178,1,0.817600888298876,0,1,regulation of exocyst localization,BP,
4416,GO:0060191,1,0.849948042925311,0,1,regulation of lipase activity,BP,
4417,GO:0060193,1,0.849948042925311,0,1,positive regulation of lipase activity,BP,
4418,GO:0060197,1,0.850452765079241,0,1,cloacal septation,BP,
4420,GO:0060215,1,0.761153424935427,0,1,primitive hemopoiesis,BP,
4421,GO:0060216,1,0.761153424935427,0,1,definitive hemopoiesis,BP,
4423,GO:0060235,1,0.850452765079241,0,1,lens induction in camera-type eye,BP,
4424,GO:0060236,1,0.853347594896784,0,1,regulation of mitotic spindle organization,BP,
4426,GO:0060251,1,0.59183921579231,0,1,regulation of glial cell proliferation,BP,
4427,GO:0060253,1,0.59183921579231,0,1,negative regulation of glial cell proliferation,BP,
4430,GO:0060272,1,0.463118674478579,0,3,embryonic skeletal joint morphogenesis,BP,
4431,GO:0060278,1,0.763405242997684,0,1,regulation of ovulation,BP,
4432,GO:0060279,1,0.763405242997684,0,1,positive regulation of ovulation,BP,
4433,GO:0060281,1,0.962412700305168,0,1,regulation of oocyte development,BP,
4434,GO:0060283,1,0.962412700305168,0,1,negative regulation of oocyte development,BP,
4436,GO:0060292,1,0.782385944864048,0,1,long term synaptic depression,BP,
4437,GO:0060297,1,0.828354528958696,0,1,regulation of sarcomere organization,BP,
4438,GO:0060298,1,0.828354528958696,0,1,positive regulation of sarcomere organization,BP,
4439,GO:0060306,1,0.602719558880463,0,2,regulation of membrane repolarization,BP,
4440,GO:0060307,1,0.763757722401656,0,1,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
4441,GO:0060314,1,0.790066751337715,0,1,regulation of ryanodine-sensitive calcium-release channel activity,BP,
4442,GO:0060315,1,0.790066751337715,0,1,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
4443,GO:0060317,1,0.19915449827204,0,6,cardiac epithelial to mesenchymal transition,BP,
4444,GO:0060318,1,0.761153424935427,0,1,definitive erythrocyte differentiation,BP,
4445,GO:0060319,1,0.761153424935427,0,1,primitive erythrocyte differentiation,BP,
4451,GO:0060337,1,0.662592268986548,0,1,type I interferon signaling pathway,BP,
4452,GO:0060338,1,0.662592268986548,0,1,regulation of type I interferon-mediated signaling pathway,BP,
4453,GO:0060340,1,0.662592268986548,0,1,positive regulation of type I interferon-mediated signaling pathway,BP,
4455,GO:0060343,1,0.814984680586157,0,1,trabecula formation,BP,
4456,GO:0060347,1,0.814984680586157,0,1,heart trabecula formation,BP,
4457,GO:0060348,1,0.194019731403593,0,8,bone development,BP,
4458,GO:0060349,1,0.494707034788865,0,4,bone morphogenesis,BP,
4459,GO:0060350,1,0.494707034788865,0,4,endochondral bone morphogenesis,BP,
4460,GO:0060351,1,0.962412700305168,0,1,cartilage development involved in endochondral bone morphogenesis,BP,
4461,GO:0060363,1,0.850452765079241,0,1,cranial suture morphogenesis,BP,
4462,GO:0060374,1,0.761153424935427,0,1,mast cell differentiation,BP,
4463,GO:0060375,1,0.761153424935427,0,1,regulation of mast cell differentiation,BP,
4464,GO:0060377,1,0.761153424935427,0,1,negative regulation of mast cell differentiation,BP,
4465,GO:0060379,1,0.59183921579231,0,1,cardiac muscle cell myoblast differentiation,BP,
4467,GO:0060390,1,0.652766003058323,0,2,regulation of SMAD protein import into nucleus,BP,
4468,GO:0060391,1,0.652766003058323,0,2,positive regulation of SMAD protein import into nucleus,BP,
4470,GO:0060395,1,0.273731356156302,0,5,SMAD protein signal transduction,BP,
4473,GO:0060402,1,0.790066751337715,0,1,calcium ion transport into cytosol,BP,
4474,GO:0060411,1,0.101474056840515,0,8,cardiac septum morphogenesis,BP,
4475,GO:0060412,1,0.156691466008559,0,6,ventricular septum morphogenesis,BP,
4476,GO:0060413,1,0.589784909170825,0,2,atrial septum morphogenesis,BP,
4477,GO:0060415,1,0.174947021849143,0,5,muscle tissue morphogenesis,BP,
4482,GO:0060423,1,0.638435711470739,0,2,foregut regionalization,BP,
4483,GO:0060424,1,0.638435711470739,0,2,lung field specification,BP,
4484,GO:0060425,1,0.243354701768629,0,7,lung morphogenesis,BP,
4485,GO:0060426,1,0.570072190206359,0,2,lung vasculature development,BP,
4486,GO:0060428,1,0.354010711777811,0,5,lung epithelium development,BP,
4488,GO:0060430,1,0.735749345071057,0,2,lung saccule development,BP,
4489,GO:0060431,1,0.638435711470739,0,2,primary lung bud formation,BP,
4490,GO:0060432,1,0.941285075943011,0,1,lung pattern specification process,BP,
4491,GO:0060433,1,0.6204917861756,0,2,bronchus development,BP,
4492,GO:0060435,1,0.941285075943011,0,1,bronchiole development,BP,
4493,GO:0060436,1,0.941285075943011,0,1,bronchiole morphogenesis,BP,
4494,GO:0060437,1,0.941285075943011,0,1,lung growth,BP,
4495,GO:0060438,1,0.6204917861756,0,2,trachea development,BP,
4496,GO:0060439,1,0.6204917861756,0,2,trachea morphogenesis,BP,
4497,GO:0060440,1,0.850452765079241,0,1,trachea formation,BP,
4498,GO:0060441,1,0.509839584490439,0,4,epithelial tube branching involved in lung morphogenesis,BP,
4499,GO:0060442,1,0.616074156900826,0,2,branching involved in prostate gland morphogenesis,BP,
4500,GO:0060443,1,0.194788063856578,0,6,mammary gland morphogenesis,BP,
4501,GO:0060444,1,0.244986683044899,0,4,branching involved in mammary gland duct morphogenesis,BP,
4503,GO:0060447,1,0.941285075943011,0,1,bud outgrowth involved in lung branching,BP,
4504,GO:0060449,1,0.800306310734822,0,2,bud elongation involved in lung branching,BP,
4506,GO:0060457,1,0.718774331523076,0,1,negative regulation of digestive system process,BP,
4507,GO:0060462,1,0.730053612763015,0,1,lung lobe development,BP,
4508,GO:0060463,1,0.730053612763015,0,1,lung lobe morphogenesis,BP,
4509,GO:0060479,1,0.941285075943011,0,1,lung cell differentiation,BP,
4510,GO:0060482,1,0.730311826899045,0,1,lobar bronchus development,BP,
4512,GO:0060487,1,0.941285075943011,0,1,lung epithelial cell differentiation,BP,
4514,GO:0060492,1,0.638435711470739,0,2,lung induction,BP,
4515,GO:0060495,1,0.941285075943011,0,1,cell-cell signaling involved in lung development,BP,
4516,GO:0060496,1,0.941285075943011,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
4517,GO:0060501,1,0.780622506963867,0,1,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
4518,GO:0060502,1,0.663360399260629,0,2,epithelial cell proliferation involved in lung morphogenesis,BP,
4519,GO:0060503,1,0.850452765079241,0,1,bud dilation involved in lung branching,BP,
4520,GO:0060510,1,0.941285075943011,0,1,Type II pneumocyte differentiation,BP,
4521,GO:0060512,1,0.224334300077913,0,5,prostate gland morphogenesis,BP,
4522,GO:0060513,1,0.382367349533684,0,4,prostatic bud formation,BP,
4523,GO:0060525,1,0.59183921579231,0,1,prostate glandular acinus development,BP,
4524,GO:0060528,1,0.59183921579231,0,1,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
4525,GO:0060534,1,0.730311826899045,0,1,trachea cartilage development,BP,
4526,GO:0060535,1,0.730311826899045,0,1,trachea cartilage morphogenesis,BP,
4527,GO:0060536,1,0.730311826899045,0,1,cartilage morphogenesis,BP,
4533,GO:0060556,1,0.698454611733275,0,1,regulation of vitamin D biosynthetic process,BP,
4534,GO:0060558,1,0.698454611733275,0,1,regulation of calcidiol 1-monooxygenase activity,BP,
4535,GO:0060560,1,0.142595083236867,0,7,developmental growth involved in morphogenesis,BP,
4536,GO:0060561,1,0.202827488457322,0,4,apoptotic process involved in morphogenesis,BP,
4544,GO:0060584,1,0.828354528958696,0,1,regulation of prostaglandin-endoperoxide synthase activity,BP,
4545,GO:0060585,1,0.828354528958696,0,1,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
4546,GO:0060586,1,0.768189760920054,0,1,multicellular organismal iron ion homeostasis,BP,
4548,GO:0060592,1,0.800306310734822,0,2,mammary gland formation,BP,
4549,GO:0060594,1,0.941285075943011,0,1,mammary gland specification,BP,
4550,GO:0060595,1,0.941285075943011,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
4551,GO:0060599,1,0.662592268986548,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
4552,GO:0060601,1,0.382367349533684,0,4,lateral sprouting from an epithelium,BP,
4553,GO:0060602,1,0.52928711799253,0,3,branch elongation of an epithelium,BP,
4554,GO:0060603,1,0.230104933262588,0,5,mammary gland duct morphogenesis,BP,
4556,GO:0060612,1,0.738574234795428,0,1,adipose tissue development,BP,
4557,GO:0060615,1,0.941285075943011,0,1,mammary gland bud formation,BP,
4559,GO:0060638,1,0.50932891288628,0,3,mesenchymal-epithelial cell signaling,BP,
4560,GO:0060644,1,0.781006884258256,0,1,mammary gland epithelial cell differentiation,BP,
4561,GO:0060648,1,0.941285075943011,0,1,mammary gland bud morphogenesis,BP,
4562,GO:0060661,1,0.941285075943011,0,1,submandibular salivary gland formation,BP,
4563,GO:0060664,1,0.941285075943011,0,1,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
4564,GO:0060665,1,0.941285075943011,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
4565,GO:0060667,1,0.941285075943011,0,1,branch elongation involved in salivary gland morphogenesis,BP,
4566,GO:0060669,1,0.528643871105362,0,2,embryonic placenta morphogenesis,BP,
4569,GO:0060676,1,0.936826423682637,0,1,ureteric bud formation,BP,
4570,GO:0060677,1,0.850452765079241,0,1,ureteric bud elongation,BP,
4571,GO:0060681,1,0.850452765079241,0,1,branch elongation involved in ureteric bud branching,BP,
4572,GO:0060684,1,0.728073288663976,0,2,epithelial-mesenchymal cell signaling,BP,
4573,GO:0060685,1,0.406783891914529,0,3,regulation of prostatic bud formation,BP,
4574,GO:0060686,1,0.406783891914529,0,3,negative regulation of prostatic bud formation,BP,
4575,GO:0060687,1,0.616074156900826,0,2,regulation of branching involved in prostate gland morphogenesis,BP,
4576,GO:0060688,1,0.226302764645002,0,7,regulation of morphogenesis of a branching structure,BP,
4577,GO:0060693,1,0.941285075943011,0,1,regulation of branching involved in salivary gland morphogenesis,BP,
4578,GO:0060706,1,0.569385981966845,0,2,cell differentiation involved in embryonic placenta development,BP,
4579,GO:0060707,1,0.730053612763015,0,1,trophoblast giant cell differentiation,BP,
4580,GO:0060708,1,0.730053612763015,0,1,spongiotrophoblast differentiation,BP,
4581,GO:0060709,1,0.781006884258256,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
4582,GO:0060710,1,0.528643871105362,0,2,chorio-allantoic fusion,BP,
4583,GO:0060711,1,0.25975702014355,0,5,labyrinthine layer development,BP,
4584,GO:0060712,1,0.569385981966845,0,2,spongiotrophoblast layer development,BP,
4585,GO:0060713,1,0.528643871105362,0,2,labyrinthine layer morphogenesis,BP,
4586,GO:0060716,1,0.495364079402172,0,3,labyrinthine layer blood vessel development,BP,
4587,GO:0060740,1,0.224334300077913,0,5,prostate gland epithelium morphogenesis,BP,
4588,GO:0060742,1,0.59183921579231,0,1,epithelial cell differentiation involved in prostate gland development,BP,
4589,GO:0060744,1,0.662592268986548,0,1,mammary gland branching involved in thelarche,BP,
4590,GO:0060745,1,0.50934770063759,0,2,mammary gland branching involved in pregnancy,BP,
4591,GO:0060748,1,0.730656633467999,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
4592,GO:0060749,1,0.733567890553574,0,1,mammary gland alveolus development,BP,
4593,GO:0060750,1,0.662592268986548,0,1,epithelial cell proliferation involved in mammary gland duct elongation,BP,
4594,GO:0060751,1,0.662592268986548,0,1,branch elongation involved in mammary gland duct branching,BP,
4598,GO:0060762,1,0.662592268986548,0,1,regulation of branching involved in mammary gland duct morphogenesis,BP,
4599,GO:0060767,1,0.59183921579231,0,1,epithelial cell proliferation involved in prostate gland development,BP,
4600,GO:0060768,1,0.59183921579231,0,1,regulation of epithelial cell proliferation involved in prostate gland development,BP,
4601,GO:0060775,1,0.662592268986548,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
4602,GO:0060788,1,0.753597902783621,0,1,ectodermal placode formation,BP,
4603,GO:0060795,1,0.622856267383487,0,2,cell fate commitment involved in formation of primary germ layer,BP,
4604,GO:0060804,1,0.766038155162373,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
4605,GO:0060809,1,0.662592268986548,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
4606,GO:0060823,1,0.753597902783621,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
4611,GO:0060840,1,0.203823419928594,0,6,artery development,BP,
4612,GO:0060841,1,0.421091420510704,0,2,venous blood vessel development,BP,
4614,GO:0060843,1,0.59183921579231,0,1,venous endothelial cell differentiation,BP,
4619,GO:0060856,1,0.62421465567788,0,2,establishment of blood-brain barrier,BP,
4620,GO:0060872,1,0.941285075943011,0,1,semicircular canal development,BP,
4621,GO:0060876,1,0.941285075943011,0,1,semicircular canal formation,BP,
4622,GO:0060879,1,0.941285075943011,0,1,semicircular canal fusion,BP,
4623,GO:0060896,1,0.753597902783621,0,1,neural plate pattern specification,BP,
4624,GO:0060897,1,0.753597902783621,0,1,neural plate regionalization,BP,
4625,GO:0060900,1,0.517196580807221,0,2,embryonic camera-type eye formation,BP,
4626,GO:0060907,1,0.662592268986548,0,1,positive regulation of macrophage cytokine production,BP,
4628,GO:0060914,1,0.850452765079241,0,1,heart formation,BP,
4629,GO:0060915,1,0.941285075943011,0,1,mesenchymal cell differentiation involved in lung development,BP,
4631,GO:0060947,1,0.59183921579231,0,1,cardiac vascular smooth muscle cell differentiation,BP,
4632,GO:0060948,1,0.59183921579231,0,1,cardiac vascular smooth muscle cell development,BP,
4633,GO:0060956,1,0.458123943077997,0,2,endocardial cell differentiation,BP,
4634,GO:0060957,1,0.775827451160419,0,1,endocardial cell fate commitment,BP,
4635,GO:0060964,1,0.850452765079241,0,1,regulation of gene silencing by miRNA,BP,
4636,GO:0060966,1,0.850452765079241,0,1,regulation of gene silencing by RNA,BP,
4637,GO:0060968,1,0.850452765079241,0,1,regulation of gene silencing,BP,
4639,GO:0060973,1,0.59183921579231,0,1,cell migration involved in heart development,BP,
4640,GO:0060976,1,0.502546403706452,0,2,coronary vasculature development,BP,
4641,GO:0060977,1,0.59183921579231,0,1,coronary vasculature morphogenesis,BP,
4642,GO:0060979,1,0.59183921579231,0,1,vasculogenesis involved in coronary vascular morphogenesis,BP,
4643,GO:0060982,1,0.59183921579231,0,1,coronary artery morphogenesis,BP,
4644,GO:0060986,1,0.370694480069297,0,3,endocrine hormone secretion,BP,
4646,GO:0060994,1,0.850452765079241,0,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
4648,GO:0060997,1,0.855530641430602,0,1,dendritic spine morphogenesis,BP,
4649,GO:0061004,1,0.850452765079241,0,1,pattern specification involved in kidney development,BP,
4652,GO:0061013,1,0.387755779325457,0,3,regulation of mRNA catabolic process,BP,
4653,GO:0061014,1,0.736743667269758,0,1,positive regulation of mRNA catabolic process,BP,
4656,GO:0061027,1,0.814984680586157,0,1,umbilical cord development,BP,
4658,GO:0061029,1,0.781943571206073,0,1,eyelid development in camera-type eye,BP,
4660,GO:0061033,1,0.941285075943011,0,1,secretion by lung epithelial cell involved in lung growth,BP,
4662,GO:0061036,1,0.328958800773506,0,4,positive regulation of cartilage development,BP,
4663,GO:0061037,1,0.850452765079241,0,1,negative regulation of cartilage development,BP,
4664,GO:0061038,1,0.668469290590451,0,2,uterus morphogenesis,BP,
4665,GO:0061041,1,0.27192302874982,0,6,regulation of wound healing,BP,
4666,GO:0061045,1,0.375717403414836,0,4,negative regulation of wound healing,BP,
4667,GO:0061046,1,0.542173863527961,0,3,regulation of branching involved in lung morphogenesis,BP,
4668,GO:0061047,1,0.542173863527961,0,3,positive regulation of branching involved in lung morphogenesis,BP,
4669,GO:0061049,1,0.828354528958696,0,1,cell growth involved in cardiac muscle cell development,BP,
4670,GO:0061050,1,0.828354528958696,0,1,regulation of cell growth involved in cardiac muscle cell development,BP,
4671,GO:0061051,1,0.828354528958696,0,1,positive regulation of cell growth involved in cardiac muscle cell development,BP,
4673,GO:0061054,1,0.730656633467999,0,1,dermatome development,BP,
4675,GO:0061072,1,0.638435711470739,0,2,iris morphogenesis,BP,
4676,GO:0061081,1,0.662592268986548,0,1,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
4680,GO:0061101,1,0.5061424921696,0,3,neuroendocrine cell differentiation,BP,
4682,GO:0061110,1,0.832024114860243,0,1,dense core granule biogenesis,BP,
4683,GO:0061115,1,0.941285075943011,0,1,lung proximal/distal axis specification,BP,
4686,GO:0061136,1,0.415383885417359,0,3,regulation of proteasomal protein catabolic process,BP,
4688,GO:0061140,1,0.941285075943011,0,1,lung secretory cell differentiation,BP,
4689,GO:0061143,1,0.781943571206073,0,1,alveolar primary septum development,BP,
4690,GO:0061146,1,0.849731904516401,0,1,Peyer's patch morphogenesis,BP,
4691,GO:0061149,1,0.850452765079241,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
4692,GO:0061150,1,0.850452765079241,0,1,renal system segmentation,BP,
4693,GO:0061151,1,0.850452765079241,0,1,BMP signaling pathway involved in renal system segmentation,BP,
4695,GO:0061155,1,0.850452765079241,0,1,pulmonary artery endothelial tube morphogenesis,BP,
4696,GO:0061156,1,0.664486153777512,0,2,pulmonary artery morphogenesis,BP,
4697,GO:0061162,1,0.480964539241892,0,2,establishment of monopolar cell polarity,BP,
4698,GO:0061180,1,0.0864924727554038,0,9,mammary gland epithelium development,BP,
4699,GO:0061183,1,0.730656633467999,0,1,regulation of dermatome development,BP,
4700,GO:0061184,1,0.730656633467999,0,1,positive regulation of dermatome development,BP,
4701,GO:0061205,1,0.570544920893751,0,2,paramesonephric duct development,BP,
4702,GO:0061209,1,0.650932589184655,0,2,cell proliferation involved in mesonephros development,BP,
4704,GO:0061216,1,0.850452765079241,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
4706,GO:0061218,1,0.850452765079241,0,1,negative regulation of mesonephros development,BP,
4707,GO:0061227,1,0.850452765079241,0,1,pattern specification involved in mesonephros development,BP,
4708,GO:0061245,1,0.480964539241892,0,2,establishment or maintenance of bipolar cell polarity,BP,
4711,GO:0061302,1,0.586703535712007,0,2,smooth muscle cell-matrix adhesion,BP,
4712,GO:0061303,1,0.700750792637143,0,2,cornea development in camera-type eye,BP,
4713,GO:0061311,1,0.157721836998592,0,6,cell surface receptor signaling pathway involved in heart development,BP,
4714,GO:0061312,1,0.659274301786046,0,2,BMP signaling pathway involved in heart development,BP,
4715,GO:0061314,1,0.48142933547353,0,2,Notch signaling involved in heart development,BP,
4717,GO:0061323,1,0.850452765079241,0,1,cell proliferation involved in heart morphogenesis,BP,
4718,GO:0061325,1,0.850452765079241,0,1,cell proliferation involved in outflow tract morphogenesis,BP,
4721,GO:0061337,1,0.101396014192016,0,8,cardiac conduction,BP,
4722,GO:0061339,1,0.480964539241892,0,2,establishment or maintenance of monopolar cell polarity,BP,
4723,GO:0061341,1,0.662592268986548,0,1,non-canonical Wnt signaling pathway involved in heart development,BP,
4724,GO:0061343,1,0.775827451160419,0,1,cell adhesion involved in heart morphogenesis,BP,
4725,GO:0061346,1,0.662592268986548,0,1,planar cell polarity pathway involved in heart morphogenesis,BP,
4726,GO:0061347,1,0.662592268986548,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
4727,GO:0061348,1,0.662592268986548,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
4728,GO:0061349,1,0.662592268986548,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
4729,GO:0061350,1,0.662592268986548,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
4730,GO:0061351,1,0.114493288726655,0,8,neural precursor cell proliferation,BP,
4731,GO:0061354,1,0.662592268986548,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
4732,GO:0061369,1,0.730656633467999,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
4733,GO:0061370,1,0.730656633467999,0,1,testosterone biosynthetic process,BP,
4735,GO:0061377,1,0.733567890553574,0,1,mammary gland lobule development,BP,
4736,GO:0061383,1,0.347697774185339,0,3,trabecula morphogenesis,BP,
4737,GO:0061384,1,0.347697774185339,0,3,heart trabecula morphogenesis,BP,
4738,GO:0061387,1,0.57689958345257,0,2,regulation of extent of cell growth,BP,
4739,GO:0061418,1,0.59183921579231,0,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
4740,GO:0061419,1,0.59183921579231,0,1,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
4743,GO:0061438,1,0.850452765079241,0,1,renal system vasculature morphogenesis,BP,
4744,GO:0061439,1,0.850452765079241,0,1,kidney vasculature morphogenesis,BP,
4746,GO:0061443,1,0.775827451160419,0,1,endocardial cushion cell differentiation,BP,
4747,GO:0061445,1,0.775827451160419,0,1,endocardial cushion cell fate commitment,BP,
4750,GO:0061462,1,0.682505945578169,0,1,protein localization to lysosome,BP,
4751,GO:0061515,1,0.437002484786404,0,3,myeloid cell development,BP,
4752,GO:0061525,1,0.662592268986548,0,1,hindgut development,BP,
4755,GO:0061614,1,0.59699569717426,0,2,pri-miRNA transcription from RNA polymerase II promoter,BP,
4756,GO:0061615,1,0.710564000841808,0,1,glycolytic process through fructose-6-phosphate,BP,
4757,GO:0061620,1,0.710564000841808,0,1,glycolytic process through glucose-6-phosphate,BP,
4758,GO:0061621,1,0.710564000841808,0,1,canonical glycolysis,BP,
4759,GO:0061624,1,0.807301335691128,0,1,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
4760,GO:0061626,1,0.850452765079241,0,1,pharyngeal arch artery morphogenesis,BP,
4761,GO:0061630,1,0.665337439618267,0,1,ubiquitin protein ligase activity,MF,
4762,GO:0061640,1,0.681433432009857,0,1,cytoskeleton-dependent cytokinesis,BP,
4763,GO:0061642,1,0.662592268986548,0,1,chemoattraction of axon,BP,
4764,GO:0061643,1,0.662592268986548,0,1,chemorepulsion of axon,BP,
4765,GO:0061659,1,0.665337439618267,0,1,ubiquitin-like protein ligase activity,MF,
4767,GO:0061700,1,0.749336515652812,0,1,GATOR2 complex,CC,
4768,GO:0061718,1,0.710564000841808,0,1,glucose catabolic process to pyruvate,BP,
4769,GO:0061724,1,0.749336515652812,0,1,lipophagy,BP,
4775,GO:0070011,1,0.389936944622905,0,3,peptidase activity, acting on L-amino acid peptides,MF,
4777,GO:0070016,1,0.753597902783621,0,1,armadillo repeat domain binding,MF,
4778,GO:0070050,1,0.728085055754081,0,1,neuron cellular homeostasis,BP,
4780,GO:0070059,1,0.839760482627469,0,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
4782,GO:0070075,1,0.941285075943011,0,1,tear secretion,BP,
4784,GO:0070085,1,0.787775492853738,0,1,glycosylation,BP,
4785,GO:0070098,1,0.764632542658883,0,2,chemokine-mediated signaling pathway,BP,
4786,GO:0070099,1,0.828354528958696,0,1,regulation of chemokine-mediated signaling pathway,BP,
4787,GO:0070101,1,0.828354528958696,0,1,positive regulation of chemokine-mediated signaling pathway,BP,
4788,GO:0070141,1,0.781006884258256,0,1,response to UV-A,BP,
4791,GO:0070162,1,0.635557644513652,0,1,adiponectin secretion,BP,
4792,GO:0070163,1,0.635557644513652,0,1,regulation of adiponectin secretion,BP,
4793,GO:0070164,1,0.635557644513652,0,1,negative regulation of adiponectin secretion,BP,
4796,GO:0070169,1,0.172045092399036,0,7,positive regulation of biomineral tissue development,BP,
4797,GO:0070170,1,0.856552884009832,0,1,regulation of tooth mineralization,BP,
4798,GO:0070172,1,0.856552884009832,0,1,positive regulation of tooth mineralization,BP,
4800,GO:0070227,1,0.438425078318913,0,3,lymphocyte apoptotic process,BP,
4801,GO:0070228,1,0.562802453817258,0,2,regulation of lymphocyte apoptotic process,BP,
4802,GO:0070229,1,0.850452765079241,0,1,negative regulation of lymphocyte apoptotic process,BP,
4803,GO:0070230,1,0.662592268986548,0,1,positive regulation of lymphocyte apoptotic process,BP,
4804,GO:0070231,1,0.438425078318913,0,3,T cell apoptotic process,BP,
4805,GO:0070232,1,0.562802453817258,0,2,regulation of T cell apoptotic process,BP,
4806,GO:0070233,1,0.850452765079241,0,1,negative regulation of T cell apoptotic process,BP,
4807,GO:0070234,1,0.662592268986548,0,1,positive regulation of T cell apoptotic process,BP,
4808,GO:0070242,1,0.562802453817258,0,2,thymocyte apoptotic process,BP,
4809,GO:0070243,1,0.562802453817258,0,2,regulation of thymocyte apoptotic process,BP,
4810,GO:0070244,1,0.850452765079241,0,1,negative regulation of thymocyte apoptotic process,BP,
4811,GO:0070245,1,0.662592268986548,0,1,positive regulation of thymocyte apoptotic process,BP,
4813,GO:0070254,1,0.782385944864048,0,1,mucus secretion,BP,
4814,GO:0070255,1,0.782385944864048,0,1,regulation of mucus secretion,BP,
4815,GO:0070256,1,0.782385944864048,0,1,negative regulation of mucus secretion,BP,
4816,GO:0070268,1,0.149604617026572,0,5,cornification,BP,
4819,GO:0070279,1,0.733962171685514,0,1,vitamin B6 binding,MF,
4821,GO:0070294,1,0.718774331523076,0,1,renal sodium ion absorption,BP,
4822,GO:0070296,1,0.790066751337715,0,1,sarcoplasmic reticulum calcium ion transport,BP,
4825,GO:0070303,1,0.781006884258256,0,1,negative regulation of stress-activated protein kinase signaling cascade,BP,
4827,GO:0070306,1,0.511720850139072,0,3,lens fiber cell differentiation,BP,
4828,GO:0070307,1,0.511720850139072,0,3,lens fiber cell development,BP,
4832,GO:0070328,1,0.749336515652812,0,1,triglyceride homeostasis,BP,
4833,GO:0070341,1,0.941285075943011,0,1,fat cell proliferation,BP,
4834,GO:0070343,1,0.941285075943011,0,1,white fat cell proliferation,BP,
4835,GO:0070344,1,0.941285075943011,0,1,regulation of fat cell proliferation,BP,
4836,GO:0070346,1,0.941285075943011,0,1,positive regulation of fat cell proliferation,BP,
4837,GO:0070350,1,0.941285075943011,0,1,regulation of white fat cell proliferation,BP,
4838,GO:0070352,1,0.941285075943011,0,1,positive regulation of white fat cell proliferation,BP,
4841,GO:0070373,1,0.730053612763015,0,1,negative regulation of ERK1 and ERK2 cascade,BP,
4844,GO:0070384,1,0.941285075943011,0,1,Harderian gland development,BP,
4845,GO:0070391,1,0.923408743724329,0,1,response to lipoteichoic acid,BP,
4846,GO:0070402,1,0.604707407962162,0,1,NADPH binding,MF,
4848,GO:0070411,1,0.753597902783621,0,1,I-SMAD binding,MF,
4849,GO:0070444,1,0.711185484621141,0,1,oligodendrocyte progenitor proliferation,BP,
4850,GO:0070445,1,0.711185484621141,0,1,regulation of oligodendrocyte progenitor proliferation,BP,
4851,GO:0070471,1,0.838425043082162,0,1,uterine smooth muscle contraction,BP,
4852,GO:0070472,1,0.838425043082162,0,1,regulation of uterine smooth muscle contraction,BP,
4853,GO:0070473,1,0.838425043082162,0,1,negative regulation of uterine smooth muscle contraction,BP,
4855,GO:0070486,1,0.725126756103963,0,1,leukocyte aggregation,BP,
4856,GO:0070487,1,0.725126756103963,0,1,monocyte aggregation,BP,
4858,GO:0070509,1,0.61579721380154,0,2,calcium ion import,BP,
4860,GO:0070528,1,0.516080314284821,0,2,protein kinase C signaling,BP,
4862,GO:0070555,1,0.764632542658883,0,2,response to interleukin-1,BP,
4864,GO:0070561,1,0.698454611733275,0,1,vitamin D receptor signaling pathway,BP,
4865,GO:0070585,1,0.655311057413809,0,2,protein localization to mitochondrion,BP,
4868,GO:0070627,1,0.784501226927412,0,1,ferrous iron import,BP,
4869,GO:0070633,1,0.828354528958696,0,1,transepithelial transport,BP,
4870,GO:0070644,1,0.698454611733275,0,1,vitamin D response element binding,MF,
4880,GO:0070670,1,0.604707407962162,0,1,response to interleukin-4,BP,
4883,GO:0070696,1,0.360371721138142,0,4,transmembrane receptor protein serine/threonine kinase binding,MF,
4884,GO:0070700,1,0.360371721138142,0,4,BMP receptor binding,MF,
4885,GO:0070724,1,0.766038155162373,0,1,BMP receptor complex,CC,
4887,GO:0070728,1,0.749336515652812,0,1,leucine binding,MF,
4889,GO:0070820,1,0.424358687232788,0,3,tertiary granule,CC,
4890,GO:0070821,1,0.630724317712244,0,2,tertiary granule membrane,CC,
4891,GO:0070822,1,0.6837505749659,0,1,Sin3-type complex,CC,
4895,GO:0070849,1,0.781006884258256,0,1,response to epidermal growth factor,BP,
4896,GO:0070851,1,0.341801236874432,0,6,growth factor receptor binding,MF,
4897,GO:0070852,1,0.670370234134071,0,1,cell body fiber,CC,
4898,GO:0070873,1,0.781006884258256,0,1,regulation of glycogen metabolic process,BP,
4899,GO:0070875,1,0.781006884258256,0,1,positive regulation of glycogen metabolic process,BP,
4900,GO:0070884,1,0.780567658291826,0,1,regulation of calcineurin-NFAT signaling cascade,BP,
4901,GO:0070885,1,0.780567658291826,0,1,negative regulation of calcineurin-NFAT signaling cascade,BP,
4903,GO:0070915,1,0.849948042925311,0,1,lysophosphatidic acid receptor activity,MF,
4904,GO:0070918,1,0.850452765079241,0,1,production of small RNA involved in gene silencing by RNA,BP,
4905,GO:0070920,1,0.850452765079241,0,1,regulation of production of small RNA involved in gene silencing by RNA,BP,
4907,GO:0070977,1,0.766038155162373,0,1,bone maturation,BP,
4909,GO:0070997,1,0.180700054103696,0,9,neuron death,BP,
4910,GO:0071062,1,0.715318261416419,0,1,alphav-beta3 integrin-vitronectin complex,CC,
4911,GO:0071071,1,0.780266268444755,0,1,regulation of phospholipid biosynthetic process,BP,
4912,GO:0071072,1,0.780266268444755,0,1,negative regulation of phospholipid biosynthetic process,BP,
4920,GO:0071223,1,0.923408743724329,0,1,cellular response to lipoteichoic acid,BP,
4922,GO:0071230,1,0.510458969002767,0,2,cellular response to amino acid stimulus,BP,
4923,GO:0071233,1,0.749336515652812,0,1,cellular response to leucine,BP,
4926,GO:0071260,1,0.528098945374106,0,3,cellular response to mechanical stimulus,BP,
4927,GO:0071276,1,0.781006884258256,0,1,cellular response to cadmium ion,BP,
4928,GO:0071277,1,0.548089348082179,0,2,cellular response to calcium ion,BP,
4929,GO:0071281,1,0.60194213563973,0,2,cellular response to iron ion,BP,
4931,GO:0071285,1,0.694582335858129,0,1,cellular response to lithium ion,BP,
4933,GO:0071300,1,0.165665830627746,0,7,cellular response to retinoic acid,BP,
4934,GO:0071305,1,0.698454611733275,0,1,cellular response to vitamin D,BP,
4937,GO:0071312,1,0.790066751337715,0,1,cellular response to alkaloid,BP,
4938,GO:0071313,1,0.790066751337715,0,1,cellular response to caffeine,BP,
4944,GO:0071335,1,0.941285075943011,0,1,hair follicle cell proliferation,BP,
4945,GO:0071336,1,0.941285075943011,0,1,regulation of hair follicle cell proliferation,BP,
4946,GO:0071338,1,0.941285075943011,0,1,positive regulation of hair follicle cell proliferation,BP,
4949,GO:0071347,1,0.764632542658883,0,2,cellular response to interleukin-1,BP,
4950,GO:0071351,1,0.608707925787425,0,2,cellular response to interleukin-18,BP,
4951,GO:0071353,1,0.604707407962162,0,1,cellular response to interleukin-4,BP,
4953,GO:0071357,1,0.662592268986548,0,1,cellular response to type I interferon,BP,
4954,GO:0071359,1,0.69487375107635,0,2,cellular response to dsRNA,BP,
4955,GO:0071360,1,0.817600888298876,0,1,cellular response to exogenous dsRNA,BP,
4957,GO:0071364,1,0.781006884258256,0,1,cellular response to epidermal growth factor stimulus,BP,
4959,GO:0071372,1,0.59183921579231,0,1,cellular response to follicle-stimulating hormone stimulus,BP,
4963,GO:0071379,1,0.781006884258256,0,1,cellular response to prostaglandin stimulus,BP,
4964,GO:0071380,1,0.781006884258256,0,1,cellular response to prostaglandin E stimulus,BP,
4965,GO:0071383,1,0.232682507931104,0,6,cellular response to steroid hormone stimulus,BP,
4966,GO:0071384,1,0.547639712765513,0,3,cellular response to corticosteroid stimulus,BP,
4967,GO:0071385,1,0.547639712765513,0,3,cellular response to glucocorticoid stimulus,BP,
4968,GO:0071389,1,0.828354528958696,0,1,cellular response to mineralocorticoid stimulus,BP,
4969,GO:0071394,1,0.727489805589545,0,1,cellular response to testosterone stimulus,BP,
4973,GO:0071415,1,0.790066751337715,0,1,cellular response to purine-containing compound,BP,
4976,GO:0071435,1,0.763757722401656,0,1,potassium ion export,BP,
4979,GO:0071450,1,0.725126756103963,0,1,cellular response to oxygen radical,BP,
4980,GO:0071451,1,0.725126756103963,0,1,cellular response to superoxide,BP,
4981,GO:0071453,1,0.229786268727168,0,5,cellular response to oxygen levels,BP,
4982,GO:0071456,1,0.229786268727168,0,5,cellular response to hypoxia,BP,
4990,GO:0071505,1,0.780266268444755,0,1,response to mycophenolic acid,BP,
4991,GO:0071506,1,0.780266268444755,0,1,cellular response to mycophenolic acid,BP,
4992,GO:0071514,1,0.738574234795428,0,1,genetic imprinting,BP,
4993,GO:0071542,1,0.406637346081064,0,4,dopaminergic neuron differentiation,BP,
4995,GO:0071549,1,0.813104792706398,0,1,cellular response to dexamethasone stimulus,BP,
4998,GO:0071599,1,0.853364031216559,0,2,otic vesicle development,BP,
4999,GO:0071600,1,0.853364031216559,0,2,otic vesicle morphogenesis,BP,
5001,GO:0071617,1,0.73462101006065,0,1,lysophospholipid acyltransferase activity,MF,
5003,GO:0071622,1,0.613171838006714,0,2,regulation of granulocyte chemotaxis,BP,
5004,GO:0071624,1,0.828354528958696,0,1,positive regulation of granulocyte chemotaxis,BP,
5005,GO:0071674,1,0.720171426197999,0,2,mononuclear cell migration,BP,
5006,GO:0071680,1,0.694582335858129,0,1,response to indole-3-methanol,BP,
5007,GO:0071681,1,0.694582335858129,0,1,cellular response to indole-3-methanol,BP,
5008,GO:0071688,1,0.634601131053728,0,1,striated muscle myosin thick filament assembly,BP,
5009,GO:0071695,1,0.50661191352048,0,2,anatomical structure maturation,BP,
5010,GO:0071696,1,0.753597902783621,0,1,ectodermal placode development,BP,
5011,GO:0071697,1,0.753597902783621,0,1,ectodermal placode morphogenesis,BP,
5012,GO:0071698,1,0.753597902783621,0,1,olfactory placode development,BP,
5013,GO:0071699,1,0.753597902783621,0,1,olfactory placode morphogenesis,BP,
5018,GO:0071709,1,0.711185484621141,0,1,membrane assembly,BP,
5019,GO:0071715,1,0.828354528958696,0,1,icosanoid transport,BP,
5020,GO:0071731,1,0.760556996405447,0,1,response to nitric oxide,BP,
5021,GO:0071732,1,0.760556996405447,0,1,cellular response to nitric oxide,BP,
5022,GO:0071733,1,0.761153424935427,0,1,transcriptional activation by promoter-enhancer looping,BP,
5028,GO:0071800,1,0.727489805589545,0,1,podosome assembly,BP,
5029,GO:0071801,1,0.727489805589545,0,1,regulation of podosome assembly,BP,
5030,GO:0071803,1,0.727489805589545,0,1,positive regulation of podosome assembly,BP,
5035,GO:0071847,1,0.755771665883275,0,1,TNFSF11-mediated signaling pathway,BP,
5037,GO:0071855,1,0.828354528958696,0,1,neuropeptide receptor binding,MF,
5044,GO:0071875,1,0.529144208457412,0,3,adrenergic receptor signaling pathway,BP,
5045,GO:0071880,1,0.529144208457412,0,3,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
5046,GO:0071883,1,0.636999731039707,0,2,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
5048,GO:0071889,1,0.781006884258256,0,1,14-3-3 protein binding,MF,
5049,GO:0071893,1,0.850452765079241,0,1,BMP signaling pathway involved in nephric duct formation,BP,
5055,GO:0071963,1,0.853129851663623,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
5057,GO:0071985,1,0.784473242465539,0,1,multivesicular body sorting pathway,BP,
5060,GO:0072007,1,0.397802661126138,0,3,mesangial cell differentiation,BP,
5061,GO:0072008,1,0.397802661126138,0,3,glomerular mesangial cell differentiation,BP,
5066,GO:0072015,1,0.850452765079241,0,1,glomerular visceral epithelial cell development,BP,
5067,GO:0072017,1,0.424183519415896,0,2,distal tubule development,BP,
5069,GO:0072033,1,0.730656633467999,0,1,renal vesicle formation,BP,
5070,GO:0072034,1,0.730656633467999,0,1,renal vesicle induction,BP,
5071,GO:0072038,1,0.725126756103963,0,1,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
5072,GO:0072039,1,0.725126756103963,0,1,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5073,GO:0072040,1,0.725126756103963,0,1,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5074,GO:0072044,1,0.36565014458021,0,3,collecting duct development,BP,
5075,GO:0072048,1,0.850452765079241,0,1,renal system pattern specification,BP,
5076,GO:0072049,1,0.850452765079241,0,1,comma-shaped body morphogenesis,BP,
5078,GO:0072053,1,0.730311826899045,0,1,renal inner medulla development,BP,
5079,GO:0072054,1,0.730311826899045,0,1,renal outer medulla development,BP,
5080,GO:0072060,1,0.730311826899045,0,1,outer medullary collecting duct development,BP,
5081,GO:0072061,1,0.730311826899045,0,1,inner medullary collecting duct development,BP,
5086,GO:0072076,1,0.725126756103963,0,1,nephrogenic mesenchyme development,BP,
5087,GO:0072077,1,0.422882007523207,0,4,renal vesicle morphogenesis,BP,
5089,GO:0072079,1,0.802226546471416,0,2,nephron tubule formation,BP,
5091,GO:0072087,1,0.422882007523207,0,4,renal vesicle development,BP,
5095,GO:0072095,1,0.850452765079241,0,1,regulation of branch elongation involved in ureteric bud branching,BP,
5096,GO:0072096,1,0.850452765079241,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
5097,GO:0072097,1,0.850452765079241,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
5098,GO:0072098,1,0.850452765079241,0,1,anterior/posterior pattern specification involved in kidney development,BP,
5099,GO:0072099,1,0.850452765079241,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
5100,GO:0072100,1,0.850452765079241,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
5101,GO:0072101,1,0.850452765079241,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
5102,GO:0072102,1,0.850452765079241,0,1,glomerulus morphogenesis,BP,
5103,GO:0072103,1,0.850452765079241,0,1,glomerulus vasculature morphogenesis,BP,
5104,GO:0072104,1,0.850452765079241,0,1,glomerular capillary formation,BP,
5105,GO:0072106,1,0.936826423682637,0,1,regulation of ureteric bud formation,BP,
5106,GO:0072107,1,0.936826423682637,0,1,positive regulation of ureteric bud formation,BP,
5107,GO:0072108,1,0.683588900267456,0,2,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
5114,GO:0072126,1,0.780266268444755,0,1,positive regulation of glomerular mesangial cell proliferation,BP,
5115,GO:0072131,1,0.725126756103963,0,1,kidney mesenchyme morphogenesis,BP,
5116,GO:0072132,1,0.103979187821922,0,8,mesenchyme morphogenesis,BP,
5117,GO:0072133,1,0.725126756103963,0,1,metanephric mesenchyme morphogenesis,BP,
5118,GO:0072134,1,0.725126756103963,0,1,nephrogenic mesenchyme morphogenesis,BP,
5119,GO:0072135,1,0.725126756103963,0,1,kidney mesenchymal cell proliferation,BP,
5120,GO:0072136,1,0.725126756103963,0,1,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
5121,GO:0072138,1,0.650932589184655,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
5122,GO:0072143,1,0.397802661126138,0,3,mesangial cell development,BP,
5123,GO:0072144,1,0.397802661126138,0,3,glomerular mesangial cell development,BP,
5125,GO:0072156,1,0.718774331523076,0,1,distal tubule morphogenesis,BP,
5126,GO:0072160,1,0.730053612763015,0,1,nephron tubule epithelial cell differentiation,BP,
5127,GO:0072161,1,0.62078556105748,0,2,mesenchymal cell differentiation involved in kidney development,BP,
5128,GO:0072162,1,0.730656633467999,0,1,metanephric mesenchymal cell differentiation,BP,
5132,GO:0072170,1,0.387558212169488,0,3,metanephric tubule development,BP,
5134,GO:0072172,1,0.936826423682637,0,1,mesonephric tubule formation,BP,
5135,GO:0072173,1,0.730656633467999,0,1,metanephric tubule morphogenesis,BP,
5136,GO:0072174,1,0.730656633467999,0,1,metanephric tubule formation,BP,
5138,GO:0072176,1,0.606232408674127,0,2,nephric duct development,BP,
5139,GO:0072178,1,0.606232408674127,0,2,nephric duct morphogenesis,BP,
5140,GO:0072179,1,0.850452765079241,0,1,nephric duct formation,BP,
5141,GO:0072182,1,0.730053612763015,0,1,regulation of nephron tubule epithelial cell differentiation,BP,
5142,GO:0072189,1,0.850452765079241,0,1,ureter development,BP,
5143,GO:0072190,1,0.850452765079241,0,1,ureter urothelium development,BP,
5144,GO:0072191,1,0.850452765079241,0,1,ureter smooth muscle development,BP,
5145,GO:0072192,1,0.850452765079241,0,1,ureter epithelial cell differentiation,BP,
5146,GO:0072193,1,0.850452765079241,0,1,ureter smooth muscle cell differentiation,BP,
5147,GO:0072197,1,0.850452765079241,0,1,ureter morphogenesis,BP,
5148,GO:0072198,1,0.850452765079241,0,1,mesenchymal cell proliferation involved in ureter development,BP,
5149,GO:0072199,1,0.850452765079241,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
5150,GO:0072200,1,0.850452765079241,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
5151,GO:0072201,1,0.562802453817258,0,2,negative regulation of mesenchymal cell proliferation,BP,
5152,GO:0072202,1,0.328635114930718,0,5,cell differentiation involved in metanephros development,BP,
5154,GO:0072205,1,0.6204917861756,0,2,metanephric collecting duct development,BP,
5156,GO:0072209,1,0.780266268444755,0,1,metanephric mesangial cell differentiation,BP,
5163,GO:0072234,1,0.532253268645277,0,2,metanephric nephron tubule development,BP,
5164,GO:0072236,1,0.730311826899045,0,1,metanephric loop of Henle development,BP,
5166,GO:0072243,1,0.532253268645277,0,2,metanephric nephron epithelium development,BP,
5167,GO:0072254,1,0.780266268444755,0,1,metanephric glomerular mesangial cell differentiation,BP,
5168,GO:0072255,1,0.780266268444755,0,1,metanephric glomerular mesangial cell development,BP,
5169,GO:0072257,1,0.730053612763015,0,1,metanephric nephron tubule epithelial cell differentiation,BP,
5172,GO:0072278,1,0.850452765079241,0,1,metanephric comma-shaped body morphogenesis,BP,
5173,GO:0072283,1,0.580630022112622,0,3,metanephric renal vesicle morphogenesis,BP,
5179,GO:0072307,1,0.730053612763015,0,1,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
5180,GO:0072310,1,0.850452765079241,0,1,glomerular epithelial cell development,BP,
5182,GO:0072320,1,0.834203192552595,0,1,volume-sensitive chloride channel activity,MF,
5183,GO:0072329,1,0.584485373100561,0,2,monocarboxylic acid catabolic process,BP,
5184,GO:0072330,1,0.424337754127046,0,3,monocarboxylic acid biosynthetic process,BP,
5195,GO:0072497,1,0.871622561621531,0,1,mesenchymal stem cell differentiation,BP,
5196,GO:0072498,1,0.463118674478579,0,3,embryonic skeletal joint development,BP,
5197,GO:0072503,1,0.18734193551637,0,6,cellular divalent inorganic cation homeostasis,BP,
5198,GO:0072507,1,0.18734193551637,0,6,divalent inorganic cation homeostasis,BP,
5200,GO:0072510,1,0.784501226927412,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
5202,GO:0072512,1,0.784501226927412,0,1,trivalent inorganic cation transport,BP,
5204,GO:0072522,1,0.433433333151153,0,4,purine-containing compound biosynthetic process,BP,
5206,GO:0072524,1,0.553813046047101,0,2,pyridine-containing compound metabolic process,BP,
5207,GO:0072562,1,0.569929560185248,0,2,blood microparticle,CC,
5208,GO:0072574,1,0.826619860236573,0,1,hepatocyte proliferation,BP,
5209,GO:0072575,1,0.826619860236573,0,1,epithelial cell proliferation involved in liver morphogenesis,BP,
5210,GO:0072576,1,0.826619860236573,0,1,liver morphogenesis,BP,
5216,GO:0072595,1,0.781006884258256,0,1,maintenance of protein localization in organelle,BP,
5217,GO:0072602,1,0.59183921579231,0,1,interleukin-4 secretion,BP,
5219,GO:0072606,1,0.662592268986548,0,1,interleukin-8 secretion,BP,
5220,GO:0072655,1,0.655311057413809,0,2,establishment of protein localization to mitochondrion,BP,
5221,GO:0072656,1,0.781006884258256,0,1,maintenance of protein location in mitochondrion,BP,
5225,GO:0072665,1,0.682505945578169,0,1,protein localization to vacuole,BP,
5226,GO:0072672,1,0.676247599336564,0,1,neutrophil extravasation,BP,
5228,GO:0072678,1,0.298289911905912,0,4,T cell migration,BP,
5229,GO:0072679,1,0.923408743724329,0,1,thymocyte migration,BP,
5230,GO:0075733,1,0.688189150954661,0,1,intracellular transport of virus,BP,
5236,GO:0086001,1,0.519110774387841,0,2,cardiac muscle cell action potential,BP,
5237,GO:0086002,1,0.519110774387841,0,2,cardiac muscle cell action potential involved in contraction,BP,
5240,GO:0086005,1,0.519110774387841,0,2,ventricular cardiac muscle cell action potential,BP,
5241,GO:0086008,1,0.763757722401656,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
5242,GO:0086009,1,0.602719558880463,0,2,membrane repolarization,BP,
5243,GO:0086010,1,0.763757722401656,0,1,membrane depolarization during action potential,BP,
5244,GO:0086011,1,0.763757722401656,0,1,membrane repolarization during action potential,BP,
5245,GO:0086013,1,0.763757722401656,0,1,membrane repolarization during cardiac muscle cell action potential,BP,
5246,GO:0086019,1,0.790066751337715,0,1,cell-cell signaling involved in cardiac conduction,BP,
5247,GO:0086023,1,0.832024114860243,0,1,adrenergic receptor signaling pathway involved in heart process,BP,
5248,GO:0086029,1,0.790066751337715,0,1,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
5249,GO:0086030,1,0.832024114860243,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
5250,GO:0086042,1,0.680900065255631,0,1,cardiac muscle cell-cardiac muscle cell adhesion,BP,
5251,GO:0086065,1,0.537098285722896,0,2,cell communication involved in cardiac conduction,BP,
5252,GO:0086068,1,0.790066751337715,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
5253,GO:0086069,1,0.680900065255631,0,1,bundle of His cell to Purkinje myocyte communication,BP,
5254,GO:0086073,1,0.680900065255631,0,1,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
5255,GO:0086080,1,0.680900065255631,0,1,protein binding involved in heterotypic cell-cell adhesion,MF,
5256,GO:0086083,1,0.680900065255631,0,1,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
5257,GO:0086091,1,0.519110774387841,0,2,regulation of heart rate by cardiac conduction,BP,
5259,GO:0086103,1,0.832024114860243,0,1,G-protein coupled receptor signaling pathway involved in heart process,BP,
5263,GO:0090005,1,0.704992319915139,0,1,negative regulation of establishment of protein localization to plasma membrane,BP,
5264,GO:0090009,1,0.662592268986548,0,1,primitive streak formation,BP,
5265,GO:0090022,1,0.613171838006714,0,2,regulation of neutrophil chemotaxis,BP,
5266,GO:0090023,1,0.828354528958696,0,1,positive regulation of neutrophil chemotaxis,BP,
5268,GO:0090031,1,0.560461161423182,0,2,positive regulation of steroid hormone biosynthetic process,BP,
5270,GO:0090036,1,0.662592268986548,0,1,regulation of protein kinase C signaling,BP,
5271,GO:0090037,1,0.662592268986548,0,1,positive regulation of protein kinase C signaling,BP,
5272,GO:0090049,1,0.59183921579231,0,1,regulation of cell migration involved in sprouting angiogenesis,BP,
5273,GO:0090051,1,0.59183921579231,0,1,negative regulation of cell migration involved in sprouting angiogenesis,BP,
5280,GO:0090100,1,0.123188227656539,0,7,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
5281,GO:0090101,1,0.201050444824166,0,5,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
5282,GO:0090102,1,0.662592268986548,0,1,cochlea development,BP,
5283,GO:0090103,1,0.662592268986548,0,1,cochlea morphogenesis,BP,
5286,GO:0090131,1,0.865219391210355,0,1,mesenchyme migration,BP,
5288,GO:0090133,1,0.906752862467527,0,1,mesendoderm migration,BP,
5289,GO:0090134,1,0.906752862467527,0,1,cell migration involved in mesendoderm migration,BP,
5291,GO:0090138,1,0.741010011526507,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
5293,GO:0090162,1,0.480964539241892,0,2,establishment of epithelial cell polarity,BP,
5294,GO:0090174,1,0.44849449631527,0,4,organelle membrane fusion,BP,
5295,GO:0090175,1,0.484688036404671,0,2,regulation of establishment of planar polarity,BP,
5296,GO:0090177,1,0.662592268986548,0,1,establishment of planar polarity involved in neural tube closure,BP,
5297,GO:0090178,1,0.662592268986548,0,1,regulation of establishment of planar polarity involved in neural tube closure,BP,
5298,GO:0090179,1,0.662592268986548,0,1,planar cell polarity pathway involved in neural tube closure,BP,
5302,GO:0090186,1,0.718774331523076,0,1,regulation of pancreatic juice secretion,BP,
5303,GO:0090188,1,0.718774331523076,0,1,negative regulation of pancreatic juice secretion,BP,
5304,GO:0090189,1,0.651389607680235,0,3,regulation of branching involved in ureteric bud morphogenesis,BP,
5305,GO:0090190,1,0.766649863268159,0,2,positive regulation of branching involved in ureteric bud morphogenesis,BP,
5306,GO:0090191,1,0.850452765079241,0,1,negative regulation of branching involved in ureteric bud morphogenesis,BP,
5308,GO:0090193,1,0.780266268444755,0,1,positive regulation of glomerulus development,BP,
5310,GO:0090199,1,0.655311057413809,0,2,regulation of release of cytochrome c from mitochondria,BP,
5311,GO:0090200,1,0.839760482627469,0,1,positive regulation of release of cytochrome c from mitochondria,BP,
5312,GO:0090201,1,0.781006884258256,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
5313,GO:0090202,1,0.761153424935427,0,1,gene looping,BP,
5314,GO:0090207,1,0.676247599336564,0,1,regulation of triglyceride metabolic process,BP,
5315,GO:0090209,1,0.676247599336564,0,1,negative regulation of triglyceride metabolic process,BP,
5316,GO:0090218,1,0.780266268444755,0,1,positive regulation of lipid kinase activity,BP,
5317,GO:0090224,1,0.853347594896784,0,1,regulation of spindle organization,BP,
5319,GO:0090263,1,0.183661488229664,0,7,positive regulation of canonical Wnt signaling pathway,BP,
5320,GO:0090276,1,0.561511797727282,0,3,regulation of peptide hormone secretion,BP,
5321,GO:0090278,1,0.763405242997684,0,1,negative regulation of peptide hormone secretion,BP,
5322,GO:0090279,1,0.61579721380154,0,2,regulation of calcium ion import,BP,
5323,GO:0090280,1,0.780266268444755,0,1,positive regulation of calcium ion import,BP,
5324,GO:0090281,1,0.790066751337715,0,1,negative regulation of calcium ion import,BP,
5326,GO:0090288,1,0.189108523343432,0,5,negative regulation of cellular response to growth factor stimulus,BP,
5327,GO:0090303,1,0.728238827282261,0,2,positive regulation of wound healing,BP,
5331,GO:0090322,1,0.725126756103963,0,1,regulation of superoxide metabolic process,BP,
5332,GO:0090324,1,0.780567658291826,0,1,negative regulation of oxidative phosphorylation,BP,
5333,GO:0090329,1,0.652766003058323,0,2,regulation of DNA-dependent DNA replication,BP,
5335,GO:0090383,1,0.591548703543027,0,3,phagosome acidification,BP,
5336,GO:0090385,1,0.674130765028217,0,2,phagosome-lysosome fusion,BP,
5341,GO:0090493,1,0.936826423682637,0,1,catecholamine uptake,BP,
5342,GO:0090494,1,0.936826423682637,0,1,dopamine uptake,BP,
5343,GO:0090504,1,0.361630446594202,0,4,epiboly,BP,
5344,GO:0090505,1,0.361630446594202,0,4,epiboly involved in wound healing,BP,
5345,GO:0090526,1,0.749336515652812,0,1,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
5347,GO:0090559,1,0.839760482627469,0,1,regulation of membrane permeability,BP,
5348,GO:0090575,1,0.698454611733275,0,1,RNA polymerase II transcription factor complex,CC,
5349,GO:0090579,1,0.761153424935427,0,1,dsDNA loop formation,BP,
5351,GO:0090598,1,0.941285075943011,0,1,male anatomical structure morphogenesis,BP,
5352,GO:0090630,1,0.662592268986548,0,1,activation of GTPase activity,BP,
5353,GO:0090659,1,0.670370234134071,0,1,walking behavior,BP,
5354,GO:0090677,1,0.780266268444755,0,1,reversible differentiation,BP,
5355,GO:0090678,1,0.780266268444755,0,1,cell dedifferentiation involved in phenotypic switching,BP,
5357,GO:0097011,1,0.781006884258256,0,1,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
5358,GO:0097012,1,0.781006884258256,0,1,response to granulocyte macrophage colony-stimulating factor,BP,
5361,GO:0097021,1,0.849731904516401,0,1,lymphocyte migration into lymphoid organs,BP,
5365,GO:0097058,1,0.849407889468112,0,1,CRLF-CLCF1 complex,CC,
5366,GO:0097059,1,0.849407889468112,0,1,CNTFR-CLCF1 complex,CC,
5370,GO:0097070,1,0.781943571206073,0,1,ductus arteriosus closure,BP,
5371,GO:0097084,1,0.59183921579231,0,1,vascular smooth muscle cell development,BP,
5372,GO:0097091,1,0.711185484621141,0,1,synaptic vesicle clustering,BP,
5373,GO:0097094,1,0.850452765079241,0,1,craniofacial suture morphogenesis,BP,
5376,GO:0097104,1,0.711185484621141,0,1,postsynaptic membrane assembly,BP,
5377,GO:0097106,1,0.711185484621141,0,1,postsynaptic density organization,BP,
5379,GO:0097118,1,0.711185484621141,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
5380,GO:0097119,1,0.711185484621141,0,1,postsynaptic density protein 95 clustering,BP,
5382,GO:0097152,1,0.725126756103963,0,1,mesenchymal cell apoptotic process,BP,
5384,GO:0097164,1,0.526680023164793,0,2,ammonium ion metabolic process,BP,
5385,GO:0097178,1,0.898270644003197,0,1,ruffle assembly,BP,
5391,GO:0097186,1,0.665308550780754,0,1,amelogenesis,BP,
5396,GO:0097194,1,0.781006884258256,0,1,execution phase of apoptosis,BP,
5397,GO:0097197,1,0.856333645467011,0,1,tetraspanin-enriched microdomain,CC,
5402,GO:0097278,1,0.784473242465539,0,1,complement-dependent cytotoxicity,BP,
5403,GO:0097284,1,0.676247599336564,0,1,hepatocyte apoptotic process,BP,
5404,GO:0097286,1,0.784501226927412,0,1,iron ion import,BP,
5406,GO:0097306,1,0.541614449917901,0,2,cellular response to alcohol,BP,
5407,GO:0097325,1,0.662592268986548,0,1,melanocyte proliferation,BP,
5409,GO:0097345,1,0.839760482627469,0,1,mitochondrial outer membrane permeabilization,BP,
5411,GO:0097381,1,0.560534968294878,0,1,photoreceptor disc membrane,CC,
5412,GO:0097386,1,0.813104792706398,0,1,glial cell projection,CC,
5414,GO:0097425,1,0.834203192552595,0,1,smooth endoplasmic reticulum part,CC,
5416,GO:0097449,1,0.813104792706398,0,1,astrocyte projection,CC,
5418,GO:0097459,1,0.784501226927412,0,1,iron ion import into cell,BP,
5419,GO:0097460,1,0.784501226927412,0,1,ferrous iron import into cell,BP,
5420,GO:0097479,1,0.402063806064191,0,4,synaptic vesicle localization,BP,
5421,GO:0097480,1,0.56736982560807,0,3,establishment of synaptic vesicle localization,BP,
5425,GO:0097531,1,0.832024114860243,0,1,mast cell migration,BP,
5427,GO:0097553,1,0.790066751337715,0,1,calcium ion transmembrane import into cytosol,BP,
5428,GO:0097581,1,0.853129851663623,0,1,lamellipodium organization,BP,
5430,GO:0097623,1,0.763757722401656,0,1,potassium ion export across plasma membrane,BP,
5433,GO:0097696,1,0.365064734570266,0,3,STAT cascade,BP,
5436,GO:0097720,1,0.780567658291826,0,1,calcineurin-mediated signaling,BP,
5441,GO:0097746,1,0.15599030630525,0,9,regulation of blood vessel diameter,BP,
5442,GO:0097755,1,0.75275519657064,0,2,positive regulation of blood vessel diameter,BP,
5443,GO:0097756,1,0.228238847248176,0,7,negative regulation of blood vessel diameter,BP,
5444,GO:0098531,1,0.698454611733275,0,1,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
5445,GO:0098542,1,0.578137239546702,0,4,defense response to other organism,BP,
5452,GO:0098596,1,0.781943571206073,0,1,imitative learning,BP,
5453,GO:0098597,1,0.781943571206073,0,1,observational learning,BP,
5454,GO:0098598,1,0.781943571206073,0,1,learned vocalization behavior or vocal learning,BP,
5457,GO:0098631,1,0.53275813987442,0,2,protein binding involved in cell adhesion,MF,
5458,GO:0098632,1,0.53275813987442,0,2,protein binding involved in cell-cell adhesion,MF,
5460,GO:0098641,1,0.783719200454775,0,1,cadherin binding involved in cell-cell adhesion,MF,
5462,GO:0098656,1,0.650957350427401,0,2,anion transmembrane transport,BP,
5463,GO:0098657,1,0.734649293515387,0,2,import into cell,BP,
5464,GO:0098659,1,0.784501226927412,0,1,inorganic cation import into cell,BP,
5466,GO:0098661,1,0.834203192552595,0,1,inorganic anion transmembrane transport,BP,
5468,GO:0098668,1,0.763757722401656,0,1,potassium ion export from cell,BP,
5470,GO:0098732,1,0.6837505749659,0,1,macromolecule deacylation,BP,
5473,GO:0098751,1,0.574473782469215,0,2,bone cell development,BP,
5474,GO:0098754,1,0.54248431734725,0,2,detoxification,BP,
5478,GO:0098791,1,0.609586403399773,0,2,Golgi subcompartment,CC,
5486,GO:0098810,1,0.936826423682637,0,1,neurotransmitter reuptake,BP,
5487,GO:0098811,1,0.459292252369848,0,2,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,
5488,GO:0098813,1,0.853347594896784,0,1,nuclear chromosome segregation,BP,
5489,GO:0098815,1,0.855530641430602,0,1,modulation of excitatory postsynaptic potential,BP,
5495,GO:0098868,1,0.962412700305168,0,1,bone growth,BP,
5496,GO:0098869,1,0.54248431734725,0,2,cellular oxidant detoxification,BP,
5497,GO:0098900,1,0.680900065255631,0,1,regulation of action potential,BP,
5498,GO:0098901,1,0.680900065255631,0,1,regulation of cardiac muscle cell action potential,BP,
5499,GO:0098911,1,0.680900065255631,0,1,regulation of ventricular cardiac muscle cell action potential,BP,
5500,GO:0098915,1,0.763757722401656,0,1,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
5502,GO:0098927,1,0.727489805589545,0,1,vesicle-mediated transport between endosomal compartments,BP,
5504,GO:0099003,1,0.56736982560807,0,3,vesicle-mediated transport in synapse,BP,
5505,GO:0099023,1,0.817600888298876,0,1,tethering complex,CC,
5507,GO:0099054,1,0.566183657895701,0,2,presynapse assembly,BP,
5508,GO:0099068,1,0.401302285969618,0,3,postsynapse assembly,BP,
5511,GO:0099084,1,0.711185484621141,0,1,postsynaptic specialization organization,BP,
5512,GO:0099094,1,0.605258026216555,0,2,ligand-gated cation channel activity,MF,
5513,GO:0099106,1,0.604576111047567,0,2,ion channel regulator activity,MF,
5516,GO:0099504,1,0.514083460838939,0,3,synaptic vesicle cycle,BP,
5519,GO:0099531,1,0.678228619833455,0,3,presynaptic process involved in chemical synaptic transmission,BP,
5522,GO:0099565,1,0.521391937215499,0,3,chemical synaptic transmission, postsynaptic,BP,
5525,GO:0099587,1,0.784501226927412,0,1,inorganic ion import into cell,BP,
5526,GO:0099600,1,0.034704856833505,0,13,transmembrane receptor activity,MF,
5527,GO:0099622,1,0.763757722401656,0,1,cardiac muscle cell membrane repolarization,BP,
5528,GO:0099623,1,0.763757722401656,0,1,regulation of cardiac muscle cell membrane repolarization,BP,
5529,GO:0099625,1,0.763757722401656,0,1,ventricular cardiac muscle cell membrane repolarization,BP,
5530,GO:0099643,1,0.724367006107158,0,2,signal release from synapse,BP,
5531,GO:0100002,1,0.781006884258256,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
5533,GO:0101003,1,0.67497188939156,0,1,ficolin-1-rich granule membrane,CC,
5534,GO:0102132,1,0.604707407962162,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
5538,GO:1900006,1,0.725126756103963,0,1,positive regulation of dendrite development,BP,
5539,GO:1900019,1,0.662592268986548,0,1,regulation of protein kinase C activity,BP,
5540,GO:1900020,1,0.662592268986548,0,1,positive regulation of protein kinase C activity,BP,
5541,GO:1900027,1,0.898270644003197,0,1,regulation of ruffle assembly,BP,
5542,GO:1900029,1,0.898270644003197,0,1,positive regulation of ruffle assembly,BP,
5543,GO:1900046,1,0.516168134235673,0,3,regulation of hemostasis,BP,
5544,GO:1900047,1,0.516168134235673,0,3,negative regulation of hemostasis,BP,
5549,GO:1900104,1,0.725126756103963,0,1,regulation of hyaluranon cable assembly,BP,
5550,GO:1900106,1,0.725126756103963,0,1,positive regulation of hyaluranon cable assembly,BP,
5551,GO:1900125,1,0.780266268444755,0,1,regulation of hyaluronan biosynthetic process,BP,
5552,GO:1900127,1,0.780266268444755,0,1,positive regulation of hyaluronan biosynthetic process,BP,
5560,GO:1900193,1,0.962412700305168,0,1,regulation of oocyte maturation,BP,
5561,GO:1900194,1,0.962412700305168,0,1,negative regulation of oocyte maturation,BP,
5562,GO:1900238,1,0.780266268444755,0,1,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
5563,GO:1900239,1,0.780266268444755,0,1,regulation of phenotypic switching,BP,
5564,GO:1900241,1,0.780266268444755,0,1,positive regulation of phenotypic switching,BP,
5565,GO:1900274,1,0.849948042925311,0,1,regulation of phospholipase C activity,BP,
5566,GO:1900371,1,0.571549327879466,0,3,regulation of purine nucleotide biosynthetic process,BP,
5567,GO:1900372,1,0.828354528958696,0,1,negative regulation of purine nucleotide biosynthetic process,BP,
5568,GO:1900373,1,0.690941304389812,0,2,positive regulation of purine nucleotide biosynthetic process,BP,
5569,GO:1900376,1,0.662592268986548,0,1,regulation of secondary metabolite biosynthetic process,BP,
5570,GO:1900377,1,0.662592268986548,0,1,negative regulation of secondary metabolite biosynthetic process,BP,
5571,GO:1900407,1,0.565528276640841,0,2,regulation of cellular response to oxidative stress,BP,
5572,GO:1900408,1,0.781006884258256,0,1,negative regulation of cellular response to oxidative stress,BP,
5573,GO:1900452,1,0.782385944864048,0,1,regulation of long term synaptic depression,BP,
5574,GO:1900453,1,0.782385944864048,0,1,negative regulation of long term synaptic depression,BP,
5575,GO:1900542,1,0.242756792244459,0,6,regulation of purine nucleotide metabolic process,BP,
5576,GO:1900543,1,0.646010841297154,0,2,negative regulation of purine nucleotide metabolic process,BP,
5577,GO:1900544,1,0.294367972064395,0,5,positive regulation of purine nucleotide metabolic process,BP,
5578,GO:1900736,1,0.832024114860243,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5579,GO:1900738,1,0.832024114860243,0,1,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5580,GO:1900739,1,0.839760482627469,0,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
5581,GO:1900740,1,0.839760482627469,0,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
5582,GO:1900744,1,0.675516485569067,0,2,regulation of p38MAPK cascade,BP,
5583,GO:1900745,1,0.675516485569067,0,2,positive regulation of p38MAPK cascade,BP,
5585,GO:1900750,1,0.850380627707629,0,1,oligopeptide binding,MF,
5590,GO:1901020,1,0.790066751337715,0,1,negative regulation of calcium ion transmembrane transporter activity,BP,
5591,GO:1901028,1,0.839760482627469,0,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
5592,GO:1901030,1,0.839760482627469,0,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
5593,GO:1901031,1,0.54248431734725,0,2,regulation of response to reactive oxygen species,BP,
5594,GO:1901068,1,0.704992319915139,0,1,guanosine-containing compound metabolic process,BP,
5597,GO:1901079,1,0.832024114860243,0,1,positive regulation of relaxation of muscle,BP,
5598,GO:1901099,1,0.688074274624324,0,3,negative regulation of signal transduction in absence of ligand,BP,
5602,GO:1901145,1,0.725126756103963,0,1,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
5603,GO:1901184,1,0.249979231984481,0,6,regulation of ERBB signaling pathway,BP,
5604,GO:1901185,1,0.65065242801495,0,2,negative regulation of ERBB signaling pathway,BP,
5605,GO:1901186,1,0.387189658710626,0,4,positive regulation of ERBB signaling pathway,BP,
5606,GO:1901201,1,0.59183921579231,0,1,regulation of extracellular matrix assembly,BP,
5607,GO:1901213,1,0.388687020371776,0,3,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
5608,GO:1901214,1,0.180700054103696,0,9,regulation of neuron death,BP,
5609,GO:1901215,1,0.222191882243575,0,8,negative regulation of neuron death,BP,
5610,GO:1901264,1,0.673891493834439,0,2,carbohydrate derivative transport,BP,
5613,GO:1901293,1,0.433433333151153,0,4,nucleoside phosphate biosynthetic process,BP,
5614,GO:1901338,1,0.636999731039707,0,2,catecholamine binding,MF,
5625,GO:1901476,1,0.61915588803758,0,2,carbohydrate transporter activity,MF,
5626,GO:1901522,1,0.337593350505577,0,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
5627,GO:1901532,1,0.59183921579231,0,1,regulation of hematopoietic progenitor cell differentiation,BP,
5628,GO:1901533,1,0.59183921579231,0,1,negative regulation of hematopoietic progenitor cell differentiation,BP,
5629,GO:1901550,1,0.834758725899505,0,1,regulation of endothelial cell development,BP,
5630,GO:1901552,1,0.834758725899505,0,1,positive regulation of endothelial cell development,BP,
5634,GO:1901568,1,0.703978953100515,0,2,fatty acid derivative metabolic process,BP,
5635,GO:1901570,1,0.703978953100515,0,2,fatty acid derivative biosynthetic process,BP,
5636,GO:1901571,1,0.828354528958696,0,1,fatty acid derivative transport,BP,
5639,GO:1901605,1,0.733962171685514,0,1,alpha-amino acid metabolic process,BP,
5640,GO:1901606,1,0.733962171685514,0,1,alpha-amino acid catabolic process,BP,
5645,GO:1901623,1,0.662592268986548,0,1,regulation of lymphocyte chemotaxis,BP,
5646,GO:1901626,1,0.711185484621141,0,1,regulation of postsynaptic membrane organization,BP,
5651,GO:1901657,1,0.704992319915139,0,1,glycosyl compound metabolic process,BP,
5652,GO:1901674,1,0.730053612763015,0,1,regulation of histone H3-K27 acetylation,BP,
5653,GO:1901676,1,0.730053612763015,0,1,positive regulation of histone H3-K27 acetylation,BP,
5654,GO:1901678,1,0.741464194934762,0,1,iron coordination entity transport,BP,
5662,GO:1901724,1,0.780266268444755,0,1,positive regulation of cell proliferation involved in kidney development,BP,
5663,GO:1901796,1,0.655311057413809,0,2,regulation of signal transduction by p53 class mediator,BP,
5664,GO:1901798,1,0.839760482627469,0,1,positive regulation of signal transduction by p53 class mediator,BP,
5665,GO:1901800,1,0.518721889976232,0,2,positive regulation of proteasomal protein catabolic process,BP,
5668,GO:1901862,1,0.430945821794874,0,4,negative regulation of muscle tissue development,BP,
5677,GO:1901899,1,0.832024114860243,0,1,positive regulation of relaxation of cardiac muscle,BP,
5678,GO:1901963,1,0.850452765079241,0,1,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
5679,GO:1901964,1,0.850452765079241,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
5680,GO:1901976,1,0.781006884258256,0,1,regulation of cell cycle checkpoint,BP,
5682,GO:1901983,1,0.730053612763015,0,1,regulation of protein acetylation,BP,
5683,GO:1901985,1,0.730053612763015,0,1,positive regulation of protein acetylation,BP,
5688,GO:1901998,1,0.852187479087815,0,1,toxin transport,BP,
5689,GO:1902001,1,0.781006884258256,0,1,fatty acid transmembrane transport,BP,
5690,GO:1902010,1,0.749336515652812,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
5693,GO:1902041,1,0.839760482627469,0,1,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
5694,GO:1902043,1,0.839760482627469,0,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
5695,GO:1902074,1,0.828354528958696,0,1,response to salt,BP,
5696,GO:1902098,1,0.698454611733275,0,1,calcitriol binding,MF,
5700,GO:1902108,1,0.839760482627469,0,1,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
5701,GO:1902110,1,0.839760482627469,0,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
5704,GO:1902121,1,0.698454611733275,0,1,lithocholic acid binding,MF,
5705,GO:1902170,1,0.760556996405447,0,1,cellular response to reactive nitrogen species,BP,
5706,GO:1902175,1,0.781006884258256,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5707,GO:1902176,1,0.781006884258256,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5709,GO:1902235,1,0.839760482627469,0,1,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
5710,GO:1902237,1,0.839760482627469,0,1,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
5711,GO:1902263,1,0.59183921579231,0,1,apoptotic process involved in embryonic digit morphogenesis,BP,
5712,GO:1902271,1,0.698454611733275,0,1,D3 vitamins binding,MF,
5713,GO:1902275,1,0.730053612763015,0,1,regulation of chromatin organization,BP,
5714,GO:1902282,1,0.763757722401656,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
5715,GO:1902284,1,0.57689958345257,0,2,neuron projection extension involved in neuron projection guidance,BP,
5716,GO:1902302,1,0.763757722401656,0,1,regulation of potassium ion export,BP,
5717,GO:1902303,1,0.763757722401656,0,1,negative regulation of potassium ion export,BP,
5718,GO:1902337,1,0.5054717456525,0,2,regulation of apoptotic process involved in morphogenesis,BP,
5719,GO:1902338,1,0.725126756103963,0,1,negative regulation of apoptotic process involved in morphogenesis,BP,
5720,GO:1902339,1,0.698454611733275,0,1,positive regulation of apoptotic process involved in morphogenesis,BP,
5721,GO:1902369,1,0.528101695200463,0,2,negative regulation of RNA catabolic process,BP,
5722,GO:1902373,1,0.528101695200463,0,2,negative regulation of mRNA catabolic process,BP,
5723,GO:1902379,1,0.662592268986548,0,1,chemoattractant activity involved in axon guidance,MF,
5727,GO:1902455,1,0.725126756103963,0,1,negative regulation of stem cell population maintenance,BP,
5728,GO:1902473,1,0.566183657895701,0,2,regulation of protein localization to synapse,BP,
5729,GO:1902474,1,0.566183657895701,0,2,positive regulation of protein localization to synapse,BP,
5730,GO:1902476,1,0.834203192552595,0,1,chloride transmembrane transport,BP,
5739,GO:1902579,1,0.585805457600735,0,2,multi-organism localization,BP,
5741,GO:1902581,1,0.688189150954661,0,1,multi-organism cellular localization,BP,
5743,GO:1902583,1,0.688189150954661,0,1,multi-organism intracellular transport,BP,
5748,GO:1902622,1,0.613171838006714,0,2,regulation of neutrophil migration,BP,
5749,GO:1902624,1,0.828354528958696,0,1,positive regulation of neutrophil migration,BP,
5752,GO:1902656,1,0.790066751337715,0,1,calcium ion import into cytosol,BP,
5753,GO:1902667,1,0.57689958345257,0,2,regulation of axon guidance,BP,
5754,GO:1902668,1,0.57689958345257,0,2,negative regulation of axon guidance,BP,
5757,GO:1902686,1,0.839760482627469,0,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
5758,GO:1902688,1,0.780567658291826,0,1,regulation of NAD metabolic process,BP,
5759,GO:1902690,1,0.780567658291826,0,1,positive regulation of NAD metabolic process,BP,
5760,GO:1902692,1,0.59183921579231,0,1,regulation of neuroblast proliferation,BP,
5761,GO:1902742,1,0.202827488457322,0,4,apoptotic process involved in development,BP,
5766,GO:1902850,1,0.853347594896784,0,1,microtubule cytoskeleton organization involved in mitosis,BP,
5767,GO:1902882,1,0.422535510258843,0,3,regulation of response to oxidative stress,BP,
5768,GO:1902883,1,0.781006884258256,0,1,negative regulation of response to oxidative stress,BP,
5769,GO:1902893,1,0.59699569717426,0,2,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5770,GO:1902894,1,0.780266268444755,0,1,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5771,GO:1902895,1,0.59699569717426,0,2,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5772,GO:1902897,1,0.711185484621141,0,1,regulation of postsynaptic density protein 95 clustering,BP,
5777,GO:1902930,1,0.698454611733275,0,1,regulation of alcohol biosynthetic process,BP,
5779,GO:1902946,1,0.727489805589545,0,1,protein localization to early endosome,BP,
5780,GO:1902965,1,0.727489805589545,0,1,regulation of protein localization to early endosome,BP,
5781,GO:1902966,1,0.727489805589545,0,1,positive regulation of protein localization to early endosome,BP,
5782,GO:1903010,1,0.755771665883275,0,1,regulation of bone development,BP,
5783,GO:1903011,1,0.755771665883275,0,1,negative regulation of bone development,BP,
5784,GO:1903018,1,0.811111303766348,0,1,regulation of glycoprotein metabolic process,BP,
5785,GO:1903019,1,0.811111303766348,0,1,negative regulation of glycoprotein metabolic process,BP,
5786,GO:1903025,1,0.730053612763015,0,1,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
5787,GO:1903034,1,0.27192302874982,0,6,regulation of response to wounding,BP,
5788,GO:1903035,1,0.375717403414836,0,4,negative regulation of response to wounding,BP,
5789,GO:1903036,1,0.728238827282261,0,2,positive regulation of response to wounding,BP,
5793,GO:1903046,1,0.287802956910327,0,4,meiotic cell cycle process,BP,
5795,GO:1903050,1,0.311651581428465,0,4,regulation of proteolysis involved in cellular protein catabolic process,BP,
5796,GO:1903052,1,0.38963771629007,0,3,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
5797,GO:1903053,1,0.432982177571878,0,2,regulation of extracellular matrix organization,BP,
5799,GO:1903077,1,0.704992319915139,0,1,negative regulation of protein localization to plasma membrane,BP,
5802,GO:1903131,1,0.850452765079241,0,1,mononuclear cell differentiation,BP,
5803,GO:1903140,1,0.834758725899505,0,1,regulation of establishment of endothelial barrier,BP,
5804,GO:1903142,1,0.834758725899505,0,1,positive regulation of establishment of endothelial barrier,BP,
5806,GO:1903170,1,0.790066751337715,0,1,negative regulation of calcium ion transmembrane transport,BP,
5807,GO:1903201,1,0.781006884258256,0,1,regulation of oxidative stress-induced cell death,BP,
5808,GO:1903202,1,0.781006884258256,0,1,negative regulation of oxidative stress-induced cell death,BP,
5809,GO:1903232,1,0.87844991147751,0,1,melanosome assembly,BP,
5810,GO:1903305,1,0.329302342183165,0,4,regulation of regulated secretory pathway,BP,
5811,GO:1903306,1,0.59183921579231,0,1,negative regulation of regulated secretory pathway,BP,
5812,GO:1903307,1,0.661289365902482,0,2,positive regulation of regulated secretory pathway,BP,
5813,GO:1903311,1,0.387755779325457,0,3,regulation of mRNA metabolic process,BP,
5814,GO:1903312,1,0.528101695200463,0,2,negative regulation of mRNA metabolic process,BP,
5815,GO:1903313,1,0.736743667269758,0,1,positive regulation of mRNA metabolic process,BP,
5817,GO:1903320,1,0.629174328088141,0,2,regulation of protein modification by small protein conjugation or removal,BP,
5818,GO:1903322,1,0.629174328088141,0,2,positive regulation of protein modification by small protein conjugation or removal,BP,
5820,GO:1903362,1,0.22524692088836,0,5,regulation of cellular protein catabolic process,BP,
5821,GO:1903364,1,0.281980366546194,0,4,positive regulation of cellular protein catabolic process,BP,
5824,GO:1903409,1,0.506057231766671,0,3,reactive oxygen species biosynthetic process,BP,
5825,GO:1903426,1,0.506057231766671,0,3,regulation of reactive oxygen species biosynthetic process,BP,
5826,GO:1903428,1,0.506057231766671,0,3,positive regulation of reactive oxygen species biosynthetic process,BP,
5827,GO:1903429,1,0.962412700305168,0,1,regulation of cell maturation,BP,
5828,GO:1903430,1,0.962412700305168,0,1,negative regulation of cell maturation,BP,
5829,GO:1903432,1,0.749336515652812,0,1,regulation of TORC1 signaling,BP,
5830,GO:1903433,1,0.784473242465539,0,1,regulation of constitutive secretory pathway,BP,
5831,GO:1903435,1,0.784473242465539,0,1,positive regulation of constitutive secretory pathway,BP,
5836,GO:1903510,1,0.478476681596556,0,3,mucopolysaccharide metabolic process,BP,
5837,GO:1903514,1,0.790066751337715,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
5838,GO:1903519,1,0.698454611733275,0,1,regulation of mammary gland involution,BP,
5839,GO:1903521,1,0.698454611733275,0,1,positive regulation of mammary gland involution,BP,
5841,GO:1903523,1,0.352558086320212,0,3,negative regulation of blood circulation,BP,
5857,GO:1903578,1,0.780567658291826,0,1,regulation of ATP metabolic process,BP,
5858,GO:1903579,1,0.780567658291826,0,1,negative regulation of ATP metabolic process,BP,
5859,GO:1903580,1,0.780567658291826,0,1,positive regulation of ATP metabolic process,BP,
5860,GO:1903649,1,0.727489805589545,0,1,regulation of cytoplasmic transport,BP,
5861,GO:1903651,1,0.727489805589545,0,1,positive regulation of cytoplasmic transport,BP,
5863,GO:1903671,1,0.59183921579231,0,1,negative regulation of sprouting angiogenesis,BP,
5868,GO:1903715,1,0.780567658291826,0,1,regulation of aerobic respiration,BP,
5869,GO:1903719,1,0.781006884258256,0,1,regulation of I-kappaB phosphorylation,BP,
5870,GO:1903721,1,0.781006884258256,0,1,positive regulation of I-kappaB phosphorylation,BP,
5872,GO:1903726,1,0.780266268444755,0,1,negative regulation of phospholipid metabolic process,BP,
5873,GO:1903727,1,0.780266268444755,0,1,positive regulation of phospholipid metabolic process,BP,
5875,GO:1903747,1,0.839760482627469,0,1,regulation of establishment of protein localization to mitochondrion,BP,
5876,GO:1903749,1,0.839760482627469,0,1,positive regulation of establishment of protein localization to mitochondrion,BP,
5877,GO:1903779,1,0.544971282494435,0,3,regulation of cardiac conduction,BP,
5878,GO:1903792,1,0.610368083398472,0,2,negative regulation of anion transport,BP,
5879,GO:1903793,1,0.828354528958696,0,1,positive regulation of anion transport,BP,
5880,GO:1903798,1,0.850452765079241,0,1,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
5881,GO:1903800,1,0.850452765079241,0,1,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
5882,GO:1903825,1,0.781006884258256,0,1,organic acid transmembrane transport,BP,
5886,GO:1903830,1,0.871848704734727,0,1,magnesium ion transmembrane transport,BP,
5888,GO:1903845,1,0.838635604722482,0,1,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
5889,GO:1903847,1,0.421091420510704,0,2,regulation of aorta morphogenesis,BP,
5890,GO:1903849,1,0.421091420510704,0,2,positive regulation of aorta morphogenesis,BP,
5891,GO:1903867,1,0.725126756103963,0,1,extraembryonic membrane development,BP,
5892,GO:1903900,1,0.59183921579231,0,1,regulation of viral life cycle,BP,
5893,GO:1903902,1,0.59183921579231,0,1,positive regulation of viral life cycle,BP,
5894,GO:1903959,1,0.781006884258256,0,1,regulation of anion transmembrane transport,BP,
5895,GO:1903960,1,0.781006884258256,0,1,negative regulation of anion transmembrane transport,BP,
5898,GO:1904023,1,0.780567658291826,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
5899,GO:1904025,1,0.780567658291826,0,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,
5908,GO:1904238,1,0.397802661126138,0,3,pericyte cell differentiation,BP,
5909,GO:1904262,1,0.749336515652812,0,1,negative regulation of TORC1 signaling,BP,
5911,GO:1904376,1,0.704992319915139,0,1,negative regulation of protein localization to cell periphery,BP,
5914,GO:1904407,1,0.646375496778584,0,2,positive regulation of nitric oxide metabolic process,BP,
5915,GO:1904502,1,0.749336515652812,0,1,regulation of lipophagy,BP,
5916,GO:1904504,1,0.749336515652812,0,1,positive regulation of lipophagy,BP,
5920,GO:1904659,1,0.821374167469034,0,1,glucose transmembrane transport,BP,
5921,GO:1904672,1,0.725126756103963,0,1,regulation of somatic stem cell population maintenance,BP,
5922,GO:1904673,1,0.725126756103963,0,1,negative regulation of somatic stem cell population maintenance,BP,
5923,GO:1904705,1,0.780266268444755,0,1,regulation of vascular smooth muscle cell proliferation,BP,
5924,GO:1904707,1,0.780266268444755,0,1,positive regulation of vascular smooth muscle cell proliferation,BP,
5925,GO:1904738,1,0.780266268444755,0,1,vascular associated smooth muscle cell migration,BP,
5926,GO:1904746,1,0.725126756103963,0,1,negative regulation of apoptotic process involved in development,BP,
5927,GO:1904747,1,0.698454611733275,0,1,positive regulation of apoptotic process involved in development,BP,
5928,GO:1904748,1,0.5054717456525,0,2,regulation of apoptotic process involved in development,BP,
5929,GO:1904752,1,0.780266268444755,0,1,regulation of vascular associated smooth muscle cell migration,BP,
5930,GO:1904754,1,0.780266268444755,0,1,positive regulation of vascular associated smooth muscle cell migration,BP,
5932,GO:1904837,1,0.759319799482521,0,1,beta-catenin-TCF complex assembly,BP,
5933,GO:1904861,1,0.566183657895701,0,2,excitatory synapse assembly,BP,
5934,GO:1904862,1,0.662592268986548,0,1,inhibitory synapse assembly,BP,
5935,GO:1904885,1,0.753597902783621,0,1,beta-catenin destruction complex assembly,BP,
5936,GO:1904886,1,0.753597902783621,0,1,beta-catenin destruction complex disassembly,BP,
5937,GO:1904888,1,0.850452765079241,0,1,cranial skeletal system development,BP,
5938,GO:1904889,1,0.855530641430602,0,1,regulation of excitatory synapse assembly,BP,
5939,GO:1904891,1,0.855530641430602,0,1,positive regulation of excitatory synapse assembly,BP,
5940,GO:1904892,1,0.365064734570266,0,3,regulation of STAT cascade,BP,
5941,GO:1904894,1,0.365064734570266,0,3,positive regulation of STAT cascade,BP,
5942,GO:1904933,1,0.662592268986548,0,1,regulation of cell proliferation in midbrain,BP,
5943,GO:1904934,1,0.662592268986548,0,1,negative regulation of cell proliferation in midbrain,BP,
5944,GO:1904938,1,0.662592268986548,0,1,planar cell polarity pathway involved in axon guidance,BP,
5945,GO:1904948,1,0.449227785515024,0,3,midbrain dopaminergic neuron differentiation,BP,
5948,GO:1904953,1,0.449227785515024,0,3,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5949,GO:1904954,1,0.67993905092804,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5950,GO:1904955,1,0.662592268986548,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
5951,GO:1905005,1,0.775827451160419,0,1,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5952,GO:1905007,1,0.775827451160419,0,1,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5953,GO:1905037,1,0.817600888298876,0,1,autophagosome organization,BP,
5954,GO:1905039,1,0.781006884258256,0,1,carboxylic acid transmembrane transport,BP,
5955,GO:1905063,1,0.780266268444755,0,1,regulation of vascular smooth muscle cell differentiation,BP,
5956,GO:1905064,1,0.780266268444755,0,1,negative regulation of vascular smooth muscle cell differentiation,BP,
5957,GO:1905069,1,0.725126756103963,0,1,allantois development,BP,
5959,GO:1905174,1,0.780266268444755,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
5960,GO:1905176,1,0.780266268444755,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
5961,GO:1905207,1,0.279036537955911,0,5,regulation of cardiocyte differentiation,BP,
5962,GO:1905208,1,0.560750639775597,0,2,negative regulation of cardiocyte differentiation,BP,
5963,GO:1905209,1,0.501270678492504,0,3,positive regulation of cardiocyte differentiation,BP,
5964,GO:1905269,1,0.730053612763015,0,1,positive regulation of chromatin organization,BP,
5965,GO:1905276,1,0.620332209472358,0,2,regulation of epithelial tube formation,BP,
5966,GO:1905278,1,0.936826423682637,0,1,positive regulation of epithelial tube formation,BP,
5967,GO:1905314,1,0.318168911863837,0,4,semi-lunar valve development,BP,
5969,GO:1905331,1,0.406783891914529,0,3,negative regulation of morphogenesis of an epithelium,BP,
5970,GO:1905332,1,0.267992736320564,0,6,positive regulation of morphogenesis of an epithelium,BP,
5971,GO:1905383,1,0.855530641430602,0,1,protein localization to presynapse,BP,
5972,GO:1905384,1,0.855530641430602,0,1,regulation of protein localization to presynapse,BP,
5973,GO:1905386,1,0.855530641430602,0,1,positive regulation of protein localization to presynapse,BP,
5974,GO:1905438,1,0.662592268986548,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5975,GO:1905456,1,0.59183921579231,0,1,regulation of lymphoid progenitor cell differentiation,BP,
5976,GO:1905457,1,0.59183921579231,0,1,negative regulation of lymphoid progenitor cell differentiation,BP,
5977,GO:1905474,1,0.871622561621531,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
5979,GO:1905476,1,0.704992319915139,0,1,negative regulation of protein localization to membrane,BP,
5981,GO:1905651,1,0.421091420510704,0,2,regulation of artery morphogenesis,BP,
5982,GO:1905653,1,0.421091420510704,0,2,positive regulation of artery morphogenesis,BP,
5983,GO:1905666,1,0.727489805589545,0,1,regulation of protein localization to endosome,BP,
5984,GO:1905668,1,0.727489805589545,0,1,positive regulation of protein localization to endosome,BP,
5985,GO:1905710,1,0.839760482627469,0,1,positive regulation of membrane permeability,BP,
5986,GO:1905809,1,0.662592268986548,0,1,negative regulation of synapse organization,BP,
5987,GO:1905867,1,0.700420857160719,0,2,epididymis development,BP,
5988,GO:1905874,1,0.711185484621141,0,1,regulation of postsynaptic density organization,BP,
5989,GO:1905879,1,0.962412700305168,0,1,regulation of oogenesis,BP,
5990,GO:1905880,1,0.962412700305168,0,1,negative regulation of oogenesis,BP,
5996,GO:1905950,1,0.821374167469034,0,1,monosaccharide transmembrane transport,BP,
5997,GO:1905952,1,0.495478867338016,0,3,regulation of lipid localization,BP,
5998,GO:1905953,1,0.781006884258256,0,1,negative regulation of lipid localization,BP,
5999,GO:1905954,1,0.635734690589842,0,2,positive regulation of lipid localization,BP,
6000,GO:1990089,1,0.781006884258256,0,1,response to nerve growth factor,BP,
6001,GO:1990090,1,0.781006884258256,0,1,cellular response to nerve growth factor stimulus,BP,
6002,GO:1990124,1,0.528101695200463,0,2,messenger ribonucleoprotein complex,CC,
6003,GO:1990134,1,0.687227117442492,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
6004,GO:1990138,1,0.421921397674384,0,3,neuron projection extension,BP,
6007,GO:1990204,1,0.733962171685514,0,1,oxidoreductase complex,CC,
6011,GO:1990316,1,0.749336515652812,0,1,ATG1/ULK1 kinase complex,CC,
6013,GO:1990418,1,0.781006884258256,0,1,response to insulin-like growth factor stimulus,BP,
6017,GO:1990459,1,0.784501226927412,0,1,transferrin receptor binding,MF,
6019,GO:1990712,1,0.784501226927412,0,1,HFE-transferrin receptor complex,CC,
6020,GO:1990748,1,0.54248431734725,0,2,cellular detoxification,BP,
6021,GO:1990769,1,0.847146262734248,0,1,proximal neuron projection,CC,
6026,GO:1990837,1,0.619683391743963,0,2,sequence-specific double-stranded DNA binding,MF,
6028,GO:1990851,1,0.764312833898763,0,1,Wnt-Frizzled-LRP5/6 complex,CC,
6029,GO:1990874,1,0.780266268444755,0,1,vascular smooth muscle cell proliferation,BP,
6030,GO:1990904,1,0.528101695200463,0,2,ribonucleoprotein complex,CC,
6031,GO:1990909,1,0.67993905092804,0,2,Wnt signalosome,CC,
6032,GO:1990936,1,0.780266268444755,0,1,vascular smooth muscle cell dedifferentiation,BP,
6033,GO:1990967,1,0.852187479087815,0,1,multi-organism toxin transport,BP,
6034,GO:2000004,1,0.850452765079241,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
6035,GO:2000005,1,0.850452765079241,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
6036,GO:2000006,1,0.850452765079241,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
6037,GO:2000007,1,0.850452765079241,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
6040,GO:2000015,1,0.775827451160419,0,1,regulation of determination of dorsal identity,BP,
6041,GO:2000017,1,0.775827451160419,0,1,positive regulation of determination of dorsal identity,BP,
6043,GO:2000019,1,0.730656633467999,0,1,negative regulation of male gonad development,BP,
6045,GO:2000021,1,0.365241898065714,0,4,regulation of ion homeostasis,BP,
6048,GO:2000036,1,0.725126756103963,0,1,regulation of stem cell population maintenance,BP,
6050,GO:2000047,1,0.662592268986548,0,1,regulation of cell-cell adhesion mediated by cadherin,BP,
6051,GO:2000049,1,0.662592268986548,0,1,positive regulation of cell-cell adhesion mediated by cadherin,BP,
6052,GO:2000050,1,0.662592268986548,0,1,regulation of non-canonical Wnt signaling pathway,BP,
6053,GO:2000052,1,0.662592268986548,0,1,positive regulation of non-canonical Wnt signaling pathway,BP,
6054,GO:2000058,1,0.753597902783621,0,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
6055,GO:2000060,1,0.753597902783621,0,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
6058,GO:2000066,1,0.730656633467999,0,1,positive regulation of cortisol biosynthetic process,BP,
6059,GO:2000097,1,0.800794052075968,0,1,regulation of smooth muscle cell-matrix adhesion,BP,
6060,GO:2000105,1,0.652766003058323,0,2,positive regulation of DNA-dependent DNA replication,BP,
6063,GO:2000108,1,0.662592268986548,0,1,positive regulation of leukocyte apoptotic process,BP,
6068,GO:2000121,1,0.725126756103963,0,1,regulation of removal of superoxide radicals,BP,
6070,GO:2000136,1,0.502546403706452,0,2,regulation of cell proliferation involved in heart morphogenesis,BP,
6071,GO:2000137,1,0.850452765079241,0,1,negative regulation of cell proliferation involved in heart morphogenesis,BP,
6072,GO:2000138,1,0.850452765079241,0,1,positive regulation of cell proliferation involved in heart morphogenesis,BP,
6076,GO:2000177,1,0.22749454281432,0,4,regulation of neural precursor cell proliferation,BP,
6077,GO:2000178,1,0.546934498103791,0,2,negative regulation of neural precursor cell proliferation,BP,
6078,GO:2000179,1,0.59183921579231,0,1,positive regulation of neural precursor cell proliferation,BP,
6080,GO:2000191,1,0.646375496778584,0,2,regulation of fatty acid transport,BP,
6081,GO:2000192,1,0.781006884258256,0,1,negative regulation of fatty acid transport,BP,
6082,GO:2000193,1,0.828354528958696,0,1,positive regulation of fatty acid transport,BP,
6085,GO:2000209,1,0.234372916291433,0,4,regulation of anoikis,BP,
6086,GO:2000224,1,0.730656633467999,0,1,regulation of testosterone biosynthetic process,BP,
6087,GO:2000225,1,0.730656633467999,0,1,negative regulation of testosterone biosynthetic process,BP,
6091,GO:2000249,1,0.898270644003197,0,1,regulation of actin cytoskeleton reorganization,BP,
6092,GO:2000251,1,0.898270644003197,0,1,positive regulation of actin cytoskeleton reorganization,BP,
6095,GO:2000272,1,0.790066751337715,0,1,negative regulation of receptor activity,BP,
6098,GO:2000345,1,0.826619860236573,0,1,regulation of hepatocyte proliferation,BP,
6099,GO:2000346,1,0.826619860236573,0,1,negative regulation of hepatocyte proliferation,BP,
6105,GO:2000383,1,0.733087029820149,0,1,regulation of ectoderm development,BP,
6106,GO:2000384,1,0.733087029820149,0,1,negative regulation of ectoderm development,BP,
6107,GO:2000401,1,0.443538727301704,0,3,regulation of lymphocyte migration,BP,
6108,GO:2000403,1,0.61139307884054,0,2,positive regulation of lymphocyte migration,BP,
6109,GO:2000404,1,0.61139307884054,0,2,regulation of T cell migration,BP,
6110,GO:2000406,1,0.61139307884054,0,2,positive regulation of T cell migration,BP,
6113,GO:2000463,1,0.855530641430602,0,1,positive regulation of excitatory postsynaptic potential,BP,
6114,GO:2000479,1,0.600004405072497,0,2,regulation of cAMP-dependent protein kinase activity,BP,
6115,GO:2000480,1,0.801649544056734,0,1,negative regulation of cAMP-dependent protein kinase activity,BP,
6116,GO:2000482,1,0.662592268986548,0,1,regulation of interleukin-8 secretion,BP,
6117,GO:2000484,1,0.662592268986548,0,1,positive regulation of interleukin-8 secretion,BP,
6123,GO:2000542,1,0.733087029820149,0,1,negative regulation of gastrulation,BP,
6124,GO:2000573,1,0.780266268444755,0,1,positive regulation of DNA biosynthetic process,BP,
6125,GO:2000586,1,0.780266268444755,0,1,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6126,GO:2000587,1,0.780266268444755,0,1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6127,GO:2000589,1,0.780266268444755,0,1,regulation of metanephric mesenchymal cell migration,BP,
6128,GO:2000591,1,0.780266268444755,0,1,positive regulation of metanephric mesenchymal cell migration,BP,
6129,GO:2000628,1,0.898270644003197,0,1,regulation of miRNA metabolic process,BP,
6130,GO:2000630,1,0.898270644003197,0,1,positive regulation of miRNA metabolic process,BP,
6131,GO:2000637,1,0.850452765079241,0,1,positive regulation of gene silencing by miRNA,BP,
6132,GO:2000641,1,0.727489805589545,0,1,regulation of early endosome to late endosome transport,BP,
6133,GO:2000643,1,0.727489805589545,0,1,positive regulation of early endosome to late endosome transport,BP,
6135,GO:2000653,1,0.738574234795428,0,1,regulation of genetic imprinting,BP,
6138,GO:2000677,1,0.594280291489348,0,2,regulation of transcription regulatory region DNA binding,BP,
6139,GO:2000678,1,0.814984680586157,0,1,negative regulation of transcription regulatory region DNA binding,BP,
6140,GO:2000696,1,0.683588900267456,0,2,regulation of epithelial cell differentiation involved in kidney development,BP,
6141,GO:2000698,1,0.683588900267456,0,2,positive regulation of epithelial cell differentiation involved in kidney development,BP,
6142,GO:2000705,1,0.832024114860243,0,1,regulation of dense core granule biogenesis,BP,
6143,GO:2000707,1,0.832024114860243,0,1,positive regulation of dense core granule biogenesis,BP,
6144,GO:2000725,1,0.279036537955911,0,5,regulation of cardiac muscle cell differentiation,BP,
6145,GO:2000726,1,0.560750639775597,0,2,negative regulation of cardiac muscle cell differentiation,BP,
6146,GO:2000727,1,0.501270678492504,0,3,positive regulation of cardiac muscle cell differentiation,BP,
6147,GO:2000736,1,0.553999206166876,0,2,regulation of stem cell differentiation,BP,
6148,GO:2000737,1,0.59183921579231,0,1,negative regulation of stem cell differentiation,BP,
6149,GO:2000756,1,0.730053612763015,0,1,regulation of peptidyl-lysine acetylation,BP,
6150,GO:2000758,1,0.730053612763015,0,1,positive regulation of peptidyl-lysine acetylation,BP,
6151,GO:2000785,1,0.817600888298876,0,1,regulation of autophagosome assembly,BP,
6152,GO:2000786,1,0.817600888298876,0,1,positive regulation of autophagosome assembly,BP,
6153,GO:2000794,1,0.780622506963867,0,1,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
6154,GO:2000807,1,0.711185484621141,0,1,regulation of synaptic vesicle clustering,BP,
6155,GO:2000809,1,0.711185484621141,0,1,positive regulation of synaptic vesicle clustering,BP,
6157,GO:2000811,1,0.234372916291433,0,4,negative regulation of anoikis,BP,
6158,GO:2000820,1,0.814984680586157,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
6159,GO:2000826,1,0.29641875705714,0,4,regulation of heart morphogenesis,BP,
6160,GO:2000831,1,0.768189760920054,0,1,regulation of steroid hormone secretion,BP,
6161,GO:2000833,1,0.768189760920054,0,1,positive regulation of steroid hormone secretion,BP,
6162,GO:2000846,1,0.768189760920054,0,1,regulation of corticosteroid hormone secretion,BP,
6163,GO:2000848,1,0.768189760920054,0,1,positive regulation of corticosteroid hormone secretion,BP,
6164,GO:2000855,1,0.768189760920054,0,1,regulation of mineralocorticoid secretion,BP,
6165,GO:2000857,1,0.768189760920054,0,1,positive regulation of mineralocorticoid secretion,BP,
6166,GO:2000858,1,0.768189760920054,0,1,regulation of aldosterone secretion,BP,
6167,GO:2000860,1,0.768189760920054,0,1,positive regulation of aldosterone secretion,BP,
6168,GO:2000973,1,0.59183921579231,0,1,regulation of pro-B cell differentiation,BP,
6169,GO:2000974,1,0.59183921579231,0,1,negative regulation of pro-B cell differentiation,BP,
6172,GO:2001012,1,0.62078556105748,0,2,mesenchymal cell differentiation involved in renal system development,BP,
6173,GO:2001020,1,0.790230357008756,0,2,regulation of response to DNA damage stimulus,BP,
6174,GO:2001022,1,0.790230357008756,0,2,positive regulation of response to DNA damage stimulus,BP,
6175,GO:2001026,1,0.59183921579231,0,1,regulation of endothelial cell chemotaxis,BP,
6176,GO:2001027,1,0.59183921579231,0,1,negative regulation of endothelial cell chemotaxis,BP,
6177,GO:2001044,1,0.826619860236573,0,1,regulation of integrin-mediated signaling pathway,BP,
6178,GO:2001046,1,0.826619860236573,0,1,positive regulation of integrin-mediated signaling pathway,BP,
6179,GO:2001053,1,0.725126756103963,0,1,regulation of mesenchymal cell apoptotic process,BP,
6180,GO:2001054,1,0.725126756103963,0,1,negative regulation of mesenchymal cell apoptotic process,BP,
6182,GO:2001057,1,0.646375496778584,0,2,reactive nitrogen species metabolic process,BP,
6188,GO:2001204,1,0.755771665883275,0,1,regulation of osteoclast development,BP,
6189,GO:2001205,1,0.755771665883275,0,1,negative regulation of osteoclast development,BP,
6190,GO:2001212,1,0.814984680586157,0,1,regulation of vasculogenesis,BP,
6191,GO:2001233,1,0.208521667742477,0,8,regulation of apoptotic signaling pathway,BP,
6192,GO:2001234,1,0.328758797389089,0,6,negative regulation of apoptotic signaling pathway,BP,
6193,GO:2001235,1,0.640498978247275,0,2,positive regulation of apoptotic signaling pathway,BP,
6194,GO:2001236,1,0.378577590162364,0,6,regulation of extrinsic apoptotic signaling pathway,BP,
6195,GO:2001237,1,0.45212477384216,0,5,negative regulation of extrinsic apoptotic signaling pathway,BP,
6196,GO:2001238,1,0.839760482627469,0,1,positive regulation of extrinsic apoptotic signaling pathway,BP,
6197,GO:2001239,1,0.688074274624324,0,3,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
6198,GO:2001240,1,0.688074274624324,0,3,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
6199,GO:2001242,1,0.655311057413809,0,2,regulation of intrinsic apoptotic signaling pathway,BP,
6200,GO:2001243,1,0.781006884258256,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
6201,GO:2001244,1,0.839760482627469,0,1,positive regulation of intrinsic apoptotic signaling pathway,BP,
6202,GO:2001252,1,0.730053612763015,0,1,positive regulation of chromosome organization,BP,
6204,GO:2001258,1,0.790066751337715,0,1,negative regulation of cation channel activity,BP,
4539,GO:0060571,1,0.242137614341082,0,6,morphogenesis of an epithelial fold,BP,
4540,GO:0060572,1,0.242137614341082,0,6,morphogenesis of an epithelial bud,BP,
2216,GO:0031331,1,0.0558368582375493,0,10,positive regulation of cellular catabolic process,BP,
